data_2jmb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jmb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 73.0 Cg_exo . . . . . 0 N--CA 1.471 0.188 0 CA-C-O 120.753 0.23 . . . . 0.0 112.584 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.525 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 21.1 m-85 -146.43 -42.06 0.2 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 21' ' ' LEU . 19.2 t 60.51 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.211 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.556 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.5 147.46 4.85 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.274 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.32 96.92 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.029 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.661 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.06 107.42 19.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.799 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 16' ' ' ILE . 69.4 t -115.04 155.77 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.46 179.38 0.79 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.146 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.424 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . . . -79.86 -19.65 47.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.532 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.11 -28.52 11.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.669 0.271 . . . . 0.0 110.916 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.45 26.26 14.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.991 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -31.04 46.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.465 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.01 155.51 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.481 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' N ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -136.32 138.82 42.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.831 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.9 tt0 -125.76 111.95 15.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.639 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.76 127.2 39.36 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 111.563 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.3 mt -92.12 114.09 26.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.29 156.42 88.29 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.92 -17.15 58.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.506 2.804 . . . . 0.0 112.545 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.37 23.98 6.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.0 54.36 21.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.876 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.2 mmm-85 -143.32 -179.74 6.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.632 0.253 . . . . 0.0 111.334 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.472 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.14 149.97 48.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.432 0.634 . . . . 0.0 112.558 -178.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.32 111.72 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.34 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.25 134.62 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.376 0.608 . . . . 0.0 111.972 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.13 105.37 10.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.09 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.431 ' HD2' ' CG2' ' A' ' 16' ' ' ILE . 14.7 mtm-85 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.775 0.322 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 153.88 38.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 111.882 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.29 149.83 15.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.82 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.82 -120.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.17 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.16 164.18 38.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 4.4 p90 -139.39 156.89 46.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.529 0.68 . . . . 0.0 112.219 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 2.8 tt0 -120.39 127.34 52.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.857 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 72.0 t -104.39 127.98 58.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.149 0.5 . . . . 0.0 112.038 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -139.51 99.76 3.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.93 42.83 96.96 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.289 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.77 -7.32 1.42 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.487 0.315 . . . . 0.0 111.664 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.8 125.65 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -136.54 145.99 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.273 0.558 . . . . 0.0 112.158 -178.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.495 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.55 145.3 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.746 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.9 m-85 -96.81 117.11 30.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.88 -0.146 . . . . 0.0 110.867 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.423 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.5 t90 -109.22 90.95 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 109.887 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.441 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.16 155.57 40.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.85 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.21 -12.67 52.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.0 t -90.01 24.76 2.33 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.806 0.336 . . . . 0.0 111.843 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.55 60.72 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -121.38 163.64 18.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.042 0.921 . . . . 0.0 109.904 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.63 141.3 14.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.848 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' ASN . . . -126.68 178.42 5.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.132 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.8 p30 -146.77 147.25 30.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.383 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.34 -175.12 35.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.176 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -168.17 129.49 1.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -67.5 110.34 3.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 110.857 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 69' ' ' HIS . 2.0 m -84.35 -18.59 9.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.189 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 -168.13 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 110.835 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.57 -27.19 29.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.24 0.1 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -107.02 148.51 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.876 0.369 . . . . 0.0 110.874 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.611 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -132.13 142.64 49.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.345 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.431 ' CD2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.57 107.79 10.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.27 136.42 26.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.816 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.4 22.0 43.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 26.13 58.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.4 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.35 165.18 13.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.945 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.1 m -118.52 107.41 13.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.581 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.4 m-85 -109.63 128.06 54.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.487 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 12' ' ' ALA . 13.9 m-85 -103.95 146.3 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.518 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 2.0 tpp85 -72.88 135.34 45.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.089 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 113.403 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 38.6 Cg_exo . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.552 0.147 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 10.0 m-85 -145.91 -43.88 0.21 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.169 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 21' ' ' LEU . 24.2 t 61.86 130.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.961 0.41 . . . . 0.0 110.993 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.596 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.98 146.93 4.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.307 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.18 98.66 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.423 0.63 . . . . 0.0 110.293 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.635 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.0 m95 -91.32 106.82 18.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.627 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 16' ' ' ILE . 73.8 t -112.78 155.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.147 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.403 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -68.14 176.33 2.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.298 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.74 -19.56 57.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.681 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -26.13 13.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.708 0.29 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.02 23.71 29.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.154 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.403 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.76 -29.51 58.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.054 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -140.59 156.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.519 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -137.5 132.51 33.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.837 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.5 tt0 -120.17 112.5 19.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.03 127.46 38.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.401 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.635 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.5 mt -92.95 110.21 21.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -62.75 156.18 66.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.444 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.0 Cg_exo -64.11 -16.84 57.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.495 2.796 . . . . 0.0 112.538 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -96.27 23.41 6.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.93 52.84 26.23 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.882 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mmt85 -141.58 -179.81 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 111.327 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -136.9 149.23 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.354 0.597 . . . . 0.0 112.54 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.43 111.61 5.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.346 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.7 tt0 -104.25 134.04 48.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.373 0.606 . . . . 0.0 112.196 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.87 105.2 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.868 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.545 -179.151 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.928 0.394 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.22 141.56 23.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.46 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.5 149.89 29.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.827 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.96 -121.0 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.158 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.19 38.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.452 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 5.5 p90 -137.32 155.29 49.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.382 0.61 . . . . 0.0 112.116 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -119.91 127.14 52.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.195 178.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.489 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 55.1 t -102.65 129.99 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 111.942 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 87.44 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.73 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 65.53 44.0 93.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.326 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 85.2 -13.14 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.516 0.326 . . . . 0.0 111.606 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.94 128.81 40.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -143.71 153.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.176 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.505 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.8 150.12 52.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 57' ' ' THR . 46.5 m-85 -99.95 116.6 32.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.165 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -109.14 90.16 3.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 0.0 109.977 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.461 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.57 158.78 28.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.16 -12.7 52.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.009 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.3 t -91.13 25.06 2.61 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.908 0.385 . . . . 0.0 111.817 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 25.92 60.9 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.541 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.75 163.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.936 0.868 . . . . 0.0 109.989 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.35 142.5 12.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.867 178.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.57 121.52 12.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.598 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 16.2 p30 -90.27 152.29 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -150.68 -163.8 11.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.133 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -168.08 132.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.46 ' CZ ' HG22 ' A' ' 48' ' ' ILE . 7.9 m-30 -77.48 110.19 12.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.744 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.4 m -85.01 -10.71 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.477 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -160.46 -176.07 5.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.867 0.365 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.13 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.056 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.69 4.13 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.572 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.0 tt0 -106.72 145.28 32.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.398 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.91 143.88 50.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.645 -179.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 73' ' ' MET . 2.6 m170 -126.32 110.01 12.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.44 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.95 135.13 30.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.641 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 23.12 21.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.286 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.61 65.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.696 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.14 163.63 13.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.921 0.391 . . . . 0.0 111.024 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -117.11 107.69 14.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.946 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.643 ' HB2' HD11 ' A' ' 68' ' ' LEU . 32.3 m-85 -109.17 120.97 44.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.42 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.38 141.95 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -71.16 142.53 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.863 0.363 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 124.743 1.217 . . . . 0.0 113.284 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 48.1 Cg_exo . . . . . 0 N--CA 1.471 0.169 0 CA-C-O 120.767 0.236 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 16.6 m-85 -145.21 -42.5 0.23 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.914 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 21' ' ' LEU . 19.9 t 60.7 129.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.999 0.428 . . . . 0.0 111.329 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.06 146.73 4.56 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.34 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.45 97.01 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.534 0.683 . . . . 0.0 110.074 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.645 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.588 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 16' ' ' ILE . 78.0 t -114.01 155.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.397 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.5 176.12 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.083 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.402 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -77.56 -19.43 55.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.445 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.65 -23.1 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.47 20.35 48.65 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.336 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -24.3 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 110.395 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.465 HD12 ' HG3' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -146.56 156.71 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.451 179.35 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -138.48 131.34 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.6 tt0 -119.24 114.33 22.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -94.66 127.37 40.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.584 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.645 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.8 mt -92.12 113.02 25.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.46 156.61 85.28 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -175.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.37 -17.57 60.67 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.509 2.806 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -96.01 23.45 6.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 52.86 28.97 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.032 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 41.7 mmt-85 -141.27 -179.97 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.582 0.229 . . . . 0.0 111.276 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.06 149.35 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.413 0.625 . . . . 0.0 112.538 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.55 112.75 5.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -104.51 133.82 48.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.292 0.568 . . . . 0.0 112.205 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.79 105.29 11.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.981 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.415 ' HD2' ' CG2' ' A' ' 16' ' ' ILE . 18.3 mtm-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.347 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.089 0 CA-C-O 121.022 0.439 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 140.82 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.69 149.71 28.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.19 -122.1 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.824 -1.179 . . . . 0.0 113.115 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.1 163.77 39.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 6.7 p90 -138.44 155.12 48.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.521 0.677 . . . . 0.0 112.192 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -119.98 127.24 52.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.891 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 73.1 t -104.73 130.89 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 112.124 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -141.75 98.14 3.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.79 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.69 43.61 97.63 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.298 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.12 -7.58 1.34 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.426 0.291 . . . . 0.0 111.543 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.414 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 125.25 38.24 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -135.02 148.33 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.225 0.536 . . . . 0.0 112.148 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.33 144.3 49.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.881 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.8 m-85 -100.2 115.14 29.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.065 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -109.06 90.51 3.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -67.09 158.69 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.652 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -85.07 -12.71 52.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.176 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.67 25.05 2.83 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.774 0.321 . . . . 0.0 111.726 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.7 25.24 60.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.546 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.2 164.12 15.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.013 0.906 . . . . 0.0 109.971 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.45 11.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.98 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.62 121.82 13.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.509 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 7.0 p-10 -90.3 155.63 18.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.975 0.417 . . . . 0.0 111.454 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.25 -170.71 28.53 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.076 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.3 p30 -168.32 133.74 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 111.227 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 48' ' ' ILE . 8.9 m-30 -72.76 110.5 7.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 m -82.53 -18.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.168 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.59 -169.43 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.22 -28.14 32.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.22 -0.25 9.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -106.92 146.79 30.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.931 0.396 . . . . 0.0 110.726 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.615 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -130.91 142.0 50.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.371 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.407 ' N ' HD11 ' A' ' 68' ' ' LEU . 4.3 m170 -126.38 107.9 10.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.759 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.64 135.41 26.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.87 21.52 44.77 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.048 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 23.78 60.53 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.49 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -114.71 164.87 13.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 m -118.37 107.35 13.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.981 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.607 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.1 m-85 -109.64 127.31 54.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 11.1 m-85 -104.66 145.12 30.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.482 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -70.73 139.5 51.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.504 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 C-N-CA 124.73 1.212 . . . . 0.0 113.155 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 32.2 Cg_exo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.659 0.191 . . . . 0.0 112.13 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 7.1 m-85 -146.81 -44.2 0.18 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.167 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 21' ' ' LEU . 21.3 t 61.86 129.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.99 0.424 . . . . 0.0 111.145 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.602 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.12 146.24 4.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.301 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.09 96.67 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.462 0.648 . . . . 0.0 109.932 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.649 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 25.7 m95 -86.57 107.79 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.418 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.6 t -113.56 155.33 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.755 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.415 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.51 -175.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.02 -20.25 33.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.42 -26.54 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.732 0.301 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.29 26.1 16.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.018 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -77.46 -29.12 52.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.469 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 154.67 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.407 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.421 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -137.56 133.51 34.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.926 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.5 tt0 -119.69 113.08 20.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.528 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -92.51 126.47 37.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.107 0.479 . . . . 0.0 111.551 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.649 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.0 mt -92.56 112.3 24.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.09 157.3 85.37 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.9 Cg_exo -64.33 -13.96 41.26 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.338 2.692 . . . . 0.0 111.929 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -93.45 20.0 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.98 50.05 63.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.6 mmt180 -137.65 -179.92 6.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.889 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.86 149.93 47.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.19 111.09 4.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.507 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -102.88 133.39 48.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.331 0.586 . . . . 0.0 111.91 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.32 105.42 10.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.351 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.997 -179.563 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.823 0.344 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -149.59 152.77 36.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.178 0.513 . . . . 0.0 111.578 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.46 149.4 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.804 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -120.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 163.97 39.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.446 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 4.3 p90 -137.26 155.65 49.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.441 0.638 . . . . 0.0 112.085 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.0 tt0 -119.97 127.19 52.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.128 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.492 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 49.2 t -102.7 129.65 53.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.426 . . . . 0.0 112.025 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -136.82 82.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 68.22 44.76 74.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.272 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 85.55 -13.14 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.6 0.36 . . . . 0.0 111.497 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.88 126.05 38.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -143.03 152.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.234 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.492 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.85 151.14 51.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.783 178.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.6 m-85 -100.32 116.45 32.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.158 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.0 t90 -109.1 90.41 3.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.007 0.432 . . . . 0.0 109.907 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.464 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.62 158.36 32.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.743 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -85.16 -12.75 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.858 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -91.08 25.23 2.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.85 0.357 . . . . 0.0 111.755 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.7 26.3 61.08 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.505 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.16 163.86 17.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.928 0.864 . . . . 0.0 109.866 179.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.68 142.4 12.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.975 178.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.52 121.56 12.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.677 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 31.3 p-10 -90.37 152.08 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.397 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -153.52 -167.49 15.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.034 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.431 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.11 131.93 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.7 m-30 -77.05 110.24 11.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 69' ' ' HIS . 3.7 m -84.84 -14.29 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.32 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.73 177.93 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.82 -27.95 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.08 -2.62 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.593 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -106.94 141.92 37.38 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.899 0.38 . . . . 0.0 110.733 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -128.18 142.97 51.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.536 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.42 ' CD2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.64 108.02 10.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.786 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.83 137.01 29.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.668 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.35 22.75 38.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.122 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.55 25.23 61.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.373 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.3 165.12 13.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.1 m -117.9 107.57 14.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.147 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.62 ' HB2' HD13 ' A' ' 68' ' ' LEU . 31.9 m-85 -110.12 123.37 49.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 8.3 m-85 -102.95 140.34 37.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.475 ' O ' ' C ' ' A' ' 78' ' ' GLU . 3.8 tpp180 -54.06 148.21 11.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.931 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.3 mt-10 . . . . . 0 N--CA 1.47 0.525 0 O-C-N 124.388 1.055 . . . . 0.0 112.564 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 72.0 Cg_exo . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.805 0.252 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.506 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 15.3 m-85 -144.88 -42.34 0.24 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.2 t 60.32 129.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.022 0.439 . . . . 0.0 111.3 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.24 146.63 4.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -93.84 96.93 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.084 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.657 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.1 m95 -89.54 107.48 19.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.695 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.1 t -113.95 155.59 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.329 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.405 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.72 1.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.104 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -79.6 -19.36 49.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.515 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.45 -26.16 12.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.995 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.04 24.83 26.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.221 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -77.13 -28.35 54.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.462 HD13 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.17 155.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.435 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -136.89 133.09 35.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.863 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.1 tt0 -121.47 113.2 19.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -94.46 128.45 41.04 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.059 0.457 . . . . 0.0 111.513 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.657 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.3 mt -92.58 113.26 25.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 156.34 86.66 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -64.0 -17.01 58.12 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.556 2.838 . . . . 0.0 112.49 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.58 24.08 6.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 110.759 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.11 54.13 22.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.92 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.0 mmm-85 -143.37 -179.93 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.593 0.235 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.72 149.2 47.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.6 . . . . 0.0 112.407 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.53 112.45 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.487 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -104.17 131.54 51.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.288 0.566 . . . . 0.0 111.907 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.4 105.21 11.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.635 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 144.33 24.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.729 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.95 149.81 26.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.25 -120.95 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.099 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 5.3 p90 -138.56 155.75 48.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.414 0.626 . . . . 0.0 112.323 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.99 127.21 52.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.717 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.506 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 78.0 t -104.98 130.46 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.173 0.511 . . . . 0.0 112.083 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -142.05 99.87 3.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.784 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.85 43.34 96.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.287 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.59 -7.03 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.47 0.308 . . . . 0.0 111.67 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.82 125.73 38.6 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.97 148.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.273 0.559 . . . . 0.0 112.153 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.43 144.13 49.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.891 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -99.6 114.79 28.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.12 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -108.97 90.29 3.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.025 0.44 . . . . 0.0 109.865 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.63 159.1 28.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.653 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -85.1 -12.65 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.987 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -91.58 25.51 2.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.809 0.337 . . . . 0.0 111.612 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.19 26.52 61.67 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.097 -0.573 . . . . 0.0 114.478 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.96 164.26 15.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.858 0.829 . . . . 0.0 109.831 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.13 142.65 11.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 178.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.52 121.71 13.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.515 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.5 p30 -89.61 155.43 19.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -162.48 -171.42 28.62 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 6.9 p-10 -168.12 133.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 111.285 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.472 ' CE1' HG22 ' A' ' 48' ' ' ILE . 9.0 m-30 -72.99 110.34 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.104 0.478 . . . . 0.0 110.716 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.44 HG12 ' CD2' ' A' ' 69' ' ' HIS . 3.1 m -82.64 -18.09 10.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.356 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -148.68 -169.13 3.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.351 . . . . 0.0 110.958 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.79 -30.2 32.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.67 1.34 10.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.485 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.0 147.93 29.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.921 0.391 . . . . 0.0 110.581 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.611 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -133.17 144.22 49.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.414 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.44 ' CD2' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.48 108.92 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.433 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.33 135.86 32.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.582 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.95 23.78 17.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.177 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.23 67.25 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.31 164.18 12.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.026 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.407 HG21 ' CZ ' ' A' ' 76' ' ' TYR . 4.4 m -117.23 107.63 14.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.07 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.598 ' HB2' HD13 ' A' ' 68' ' ' LEU . 31.2 m-85 -109.48 127.13 54.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.355 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.411 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 9.5 m-85 -105.16 143.58 33.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.402 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -68.18 140.68 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 124.569 1.148 . . . . 0.0 112.955 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 46.2 Cg_exo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.718 0.216 . . . . 0.0 112.279 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.509 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 5.3 m-85 -145.64 -44.81 0.21 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.941 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.0 t 62.24 129.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.188 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.596 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 153.87 146.14 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.388 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.71 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.411 0.624 . . . . 0.0 109.856 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.637 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.6 m95 -86.38 108.47 18.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.381 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.32 155.7 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.778 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.68 -175.16 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.331 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.0 -20.45 32.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.05 -25.48 12.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.828 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.59 23.21 24.34 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.315 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -26.87 60.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.742 0.306 . . . . 0.0 110.271 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.504 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -143.67 157.7 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.345 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -140.27 138.33 34.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.6 tt0 -125.44 112.91 16.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.66 126.67 36.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 111.669 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.4 mt -92.91 111.66 23.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.06 156.32 81.07 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.9 -17.22 58.97 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.467 2.778 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.7 22.9 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.27 52.54 26.51 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.843 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.7 mmt85 -140.94 -179.81 6.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.562 0.22 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.477 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -137.0 150.36 48.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.41 0.624 . . . . 0.0 112.459 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.16 110.74 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.0 tt0 -103.3 132.48 49.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.415 0.626 . . . . 0.0 111.895 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.58 105.16 10.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.352 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 4.4 mtm180 . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.051 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.798 0.332 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.409 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -151.0 153.48 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.038 0.447 . . . . 0.0 111.754 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.477 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.82 148.92 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.045 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.98 -121.82 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.982 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.14 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 3.2 p90 -138.09 157.64 45.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.355 0.597 . . . . 0.0 112.284 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.38 127.21 49.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.087 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 29.8 t -101.07 135.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.209 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -141.45 82.86 1.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.492 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 68.38 44.7 72.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.223 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 86.04 -14.4 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.551 0.34 . . . . 0.0 111.539 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.87 127.56 39.69 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -141.48 149.54 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.471 0.653 . . . . 0.0 112.516 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 4.5 t-20 -117.69 166.81 11.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.94 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 57' ' ' THR . 72.2 m-85 -125.22 113.07 17.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.597 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -109.0 91.67 3.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 110.058 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.4 159.18 29.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.642 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.98 -12.81 52.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.216 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -91.53 25.64 2.57 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.841 0.353 . . . . 0.0 111.681 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.13 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.378 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.84 164.27 15.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.842 0.821 . . . . 0.0 109.903 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.47 142.32 11.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.7 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -149.07 125.89 11.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.847 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.2 p30 -92.92 152.79 19.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.417 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.22 15.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.074 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -168.07 132.7 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 0.0 111.274 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.426 ' CZ ' HG23 ' A' ' 48' ' ' ILE . 6.5 m-30 -79.64 110.33 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.48 -19.69 12.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.304 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -150.2 -175.64 5.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.27 57.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.064 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.69 -2.64 11.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.439 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -106.92 144.4 33.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.963 0.411 . . . . 0.0 110.643 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.607 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -130.54 143.98 51.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.509 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.425 ' N ' HD12 ' A' ' 68' ' ' LEU . 3.3 m170 -126.36 108.91 11.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.841 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 136.93 32.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.56 23.5 14.26 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.138 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.21 67.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.729 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.46 164.06 12.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.011 0.405 . . . . 0.0 111.064 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -116.46 107.64 15.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.607 ' HB2' HD13 ' A' ' 68' ' ' LEU . 24.7 m-85 -110.0 123.58 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.403 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.8 m-85 -101.2 140.91 34.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -58.31 147.51 30.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.226 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.6 mt-10 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 124.674 1.19 . . . . 0.0 113.071 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 50.3 Cg_exo . . . . . 0 N--CA 1.47 0.138 0 CA-C-O 120.773 0.239 . . . . 0.0 112.631 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.51 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 14.6 m-85 -145.49 -42.46 0.22 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.798 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 21' ' ' LEU . 20.5 t 60.57 128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.206 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.555 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.14 147.51 4.89 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.27 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.75 96.77 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.396 0.617 . . . . 0.0 110.009 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.2 m95 -88.88 108.59 19.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.8 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.9 t -116.42 155.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.402 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.44 -178.29 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.139 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . . . -81.84 -19.54 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.475 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.74 -27.2 11.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.72 0.295 . . . . 0.0 110.933 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 26.21 16.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.192 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.402 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -78.33 -29.32 47.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.353 . . . . 0.0 110.106 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.498 HD13 ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -139.45 157.3 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 4.2 ttp-105 -137.81 141.73 40.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.884 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.4 tt0 -131.01 111.92 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.594 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -94.76 127.71 40.95 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.047 0.451 . . . . 0.0 111.655 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.669 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.3 mt -91.89 114.01 26.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.3 156.53 88.06 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.57 -17.41 59.87 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.47 2.78 . . . . 0.0 112.498 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.22 23.75 6.32 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.842 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.09 53.95 23.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.905 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 4.5 mmm-85 -142.99 -179.76 6.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 0.0 111.251 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.42 149.72 48.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.396 0.617 . . . . 0.0 112.543 -178.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 112.02 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.435 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -104.03 132.36 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.353 0.597 . . . . 0.0 111.958 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.44 105.18 10.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.782 0.325 . . . . 0.0 111.636 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.41 153.58 36.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.187 0.518 . . . . 0.0 111.672 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.463 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.92 149.48 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.818 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.78 -120.32 0.54 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 119.691 -1.243 . . . . 0.0 113.075 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.14 164.18 38.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.503 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 4.8 p90 -139.7 154.72 47.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 112.354 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.9 127.34 52.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.824 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.51 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 78.2 t -104.15 131.37 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 112.078 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -142.72 100.48 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.741 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.26 42.84 95.64 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.369 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.98 -7.98 1.33 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 122.514 0.326 . . . . 0.0 111.703 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.82 127.19 39.43 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -136.97 148.65 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.194 0.521 . . . . 0.0 112.153 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.531 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.72 143.83 49.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.878 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 57' ' ' THR . 45.5 m-85 -98.95 114.66 27.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.037 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -109.03 90.25 3.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.929 0.395 . . . . 0.0 109.94 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.94 158.46 30.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.91 -12.81 52.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.981 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.1 t -91.38 25.14 2.68 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.848 0.356 . . . . 0.0 111.73 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.74 26.52 60.57 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.932 -0.651 . . . . 0.0 114.425 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.86 163.91 16.82 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.915 0.858 . . . . 0.0 109.935 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.37 142.37 12.77 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.882 178.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.34 121.74 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.477 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.49 156.08 19.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.085 0.469 . . . . 0.0 111.402 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.1 -174.76 35.13 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.4 p-10 -168.14 132.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.38 . . . . 0.0 111.328 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.42 110.29 5.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.716 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 m -82.31 -19.2 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.253 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -147.25 -168.68 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.77 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.197 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.94 -0.08 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.579 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -106.93 147.23 30.07 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.6 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -130.6 142.84 50.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 -179.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -126.19 107.8 10.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.213 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.96 137.72 25.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.691 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.69 22.26 39.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.915 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.63 23.39 64.84 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.368 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.02 164.45 14.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.217 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -117.03 107.5 14.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.54 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.6 ' HB2' HD11 ' A' ' 68' ' ' LEU . 22.0 m-85 -110.67 127.43 55.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 12' ' ' ALA . 15.2 m-85 -102.69 146.04 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.481 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.449 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 1.5 tpp85 -73.07 136.87 45.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.955 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 124.688 1.195 . . . . 0.0 113.266 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 77.5 Cg_exo . . . . . 0 N--CA 1.471 0.196 0 CA-C-O 120.827 0.261 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 22.2 m-85 -146.26 -41.71 0.2 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 21' ' ' LEU . 19.2 t 60.53 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.57 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.62 146.58 4.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.79 96.93 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.496 0.665 . . . . 0.0 110.133 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.648 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 18.8 m95 -89.52 107.32 19.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.601 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 16' ' ' ILE . 79.6 t -113.28 155.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.401 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.76 172.75 5.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.193 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.77 -19.47 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.7 -25.95 13.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.94 24.14 36.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.151 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -26.07 44.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.279 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.508 HG22 ' HD2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -141.64 156.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.281 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -139.16 130.97 27.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.962 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 2.4 tt0 -117.64 112.67 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -93.74 127.33 39.41 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.648 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.1 mt -92.48 113.97 26.4 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.46 156.75 87.82 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -175.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.465 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.9 -17.18 58.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.448 2.765 . . . . 0.0 112.499 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.7 24.23 6.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.08 53.52 25.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.94 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.4 mmt85 -142.22 -179.78 6.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.649 0.261 . . . . 0.0 111.438 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.23 148.65 48.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.26 0.552 . . . . 0.0 112.424 -178.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 109.65 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.9 tt0 -102.9 134.29 46.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.396 0.617 . . . . 0.0 112.134 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.11 105.29 12.11 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.063 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HD2' HG22 ' A' ' 16' ' ' ILE . 6.5 mtm180 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.385 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.941 0.4 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 142.23 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.45 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -150.94 150.35 30.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.845 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.55 -122.73 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.037 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -154.14 164.05 39.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 4.0 p90 -138.73 157.34 46.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.612 0.72 . . . . 0.0 112.221 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -120.73 127.27 51.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.834 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.527 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 81.0 t -104.59 128.77 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 112.133 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.93 98.61 3.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.69 43.21 97.98 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.232 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.76 -6.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.458 0.303 . . . . 0.0 111.608 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.75 125.33 38.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -135.15 148.05 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.292 0.567 . . . . 0.0 111.995 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.544 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -134.9 145.24 48.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.675 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.7 m-85 -97.47 117.03 30.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.007 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.429 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.2 t90 -109.32 90.9 3.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.996 0.427 . . . . 0.0 109.953 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.61 155.64 40.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.742 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.35 -12.62 51.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.088 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -90.85 24.18 2.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 0.0 111.918 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.6 22.43 60.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.32 163.48 17.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.224 1.012 . . . . 0.0 109.893 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.89 141.29 14.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.897 178.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.21 178.37 6.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 22.5 p-10 -147.07 148.8 32.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.112 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -166.13 -174.09 35.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.329 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -168.12 129.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 48' ' ' ILE . 5.9 m-30 -68.58 110.5 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.48 . . . . 0.0 110.81 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.415 HG11 ' CD2' ' A' ' 69' ' ' HIS . 2.5 m -85.81 -17.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.273 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -148.37 -168.05 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.82 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.63 -26.92 29.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 0.97 7.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -107.18 146.54 31.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.61 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -130.53 142.88 50.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.415 ' CD2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.63 107.85 10.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.02 135.99 26.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.711 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.31 22.13 43.04 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.029 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.29 23.85 62.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.487 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.64 13.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.901 0.381 . . . . 0.0 111.017 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 m -118.17 107.43 13.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.874 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.6 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.3 m-85 -109.33 126.26 53.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.309 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -103.36 145.45 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.491 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -71.87 137.65 47.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.69 -179.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.426 0 C-N-CA 124.671 1.188 . . . . 0.0 113.354 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 61.1 Cg_exo . . . . . 0 N--CA 1.471 0.152 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 17.1 m-85 -146.43 -43.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 21' ' ' LEU . 17.4 t 60.74 129.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.285 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.561 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.69 146.95 4.65 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.418 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.79 96.96 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.518 0.675 . . . . 0.0 110.15 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.667 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.6 m95 -89.08 107.82 19.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.571 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.99 155.29 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.466 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.409 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.28 176.76 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.245 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.91 -19.95 53.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.36 -25.19 13.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.012 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.41 23.79 33.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.204 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.56 -27.23 55.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.85 0.357 . . . . 0.0 110.128 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.505 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -141.95 154.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.388 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.32 132.73 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 21.6 tt0 -121.82 114.13 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.891 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -93.34 128.55 39.41 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.514 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.4 mt -93.26 113.69 25.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 158.13 80.47 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.464 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.8 Cg_exo -63.26 -18.79 66.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.586 2.858 . . . . 0.0 112.868 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.66 20.92 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.741 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.37 51.27 27.66 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.382 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 87.5 mmt-85 -137.17 -179.81 5.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.599 -0.3 . . . . 0.0 110.927 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.6 152.32 50.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.426 0.632 . . . . 0.0 112.512 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.01 110.6 4.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.425 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -103.12 134.09 47.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 112.102 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.26 105.1 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.969 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.502 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.906 0.384 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.06 141.61 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.504 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.459 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.42 149.86 29.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.5 -122.46 0.64 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.912 -1.137 . . . . 0.0 113.088 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.03 164.18 38.87 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.489 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.6 p90 -138.45 156.73 47.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.537 0.684 . . . . 0.0 112.317 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -120.21 127.35 52.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.953 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 77.2 t -104.06 126.82 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 111.952 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -136.38 92.34 2.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 63.2 43.3 98.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.199 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 83.98 -10.25 0.93 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 122.558 0.343 . . . . 0.0 111.706 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.9 125.59 38.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -139.43 147.28 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.184 0.516 . . . . 0.0 112.263 -179.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -129.23 146.56 51.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.642 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 57' ' ' THR . 42.8 m-85 -97.08 118.26 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.38 0.133 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.411 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 30.4 t90 -109.47 91.29 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.145 0.498 . . . . 0.0 110.003 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.21 155.1 41.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.744 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.2 -12.65 52.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.055 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 t -90.17 23.52 2.83 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.885 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.45 22.32 58.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -121.05 162.73 19.48 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.251 1.026 . . . . 0.0 110.048 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.78 140.71 16.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.748 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 49' ' ' ASN . . . -125.66 178.47 5.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.4 p-10 -145.73 145.87 31.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -176.96 33.84 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.355 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.0 p-10 -168.1 123.62 1.0 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.059 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 4.9 m-30 -64.96 110.15 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 69' ' ' HIS . 2.8 m -83.48 -19.2 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.246 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.47 -166.33 2.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.4 -29.18 26.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.208 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.83 1.12 9.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.604 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -107.02 149.52 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.883 0.373 . . . . 0.0 110.705 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.61 144.53 49.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.437 ' CD2' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.4 108.24 11.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.413 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.45 134.96 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.61 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.22 23.55 18.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.16 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.72 66.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.698 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.35 163.87 12.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.956 0.407 . . . . 0.0 111.093 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 m -116.74 107.75 15.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.894 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.616 ' HB2' HD13 ' A' ' 68' ' ' LEU . 27.2 m-85 -109.78 127.57 54.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -103.7 145.96 29.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.26 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.463 ' CZ ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -72.56 137.87 46.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.916 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 124.753 1.221 . . . . 0.0 113.249 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 52.2 Cg_exo . . . . . 0 N--CA 1.47 0.128 0 CA-C-O 120.77 0.238 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.523 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 12.3 m-85 -143.29 -43.78 0.29 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.715 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 21' ' ' LEU . 21.1 t 60.6 129.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.572 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.9 147.37 4.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.273 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.23 96.88 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.582 0.706 . . . . 0.0 110.151 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.655 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.5 m95 -89.25 106.63 18.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.707 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 16' ' ' ILE . 74.8 t -113.67 155.76 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.267 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.67 178.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.129 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -79.09 -19.62 50.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -27.19 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.73 24.38 23.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.077 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -31.62 58.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 109.956 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.474 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -138.34 155.89 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.455 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.408 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -137.44 132.27 33.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.678 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.6 tt0 -120.32 112.61 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -93.2 127.6 38.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.539 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.655 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.2 mt -92.51 112.79 24.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.89 156.29 84.13 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.3 Cg_exo -63.68 -17.27 59.22 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.569 2.846 . . . . 0.0 112.514 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.09 23.71 6.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 53.45 25.73 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.882 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.9 mmm-85 -143.11 -179.78 6.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.457 0.17 . . . . 0.0 111.42 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.29 149.85 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.438 0.637 . . . . 0.0 112.639 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.92 111.89 5.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.358 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.43 135.65 45.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.394 0.616 . . . . 0.0 112.16 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.16 105.35 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.972 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.433 -179.236 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.016 0 CA-C-O 120.898 0.38 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 149.89 31.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.457 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.96 149.72 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.96 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.7 -121.59 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 119.826 -1.178 . . . . 0.0 112.926 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.01 162.72 40.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 5.5 p90 -136.86 155.52 49.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.381 0.61 . . . . 0.0 112.094 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.65 127.17 52.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.167 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 55.7 t -103.46 129.21 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.108 0.48 . . . . 0.0 111.973 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.31 94.34 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.653 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 61.66 42.81 99.82 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.259 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 84.17 -11.57 0.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.392 0.277 . . . . 0.0 111.725 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 128.96 40.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -143.85 153.43 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.225 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.522 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.37 151.0 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.907 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 57' ' ' THR . 51.3 m-85 -101.79 115.89 31.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.414 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 87.9 t90 -109.11 90.55 3.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.019 0.438 . . . . 0.0 110.12 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.62 158.84 28.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.778 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.14 -12.71 52.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.01 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.7 t -91.38 25.2 2.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.871 0.367 . . . . 0.0 111.72 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.19 25.73 61.15 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.014 -0.613 . . . . 0.0 114.505 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.02 163.71 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.044 0.922 . . . . 0.0 109.935 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.19 142.37 11.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.121 178.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.46 121.56 12.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.462 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -90.97 153.13 20.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 0.0 111.441 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -154.13 -164.92 13.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.223 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -168.09 133.31 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.042 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 8.7 m-30 -76.63 110.31 11.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.25 -10.17 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.043 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.85 156.51 11.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.824 0.345 . . . . 0.0 110.611 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.27 32.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.552 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -119.06 -10.53 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.853 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -106.66 147.84 29.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.633 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.16 143.23 49.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.289 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -126.45 108.78 11.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.847 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.529 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.38 136.44 29.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.61 22.96 34.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.21 63.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.538 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.01 164.33 13.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 m -117.84 107.58 14.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.006 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.633 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.4 m-85 -109.33 126.28 53.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.381 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.9 m-85 -103.81 145.36 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.252 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.419 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -72.33 137.7 46.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.933 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 113.478 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 83.5 Cg_exo . . . . . 0 C--O 1.231 0.151 0 N-CA-C 112.86 0.292 . . . . 0.0 112.86 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.468 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.5 m-85 -136.62 -46.4 0.61 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 21' ' ' LEU . 22.1 t 59.9 125.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.548 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.27 148.63 5.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.14 96.68 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.181 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.626 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.7 m95 -89.22 106.71 18.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.612 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.7 t -111.08 155.78 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.349 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.32 172.14 7.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.228 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.94 60.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.13 -16.86 14.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 17.13 68.58 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.293 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -23.41 62.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 0.0 110.284 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.44 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -147.71 156.4 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.563 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.77 131.32 31.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.771 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 27.9 tt0 -119.2 112.55 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.004 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -92.64 127.14 38.03 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 111.326 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.626 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 11.8 mt -93.08 112.66 24.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.549 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.58 156.69 81.77 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 27.9 Cg_exo -62.92 -17.97 62.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.583 2.855 . . . . 0.0 112.438 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -94.74 21.95 6.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.942 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.421 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.34 50.5 38.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 84.5 mmt-85 -139.36 -179.73 6.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.385 0.136 . . . . 0.0 111.02 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -135.36 150.99 50.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 0.0 112.758 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.69 109.93 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.275 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 3.1 tt0 -103.26 134.51 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.393 0.616 . . . . 0.0 112.183 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.61 105.29 11.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.061 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.226 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 121.069 0.461 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 152.42 35.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.282 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -158.89 149.9 20.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.075 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.71 -128.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.908 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.14 164.2 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.464 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 0.8 OUTLIER -133.47 157.38 45.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.502 0.668 . . . . 0.0 112.184 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.1 tt0 -119.87 127.47 52.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.983 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.468 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 54.6 t -102.88 126.08 57.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.141 0.496 . . . . 0.0 112.214 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -137.2 88.62 2.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.669 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 64.83 43.85 95.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.398 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 84.47 -12.15 0.78 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.43 0.292 . . . . 0.0 111.66 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.71 127.02 39.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -140.18 151.07 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.043 -179.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.447 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.43 145.15 50.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.987 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 57' ' ' THR . 34.5 m-85 -93.49 117.24 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.952 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -109.28 91.36 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.977 0.418 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.417 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -71.4 155.37 40.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.684 -179.176 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.22 -12.72 51.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.029 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -90.66 24.12 2.8 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.73 22.4 59.94 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 114.87 0.708 . . . . 0.0 114.87 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.52 163.4 17.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.318 1.059 . . . . 0.0 109.935 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.57 140.7 13.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.934 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 49' ' ' ASN . . . -127.07 178.31 6.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.069 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 28.4 p-10 -146.78 146.76 30.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.163 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -157.66 -170.56 22.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 9.5 p-10 -168.04 123.12 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.563 ' CE2' HG22 ' A' ' 48' ' ' ILE . 89.8 m-85 -65.82 110.34 2.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.7 m -91.14 -6.02 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.29 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.14 173.49 10.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.44 -22.45 63.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.22 1.56 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.783 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -111.25 149.06 31.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.927 0.394 . . . . 0.0 111.006 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.95 144.08 48.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.299 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.403 ' N ' HD12 ' A' ' 68' ' ' LEU . 4.5 m170 -126.5 107.91 10.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.48 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.48 141.55 29.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 179.197 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.19 19.13 22.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.084 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.04 68.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.999 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ttm -115.72 171.8 7.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.289 0.545 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.8 m -117.54 107.99 14.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.711 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.644 ' HB2' HD13 ' A' ' 68' ' ' LEU . 20.5 m-85 -106.03 121.88 45.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -100.39 147.12 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.413 ' HD2' ' HA3' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -73.01 137.43 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.8 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 C-N-CA 124.79 1.236 . . . . 0.0 113.416 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 76.6 Cg_exo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.878 0.282 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.505 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 7.5 m-85 -144.48 -44.09 0.25 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.6 t 61.58 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.591 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.48 145.0 4.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.393 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.67 96.56 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.516 0.674 . . . . 0.0 109.872 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.645 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.0 m95 -85.87 108.04 17.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.243 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 17' ' ' ARG . 72.9 t -113.41 155.07 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.849 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.407 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -66.38 -177.04 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.311 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -83.09 -20.1 35.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.526 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.61 -25.26 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.77 25.77 24.23 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.022 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -78.03 -28.01 48.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.132 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.466 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.98 155.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.376 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -138.69 138.1 37.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -124.3 111.95 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.937 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -90.09 125.21 35.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.645 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.2 mt -92.61 113.54 25.85 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.16 158.26 82.11 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -176.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -63.65 -18.84 65.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.642 2.894 . . . . 0.0 112.868 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.78 22.27 7.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.331 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.68 53.03 22.1 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.575 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -138.64 179.06 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.849 -0.175 . . . . 0.0 110.954 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.01 152.75 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.474 0.654 . . . . 0.0 112.745 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.04 110.56 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.28 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.89 134.99 45.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.423 0.63 . . . . 0.0 112.079 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.37 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.161 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.361 -179.439 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 142.1 22.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.38 149.79 28.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.93 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.39 -122.57 0.64 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.038 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.04 163.6 39.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 4.7 p90 -138.92 154.92 48.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.516 0.674 . . . . 0.0 112.31 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -120.39 127.47 52.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.285 178.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 58.0 t -102.27 132.01 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 112.003 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -138.59 83.32 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.715 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 68.29 44.46 74.87 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.183 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 85.6 -13.02 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.593 0.357 . . . . 0.0 111.441 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 126.02 38.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.035 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -141.77 147.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 4.8 t-20 -118.41 166.72 12.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.847 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 57' ' ' THR . 73.1 m-85 -125.17 113.59 17.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.642 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.402 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 84.6 t90 -108.82 91.39 3.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.041 0.448 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.12 160.06 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.439 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.08 -12.8 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.26 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.95 25.58 2.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.888 0.375 . . . . 0.0 111.72 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.88 25.73 61.8 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.384 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 164.5 14.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.839 0.819 . . . . 0.0 109.908 179.041 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.16 143.03 12.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.75 177.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -146.78 124.5 11.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.872 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 29.6 t70 -91.23 153.14 20.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.52 -168.93 17.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.104 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 11.2 p-10 -168.09 132.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.476 ' CZ ' HG22 ' A' ' 48' ' ' ILE . 7.4 m-30 -77.28 110.35 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' A' ' 69' ' ' HIS . 3.1 m -83.94 -14.63 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.396 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 t -156.42 179.83 8.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.99 62.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.289 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.3 -3.15 10.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.494 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.84 145.61 31.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.61 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -131.74 143.82 50.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.301 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.431 ' CD2' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.4 109.08 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.896 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.448 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.53 136.0 32.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.663 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.17 23.73 18.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.192 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.99 19.44 67.38 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.726 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 164.54 12.44 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.04 0.448 . . . . 0.0 111.016 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.422 HG21 ' CZ ' ' A' ' 76' ' ' TYR . 3.6 m -117.22 107.58 14.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.61 ' HB2' HD13 ' A' ' 68' ' ' LEU . 34.4 m-85 -109.76 122.94 48.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.484 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 74' ' ' THR . 12.1 m-85 -100.21 141.86 32.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.63 148.45 33.65 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.1 mt-10 . . . . . 0 N--CA 1.465 0.3 0 C-N-CA 124.758 1.223 . . . . 0.0 113.125 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 49.5 Cg_exo . . . . . 0 N--CA 1.471 0.178 0 CA-C-O 120.757 0.232 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 13.5 m-85 -145.38 -42.75 0.22 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' LEU . 18.9 t 60.31 129.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.14 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.57 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.16 147.67 4.9 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.295 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.86 96.79 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 110.225 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.661 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.7 m95 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.748 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 16' ' ' ILE . 68.9 t -114.11 155.7 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.83 176.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.146 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -78.01 -19.47 54.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.93 -23.84 13.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.22 21.76 40.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.334 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -24.65 59.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.716 0.293 . . . . 0.0 110.392 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.46 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.36 156.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.301 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -137.58 135.41 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.9 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 5.3 tt0 -122.34 113.6 19.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.6 126.92 41.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.079 0.466 . . . . 0.0 111.457 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 10.0 mt -91.64 113.64 25.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.495 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.05 157.63 86.44 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.056 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.42 -13.49 38.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.326 2.684 . . . . 0.0 111.852 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -93.89 20.09 8.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.145 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.6 49.89 65.89 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.5 mmt85 -137.37 -179.84 5.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.129 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.19 149.28 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.16 112.14 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.441 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -104.24 132.66 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.324 0.583 . . . . 0.0 112.15 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.74 105.37 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.983 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.419 ' HD2' ' CG2' ' A' ' 16' ' ' ILE . 7.2 mtm180 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.137 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.697 0.284 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.7 27.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 111.794 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.97 149.78 26.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.541 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.23 -122.14 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.699 -1.239 . . . . 0.0 113.194 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.11 164.12 39.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.464 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 6.7 p90 -139.31 155.68 47.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.519 0.676 . . . . 0.0 112.275 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.89 127.15 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.89 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.514 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 78.5 t -104.32 129.89 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.463 . . . . 0.0 112.097 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 99.6 3.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.707 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.73 42.93 96.63 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.306 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.0 -7.76 1.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.393 0.277 . . . . 0.0 111.629 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.93 126.43 39.13 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -137.28 148.87 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.221 0.534 . . . . 0.0 112.237 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.541 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.29 144.68 49.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.789 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.675 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.4 m-85 -98.61 115.06 27.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.012 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.7 t90 -109.05 90.45 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.035 0.445 . . . . 0.0 109.899 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.68 158.91 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.08 -12.63 52.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.038 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.55 25.29 2.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.796 0.331 . . . . 0.0 111.711 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.45 26.76 60.68 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.14 164.17 15.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.768 0.784 . . . . 0.0 109.765 179.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.34 142.68 11.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.965 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.68 121.65 12.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.5 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 9.9 p-10 -88.95 157.61 18.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 111.651 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.16 -172.1 32.2 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.888 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -168.17 132.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.308 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.8 m-30 -71.63 110.24 6.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.0 m -81.74 -18.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.335 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 t -148.61 -168.47 3.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.853 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.95 -28.25 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.194 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 -0.13 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.582 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -106.89 147.75 29.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.74 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.612 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -131.64 142.24 49.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.402 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.2 m170 -126.39 107.88 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.72 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.67 135.61 26.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.7 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.67 21.7 43.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.1 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.92 24.53 59.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.418 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -115.43 164.71 13.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -118.26 107.37 13.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.063 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' HD11 ' A' ' 68' ' ' LEU . 29.1 m-85 -109.83 127.77 54.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.34 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.419 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 15.2 m-85 -104.17 146.31 28.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.461 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 1.3 tpp85 -73.37 135.42 44.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.916 0.389 . . . . 0.0 111.991 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 124.599 1.16 . . . . 0.0 113.37 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 67.0 Cg_exo . . . . . 0 N--CA 1.472 0.209 0 CA-C-O 120.726 0.219 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.509 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 14.6 m-85 -145.58 -42.29 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.866 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 21' ' ' LEU . 20.0 t 60.19 128.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.029 0.443 . . . . 0.0 111.263 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.58 148.45 5.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.242 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -96.05 96.57 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.592 0.711 . . . . 0.0 110.035 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.1 m95 -88.42 107.63 18.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.597 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.44 155.74 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.411 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.76 176.9 1.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.385 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.5 -19.9 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.574 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.41 -24.82 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.707 0.289 . . . . 0.0 110.945 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.15 22.98 30.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.461 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -28.32 56.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.81 0.338 . . . . 0.0 110.165 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.499 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -139.1 158.39 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 3.7 ttp180 -138.67 142.76 39.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.804 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 14.9 tt0 -130.21 111.88 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -95.14 127.11 40.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.669 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.5 mt -92.14 113.91 26.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.27 156.58 87.84 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.44 -17.57 60.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.62 2.88 . . . . 0.0 112.474 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -95.86 23.26 6.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.44 53.55 24.38 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.846 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.8 mmt85 -141.94 -179.97 6.53 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 111.413 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.08 149.28 47.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 112.562 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.33 110.93 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.381 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.66 134.08 47.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.61 . . . . 0.0 112.277 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.32 105.03 11.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.775 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HD2' HG23 ' A' ' 16' ' ' ILE . 12.9 mtm180 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.848 0.356 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.84 141.84 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.469 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.14 149.9 29.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.737 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.32 -120.74 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 119.833 -1.175 . . . . 0.0 113.03 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 164.02 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 5.4 p90 -138.42 155.78 48.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.484 0.659 . . . . 0.0 112.276 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -120.46 127.28 52.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.843 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 73.2 t -105.2 130.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.537 . . . . 0.0 112.085 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.19 96.91 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.777 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 60.5 43.85 98.36 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.351 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 82.13 -7.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.417 0.287 . . . . 0.0 111.563 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.79 124.91 38.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.5 148.15 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.0 112.153 -178.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.559 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.5 144.09 49.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.895 178.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.5 m-85 -99.35 115.04 28.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -109.14 90.18 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.012 0.434 . . . . 0.0 109.849 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.65 158.69 29.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.704 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -85.09 -12.7 52.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.975 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.5 t -91.41 25.26 2.65 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 120.907 0.384 . . . . 0.0 111.807 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 26.09 61.22 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.026 -0.606 . . . . 0.0 114.467 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.9 164.09 15.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.873 0.836 . . . . 0.0 109.918 179.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.95 142.69 12.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.94 178.07 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.72 121.7 12.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.601 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.0 p30 -89.44 156.24 18.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.585 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.53 -171.67 30.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.025 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.3 p-10 -168.19 133.74 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.236 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.481 ' CE1' HG22 ' A' ' 48' ' ' ILE . 8.3 m-30 -73.57 110.42 7.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.438 HG13 ' CD2' ' A' ' 69' ' ' HIS . 3.1 m -82.28 -18.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.215 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.46 -168.81 3.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.876 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.82 -27.62 28.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.01 2.05 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.588 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.97 149.8 28.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 110.78 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -133.2 143.46 49.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.438 ' CD2' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.37 107.77 10.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.246 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.99 137.33 17.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.224 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.86 13.19 58.91 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.762 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.23 20.18 59.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.945 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.4 ttm -120.49 171.57 8.45 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.216 0.508 . . . . 0.0 111.714 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 m -116.41 107.64 15.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.348 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.598 ' HB2' HD13 ' A' ' 68' ' ' LEU . 13.6 m-85 -106.01 127.77 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.334 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -102.46 147.13 27.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.728 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.482 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 2.1 tpp85 -75.71 130.42 38.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.103 0.478 . . . . 0.0 112.228 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 55.0 Cg_exo . . . . . 0 C--O 1.231 0.158 0 N-CA-C 112.871 0.296 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.538 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 9.7 m-85 -145.77 -43.43 0.21 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.792 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 19.9 t 60.86 129.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 111.286 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.583 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.29 145.49 4.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -91.94 96.82 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.36 0.6 . . . . 0.0 110.141 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.5 m95 -88.24 108.18 19.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.405 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.75 155.15 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.694 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.409 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.94 -176.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.312 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.53 -20.41 33.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.584 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.67 -24.47 12.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.987 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.87 23.79 26.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.024 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -74.96 -30.66 61.27 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.44 155.81 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.58 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -137.93 128.66 26.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.9 tt0 -116.31 112.2 21.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.92 126.83 38.2 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.504 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.654 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 10.0 mt -91.84 113.26 25.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.04 157.41 87.09 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.5 Cg_exo -64.72 -13.18 37.7 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.445 2.763 . . . . 0.0 111.854 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -93.89 20.3 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.173 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.46 50.4 62.52 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -139.93 -179.91 6.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.971 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.25 149.57 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.59 110.34 5.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.255 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.59 133.09 49.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.414 0.626 . . . . 0.0 112.288 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.85 105.45 11.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.905 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HD2' ' CG2' ' A' ' 16' ' ' ILE . 20.8 mtm-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.905 0.383 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 143.59 25.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.464 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.82 149.9 29.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.877 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.03 -123.65 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.899 -1.144 . . . . 0.0 113.025 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.04 164.05 39.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CZ ' HD12 ' A' ' 20' ' ' LEU . 4.5 p90 -139.78 154.74 47.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 112.142 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.78 127.34 52.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.249 178.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 55.9 t -102.84 129.49 54.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.857 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.68 92.26 2.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.629 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 62.5 43.61 98.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.357 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.7 0.85 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 122.461 0.304 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.9 128.9 40.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -146.36 151.5 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.073 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 48' ' ' ILE . 1.3 m-20 -127.24 171.17 11.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.551 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' A' ' 57' ' ' THR . 79.1 m-85 -124.1 114.84 20.24 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.08 90.99 3.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.434 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.64 160.39 22.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.694 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -12.76 52.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.157 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -92.19 25.32 2.94 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.821 0.343 . . . . 0.0 111.719 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 25.79 61.67 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.59 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.16 164.32 14.95 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 117.82 0.81 . . . . 0.0 109.783 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.62 142.48 10.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.008 177.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -143.93 121.55 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.545 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p-10 -90.37 150.75 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 0.0 111.523 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -156.24 -171.92 23.08 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.109 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 2.0 p30 -168.28 132.97 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.262 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 48' ' ' ILE . 5.6 m-30 -73.1 110.33 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.93 -18.91 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.335 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -147.3 -169.04 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.99 -29.28 32.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.217 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.77 -0.14 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.512 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.82 148.8 28.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 110.702 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.42 144.4 49.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -126.35 108.76 11.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.85 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.425 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.95 135.32 32.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.621 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.04 23.72 17.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.276 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.62 18.95 67.07 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.717 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -108.76 164.05 12.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 111.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.5 m -116.73 107.66 14.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.626 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.0 m-85 -110.27 124.63 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.099 0.476 . . . . 0.0 111.667 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -97.72 147.18 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.769 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.478 ' CD ' ' CE2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -73.03 140.68 47.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.33 0.586 . . . . 0.0 112.318 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.612 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.289 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 47.9 Cg_exo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.753 0.231 . . . . 0.0 112.476 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 10.8 m-85 -145.54 -43.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 20.5 t 60.8 128.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.352 . . . . 0.0 111.302 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.582 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.76 147.23 4.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.324 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.8 98.85 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.356 0.598 . . . . 0.0 110.206 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.638 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.7 m95 -91.38 105.34 17.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.707 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.7 t -109.98 155.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.282 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.42 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.72 178.67 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.368 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.97 -20.27 49.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.62 -24.6 13.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.14 23.56 31.86 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.59 -0.815 . . . . 0.0 112.234 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.52 -27.73 58.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.068 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.5 155.89 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.589 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 126.13 22.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.519 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 35.4 tt0 -115.72 114.35 24.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.672 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -94.33 127.15 40.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.367 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.638 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 10.8 mt -90.65 112.75 24.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.39 157.62 84.94 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.31 -13.4 37.97 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.291 2.661 . . . . 0.0 111.872 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -93.56 19.93 7.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.192 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.41 50.22 64.06 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.0 mmt85 -139.8 -179.89 6.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.527 -0.337 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -135.95 149.63 48.98 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.73 114.64 6.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.181 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -105.66 132.23 52.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.0 112.185 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -113.64 105.18 13.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.058 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.406 -179.313 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.063 0.459 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.53 140.1 19.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.042 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.44 149.76 29.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.927 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.68 -123.92 0.7 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.982 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.03 164.0 39.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.474 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 6.9 p90 -138.34 155.08 48.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.443 0.64 . . . . 0.0 112.056 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.2 tt0 -119.75 127.25 52.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.069 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.518 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 67.6 t -104.42 127.27 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.969 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.26 91.99 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.414 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 63.21 43.25 98.85 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.14 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.05 0.89 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.506 0.322 . . . . 0.0 111.564 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.75 127.11 39.3 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -143.19 152.68 16.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 112.252 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.516 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.46 149.3 51.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.858 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.81 115.44 30.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 t90 -109.08 90.43 3.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.433 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.69 157.83 33.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.604 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -85.16 -12.68 52.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -91.73 24.31 3.19 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.878 0.371 . . . . 0.0 111.866 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.18 22.77 60.23 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 163.48 16.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.172 0.986 . . . . 0.0 109.963 179.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.46 11.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.879 178.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.98 121.68 11.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.648 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 6.9 p-10 -90.33 152.22 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 111.346 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -154.03 -167.58 16.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.024 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.7 p-10 -168.11 130.8 1.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.319 . . . . 0.0 111.218 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.483 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 7.6 m-30 -74.03 110.04 8.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.688 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -86.58 -11.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -158.59 -177.95 6.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.835 0.35 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -25.77 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.259 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.01 1.52 7.98 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.631 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -109.43 147.87 32.11 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.819 0.342 . . . . 0.0 110.792 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.27 144.15 49.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.4 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.47 109.25 11.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.915 0.388 . . . . 0.0 110.712 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.421 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.37 134.49 30.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.11 22.96 22.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.144 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.69 67.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.752 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.49 163.55 12.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 111.041 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 m -116.77 107.64 14.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.775 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 68' ' ' LEU . 28.4 m-85 -108.98 125.11 51.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -102.08 147.12 26.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.331 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.462 ' CZ ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -74.26 137.17 42.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.812 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 124.607 1.163 . . . . 0.0 113.012 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 31.3 Cg_exo . . . . . 0 N--CA 1.471 0.147 0 CA-C-O 120.783 0.243 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.469 ' CE1' HG22 ' A' ' 43' ' ' VAL . 15.0 m-85 -143.78 -42.62 0.28 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 21' ' ' LEU . 18.6 t 60.73 131.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.45 144.98 4.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.36 96.55 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.523 0.678 . . . . 0.0 109.782 179.288 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.673 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 26.0 m95 -86.48 109.88 19.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.167 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.3 t -115.24 154.82 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.777 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.409 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.06 -176.88 0.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.15 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -83.33 -19.97 35.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.6 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.1 -27.04 12.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 24.98 18.02 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.055 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.09 -31.06 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.467 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.31 155.48 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.407 ' N ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -138.31 131.23 29.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.686 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.7 tt0 -118.38 113.75 21.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.828 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.16 125.68 36.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.552 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 6.8 mt -90.9 112.13 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.57 156.64 81.9 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.456 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.18 -17.81 61.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.513 2.809 . . . . 0.0 112.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.61 23.11 6.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.46 52.03 33.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.005 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -140.05 -179.79 6.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.382 0.134 . . . . 0.0 110.963 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.467 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.69 149.95 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.17 111.23 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.523 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -102.93 134.33 46.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.968 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.79 105.27 11.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.321 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.316 -179.593 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.006 0.432 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.04 140.06 19.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.217 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.43 150.1 29.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.735 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.95 -122.52 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.054 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.99 39.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.481 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.3 p90 -138.02 157.89 45.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.539 0.685 . . . . 0.0 112.403 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -122.54 127.42 49.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.804 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.469 HG22 ' CE1' ' A' ' 5' ' ' TYR . 79.2 t -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 82.57 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.17 -96.35 2.05 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.99 15.26 7.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -111.12 141.42 44.65 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.173 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.55 HG12 ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -147.66 148.26 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.244 -179.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.55 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.3 144.92 50.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.708 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.645 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -102.2 115.4 30.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.157 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -109.23 90.64 3.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.7 157.82 33.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.74 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.12 -12.7 52.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.199 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.7 24.77 2.96 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.9 0.381 . . . . 0.0 111.898 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.3 23.36 61.07 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.766 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.64 164.02 15.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.049 0.924 . . . . 0.0 109.931 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.25 141.34 12.21 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.735 177.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.34 121.76 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.619 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.67 151.16 20.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 111.465 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.12 -170.98 26.49 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.875 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.415 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.9 p-10 -168.15 132.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.485 ' CE1' ' CG2' ' A' ' 48' ' ' ILE . 8.3 m-30 -68.28 110.18 3.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.516 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.433 HG13 ' CD2' ' A' ' 69' ' ' HIS . 2.6 m -84.86 -16.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.284 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -152.03 -175.26 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 0.0 110.813 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.76 -26.69 50.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -122.48 -2.38 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.646 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -106.98 144.86 32.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 111.004 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.619 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -129.97 143.58 50.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.365 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.433 ' CD2' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.64 107.82 10.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.522 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -143.71 137.42 28.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.607 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.52 22.82 40.33 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.091 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.87 62.17 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 165.94 12.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 0.0 111.151 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 m -118.07 107.54 14.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.082 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.617 ' HB2' HD13 ' A' ' 68' ' ' LEU . 30.5 m-85 -110.72 126.64 54.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.328 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.418 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 10.8 m-85 -103.19 141.71 35.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.816 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HG3' ' HG3' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -58.28 146.18 35.1 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.899 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.2 mt-10 . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 124.553 1.141 . . . . 0.0 113.104 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.4 Cg_exo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.669 0.195 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 14.5 m-85 -145.38 -42.88 0.22 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.888 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.547 HG21 ' O ' ' A' ' 21' ' ' LEU . 17.5 t 60.72 129.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 111.265 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.85 147.29 4.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.342 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.8 96.89 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 110.119 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.638 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.2 m95 -88.91 106.95 18.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.729 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.6 t -114.33 155.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.376 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.406 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.27 178.95 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.182 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.0 -18.79 49.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.5 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.48 -27.54 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 26.3 18.83 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.158 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.406 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -79.08 -28.4 43.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.133 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.463 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 155.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.35 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -137.19 137.8 39.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.834 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.5 tt0 -125.17 112.94 17.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.731 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.4 127.4 39.01 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.588 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.638 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.3 mt -93.09 113.0 25.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.547 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.36 158.01 79.66 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.53 -18.91 66.5 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.644 2.896 . . . . 0.0 112.953 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.23 21.54 7.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.62 52.33 21.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.473 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.462 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 10.3 mmt180 -138.39 179.89 6.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.21 . . . . 0.0 111.115 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.509 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -138.53 153.01 48.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.471 0.653 . . . . 0.0 112.561 -178.138 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.22 111.76 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.92 131.33 49.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.306 0.574 . . . . 0.0 111.962 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.27 105.28 11.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.143 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.41 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.807 0.337 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.77 148.18 28.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.242 0.544 . . . . 0.0 111.766 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.491 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.73 149.67 25.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.3 -122.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.651 -1.261 . . . . 0.0 113.108 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.09 163.77 39.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.47 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 7.5 p90 -137.9 156.4 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 0.0 112.414 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -120.98 127.27 51.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.729 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.511 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 75.5 t -105.2 131.93 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.183 0.515 . . . . 0.0 112.226 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -142.94 101.45 3.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.651 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.87 42.94 94.93 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.406 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.72 -6.9 1.46 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.458 0.303 . . . . 0.0 111.679 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.84 126.24 38.92 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.54 148.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.302 0.572 . . . . 0.0 112.069 -178.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.558 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.35 143.25 48.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.952 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.7 m-85 -99.5 113.97 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.946 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -109.1 89.9 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.99 0.424 . . . . 0.0 109.985 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.439 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.8 158.07 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.648 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.93 -12.68 52.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.164 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -92.0 24.84 3.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.852 0.358 . . . . 0.0 111.708 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 27.26 55.97 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.621 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.38 164.1 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.006 0.903 . . . . 0.0 109.823 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.36 143.05 11.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.125 178.063 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.59 121.79 12.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.553 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.81 155.16 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 0.0 111.541 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -171.77 27.6 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.051 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 3.8 p-10 -168.21 133.88 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.341 . . . . 0.0 111.15 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.481 ' CE1' HG22 ' A' ' 48' ' ' ILE . 9.4 m-30 -75.63 110.33 9.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 69' ' ' HIS . 2.5 m -83.24 -18.43 10.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.881 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.21 174.72 13.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.38 -21.57 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.298 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -121.41 -8.55 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.802 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -106.61 149.01 27.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 111.166 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.612 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -131.4 142.41 50.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.278 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.427 ' CD2' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.64 107.88 10.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.8 135.8 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.724 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.69 21.84 44.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.049 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.24 25.13 59.93 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.389 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.86 165.15 13.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.991 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -118.59 107.44 13.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.004 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 68' ' ' LEU . 31.1 m-85 -110.14 128.78 55.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -105.02 145.83 29.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.458 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 1.1 tpp85 -72.26 136.78 46.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 C-N-CA 124.569 1.148 . . . . 0.0 113.1 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.0 Cg_exo . . . . . 0 N--CA 1.471 0.193 0 CA-C-O 120.787 0.245 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.505 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 11.7 m-85 -144.79 -43.29 0.24 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.801 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 21' ' ' LEU . 20.9 t 61.22 130.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.933 0.397 . . . . 0.0 111.401 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.582 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 155.69 145.82 4.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.254 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.98 96.8 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 121.452 0.644 . . . . 0.0 109.84 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.662 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.8 m95 -87.41 109.8 19.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.419 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.1 t -117.22 155.0 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.766 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -176.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.219 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . . . -83.13 -20.19 35.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.69 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -23.39 12.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.317 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.48 21.66 33.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.376 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -25.46 61.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.29 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.457 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -146.83 155.3 11.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.389 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -136.0 138.75 42.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.644 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.2 tt0 -125.33 111.88 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -92.51 125.63 37.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 111.535 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.4 mt -91.61 111.98 23.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -64.78 155.97 80.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -176.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.4 Cg_exo -64.11 -16.76 56.77 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.571 2.848 . . . . 0.0 112.47 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.38 23.6 6.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.769 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.52 53.6 23.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.926 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 5.6 mmm-85 -143.3 -179.85 6.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.512 0.196 . . . . 0.0 111.31 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.03 150.1 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.494 0.664 . . . . 0.0 112.716 -178.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.47 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.221 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.79 137.6 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.368 0.604 . . . . 0.0 112.448 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.15 105.57 9.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.851 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.023 0.44 . . . . 0.0 111.867 -178.76 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.86 0.362 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.72 150.44 32.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.326 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -159.39 149.88 19.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.98 179.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.67 -121.38 0.58 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.913 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.81 39.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.9 p90 -138.64 154.11 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 112.274 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -119.84 127.29 52.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.828 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 72.4 t -104.2 131.37 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.178 0.513 . . . . 0.0 112.01 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.05 100.85 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.24 42.81 95.59 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.335 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.61 -7.22 1.45 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.369 0.268 . . . . 0.0 111.53 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.02 39.4 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.551 HG12 ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -136.1 148.43 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 112.167 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.551 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.45 144.81 49.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.881 178.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.97 114.48 28.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.136 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -109.08 90.34 3.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.031 0.443 . . . . 0.0 109.955 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.86 158.52 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.65 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.04 -12.6 52.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.99 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -91.58 24.81 2.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.787 0.327 . . . . 0.0 111.752 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.64 25.61 60.39 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.5 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.61 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.99 163.44 16.94 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 117.888 0.844 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.31 142.24 12.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.46 121.71 13.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.488 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -90.63 154.79 19.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.69 -172.5 31.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.922 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.9 p-10 -168.18 132.93 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.861 0.362 . . . . 0.0 111.305 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.465 ' CE1' HG22 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.73 110.28 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 69' ' ' HIS . 3.1 m -82.71 -18.58 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.407 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -170.02 3.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.46 -29.34 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.158 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 0.21 9.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.656 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -106.89 149.53 27.35 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.383 . . . . 0.0 110.664 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.619 ' CD1' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -134.04 144.46 48.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.442 ' CD2' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.875 0.369 . . . . 0.0 110.908 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.447 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.38 136.04 32.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.491 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.08 23.58 17.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.245 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.56 67.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.743 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.68 164.82 12.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.848 0.356 . . . . 0.0 111.072 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.6 m -117.26 107.77 14.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.02 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.619 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . 33.2 m-85 -110.03 125.68 53.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.661 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 12' ' ' ALA . 25.1 m-85 -98.68 147.03 25.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.834 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.456 ' HD3' ' CZ2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -71.67 141.13 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.293 0.568 . . . . 0.0 112.252 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 8' ' ' ILE . 11.5 mt-10 . . . . . 0 CA--C 1.51 -0.584 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.268 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 35.0 Cg_exo . . . . . 0 N--CA 1.472 0.231 0 CA-C-O 120.642 0.184 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 19.0 m-85 -145.74 -42.48 0.21 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.995 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 21' ' ' LEU . 19.0 t 60.26 129.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.563 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.45 148.2 5.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.382 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.59 96.88 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.589 0.709 . . . . 0.0 110.16 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.657 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.2 m95 -89.19 105.31 17.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.693 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.9 t -111.24 155.92 12.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.494 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.74 171.77 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.55 60.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.374 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.14 -26.86 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.17 25.61 30.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.111 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -26.5 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.361 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.511 HG23 ' HD2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -140.0 156.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.239 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' N ' HD11 ' A' ' 16' ' ' ILE . 0.9 OUTLIER -139.98 128.65 23.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.795 0.331 . . . . 0.0 110.973 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 tt0 -114.56 112.0 22.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.682 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.7 126.56 38.95 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.98 0.419 . . . . 0.0 111.336 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.657 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.4 mt -91.84 114.31 26.82 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.68 157.53 88.21 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.45 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.4 Cg_exo -64.77 -12.86 36.1 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.343 2.695 . . . . 0.0 111.792 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.4 20.42 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.096 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.39 50.66 60.7 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.1 mmm-85 -139.61 -179.88 6.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.965 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -135.36 149.28 49.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 109.63 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.205 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -103.49 134.18 47.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.421 0.629 . . . . 0.0 112.355 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.95 105.26 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.852 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HD2' HG23 ' A' ' 16' ' ' ILE . 11.2 mtm180 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.367 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.892 0.377 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.68 143.49 26.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.546 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.455 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.98 150.05 29.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.844 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.3 -122.1 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.099 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.407 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.17 164.05 39.14 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.475 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.4 p90 -138.37 156.45 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.499 0.666 . . . . 0.0 112.229 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -119.94 127.17 52.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.902 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.511 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 73.6 t -104.74 127.66 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.044 0.449 . . . . 0.0 112.078 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -140.24 101.53 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.627 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.16 42.65 95.36 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.253 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.33 -6.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 126.12 38.94 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -135.38 147.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.286 0.565 . . . . 0.0 111.985 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.533 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -135.11 145.58 48.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.826 179.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.4 m-85 -97.81 116.99 31.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.013 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.407 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.6 t90 -109.28 90.85 3.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 109.835 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.422 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.72 155.65 40.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.855 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -85.22 -12.63 52.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.008 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 t -90.66 24.46 2.67 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.866 0.365 . . . . 0.0 111.917 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 23.38 60.7 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 114.811 0.685 . . . . 0.0 114.811 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.6 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.99 163.46 17.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.11 0.955 . . . . 0.0 109.9 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.54 141.3 14.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.998 178.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.42 178.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.007 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.2 t70 -148.79 147.86 29.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.257 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.58 -173.21 33.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.261 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -167.96 130.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.482 ' CE1' HG22 ' A' ' 48' ' ' ILE . 5.9 m-30 -69.68 110.44 4.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.788 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.83 -17.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.158 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.24 -166.41 2.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.894 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.68 -27.14 27.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.235 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.43 0.97 7.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -107.1 147.06 30.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.616 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -131.09 142.68 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.388 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.41 ' N ' HD11 ' A' ' 68' ' ' LEU . 6.0 m170 -126.47 107.9 10.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 135.55 26.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.752 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.45 21.84 42.9 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.042 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.27 21.71 64.37 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.503 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.08 164.45 13.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.3 m -118.26 107.31 13.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.801 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.8 m-85 -109.44 126.37 53.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.367 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -102.77 146.88 27.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.463 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.422 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -74.33 130.98 40.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 112.066 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.677 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.214 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.884 0.374 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -146.42 156.9 43.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -133.4 98.8 14.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 73.0 Cg_exo -52.27 164.83 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.852 2.368 . . . . 0.0 112.584 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.525 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 21.1 m-85 -146.43 -42.06 0.2 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 21' ' ' LEU . 19.2 t 60.51 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.211 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.556 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.5 147.46 4.85 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.274 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.32 96.92 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.029 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.661 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.06 107.42 19.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.799 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 16' ' ' ILE . 69.4 t -115.04 155.77 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.46 179.38 0.79 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.146 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . . . -79.86 -19.65 47.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.532 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.11 -28.52 11.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.669 0.271 . . . . 0.0 110.916 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.45 26.26 14.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.991 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -31.04 46.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.465 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.01 155.51 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.481 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' N ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -136.32 138.82 42.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.831 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.9 tt0 -125.76 111.95 15.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.639 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.76 127.2 39.36 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 111.563 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.3 mt -92.12 114.09 26.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.29 156.42 88.29 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.92 -17.15 58.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.506 2.804 . . . . 0.0 112.545 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.37 23.98 6.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.0 54.36 21.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.876 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.2 mmm-85 -143.32 -179.74 6.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.632 0.253 . . . . 0.0 111.334 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.472 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.14 149.97 48.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.432 0.634 . . . . 0.0 112.558 -178.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.32 111.72 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.34 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.25 134.62 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.376 0.608 . . . . 0.0 111.972 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.13 105.37 10.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.09 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.431 ' HD2' ' CG2' ' A' ' 16' ' ' ILE . 14.7 mtm-85 -97.72 148.0 23.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.75 128.48 15.52 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.848 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.46 31.14 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -172.67 38.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 168.84 0.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.658 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 47.4 29.83 1.42 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.442 . . . . 0.0 110.643 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.82 -53.74 54.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.631 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 153.88 38.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 111.882 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.29 149.83 15.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.82 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.82 -120.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.17 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.16 164.18 38.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 4.4 p90 -139.39 156.89 46.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.529 0.68 . . . . 0.0 112.219 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 2.8 tt0 -120.39 127.34 52.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.857 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 72.0 t -104.39 127.98 58.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.149 0.5 . . . . 0.0 112.038 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -139.51 99.76 3.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.93 42.83 96.96 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.289 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.77 -7.32 1.42 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.487 0.315 . . . . 0.0 111.664 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.8 125.65 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -136.54 145.99 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.273 0.558 . . . . 0.0 112.158 -178.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.495 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.55 145.3 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.746 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.9 m-85 -96.81 117.11 30.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.88 -0.146 . . . . 0.0 110.867 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.423 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.5 t90 -109.22 90.95 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 109.887 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.441 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.16 155.57 40.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.85 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.21 -12.67 52.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.0 t -90.01 24.76 2.33 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.806 0.336 . . . . 0.0 111.843 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.55 60.72 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -121.38 163.64 18.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.042 0.921 . . . . 0.0 109.904 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.63 141.3 14.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.848 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' ASN . . . -126.68 178.42 5.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.132 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.8 p30 -146.77 147.25 30.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.383 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.34 -175.12 35.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.176 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -168.17 129.49 1.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -67.5 110.34 3.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 110.857 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 69' ' ' HIS . 2.0 m -84.35 -18.59 9.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.189 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 -168.13 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 110.835 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.57 -27.19 29.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.24 0.1 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -107.02 148.51 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.876 0.369 . . . . 0.0 110.874 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.611 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -132.13 142.64 49.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.345 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.431 ' CD2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.57 107.79 10.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.27 136.42 26.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.816 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.4 22.0 43.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 26.13 58.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.4 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.35 165.18 13.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.945 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.1 m -118.52 107.41 13.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.581 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.4 m-85 -109.63 128.06 54.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.487 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 12' ' ' ALA . 13.9 m-85 -103.95 146.3 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.518 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.756 ' O ' ' N ' ' A' ' 79' ' ' LYS . 2.0 tpp85 -72.88 135.34 45.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.089 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 43.78 -55.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 113.403 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.756 ' N ' ' O ' ' A' ' 77' ' ' ARG . 7.2 mtpm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.912 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.819 0.342 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -79.28 169.17 18.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.804 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.72 95.92 24.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.236 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 38.6 Cg_exo -61.51 159.37 32.22 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.754 2.303 . . . . 0.0 112.071 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 10.0 m-85 -145.91 -43.88 0.21 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.169 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 21' ' ' LEU . 24.2 t 61.86 130.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.961 0.41 . . . . 0.0 110.993 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.596 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.98 146.93 4.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.307 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.18 98.66 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.423 0.63 . . . . 0.0 110.293 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.635 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.0 m95 -91.32 106.82 18.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.627 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 16' ' ' ILE . 73.8 t -112.78 155.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.147 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.403 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -68.14 176.33 2.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.298 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.74 -19.56 57.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.681 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -26.13 13.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.708 0.29 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.02 23.71 29.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.154 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.403 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.76 -29.51 58.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.054 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -140.59 156.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.519 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -137.5 132.51 33.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.837 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.5 tt0 -120.17 112.5 19.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.03 127.46 38.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.401 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.635 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.5 mt -92.95 110.21 21.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -62.75 156.18 66.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.444 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.0 Cg_exo -64.11 -16.84 57.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.495 2.796 . . . . 0.0 112.538 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -96.27 23.41 6.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.93 52.84 26.23 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.882 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mmt85 -141.58 -179.81 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 111.327 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -136.9 149.23 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.354 0.597 . . . . 0.0 112.54 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.43 111.61 5.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.346 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.7 tt0 -104.25 134.04 48.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.373 0.606 . . . . 0.0 112.196 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.87 105.2 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.868 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -99.62 106.58 18.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.545 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.9 -146.08 10.05 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.932 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -55.68 -23.12 26.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.752 0.311 . . . . 0.0 111.142 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -93.6 79.63 4.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.549 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 169.05 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.507 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.87 29.14 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.788 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.93 -47.9 67.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.257 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.22 141.56 23.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.46 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.5 149.89 29.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.827 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.96 -121.0 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.158 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.19 38.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.452 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 5.5 p90 -137.32 155.29 49.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.382 0.61 . . . . 0.0 112.116 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -119.91 127.14 52.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.195 178.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.489 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 55.1 t -102.65 129.99 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 111.942 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 87.44 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.73 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 65.53 44.0 93.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.326 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 85.2 -13.14 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.516 0.326 . . . . 0.0 111.606 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.94 128.81 40.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -143.71 153.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.176 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.505 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.8 150.12 52.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 57' ' ' THR . 46.5 m-85 -99.95 116.6 32.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.165 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -109.14 90.16 3.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 0.0 109.977 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.461 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.57 158.78 28.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.16 -12.7 52.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.009 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.3 t -91.13 25.06 2.61 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.908 0.385 . . . . 0.0 111.817 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 25.92 60.9 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.541 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.75 163.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.936 0.868 . . . . 0.0 109.989 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.35 142.5 12.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.867 178.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.57 121.52 12.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.598 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 16.2 p30 -90.27 152.29 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -150.68 -163.8 11.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.133 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -168.08 132.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.46 ' CZ ' HG22 ' A' ' 48' ' ' ILE . 7.9 m-30 -77.48 110.19 12.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.744 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.4 m -85.01 -10.71 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.477 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -160.46 -176.07 5.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.867 0.365 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.13 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.056 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.69 4.13 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.572 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.0 tt0 -106.72 145.28 32.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.398 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.91 143.88 50.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.645 -179.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 73' ' ' MET . 2.6 m170 -126.32 110.01 12.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.44 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.95 135.13 30.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.641 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 23.12 21.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.286 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.61 65.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.696 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.14 163.63 13.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.921 0.391 . . . . 0.0 111.024 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -117.11 107.69 14.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.946 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.643 ' HB2' HD11 ' A' ' 68' ' ' LEU . 32.3 m-85 -109.17 120.97 44.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.42 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.38 141.95 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.834 ' O ' ' N ' ' A' ' 79' ' ' LYS . 4.9 ttt180 -71.16 142.53 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.863 0.363 . . . . 0.0 111.735 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 37.11 -56.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.743 1.217 . . . . 0.0 113.284 179.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.834 ' N ' ' O ' ' A' ' 77' ' ' ARG . 33.7 mtpt . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.774 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.32 165.3 12.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -139.62 110.35 7.42 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.831 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 48.1 Cg_exo -57.74 162.69 10.29 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.889 2.393 . . . . 0.0 112.49 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 16.6 m-85 -145.21 -42.5 0.23 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.914 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 21' ' ' LEU . 19.9 t 60.7 129.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.999 0.428 . . . . 0.0 111.329 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.06 146.73 4.56 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.34 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.45 97.01 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.534 0.683 . . . . 0.0 110.074 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.645 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.588 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 16' ' ' ILE . 78.0 t -114.01 155.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.397 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.5 176.12 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.083 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.402 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -77.56 -19.43 55.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.445 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.65 -23.1 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.47 20.35 48.65 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.336 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -24.3 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 110.395 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.465 HD12 ' HG3' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -146.56 156.71 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.451 179.35 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -138.48 131.34 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.6 tt0 -119.24 114.33 22.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -94.66 127.37 40.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.584 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.645 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.8 mt -92.12 113.02 25.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.46 156.61 85.28 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -175.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.37 -17.57 60.67 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.509 2.806 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -96.01 23.45 6.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 52.86 28.97 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.032 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 41.7 mmt-85 -141.27 -179.97 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.582 0.229 . . . . 0.0 111.276 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.06 149.35 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.413 0.625 . . . . 0.0 112.538 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.55 112.75 5.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -104.51 133.82 48.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.292 0.568 . . . . 0.0 112.205 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.79 105.29 11.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.981 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.415 ' HD2' ' CG2' ' A' ' 16' ' ' ILE . 18.3 mtm-85 -103.14 114.0 27.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.347 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.41 -154.72 11.26 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.719 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -56.79 -22.57 37.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.732 0.301 . . . . 0.0 111.093 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -91.43 83.88 5.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.718 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 169.36 17.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.511 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.21 29.99 7.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.79 0.329 . . . . 0.0 110.717 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.58 71.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 140.82 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.69 149.71 28.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.19 -122.1 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.824 -1.179 . . . . 0.0 113.115 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.1 163.77 39.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 6.7 p90 -138.44 155.12 48.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.521 0.677 . . . . 0.0 112.192 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -119.98 127.24 52.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.891 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 73.1 t -104.73 130.89 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 112.124 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -141.75 98.14 3.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.79 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.69 43.61 97.63 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.298 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.12 -7.58 1.34 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.426 0.291 . . . . 0.0 111.543 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.414 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 125.25 38.24 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -135.02 148.33 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.225 0.536 . . . . 0.0 112.148 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.33 144.3 49.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.881 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.8 m-85 -100.2 115.14 29.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.065 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -109.06 90.51 3.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -67.09 158.69 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.652 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -85.07 -12.71 52.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.176 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.67 25.05 2.83 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.774 0.321 . . . . 0.0 111.726 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.7 25.24 60.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.546 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.2 164.12 15.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.013 0.906 . . . . 0.0 109.971 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.45 11.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.98 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.62 121.82 13.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.509 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 7.0 p-10 -90.3 155.63 18.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.975 0.417 . . . . 0.0 111.454 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.25 -170.71 28.53 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.076 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.3 p30 -168.32 133.74 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 111.227 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 48' ' ' ILE . 8.9 m-30 -72.76 110.5 7.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 m -82.53 -18.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.168 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.59 -169.43 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.22 -28.14 32.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.22 -0.25 9.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -106.92 146.79 30.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.931 0.396 . . . . 0.0 110.726 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.615 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -130.91 142.0 50.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.371 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.407 ' N ' HD11 ' A' ' 68' ' ' LEU . 4.3 m170 -126.38 107.9 10.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.759 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.64 135.41 26.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.87 21.52 44.77 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.048 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 23.78 60.53 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.49 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -114.71 164.87 13.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 m -118.37 107.35 13.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.981 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.607 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.1 m-85 -109.64 127.31 54.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.419 ' CG ' ' HE3' ' A' ' 79' ' ' LYS . 11.1 m-85 -104.66 145.12 30.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.482 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.851 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -70.73 139.5 51.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.504 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 34.28 -57.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.73 1.212 . . . . 0.0 113.155 179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.851 ' N ' ' O ' ' A' ' 77' ' ' ARG . 1.9 mttt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.818 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.797 0.332 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 165.13 11.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.982 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.84 96.57 13.09 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 32.2 Cg_exo -59.29 159.27 23.37 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.686 2.257 . . . . 0.0 112.13 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 7.1 m-85 -146.81 -44.2 0.18 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.167 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 21' ' ' LEU . 21.3 t 61.86 129.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.99 0.424 . . . . 0.0 111.145 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.602 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.12 146.24 4.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.301 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.09 96.67 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.462 0.648 . . . . 0.0 109.932 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.649 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 25.7 m95 -86.57 107.79 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.418 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.6 t -113.56 155.33 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.755 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.415 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.51 -175.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.02 -20.25 33.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.42 -26.54 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.732 0.301 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.29 26.1 16.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.018 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -77.46 -29.12 52.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.469 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 154.67 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.407 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -137.56 133.51 34.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.926 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.5 tt0 -119.69 113.08 20.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.528 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -92.51 126.47 37.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.107 0.479 . . . . 0.0 111.551 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.649 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.0 mt -92.56 112.3 24.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.09 157.3 85.37 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.9 Cg_exo -64.33 -13.96 41.26 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.338 2.692 . . . . 0.0 111.929 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -93.45 20.0 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.98 50.05 63.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.6 mmt180 -137.65 -179.92 6.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.889 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.86 149.93 47.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.19 111.09 4.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.507 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -102.88 133.39 48.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.331 0.586 . . . . 0.0 111.91 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.32 105.42 10.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.351 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -97.77 149.24 22.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.997 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.27 133.88 28.9 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.702 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.9 t30 56.98 27.26 12.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.809 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -176.49 58.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 169.19 17.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.419 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 48.19 29.38 1.83 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.882 0.373 . . . . 0.0 110.661 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.69 -51.99 63.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.563 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -149.59 152.77 36.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.178 0.513 . . . . 0.0 111.578 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.46 149.4 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.804 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -120.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 163.97 39.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.446 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 4.3 p90 -137.26 155.65 49.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.441 0.638 . . . . 0.0 112.085 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.0 tt0 -119.97 127.19 52.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.128 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.492 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 49.2 t -102.7 129.65 53.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.426 . . . . 0.0 112.025 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -136.82 82.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 68.22 44.76 74.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.272 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 85.55 -13.14 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.6 0.36 . . . . 0.0 111.497 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.88 126.05 38.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -143.03 152.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.234 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.492 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.85 151.14 51.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.783 178.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.6 m-85 -100.32 116.45 32.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.158 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.0 t90 -109.1 90.41 3.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.007 0.432 . . . . 0.0 109.907 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.62 158.36 32.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.743 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -85.16 -12.75 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.858 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -91.08 25.23 2.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.85 0.357 . . . . 0.0 111.755 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.7 26.3 61.08 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.505 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.16 163.86 17.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.928 0.864 . . . . 0.0 109.866 179.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.68 142.4 12.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.975 178.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.52 121.56 12.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.677 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 31.3 p-10 -90.37 152.08 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.397 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -153.52 -167.49 15.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.034 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.431 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.11 131.93 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.7 m-30 -77.05 110.24 11.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 69' ' ' HIS . 3.7 m -84.84 -14.29 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.32 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.73 177.93 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.82 -27.95 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.08 -2.62 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.593 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -106.94 141.92 37.38 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.899 0.38 . . . . 0.0 110.733 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -128.18 142.97 51.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.536 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.42 ' CD2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.64 108.02 10.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.786 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.83 137.01 29.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.668 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.35 22.75 38.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.122 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.55 25.23 61.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.373 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.3 165.12 13.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.1 m -117.9 107.57 14.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.147 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.62 ' HB2' HD13 ' A' ' 68' ' ' LEU . 31.9 m-85 -110.12 123.37 49.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 8.3 m-85 -102.95 140.34 37.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.692 ' O ' ' N ' ' A' ' 79' ' ' LYS . 3.8 tpp180 -54.06 148.21 11.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.931 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.3 mt-10 9.78 -65.14 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.388 1.055 . . . . 0.0 112.564 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.871 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.745 0.307 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.72 157.95 17.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -121.02 91.13 47.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 72.0 Cg_exo -52.76 164.88 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.907 2.405 . . . . 0.0 112.67 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.506 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 15.3 m-85 -144.88 -42.34 0.24 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.2 t 60.32 129.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.022 0.439 . . . . 0.0 111.3 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.24 146.63 4.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -93.84 96.93 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.084 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.657 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.1 m95 -89.54 107.48 19.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.695 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.1 t -113.95 155.59 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.329 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.405 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.72 1.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.104 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -79.6 -19.36 49.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.515 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.45 -26.16 12.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.995 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.04 24.83 26.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.221 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -77.13 -28.35 54.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.462 HD13 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.17 155.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.435 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -136.89 133.09 35.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.863 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.1 tt0 -121.47 113.2 19.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -94.46 128.45 41.04 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.059 0.457 . . . . 0.0 111.513 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.657 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.3 mt -92.58 113.26 25.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 156.34 86.66 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -64.0 -17.01 58.12 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.556 2.838 . . . . 0.0 112.49 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.58 24.08 6.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 110.759 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.11 54.13 22.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.92 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.0 mmm-85 -143.37 -179.93 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.593 0.235 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.72 149.2 47.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.6 . . . . 0.0 112.407 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.53 112.45 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.487 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -104.17 131.54 51.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.288 0.566 . . . . 0.0 111.907 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.4 105.21 11.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -98.62 150.47 21.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.55 -41.19 56.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.643 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -58.99 -30.86 68.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 0.0 110.799 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -179.6 119.54 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.553 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.91 169.43 13.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.342 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.52 29.13 1.96 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.891 0.377 . . . . 0.0 110.52 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.56 -49.89 66.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.503 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 144.33 24.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.729 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.95 149.81 26.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.25 -120.95 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.099 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 5.3 p90 -138.56 155.75 48.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.414 0.626 . . . . 0.0 112.323 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.99 127.21 52.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.717 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.506 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 78.0 t -104.98 130.46 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.173 0.511 . . . . 0.0 112.083 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -142.05 99.87 3.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.784 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.85 43.34 96.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.287 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.59 -7.03 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.47 0.308 . . . . 0.0 111.67 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.82 125.73 38.6 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.97 148.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.273 0.559 . . . . 0.0 112.153 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.43 144.13 49.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.891 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -99.6 114.79 28.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.12 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -108.97 90.29 3.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.025 0.44 . . . . 0.0 109.865 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.63 159.1 28.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.653 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -85.1 -12.65 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.987 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -91.58 25.51 2.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.809 0.337 . . . . 0.0 111.612 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.19 26.52 61.67 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.097 -0.573 . . . . 0.0 114.478 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.96 164.26 15.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.858 0.829 . . . . 0.0 109.831 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.13 142.65 11.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 178.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.52 121.71 13.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.515 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.5 p30 -89.61 155.43 19.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -162.48 -171.42 28.62 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 6.9 p-10 -168.12 133.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 111.285 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.472 ' CE1' HG22 ' A' ' 48' ' ' ILE . 9.0 m-30 -72.99 110.34 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.104 0.478 . . . . 0.0 110.716 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.44 HG12 ' CD2' ' A' ' 69' ' ' HIS . 3.1 m -82.64 -18.09 10.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.356 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -148.68 -169.13 3.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.351 . . . . 0.0 110.958 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.79 -30.2 32.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.67 1.34 10.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.485 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.0 147.93 29.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.921 0.391 . . . . 0.0 110.581 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.611 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -133.17 144.22 49.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.414 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.44 ' CD2' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.48 108.92 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.433 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.33 135.86 32.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.582 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.95 23.78 17.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.177 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.23 67.25 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.31 164.18 12.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.026 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.407 HG21 ' CZ ' ' A' ' 76' ' ' TYR . 4.4 m -117.23 107.63 14.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.07 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.598 ' HB2' HD13 ' A' ' 68' ' ' LEU . 31.2 m-85 -109.48 127.13 54.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.355 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.411 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 9.5 m-85 -105.16 143.58 33.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.861 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.18 140.68 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 31.36 -58.26 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.569 1.148 . . . . 0.0 112.955 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.861 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.746 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.831 0.348 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 153.77 42.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.96 95.44 47.57 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 46.2 Cg_exo -57.0 159.63 14.34 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.73 2.287 . . . . 0.0 112.279 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.509 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 5.3 m-85 -145.64 -44.81 0.21 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.941 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.0 t 62.24 129.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.188 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.596 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 153.87 146.14 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.388 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.71 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.411 0.624 . . . . 0.0 109.856 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.637 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.6 m95 -86.38 108.47 18.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.381 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.32 155.7 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.778 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.68 -175.16 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.331 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.0 -20.45 32.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.05 -25.48 12.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.828 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.59 23.21 24.34 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.315 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -26.87 60.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.742 0.306 . . . . 0.0 110.271 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.504 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -143.67 157.7 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.345 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -140.27 138.33 34.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.6 tt0 -125.44 112.91 16.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.66 126.67 36.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 111.669 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.4 mt -92.91 111.66 23.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.06 156.32 81.07 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.9 -17.22 58.97 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.467 2.778 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.7 22.9 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.27 52.54 26.51 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.843 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.7 mmt85 -140.94 -179.81 6.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.562 0.22 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.477 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -137.0 150.36 48.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.41 0.624 . . . . 0.0 112.459 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.16 110.74 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.0 tt0 -103.3 132.48 49.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.415 0.626 . . . . 0.0 111.895 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.58 105.16 10.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.352 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 4.4 mtm180 -97.81 146.64 25.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.051 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.99 136.59 24.55 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.853 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.95 25.16 10.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 0.0 111.036 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -176.98 58.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.389 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 169.93 14.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.459 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 49.34 29.93 2.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.934 0.397 . . . . 0.0 110.619 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -52.42 61.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.685 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.409 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -151.0 153.48 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.038 0.447 . . . . 0.0 111.754 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.477 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.82 148.92 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.045 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.98 -121.82 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.982 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.14 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 3.2 p90 -138.09 157.64 45.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.355 0.597 . . . . 0.0 112.284 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.38 127.21 49.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.087 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 29.8 t -101.07 135.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.209 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -141.45 82.86 1.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.492 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 68.38 44.7 72.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.223 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 86.04 -14.4 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.551 0.34 . . . . 0.0 111.539 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.87 127.56 39.69 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -141.48 149.54 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.471 0.653 . . . . 0.0 112.516 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 4.5 t-20 -117.69 166.81 11.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.94 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 57' ' ' THR . 72.2 m-85 -125.22 113.07 17.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.597 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -109.0 91.67 3.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 110.058 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.4 159.18 29.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.642 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.98 -12.81 52.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.216 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -91.53 25.64 2.57 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.841 0.353 . . . . 0.0 111.681 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.13 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.378 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.84 164.27 15.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.842 0.821 . . . . 0.0 109.903 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.47 142.32 11.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.7 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -149.07 125.89 11.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.847 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.2 p30 -92.92 152.79 19.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.417 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.22 15.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.074 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -168.07 132.7 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 0.0 111.274 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.426 ' CZ ' HG23 ' A' ' 48' ' ' ILE . 6.5 m-30 -79.64 110.33 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.48 -19.69 12.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.304 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -150.2 -175.64 5.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.27 57.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.064 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.69 -2.64 11.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.439 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -106.92 144.4 33.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.963 0.411 . . . . 0.0 110.643 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.607 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -130.54 143.98 51.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.509 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.425 ' N ' HD12 ' A' ' 68' ' ' LEU . 3.3 m170 -126.36 108.91 11.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.841 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 136.93 32.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.56 23.5 14.26 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.138 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.21 67.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.729 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.46 164.06 12.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.011 0.405 . . . . 0.0 111.064 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -116.46 107.64 15.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.607 ' HB2' HD13 ' A' ' 68' ' ' LEU . 24.7 m-85 -110.0 123.58 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.403 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.424 ' HB2' ' HG3' ' A' ' 79' ' ' LYS . 10.8 m-85 -101.2 140.91 34.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.799 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -58.31 147.51 30.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.226 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.6 mt-10 15.96 -62.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.674 1.19 . . . . 0.0 113.071 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.799 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.869 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtp . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.832 0.349 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.01 151.99 41.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -124.74 102.33 32.24 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 50.3 Cg_exo -55.22 163.6 4.48 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.827 2.351 . . . . 0.0 112.631 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.51 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 14.6 m-85 -145.49 -42.46 0.22 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.798 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 21' ' ' LEU . 20.5 t 60.57 128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.206 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.555 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.14 147.51 4.89 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.27 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.75 96.77 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.396 0.617 . . . . 0.0 110.009 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.2 m95 -88.88 108.59 19.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.8 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.9 t -116.42 155.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.402 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.44 -178.29 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.139 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . . . -81.84 -19.54 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.475 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.74 -27.2 11.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.72 0.295 . . . . 0.0 110.933 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 26.21 16.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.192 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.402 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -78.33 -29.32 47.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.353 . . . . 0.0 110.106 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.498 HD13 ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -139.45 157.3 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 4.2 ttp-105 -137.81 141.73 40.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.884 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.4 tt0 -131.01 111.92 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.594 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -94.76 127.71 40.95 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.047 0.451 . . . . 0.0 111.655 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.669 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.3 mt -91.89 114.01 26.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.3 156.53 88.06 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.57 -17.41 59.87 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.47 2.78 . . . . 0.0 112.498 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.22 23.75 6.32 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.842 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.09 53.95 23.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.905 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 4.5 mmm-85 -142.99 -179.76 6.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 0.0 111.251 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.42 149.72 48.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.396 0.617 . . . . 0.0 112.543 -178.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 112.02 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.435 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -104.03 132.36 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.353 0.597 . . . . 0.0 111.958 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.44 105.18 10.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -97.62 148.31 23.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.6 137.64 25.76 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.778 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 56.51 24.04 8.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -177.02 65.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 169.65 17.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.565 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.05 29.92 2.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 110.58 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.18 -52.45 61.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.636 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.41 153.58 36.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.187 0.518 . . . . 0.0 111.672 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.463 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.92 149.48 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.818 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.78 -120.32 0.54 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 119.691 -1.243 . . . . 0.0 113.075 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.14 164.18 38.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.503 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 4.8 p90 -139.7 154.72 47.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 112.354 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.9 127.34 52.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.824 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.51 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 78.2 t -104.15 131.37 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 112.078 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -142.72 100.48 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.741 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.26 42.84 95.64 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.369 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.98 -7.98 1.33 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 122.514 0.326 . . . . 0.0 111.703 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.82 127.19 39.43 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -136.97 148.65 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.194 0.521 . . . . 0.0 112.153 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.531 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.72 143.83 49.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.878 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 57' ' ' THR . 45.5 m-85 -98.95 114.66 27.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.037 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -109.03 90.25 3.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.929 0.395 . . . . 0.0 109.94 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.94 158.46 30.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.91 -12.81 52.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.981 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.1 t -91.38 25.14 2.68 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.848 0.356 . . . . 0.0 111.73 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.74 26.52 60.57 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.932 -0.651 . . . . 0.0 114.425 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.86 163.91 16.82 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.915 0.858 . . . . 0.0 109.935 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.37 142.37 12.77 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.882 178.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.34 121.74 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.477 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.49 156.08 19.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.085 0.469 . . . . 0.0 111.402 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.1 -174.76 35.13 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.4 p-10 -168.14 132.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.38 . . . . 0.0 111.328 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.42 110.29 5.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.716 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 m -82.31 -19.2 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.253 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -147.25 -168.68 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.77 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.197 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.94 -0.08 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.579 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -106.93 147.23 30.07 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.6 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -130.6 142.84 50.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 -179.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -126.19 107.8 10.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.213 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.96 137.72 25.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.691 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.69 22.26 39.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.915 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.63 23.39 64.84 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.368 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.02 164.45 14.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.217 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -117.03 107.5 14.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.54 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.6 ' HB2' HD11 ' A' ' 68' ' ' LEU . 22.0 m-85 -110.67 127.43 55.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 12' ' ' ALA . 15.2 m-85 -102.69 146.04 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.481 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.798 ' O ' ' N ' ' A' ' 79' ' ' LYS . 1.5 tpp85 -73.07 136.87 45.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.955 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 39.88 -56.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.688 1.195 . . . . 0.0 113.266 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.798 ' N ' ' O ' ' A' ' 77' ' ' ARG . 4.0 mtpm? . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.818 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.832 0.348 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -158.73 160.54 36.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -131.29 97.58 19.63 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 77.5 Cg_exo -51.83 165.12 0.85 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.795 2.33 . . . . 0.0 112.65 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 22.2 m-85 -146.26 -41.71 0.2 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 21' ' ' LEU . 19.2 t 60.53 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.57 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.62 146.58 4.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.79 96.93 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.496 0.665 . . . . 0.0 110.133 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.648 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 18.8 m95 -89.52 107.32 19.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.601 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 16' ' ' ILE . 79.6 t -113.28 155.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.401 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.76 172.75 5.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.193 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.77 -19.47 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.7 -25.95 13.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.94 24.14 36.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.151 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -26.07 44.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.279 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.508 HG22 ' HD2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -141.64 156.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.281 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -139.16 130.97 27.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.962 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 2.4 tt0 -117.64 112.67 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -93.74 127.33 39.41 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.648 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.1 mt -92.48 113.97 26.4 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.46 156.75 87.82 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -175.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.465 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.9 -17.18 58.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.448 2.765 . . . . 0.0 112.499 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.7 24.23 6.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.08 53.52 25.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.94 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.4 mmt85 -142.22 -179.78 6.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.649 0.261 . . . . 0.0 111.438 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.23 148.65 48.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.26 0.552 . . . . 0.0 112.424 -178.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 109.65 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.9 tt0 -102.9 134.29 46.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.396 0.617 . . . . 0.0 112.134 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.11 105.29 12.11 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.063 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HD2' HG22 ' A' ' 16' ' ' ILE . 6.5 mtm180 -103.66 117.44 34.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.385 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.3 -157.03 6.47 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.801 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -56.26 -23.22 34.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.694 0.283 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -89.24 83.61 6.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.506 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -75.73 172.0 13.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.428 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 4.3 m 43.87 34.56 0.92 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.295 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.59 -47.17 63.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.171 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 142.23 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.45 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -150.94 150.35 30.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.845 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.55 -122.73 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.037 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -154.14 164.05 39.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 4.0 p90 -138.73 157.34 46.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.612 0.72 . . . . 0.0 112.221 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -120.73 127.27 51.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.834 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.527 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 81.0 t -104.59 128.77 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 112.133 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.93 98.61 3.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.69 43.21 97.98 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.232 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.76 -6.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.458 0.303 . . . . 0.0 111.608 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.75 125.33 38.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -135.15 148.05 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.292 0.567 . . . . 0.0 111.995 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.544 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -134.9 145.24 48.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.675 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.7 m-85 -97.47 117.03 30.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.007 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.429 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.2 t90 -109.32 90.9 3.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.996 0.427 . . . . 0.0 109.953 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.61 155.64 40.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.742 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.35 -12.62 51.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.088 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -90.85 24.18 2.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 0.0 111.918 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.6 22.43 60.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.32 163.48 17.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.224 1.012 . . . . 0.0 109.893 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.89 141.29 14.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.897 178.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.21 178.37 6.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 22.5 p-10 -147.07 148.8 32.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.112 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -166.13 -174.09 35.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.329 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -168.12 129.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 48' ' ' ILE . 5.9 m-30 -68.58 110.5 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.48 . . . . 0.0 110.81 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.415 HG11 ' CD2' ' A' ' 69' ' ' HIS . 2.5 m -85.81 -17.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.273 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -148.37 -168.05 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.82 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.63 -26.92 29.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 0.97 7.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -107.18 146.54 31.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.61 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -130.53 142.88 50.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.415 ' CD2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.63 107.85 10.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.02 135.99 26.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.711 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.31 22.13 43.04 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.029 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.29 23.85 62.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.487 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.64 13.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.901 0.381 . . . . 0.0 111.017 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 m -118.17 107.43 13.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.874 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.6 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.3 m-85 -109.33 126.26 53.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.309 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -103.36 145.45 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.491 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.787 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -71.87 137.65 47.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.69 -179.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 39.83 -55.89 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.671 1.188 . . . . 0.0 113.354 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.787 ' N ' ' O ' ' A' ' 77' ' ' ARG . 2.4 mttt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.853 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.764 0.316 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.78 157.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -129.46 104.76 17.57 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.79 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 61.1 Cg_exo -53.22 164.45 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.798 2.332 . . . . 0.0 112.841 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 17.1 m-85 -146.43 -43.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 21' ' ' LEU . 17.4 t 60.74 129.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.285 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.561 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.69 146.95 4.65 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.418 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.79 96.96 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.518 0.675 . . . . 0.0 110.15 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.667 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.6 m95 -89.08 107.82 19.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.571 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.99 155.29 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.466 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.409 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.28 176.76 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.245 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.91 -19.95 53.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.36 -25.19 13.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.012 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.41 23.79 33.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.204 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.56 -27.23 55.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.85 0.357 . . . . 0.0 110.128 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.505 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -141.95 154.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.388 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.32 132.73 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 21.6 tt0 -121.82 114.13 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.891 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -93.34 128.55 39.41 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.514 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.4 mt -93.26 113.69 25.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 158.13 80.47 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.464 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.8 Cg_exo -63.26 -18.79 66.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.586 2.858 . . . . 0.0 112.868 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.66 20.92 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.741 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.37 51.27 27.66 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.382 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 87.5 mmt-85 -137.17 -179.81 5.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.599 -0.3 . . . . 0.0 110.927 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.6 152.32 50.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.426 0.632 . . . . 0.0 112.512 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.01 110.6 4.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.425 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -103.12 134.09 47.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 112.102 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.26 105.1 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.969 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -102.91 111.74 24.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.502 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.34 -150.72 11.04 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.884 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -58.54 -20.44 46.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.703 0.287 . . . . 0.0 111.167 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.68 76.91 4.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.838 0.352 . . . . 0.0 110.75 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.69 169.52 18.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.455 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 51.91 30.07 6.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.68 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -43.07 71.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.176 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.06 141.61 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.504 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.459 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.42 149.86 29.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.5 -122.46 0.64 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.912 -1.137 . . . . 0.0 113.088 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.03 164.18 38.87 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.489 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.6 p90 -138.45 156.73 47.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.537 0.684 . . . . 0.0 112.317 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -120.21 127.35 52.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.953 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 77.2 t -104.06 126.82 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 111.952 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -136.38 92.34 2.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 63.2 43.3 98.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.199 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 83.98 -10.25 0.93 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 122.558 0.343 . . . . 0.0 111.706 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.9 125.59 38.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -139.43 147.28 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.184 0.516 . . . . 0.0 112.263 -179.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -129.23 146.56 51.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.642 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 57' ' ' THR . 42.8 m-85 -97.08 118.26 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.38 0.133 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.411 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 30.4 t90 -109.47 91.29 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.145 0.498 . . . . 0.0 110.003 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.21 155.1 41.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.744 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.2 -12.65 52.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.055 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 t -90.17 23.52 2.83 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.885 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.45 22.32 58.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -121.05 162.73 19.48 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.251 1.026 . . . . 0.0 110.048 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.78 140.71 16.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.748 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 49' ' ' ASN . . . -125.66 178.47 5.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.4 p-10 -145.73 145.87 31.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -176.96 33.84 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.355 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.0 p-10 -168.1 123.62 1.0 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.059 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 4.9 m-30 -64.96 110.15 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 69' ' ' HIS . 2.8 m -83.48 -19.2 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.246 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.47 -166.33 2.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.4 -29.18 26.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.208 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.83 1.12 9.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.604 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -107.02 149.52 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.883 0.373 . . . . 0.0 110.705 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.61 144.53 49.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.437 ' CD2' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.4 108.24 11.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.413 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.45 134.96 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.61 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.22 23.55 18.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.16 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.72 66.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.698 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.35 163.87 12.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.956 0.407 . . . . 0.0 111.093 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 m -116.74 107.75 15.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.894 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.616 ' HB2' HD13 ' A' ' 68' ' ' LEU . 27.2 m-85 -109.78 127.57 54.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -103.7 145.96 29.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.26 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.798 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -72.56 137.87 46.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.916 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 39.88 -56.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.753 1.221 . . . . 0.0 113.249 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.798 ' N ' ' O ' ' A' ' 77' ' ' ARG . 3.7 mtpm? . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.8 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' O ' ' CD2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -89.58 -24.61 21.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.246 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.409 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 15.0 m80 -155.39 91.3 2.84 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.954 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 52.2 Cg_exo -55.73 163.04 5.88 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.693 2.262 . . . . 0.0 112.315 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.523 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 12.3 m-85 -143.29 -43.78 0.29 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.715 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 21' ' ' LEU . 21.1 t 60.6 129.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.572 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.9 147.37 4.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.273 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.23 96.88 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.582 0.706 . . . . 0.0 110.151 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.655 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.5 m95 -89.25 106.63 18.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.707 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 16' ' ' ILE . 74.8 t -113.67 155.76 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.267 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.67 178.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.129 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -79.09 -19.62 50.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -27.19 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.73 24.38 23.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.077 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -31.62 58.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 109.956 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.474 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -138.34 155.89 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.455 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.408 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -137.44 132.27 33.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.678 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.6 tt0 -120.32 112.61 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -93.2 127.6 38.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.539 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.655 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.2 mt -92.51 112.79 24.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.89 156.29 84.13 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.3 Cg_exo -63.68 -17.27 59.22 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.569 2.846 . . . . 0.0 112.514 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.09 23.71 6.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 53.45 25.73 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.882 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.9 mmm-85 -143.11 -179.78 6.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.457 0.17 . . . . 0.0 111.42 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.29 149.85 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.438 0.637 . . . . 0.0 112.639 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.92 111.89 5.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.358 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.43 135.65 45.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.394 0.616 . . . . 0.0 112.16 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.16 105.35 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.972 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -102.17 112.53 25.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.433 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.82 -150.54 9.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.946 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -58.13 -20.98 44.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 0.0 111.187 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 tpp85 -93.59 79.18 4.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.839 0.352 . . . . 0.0 110.73 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 169.33 17.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.439 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.18 29.58 6.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 110.762 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.89 -46.61 71.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.184 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 149.89 31.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.457 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.96 149.72 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.96 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.7 -121.59 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 119.826 -1.178 . . . . 0.0 112.926 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.01 162.72 40.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 5.5 p90 -136.86 155.52 49.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.381 0.61 . . . . 0.0 112.094 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.65 127.17 52.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.167 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 55.7 t -103.46 129.21 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.108 0.48 . . . . 0.0 111.973 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.31 94.34 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.653 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 61.66 42.81 99.82 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.259 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 84.17 -11.57 0.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.392 0.277 . . . . 0.0 111.725 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 128.96 40.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -143.85 153.43 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.225 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.522 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.37 151.0 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.907 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 57' ' ' THR . 51.3 m-85 -101.79 115.89 31.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.414 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 87.9 t90 -109.11 90.55 3.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.019 0.438 . . . . 0.0 110.12 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.62 158.84 28.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.778 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.14 -12.71 52.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.01 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.7 t -91.38 25.2 2.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.871 0.367 . . . . 0.0 111.72 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.19 25.73 61.15 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.014 -0.613 . . . . 0.0 114.505 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.02 163.71 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.044 0.922 . . . . 0.0 109.935 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.19 142.37 11.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.121 178.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.46 121.56 12.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.462 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -90.97 153.13 20.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 0.0 111.441 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -154.13 -164.92 13.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.223 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -168.09 133.31 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.042 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 8.7 m-30 -76.63 110.31 11.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.25 -10.17 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.043 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.85 156.51 11.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.824 0.345 . . . . 0.0 110.611 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.27 32.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.552 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -119.06 -10.53 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.853 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -106.66 147.84 29.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.633 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.16 143.23 49.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.289 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -126.45 108.78 11.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.847 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.529 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.38 136.44 29.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.61 22.96 34.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.21 63.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.538 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.01 164.33 13.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 m -117.84 107.58 14.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.006 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.633 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.4 m-85 -109.33 126.28 53.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.381 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.9 m-85 -103.81 145.36 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.252 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.766 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -72.33 137.7 46.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.933 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 42.64 -54.53 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 113.478 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' A' ' 77' ' ' ARG . 21.9 mtpp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.749 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.78 0.324 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -117.58 156.17 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -129.4 111.45 17.92 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 83.5 Cg_exo -46.78 160.92 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.721 2.281 . . . . 0.0 112.86 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.468 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.5 m-85 -136.62 -46.4 0.61 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 21' ' ' LEU . 22.1 t 59.9 125.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.548 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.27 148.63 5.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.14 96.68 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.181 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.626 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.7 m95 -89.22 106.71 18.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.612 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.7 t -111.08 155.78 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.349 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.32 172.14 7.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.228 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.94 60.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.13 -16.86 14.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 17.13 68.58 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.293 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -23.41 62.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 0.0 110.284 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.44 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -147.71 156.4 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.563 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.77 131.32 31.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.771 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 27.9 tt0 -119.2 112.55 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.004 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -92.64 127.14 38.03 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 111.326 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.626 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 11.8 mt -93.08 112.66 24.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.549 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.58 156.69 81.77 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 27.9 Cg_exo -62.92 -17.97 62.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.583 2.855 . . . . 0.0 112.438 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -94.74 21.95 6.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.942 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.34 50.5 38.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 84.5 mmt-85 -139.36 -179.73 6.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.385 0.136 . . . . 0.0 111.02 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -135.36 150.99 50.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 0.0 112.758 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.69 109.93 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.275 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 3.1 tt0 -103.26 134.51 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.393 0.616 . . . . 0.0 112.183 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.61 105.29 11.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.061 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -103.79 116.99 33.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.34 -153.46 6.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.906 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -58.04 -21.3 44.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.679 0.276 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -92.48 80.84 4.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.701 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 169.67 17.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.413 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.28 30.83 6.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 110.669 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.21 -45.61 68.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.069 0.461 . . . . 0.0 111.084 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 152.42 35.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.282 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -158.89 149.9 20.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.075 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.71 -128.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.908 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.14 164.2 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.464 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 0.8 OUTLIER -133.47 157.38 45.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.502 0.668 . . . . 0.0 112.184 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.1 tt0 -119.87 127.47 52.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.983 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.468 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 54.6 t -102.88 126.08 57.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.141 0.496 . . . . 0.0 112.214 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -137.2 88.62 2.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.669 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 64.83 43.85 95.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.398 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 84.47 -12.15 0.78 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.43 0.292 . . . . 0.0 111.66 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.71 127.02 39.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -140.18 151.07 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.043 -179.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.447 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.43 145.15 50.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.987 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 57' ' ' THR . 34.5 m-85 -93.49 117.24 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.952 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -109.28 91.36 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.977 0.418 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.417 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -71.4 155.37 40.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.684 -179.176 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.22 -12.72 51.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.029 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -90.66 24.12 2.8 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.73 22.4 59.94 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 114.87 0.708 . . . . 0.0 114.87 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.52 163.4 17.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.318 1.059 . . . . 0.0 109.935 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.57 140.7 13.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.934 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 49' ' ' ASN . . . -127.07 178.31 6.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.069 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 28.4 p-10 -146.78 146.76 30.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.163 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -157.66 -170.56 22.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 9.5 p-10 -168.04 123.12 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.563 ' CE2' HG22 ' A' ' 48' ' ' ILE . 89.8 m-85 -65.82 110.34 2.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.7 m -91.14 -6.02 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.29 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.14 173.49 10.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.44 -22.45 63.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.22 1.56 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.783 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -111.25 149.06 31.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.927 0.394 . . . . 0.0 111.006 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.95 144.08 48.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.299 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.403 ' N ' HD12 ' A' ' 68' ' ' LEU . 4.5 m170 -126.5 107.91 10.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.48 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.48 141.55 29.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 179.197 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.19 19.13 22.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.084 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.04 68.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.999 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ttm -115.72 171.8 7.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.289 0.545 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.8 m -117.54 107.99 14.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.711 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.644 ' HB2' HD13 ' A' ' 68' ' ' LEU . 20.5 m-85 -106.03 121.88 45.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -100.39 147.12 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.788 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -73.01 137.43 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.8 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 40.02 -55.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.79 1.236 . . . . 0.0 113.416 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 77' ' ' ARG . 13.5 mtpp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.855 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpp . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.762 0.315 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.87 161.54 13.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -116.86 104.19 51.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 76.6 Cg_exo -51.67 164.11 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.588 2.192 . . . . 0.0 112.67 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.505 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 7.5 m-85 -144.48 -44.09 0.25 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.6 t 61.58 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.591 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.48 145.0 4.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.393 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.67 96.56 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.516 0.674 . . . . 0.0 109.872 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.645 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.0 m95 -85.87 108.04 17.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.243 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 17' ' ' ARG . 72.9 t -113.41 155.07 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.849 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.407 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -66.38 -177.04 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.311 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -83.09 -20.1 35.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.526 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.61 -25.26 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.77 25.77 24.23 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.022 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -78.03 -28.01 48.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.132 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.466 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.98 155.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.376 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -138.69 138.1 37.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -124.3 111.95 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.937 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -90.09 125.21 35.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.645 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.2 mt -92.61 113.54 25.85 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.16 158.26 82.11 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -176.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -63.65 -18.84 65.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.642 2.894 . . . . 0.0 112.868 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.78 22.27 7.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.331 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.68 53.03 22.1 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.575 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -138.64 179.06 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.849 -0.175 . . . . 0.0 110.954 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.01 152.75 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.474 0.654 . . . . 0.0 112.745 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.04 110.56 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.28 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.89 134.99 45.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.423 0.63 . . . . 0.0 112.079 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.37 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.161 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -100.24 111.86 24.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.361 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.06 -148.48 10.67 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.932 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -58.38 -20.63 45.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.556 0.217 . . . . 0.0 111.226 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -94.7 80.5 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.775 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 169.25 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.589 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.1 30.2 7.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.799 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.17 -44.44 75.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.163 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 142.1 22.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.38 149.79 28.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.93 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.39 -122.57 0.64 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.038 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.04 163.6 39.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 4.7 p90 -138.92 154.92 48.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.516 0.674 . . . . 0.0 112.31 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -120.39 127.47 52.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.285 178.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 58.0 t -102.27 132.01 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 112.003 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -138.59 83.32 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.715 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 68.29 44.46 74.87 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.183 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 85.6 -13.02 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.593 0.357 . . . . 0.0 111.441 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 126.02 38.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.035 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -141.77 147.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 4.8 t-20 -118.41 166.72 12.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.847 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 57' ' ' THR . 73.1 m-85 -125.17 113.59 17.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.642 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.402 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 84.6 t90 -108.82 91.39 3.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.041 0.448 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.12 160.06 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.439 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.08 -12.8 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.26 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.95 25.58 2.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.888 0.375 . . . . 0.0 111.72 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.88 25.73 61.8 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.384 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 164.5 14.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.839 0.819 . . . . 0.0 109.908 179.041 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.16 143.03 12.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.75 177.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -146.78 124.5 11.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.872 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 29.6 t70 -91.23 153.14 20.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.52 -168.93 17.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.104 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 11.2 p-10 -168.09 132.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.476 ' CZ ' HG22 ' A' ' 48' ' ' ILE . 7.4 m-30 -77.28 110.35 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' A' ' 69' ' ' HIS . 3.1 m -83.94 -14.63 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.396 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 t -156.42 179.83 8.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.99 62.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.289 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.3 -3.15 10.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.494 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.84 145.61 31.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.61 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -131.74 143.82 50.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.301 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.431 ' CD2' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.4 109.08 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.896 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.53 136.0 32.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.663 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.17 23.73 18.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.192 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.99 19.44 67.38 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.726 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 164.54 12.44 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.04 0.448 . . . . 0.0 111.016 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.422 HG21 ' CZ ' ' A' ' 76' ' ' TYR . 3.6 m -117.22 107.58 14.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.61 ' HB2' HD13 ' A' ' 68' ' ' LEU . 34.4 m-85 -109.76 122.94 48.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.484 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 74' ' ' THR . 12.1 m-85 -100.21 141.86 32.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.812 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -59.63 148.45 33.65 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.026 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.1 mt-10 17.81 -62.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.758 1.223 . . . . 0.0 113.125 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.812 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.862 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.899 0.38 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.61 160.78 29.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -108.28 109.11 61.68 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 49.5 Cg_exo -57.49 162.65 9.84 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.718 2.279 . . . . 0.0 112.546 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 13.5 m-85 -145.38 -42.75 0.22 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' LEU . 18.9 t 60.31 129.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.14 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.57 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.16 147.67 4.9 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.295 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.86 96.79 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 110.225 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.661 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.7 m95 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.748 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 16' ' ' ILE . 68.9 t -114.11 155.7 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.83 176.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.146 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -78.01 -19.47 54.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.93 -23.84 13.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.22 21.76 40.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.334 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -24.65 59.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.716 0.293 . . . . 0.0 110.392 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.46 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.36 156.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.301 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -137.58 135.41 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.9 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 5.3 tt0 -122.34 113.6 19.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.6 126.92 41.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.079 0.466 . . . . 0.0 111.457 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 10.0 mt -91.64 113.64 25.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.05 157.63 86.44 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.056 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.42 -13.49 38.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.326 2.684 . . . . 0.0 111.852 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -93.89 20.09 8.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.145 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.6 49.89 65.89 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.5 mmt85 -137.37 -179.84 5.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.129 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.19 149.28 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.16 112.14 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.441 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -104.24 132.66 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.324 0.583 . . . . 0.0 112.15 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.74 105.37 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.983 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.419 ' HD2' ' CG2' ' A' ' 16' ' ' ILE . 7.2 mtm180 -97.58 149.53 22.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.137 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.51 138.7 13.16 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.992 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 56.92 22.16 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 0.0 111.268 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -177.8 79.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.025 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 169.21 14.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.398 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.87 29.56 2.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.984 0.421 . . . . 0.0 110.515 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.99 -51.18 67.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.71 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.7 27.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 111.794 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.97 149.78 26.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.541 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.23 -122.14 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.699 -1.239 . . . . 0.0 113.194 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.11 164.12 39.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.464 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 6.7 p90 -139.31 155.68 47.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.519 0.676 . . . . 0.0 112.275 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.89 127.15 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.89 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.514 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 78.5 t -104.32 129.89 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.463 . . . . 0.0 112.097 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 99.6 3.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.707 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.73 42.93 96.63 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.306 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.0 -7.76 1.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.393 0.277 . . . . 0.0 111.629 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.93 126.43 39.13 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -137.28 148.87 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.221 0.534 . . . . 0.0 112.237 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.541 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.29 144.68 49.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.789 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.675 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.4 m-85 -98.61 115.06 27.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.012 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.7 t90 -109.05 90.45 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.035 0.445 . . . . 0.0 109.899 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.68 158.91 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.08 -12.63 52.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.038 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.55 25.29 2.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.796 0.331 . . . . 0.0 111.711 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.45 26.76 60.68 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.14 164.17 15.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.768 0.784 . . . . 0.0 109.765 179.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.34 142.68 11.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.965 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.68 121.65 12.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.5 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 9.9 p-10 -88.95 157.61 18.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 111.651 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.16 -172.1 32.2 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.888 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -168.17 132.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.308 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.8 m-30 -71.63 110.24 6.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.0 m -81.74 -18.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.335 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 t -148.61 -168.47 3.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.853 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.95 -28.25 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.194 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 -0.13 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.582 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -106.89 147.75 29.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.74 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.612 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -131.64 142.24 49.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.402 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.2 m170 -126.39 107.88 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.72 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.67 135.61 26.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.7 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.67 21.7 43.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.1 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.92 24.53 59.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.418 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -115.43 164.71 13.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -118.26 107.37 13.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.063 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' HD11 ' A' ' 68' ' ' LEU . 29.1 m-85 -109.83 127.77 54.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.34 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.424 ' CD1' ' HE3' ' A' ' 79' ' ' LYS . 15.2 m-85 -104.17 146.31 28.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.754 ' O ' ' N ' ' A' ' 79' ' ' LYS . 1.3 tpp85 -73.37 135.42 44.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.916 0.389 . . . . 0.0 111.991 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 44.01 -55.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.599 1.16 . . . . 0.0 113.37 178.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' A' ' 77' ' ' ARG . 7.2 mttm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.878 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.833 0.349 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -114.68 160.79 18.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -118.11 100.21 51.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 67.0 Cg_exo -53.09 164.45 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.726 2.284 . . . . 0.0 112.656 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.509 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 14.6 m-85 -145.58 -42.29 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.866 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 21' ' ' LEU . 20.0 t 60.19 128.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.029 0.443 . . . . 0.0 111.263 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.58 148.45 5.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.242 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -96.05 96.57 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.592 0.711 . . . . 0.0 110.035 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.1 m95 -88.42 107.63 18.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.597 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.44 155.74 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.411 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.76 176.9 1.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.385 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.5 -19.9 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.574 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.41 -24.82 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.707 0.289 . . . . 0.0 110.945 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.15 22.98 30.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.461 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -28.32 56.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.81 0.338 . . . . 0.0 110.165 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.499 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -139.1 158.39 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 3.7 ttp180 -138.67 142.76 39.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.804 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 14.9 tt0 -130.21 111.88 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -95.14 127.11 40.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.669 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.5 mt -92.14 113.91 26.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.27 156.58 87.84 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.44 -17.57 60.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.62 2.88 . . . . 0.0 112.474 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -95.86 23.26 6.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.44 53.55 24.38 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.846 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.8 mmt85 -141.94 -179.97 6.53 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 111.413 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.08 149.28 47.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 112.562 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.33 110.93 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.381 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.66 134.08 47.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.61 . . . . 0.0 112.277 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.32 105.03 11.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.775 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HD2' HG23 ' A' ' 16' ' ' ILE . 12.9 mtm180 -100.28 108.05 20.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.36 -148.95 13.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.859 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -57.06 -22.03 36.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.74 0.305 . . . . 0.0 111.188 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -93.52 79.96 4.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.625 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 169.45 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.49 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.72 29.66 6.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.399 . . . . 0.0 110.626 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.08 -47.09 72.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.117 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.84 141.84 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.469 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.14 149.9 29.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.737 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.32 -120.74 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 119.833 -1.175 . . . . 0.0 113.03 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 164.02 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 5.4 p90 -138.42 155.78 48.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.484 0.659 . . . . 0.0 112.276 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -120.46 127.28 52.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.843 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 73.2 t -105.2 130.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.537 . . . . 0.0 112.085 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.19 96.91 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.777 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 60.5 43.85 98.36 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.351 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 82.13 -7.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.417 0.287 . . . . 0.0 111.563 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.79 124.91 38.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.5 148.15 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.0 112.153 -178.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.559 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.5 144.09 49.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.895 178.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.5 m-85 -99.35 115.04 28.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -109.14 90.18 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.012 0.434 . . . . 0.0 109.849 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.65 158.69 29.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.704 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -85.09 -12.7 52.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.975 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.5 t -91.41 25.26 2.65 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 120.907 0.384 . . . . 0.0 111.807 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 26.09 61.22 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.026 -0.606 . . . . 0.0 114.467 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.9 164.09 15.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.873 0.836 . . . . 0.0 109.918 179.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.95 142.69 12.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.94 178.07 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.72 121.7 12.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.601 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.0 p30 -89.44 156.24 18.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.585 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.53 -171.67 30.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.025 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.3 p-10 -168.19 133.74 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.236 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.481 ' CE1' HG22 ' A' ' 48' ' ' ILE . 8.3 m-30 -73.57 110.42 7.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.438 HG13 ' CD2' ' A' ' 69' ' ' HIS . 3.1 m -82.28 -18.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.215 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.46 -168.81 3.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.876 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.82 -27.62 28.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.01 2.05 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.588 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -108.97 149.8 28.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 110.78 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -133.2 143.46 49.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.438 ' CD2' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.37 107.77 10.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.246 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.99 137.33 17.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.224 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.86 13.19 58.91 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.762 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.23 20.18 59.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.945 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.4 ttm -120.49 171.57 8.45 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.216 0.508 . . . . 0.0 111.714 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 m -116.41 107.64 15.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.348 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.598 ' HB2' HD13 ' A' ' 68' ' ' LEU . 13.6 m-85 -106.01 127.77 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.334 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -102.46 147.13 27.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.728 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 79' ' ' LYS . 2.1 tpp85 -75.71 130.42 38.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.103 0.478 . . . . 0.0 112.228 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 53.73 -35.37 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 178.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.819 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.893 0.377 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.18 163.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -119.46 100.07 49.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 55.0 Cg_exo -53.89 163.6 2.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.732 2.288 . . . . 0.0 112.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.538 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 9.7 m-85 -145.77 -43.43 0.21 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.792 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 19.9 t 60.86 129.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 111.286 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.583 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.29 145.49 4.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -91.94 96.82 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.36 0.6 . . . . 0.0 110.141 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.5 m95 -88.24 108.18 19.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.405 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.75 155.15 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.694 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.409 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.94 -176.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.312 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.53 -20.41 33.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.584 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.67 -24.47 12.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.987 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.87 23.79 26.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.024 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -74.96 -30.66 61.27 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.44 155.81 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.58 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -137.93 128.66 26.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.9 tt0 -116.31 112.2 21.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.92 126.83 38.2 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.504 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.654 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 10.0 mt -91.84 113.26 25.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.04 157.41 87.09 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.5 Cg_exo -64.72 -13.18 37.7 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.445 2.763 . . . . 0.0 111.854 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -93.89 20.3 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.173 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.46 50.4 62.52 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -139.93 -179.91 6.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.971 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.25 149.57 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.59 110.34 5.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.255 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.59 133.09 49.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.414 0.626 . . . . 0.0 112.288 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.85 105.45 11.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.905 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HD2' ' CG2' ' A' ' 16' ' ' ILE . 20.8 mtm-85 -101.6 109.45 21.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.11 -150.73 18.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.799 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.83 -21.28 41.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.721 0.296 . . . . 0.0 111.096 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.18 80.4 4.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.922 0.391 . . . . 0.0 110.624 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 168.88 18.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.645 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.0 30.35 7.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.943 0.402 . . . . 0.0 110.714 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.57 -47.11 73.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.229 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 143.59 25.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.464 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.82 149.9 29.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.877 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.03 -123.65 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.899 -1.144 . . . . 0.0 113.025 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.04 164.05 39.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CZ ' HD12 ' A' ' 20' ' ' LEU . 4.5 p90 -139.78 154.74 47.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 112.142 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.78 127.34 52.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.249 178.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 55.9 t -102.84 129.49 54.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.857 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.68 92.26 2.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.629 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 62.5 43.61 98.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.357 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.7 0.85 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 122.461 0.304 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.9 128.9 40.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -146.36 151.5 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.073 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 48' ' ' ILE . 1.3 m-20 -127.24 171.17 11.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.551 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' A' ' 57' ' ' THR . 79.1 m-85 -124.1 114.84 20.24 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.08 90.99 3.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.64 160.39 22.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.694 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -12.76 52.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.157 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -92.19 25.32 2.94 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.821 0.343 . . . . 0.0 111.719 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 25.79 61.67 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.59 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.16 164.32 14.95 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 117.82 0.81 . . . . 0.0 109.783 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.62 142.48 10.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.008 177.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -143.93 121.55 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.545 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p-10 -90.37 150.75 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 0.0 111.523 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -156.24 -171.92 23.08 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.109 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 2.0 p30 -168.28 132.97 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.262 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 48' ' ' ILE . 5.6 m-30 -73.1 110.33 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.93 -18.91 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.335 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -147.3 -169.04 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.99 -29.28 32.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.217 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.77 -0.14 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.512 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.82 148.8 28.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 110.702 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.42 144.4 49.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -126.35 108.76 11.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.85 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.425 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.95 135.32 32.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.621 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.04 23.72 17.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.276 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.62 18.95 67.07 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.717 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -108.76 164.05 12.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 111.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.5 m -116.73 107.66 14.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.626 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.0 m-85 -110.27 124.63 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.099 0.476 . . . . 0.0 111.667 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -97.72 147.18 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.769 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.478 ' CD ' ' CE2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -73.03 140.68 47.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.33 0.586 . . . . 0.0 112.318 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER 27.84 104.37 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.289 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt . . . . . 0 C--N 1.308 -1.235 0 CA-C-N 113.237 -1.801 . . . . 0.0 110.931 179.656 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.891 0.377 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.02 164.62 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -130.34 113.99 17.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 47.9 Cg_exo -57.61 161.76 11.64 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.79 2.327 . . . . 0.0 112.476 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 10.8 m-85 -145.54 -43.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 20.5 t 60.8 128.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.352 . . . . 0.0 111.302 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.582 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.76 147.23 4.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.324 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.8 98.85 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.356 0.598 . . . . 0.0 110.206 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.638 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.7 m95 -91.38 105.34 17.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.707 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.7 t -109.98 155.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.282 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.42 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.72 178.67 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.368 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.97 -20.27 49.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.62 -24.6 13.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.14 23.56 31.86 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.59 -0.815 . . . . 0.0 112.234 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.52 -27.73 58.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.068 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.5 155.89 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.589 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 126.13 22.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.519 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 35.4 tt0 -115.72 114.35 24.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.672 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -94.33 127.15 40.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.367 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.638 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 10.8 mt -90.65 112.75 24.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.39 157.62 84.94 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.31 -13.4 37.97 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.291 2.661 . . . . 0.0 111.872 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -93.56 19.93 7.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.192 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.41 50.22 64.06 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.0 mmt85 -139.8 -179.89 6.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.527 -0.337 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -135.95 149.63 48.98 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.73 114.64 6.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.181 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -105.66 132.23 52.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.0 112.185 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -113.64 105.18 13.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.058 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -108.36 128.37 54.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.406 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.73 -148.49 31.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.598 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -67.43 -25.41 65.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.629 0.252 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -89.86 109.23 20.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.628 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.37 169.55 10.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.103 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 47.39 29.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.692 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.52 -34.92 27.12 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.782 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.53 140.1 19.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.042 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.44 149.76 29.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.927 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.68 -123.92 0.7 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.982 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.03 164.0 39.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.474 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 6.9 p90 -138.34 155.08 48.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.443 0.64 . . . . 0.0 112.056 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.2 tt0 -119.75 127.25 52.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.069 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 67.6 t -104.42 127.27 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.969 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.26 91.99 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.414 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 63.21 43.25 98.85 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.14 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.05 0.89 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.506 0.322 . . . . 0.0 111.564 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.75 127.11 39.3 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -143.19 152.68 16.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 112.252 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.516 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.46 149.3 51.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.858 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.81 115.44 30.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 t90 -109.08 90.43 3.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.69 157.83 33.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.604 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -85.16 -12.68 52.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -91.73 24.31 3.19 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.878 0.371 . . . . 0.0 111.866 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.18 22.77 60.23 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 163.48 16.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.172 0.986 . . . . 0.0 109.963 179.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.46 11.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.879 178.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.98 121.68 11.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.648 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 6.9 p-10 -90.33 152.22 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 111.346 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -154.03 -167.58 16.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.024 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.7 p-10 -168.11 130.8 1.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.319 . . . . 0.0 111.218 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.483 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 7.6 m-30 -74.03 110.04 8.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.688 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -86.58 -11.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -158.59 -177.95 6.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.835 0.35 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -25.77 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.259 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.01 1.52 7.98 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.631 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -109.43 147.87 32.11 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.819 0.342 . . . . 0.0 110.792 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.27 144.15 49.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.4 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.47 109.25 11.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.915 0.388 . . . . 0.0 110.712 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.421 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.37 134.49 30.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.11 22.96 22.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.144 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.69 67.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.752 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.49 163.55 12.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 111.041 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 m -116.77 107.64 14.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.775 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 68' ' ' LEU . 28.4 m-85 -108.98 125.11 51.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -102.08 147.12 26.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.331 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.782 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -74.26 137.17 42.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.812 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 41.16 -56.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.607 1.163 . . . . 0.0 113.012 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.782 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.909 0.385 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.32 160.57 32.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -117.59 113.05 38.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.805 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 31.3 Cg_exo -60.47 160.96 21.95 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.702 2.268 . . . . 0.0 112.562 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.469 ' CE1' HG22 ' A' ' 43' ' ' VAL . 15.0 m-85 -143.78 -42.62 0.28 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 21' ' ' LEU . 18.6 t 60.73 131.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.45 144.98 4.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.36 96.55 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.523 0.678 . . . . 0.0 109.782 179.288 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.673 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 26.0 m95 -86.48 109.88 19.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.167 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.3 t -115.24 154.82 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.777 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.409 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.06 -176.88 0.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.15 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 76' ' ' TYR . . . -83.33 -19.97 35.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.6 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.1 -27.04 12.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 24.98 18.02 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.055 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.09 -31.06 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.467 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.31 155.48 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.407 ' N ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -138.31 131.23 29.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.686 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.7 tt0 -118.38 113.75 21.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.828 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.16 125.68 36.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.552 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 6.8 mt -90.9 112.13 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.57 156.64 81.9 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.456 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.18 -17.81 61.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.513 2.809 . . . . 0.0 112.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.61 23.11 6.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.46 52.03 33.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.005 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -140.05 -179.79 6.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.382 0.134 . . . . 0.0 110.963 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.467 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.69 149.95 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.17 111.23 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.523 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -102.93 134.33 46.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.968 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.79 105.27 11.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.321 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -104.29 115.68 30.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.316 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.4 -153.78 7.55 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.894 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -58.04 -21.74 46.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.699 0.285 . . . . 0.0 111.154 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -91.94 82.33 5.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.86 0.362 . . . . 0.0 110.755 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.71 169.21 18.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.486 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 51.88 29.12 5.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.694 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.77 -43.46 58.46 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.998 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.04 140.06 19.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.217 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.43 150.1 29.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.735 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.95 -122.52 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.054 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.99 39.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.481 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.3 p90 -138.02 157.89 45.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.539 0.685 . . . . 0.0 112.403 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -122.54 127.42 49.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.804 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.469 HG22 ' CE1' ' A' ' 5' ' ' TYR . 79.2 t -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 82.57 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.17 -96.35 2.05 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.99 15.26 7.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -111.12 141.42 44.65 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.173 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.55 HG12 ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -147.66 148.26 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.244 -179.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.55 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.3 144.92 50.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.708 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.645 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -102.2 115.4 30.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.157 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -109.23 90.64 3.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.7 157.82 33.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.74 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.12 -12.7 52.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.199 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.7 24.77 2.96 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.9 0.381 . . . . 0.0 111.898 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.3 23.36 61.07 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.766 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.64 164.02 15.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.049 0.924 . . . . 0.0 109.931 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.25 141.34 12.21 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.735 177.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.34 121.76 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.619 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.67 151.16 20.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 111.465 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.12 -170.98 26.49 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.875 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.415 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.9 p-10 -168.15 132.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.485 ' CE1' ' CG2' ' A' ' 48' ' ' ILE . 8.3 m-30 -68.28 110.18 3.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.516 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.433 HG13 ' CD2' ' A' ' 69' ' ' HIS . 2.6 m -84.86 -16.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.284 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -152.03 -175.26 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 0.0 110.813 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.76 -26.69 50.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -122.48 -2.38 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.646 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -106.98 144.86 32.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 111.004 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.619 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -129.97 143.58 50.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.365 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.433 ' CD2' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.64 107.82 10.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.522 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -143.71 137.42 28.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.607 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.52 22.82 40.33 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.091 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.87 62.17 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 165.94 12.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 0.0 111.151 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 m -118.07 107.54 14.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.082 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.617 ' HB2' HD13 ' A' ' 68' ' ' LEU . 30.5 m-85 -110.72 126.64 54.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.328 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.418 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 10.8 m-85 -103.19 141.71 35.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.816 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.812 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -58.28 146.18 35.1 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.899 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.2 mt-10 15.29 -61.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.553 1.141 . . . . 0.0 113.104 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.812 ' N ' ' O ' ' A' ' 77' ' ' ARG . 1.1 mtpm? . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.86 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.696 0.284 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.89 167.43 12.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.954 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -139.31 115.8 8.48 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.4 Cg_exo -59.04 162.04 14.57 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.748 2.299 . . . . 0.0 112.46 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 14.5 m-85 -145.38 -42.88 0.22 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.888 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.547 HG21 ' O ' ' A' ' 21' ' ' LEU . 17.5 t 60.72 129.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 111.265 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.85 147.29 4.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.342 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.8 96.89 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 110.119 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.638 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.2 m95 -88.91 106.95 18.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.729 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.6 t -114.33 155.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.376 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.406 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.27 178.95 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.182 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.0 -18.79 49.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.5 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.48 -27.54 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 26.3 18.83 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.158 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.406 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -79.08 -28.4 43.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.133 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.463 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 155.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.35 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -137.19 137.8 39.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.834 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.5 tt0 -125.17 112.94 17.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.731 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.4 127.4 39.01 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.588 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.638 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.3 mt -93.09 113.0 25.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.547 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.36 158.01 79.66 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.53 -18.91 66.5 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.644 2.896 . . . . 0.0 112.953 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.23 21.54 7.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.62 52.33 21.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.473 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 10.3 mmt180 -138.39 179.89 6.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.21 . . . . 0.0 111.115 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -138.53 153.01 48.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.471 0.653 . . . . 0.0 112.561 -178.138 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.22 111.76 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.92 131.33 49.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.306 0.574 . . . . 0.0 111.962 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.27 105.28 11.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.143 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -97.76 149.27 22.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.97 139.83 17.98 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.938 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 57.48 21.84 7.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.596 0.236 . . . . 0.0 111.072 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.2 tpp85 -179.24 78.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.959 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 169.66 13.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.432 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.05 29.52 2.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.967 0.413 . . . . 0.0 110.548 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.86 66.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.531 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.77 148.18 28.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.242 0.544 . . . . 0.0 111.766 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.491 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.73 149.67 25.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.3 -122.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.651 -1.261 . . . . 0.0 113.108 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.09 163.77 39.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.47 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 7.5 p90 -137.9 156.4 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 0.0 112.414 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -120.98 127.27 51.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.729 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.511 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 75.5 t -105.2 131.93 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.183 0.515 . . . . 0.0 112.226 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -142.94 101.45 3.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.651 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.87 42.94 94.93 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.406 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.72 -6.9 1.46 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.458 0.303 . . . . 0.0 111.679 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.84 126.24 38.92 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.54 148.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.302 0.572 . . . . 0.0 112.069 -178.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.558 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.35 143.25 48.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.952 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.7 m-85 -99.5 113.97 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.946 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -109.1 89.9 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.99 0.424 . . . . 0.0 109.985 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.439 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.8 158.07 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.648 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.93 -12.68 52.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.164 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -92.0 24.84 3.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.852 0.358 . . . . 0.0 111.708 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 27.26 55.97 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.621 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.38 164.1 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.006 0.903 . . . . 0.0 109.823 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.36 143.05 11.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.125 178.063 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.59 121.79 12.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.553 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.81 155.16 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 0.0 111.541 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -171.77 27.6 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.051 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 3.8 p-10 -168.21 133.88 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.341 . . . . 0.0 111.15 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.481 ' CE1' HG22 ' A' ' 48' ' ' ILE . 9.4 m-30 -75.63 110.33 9.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 69' ' ' HIS . 2.5 m -83.24 -18.43 10.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.881 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.21 174.72 13.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.38 -21.57 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.298 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -121.41 -8.55 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.802 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -106.61 149.01 27.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 111.166 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.612 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -131.4 142.41 50.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.278 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.427 ' CD2' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.64 107.88 10.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.8 135.8 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.724 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.69 21.84 44.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.049 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.24 25.13 59.93 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.389 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.86 165.15 13.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.991 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -118.59 107.44 13.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.004 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 68' ' ' LEU . 31.1 m-85 -110.14 128.78 55.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -105.02 145.83 29.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.817 ' O ' ' N ' ' A' ' 79' ' ' LYS . 1.1 tpp85 -72.26 136.78 46.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 38.47 -57.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.569 1.148 . . . . 0.0 113.1 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.817 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.291 -0.862 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.09 148.45 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -109.86 112.42 58.13 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.829 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.0 Cg_exo -58.97 161.28 16.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.72 2.28 . . . . 0.0 112.507 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.505 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 11.7 m-85 -144.79 -43.29 0.24 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.801 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 21' ' ' LEU . 20.9 t 61.22 130.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.933 0.397 . . . . 0.0 111.401 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.582 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 155.69 145.82 4.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.254 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.98 96.8 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 121.452 0.644 . . . . 0.0 109.84 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.662 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.8 m95 -87.41 109.8 19.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.419 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.1 t -117.22 155.0 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.766 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -176.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.219 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . . . -83.13 -20.19 35.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.69 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -23.39 12.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.317 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.48 21.66 33.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.376 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -25.46 61.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.29 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.457 HD11 ' HG3' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -146.83 155.3 11.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.389 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -136.0 138.75 42.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.644 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.2 tt0 -125.33 111.88 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -92.51 125.63 37.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 111.535 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 8.4 mt -91.61 111.98 23.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -64.78 155.97 80.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -176.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.4 Cg_exo -64.11 -16.76 56.77 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.571 2.848 . . . . 0.0 112.47 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.38 23.6 6.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.769 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.52 53.6 23.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.926 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 5.6 mmm-85 -143.3 -179.85 6.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.512 0.196 . . . . 0.0 111.31 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.03 150.1 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.494 0.664 . . . . 0.0 112.716 -178.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.47 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.221 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.79 137.6 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.368 0.604 . . . . 0.0 112.448 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . . . -124.15 105.57 9.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.851 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -98.01 107.14 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.023 0.44 . . . . 0.0 111.867 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 46.74 -143.17 5.18 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.25 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -50.55 -27.06 6.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.248 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -96.57 100.66 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.605 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -102.52 170.03 8.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.495 179.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.8 27.68 3.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.392 . . . . 0.0 110.491 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.45 67.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.287 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.72 150.44 32.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.326 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -159.39 149.88 19.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.98 179.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.67 -121.38 0.58 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.913 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.81 39.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.9 p90 -138.64 154.11 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 112.274 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -119.84 127.29 52.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.828 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 72.4 t -104.2 131.37 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.178 0.513 . . . . 0.0 112.01 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.05 100.85 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.24 42.81 95.59 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.335 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.61 -7.22 1.45 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.369 0.268 . . . . 0.0 111.53 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.02 39.4 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.551 HG12 ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -136.1 148.43 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 112.167 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.551 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.45 144.81 49.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.881 178.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.97 114.48 28.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.136 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -109.08 90.34 3.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.031 0.443 . . . . 0.0 109.955 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.86 158.52 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.65 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.04 -12.6 52.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.99 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -91.58 24.81 2.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.787 0.327 . . . . 0.0 111.752 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.64 25.61 60.39 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.5 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.61 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.99 163.44 16.94 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 117.888 0.844 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.31 142.24 12.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.46 121.71 13.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.488 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -90.63 154.79 19.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.69 -172.5 31.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.922 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.9 p-10 -168.18 132.93 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.861 0.362 . . . . 0.0 111.305 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.465 ' CE1' HG22 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.73 110.28 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 69' ' ' HIS . 3.1 m -82.71 -18.58 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.407 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -170.02 3.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.46 -29.34 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.158 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 0.21 9.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.656 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -106.89 149.53 27.35 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.383 . . . . 0.0 110.664 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.619 ' CD1' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -134.04 144.46 48.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.442 ' CD2' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.875 0.369 . . . . 0.0 110.908 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.447 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.38 136.04 32.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.491 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.08 23.58 17.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.245 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.56 67.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.743 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.68 164.82 12.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.848 0.356 . . . . 0.0 111.072 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.6 m -117.26 107.77 14.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.02 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.619 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . 33.2 m-85 -110.03 125.68 53.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.661 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 12' ' ' ALA . 25.1 m-85 -98.68 147.03 25.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.834 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.456 ' HD3' ' CZ2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -71.67 141.13 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.293 0.568 . . . . 0.0 112.252 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 8' ' ' ILE . 11.5 mt-10 26.66 104.28 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.268 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt . . . . . 0 C--N 1.308 -1.221 0 CA-C-N 113.314 -1.766 . . . . 0.0 110.903 179.696 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.744 0.307 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -127.32 164.81 20.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -126.02 114.4 24.17 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 35.0 Cg_exo -59.05 162.28 14.04 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.726 2.284 . . . . 0.0 112.432 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 19.0 m-85 -145.74 -42.48 0.21 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.995 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 21' ' ' LEU . 19.0 t 60.26 129.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.563 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.45 148.2 5.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.382 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.59 96.88 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.589 0.709 . . . . 0.0 110.16 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.657 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.2 m95 -89.19 105.31 17.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.693 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.9 t -111.24 155.92 12.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.494 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.74 171.77 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.55 60.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.374 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.14 -26.86 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.17 25.61 30.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.111 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -26.5 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.361 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.511 HG23 ' HD2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -140.0 156.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.239 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' N ' HD11 ' A' ' 16' ' ' ILE . 0.9 OUTLIER -139.98 128.65 23.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.795 0.331 . . . . 0.0 110.973 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 tt0 -114.56 112.0 22.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.682 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.7 126.56 38.95 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.98 0.419 . . . . 0.0 111.336 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.657 ' HG ' ' CD1' ' A' ' 9' ' ' TRP . 9.4 mt -91.84 114.31 26.82 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.68 157.53 88.21 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.4 Cg_exo -64.77 -12.86 36.1 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.343 2.695 . . . . 0.0 111.792 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.4 20.42 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.096 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.39 50.66 60.7 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.1 mmm-85 -139.61 -179.88 6.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.965 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -135.36 149.28 49.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 109.63 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.205 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -103.49 134.18 47.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.421 0.629 . . . . 0.0 112.355 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.95 105.26 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.852 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HD2' HG23 ' A' ' 16' ' ' ILE . 11.2 mtm180 -101.96 111.84 24.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.367 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.25 -152.98 13.17 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.687 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -56.56 -22.48 33.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.783 0.325 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -91.94 83.87 5.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.607 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.82 169.19 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.554 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.55 30.1 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 110.762 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.92 -47.57 71.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.199 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.68 143.49 26.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.546 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.455 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.98 150.05 29.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.844 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.3 -122.1 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.099 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.407 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.17 164.05 39.14 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.475 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.4 p90 -138.37 156.45 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.499 0.666 . . . . 0.0 112.229 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -119.94 127.17 52.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.902 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.511 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 73.6 t -104.74 127.66 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.044 0.449 . . . . 0.0 112.078 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -140.24 101.53 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.627 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.16 42.65 95.36 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.253 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.33 -6.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 126.12 38.94 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -135.38 147.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.286 0.565 . . . . 0.0 111.985 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.533 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -135.11 145.58 48.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.826 179.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.4 m-85 -97.81 116.99 31.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.013 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.407 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.6 t90 -109.28 90.85 3.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 109.835 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.422 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.72 155.65 40.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.855 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -85.22 -12.63 52.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.008 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 t -90.66 24.46 2.67 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.866 0.365 . . . . 0.0 111.917 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 23.38 60.7 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 114.811 0.685 . . . . 0.0 114.811 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.6 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.99 163.46 17.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.11 0.955 . . . . 0.0 109.9 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.54 141.3 14.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.998 178.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.42 178.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.007 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.2 t70 -148.79 147.86 29.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.257 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.58 -173.21 33.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.261 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -167.96 130.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.482 ' CE1' HG22 ' A' ' 48' ' ' ILE . 5.9 m-30 -69.68 110.44 4.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.788 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.83 -17.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.158 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.24 -166.41 2.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.894 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.68 -27.14 27.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.235 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.43 0.97 7.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -107.1 147.06 30.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.616 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -131.09 142.68 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.388 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.41 ' N ' HD11 ' A' ' 68' ' ' LEU . 6.0 m170 -126.47 107.9 10.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 135.55 26.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.752 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.45 21.84 42.9 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.042 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.27 21.71 64.37 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.503 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.08 164.45 13.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.3 m -118.26 107.31 13.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.801 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.8 m-85 -109.44 126.37 53.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.367 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -102.77 146.88 27.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.463 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -74.33 130.98 40.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 112.066 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 53.21 -36.75 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.214 178.424 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 73.0 Cg_exo . . . . . 0 N--CA 1.471 0.188 0 CA-C-O 120.753 0.23 . . . . 0.0 112.584 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.967 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.1 m-85 -146.43 -42.06 0.2 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.2 t 60.51 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.211 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.5 147.46 4.85 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.274 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.32 96.92 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.029 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.672 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.06 107.42 19.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.799 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.721 HG22 ' HB2' ' A' ' 17' ' ' ARG . 69.4 t -115.04 155.77 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.433 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.46 179.38 0.79 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.146 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -79.86 -19.65 47.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.532 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.11 -28.52 11.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.669 0.271 . . . . 0.0 110.916 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.45 26.26 14.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.991 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -78.68 -31.04 46.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.01 155.51 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.481 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.721 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -136.32 138.82 42.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.831 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 20.1 tt0 -125.76 111.95 15.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.639 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.76 127.2 39.36 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 111.563 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 41' ' ' TYR . 8.3 mt -92.12 114.09 26.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.492 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.29 156.42 88.29 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.496 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.92 -17.15 58.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.506 2.804 . . . . 0.0 112.545 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.37 23.98 6.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.0 54.36 21.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.876 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.2 mmm-85 -143.32 -179.74 6.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.632 0.253 . . . . 0.0 111.334 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.472 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.14 149.97 48.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.432 0.634 . . . . 0.0 112.558 -178.377 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.32 111.72 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.34 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.25 134.62 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.376 0.608 . . . . 0.0 111.972 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.13 105.37 10.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.09 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.486 ' HD2' HG21 ' A' ' 16' ' ' ILE . 14.7 mtm-85 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.775 0.322 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 153.88 38.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 111.882 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.29 149.83 15.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.82 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.82 -120.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.17 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.16 164.18 38.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.737 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.4 p90 -139.39 156.89 46.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.529 0.68 . . . . 0.0 112.219 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 2.8 tt0 -120.39 127.34 52.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.857 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.967 HG21 ' CE1' ' A' ' 5' ' ' TYR . 72.0 t -104.39 127.98 58.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.149 0.5 . . . . 0.0 112.038 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -139.51 99.76 3.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.93 42.83 96.96 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.289 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.77 -7.32 1.42 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.487 0.315 . . . . 0.0 111.664 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.4 ' ND1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.8 125.65 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.665 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.54 145.99 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.273 0.558 . . . . 0.0 112.158 -178.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.55 145.3 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.746 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 41.9 m-85 -96.81 117.11 30.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.88 -0.146 . . . . 0.0 110.867 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.429 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.5 t90 -109.22 90.95 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 109.887 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.16 155.57 40.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.85 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.21 -12.67 52.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.0 t -90.01 24.76 2.33 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.806 0.336 . . . . 0.0 111.843 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.55 60.72 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -121.38 163.64 18.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.042 0.921 . . . . 0.0 109.904 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.63 141.3 14.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.848 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -126.68 178.42 5.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.132 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.8 p30 -146.77 147.25 30.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.383 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.34 -175.12 35.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.176 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' HB3' ' ND1' ' A' ' 47' ' ' HIS . 11.5 p30 -168.17 129.49 1.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.165 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.665 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -67.5 110.34 3.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 110.857 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.0 m -84.35 -18.59 9.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.189 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 -168.13 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 110.835 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.57 -27.19 29.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -124.24 0.1 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.626 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.2 tt0 -107.02 148.51 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.876 0.369 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.975 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.13 142.64 49.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.345 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.723 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.57 107.79 10.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.27 136.42 26.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.816 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.4 22.0 43.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 26.13 58.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.4 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.35 165.18 13.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.945 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.1 m -118.52 107.41 13.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.975 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.4 m-85 -109.63 128.06 54.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.487 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.625 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 13.9 m-85 -103.95 146.3 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.518 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.464 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 2.0 tpp85 -72.88 135.34 45.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.089 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 113.403 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 38.6 Cg_exo . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.552 0.147 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE1' HG21 ' A' ' 43' ' ' VAL . 10.0 m-85 -145.91 -43.88 0.21 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.169 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 21' ' ' LEU . 24.2 t 61.86 130.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.961 0.41 . . . . 0.0 110.993 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.98 146.93 4.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.307 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.473 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -93.18 98.66 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.423 0.63 . . . . 0.0 110.293 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.643 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.0 m95 -91.32 106.82 18.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.627 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.739 HG22 ' HB2' ' A' ' 17' ' ' ARG . 73.8 t -112.78 155.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.147 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.426 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -68.14 176.33 2.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.298 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -76.74 -19.56 57.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.681 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -26.13 13.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.708 0.29 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.02 23.71 29.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.154 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.76 -29.51 58.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.054 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.57 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -140.59 156.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.519 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.739 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.5 132.51 33.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.837 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 13.0 tt0 -120.17 112.5 19.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.03 127.46 38.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.401 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.748 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.5 mt -92.95 110.21 21.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -62.75 156.18 66.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.176 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.0 Cg_exo -64.11 -16.84 57.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.495 2.796 . . . . 0.0 112.538 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -96.27 23.41 6.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.93 52.84 26.23 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.882 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mmt85 -141.58 -179.81 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 111.327 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -136.9 149.23 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.354 0.597 . . . . 0.0 112.54 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.43 111.61 5.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.346 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.7 tt0 -104.25 134.04 48.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.373 0.606 . . . . 0.0 112.196 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.87 105.2 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.868 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.478 ' HD2' HG21 ' A' ' 16' ' ' ILE . 10.3 mtm180 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.545 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.928 0.394 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.22 141.56 23.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.46 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.5 149.89 29.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.827 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.96 -121.0 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.158 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.19 38.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.748 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.5 p90 -137.32 155.29 49.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.382 0.61 . . . . 0.0 112.116 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -119.91 127.14 52.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.195 178.557 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.015 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.1 t -102.65 129.99 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 111.942 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 87.44 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.73 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 65.53 44.0 93.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.326 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.2 -13.14 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.516 0.326 . . . . 0.0 111.606 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.94 128.81 40.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.64 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.71 153.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.176 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.8 150.12 52.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' A' ' 57' ' ' THR . 46.5 m-85 -99.95 116.6 32.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.165 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -109.14 90.16 3.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 0.0 109.977 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.57 158.78 28.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.16 -12.7 52.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.009 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.3 t -91.13 25.06 2.61 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.908 0.385 . . . . 0.0 111.817 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 25.92 60.9 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.541 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.75 163.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.936 0.868 . . . . 0.0 109.989 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.35 142.5 12.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.867 178.198 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.57 121.52 12.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.598 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 16.2 p30 -90.27 152.29 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -150.68 -163.8 11.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.133 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 6.3 p-10 -168.08 132.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.506 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.9 m-30 -77.48 110.19 12.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.744 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.4 m -85.01 -10.71 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.477 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -160.46 -176.07 5.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.867 0.365 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.13 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.056 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -120.69 4.13 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.572 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.693 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.0 tt0 -106.72 145.28 32.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.398 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.036 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.91 143.88 50.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.645 -179.121 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.72 ' N ' HD13 ' A' ' 68' ' ' LEU . 2.6 m170 -126.32 110.01 12.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.44 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.95 135.13 30.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.641 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 23.12 21.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.286 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.61 65.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.696 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.14 163.63 13.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.921 0.391 . . . . 0.0 111.024 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -117.11 107.69 14.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.946 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.036 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.3 m-85 -109.17 120.97 44.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.42 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.573 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 5.0 m-85 -101.38 141.95 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -71.16 142.53 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.863 0.363 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 124.743 1.217 . . . . 0.0 113.284 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 48.1 Cg_exo . . . . . 0 N--CA 1.471 0.169 0 CA-C-O 120.767 0.236 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.957 ' CE1' HG21 ' A' ' 43' ' ' VAL . 16.6 m-85 -145.21 -42.5 0.23 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.914 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 21' ' ' LEU . 19.9 t 60.7 129.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.999 0.428 . . . . 0.0 111.329 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.599 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.06 146.73 4.56 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.34 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.45 97.01 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.534 0.683 . . . . 0.0 110.074 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.588 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 17' ' ' ARG . 78.0 t -114.01 155.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.397 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.5 176.12 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.083 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.56 -19.43 55.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.445 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.65 -23.1 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.47 20.35 48.65 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.336 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' CD ' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -72.51 -24.3 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 110.395 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.56 156.71 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.451 179.35 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.48 131.34 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 8.7 tt0 -119.24 114.33 22.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -94.66 127.37 40.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.584 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.726 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.8 mt -92.12 113.02 25.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.46 156.61 85.28 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -175.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.37 -17.57 60.67 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.509 2.806 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -96.01 23.45 6.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 52.86 28.97 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.032 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 41.7 mmt-85 -141.27 -179.97 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.582 0.229 . . . . 0.0 111.276 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.06 149.35 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.413 0.625 . . . . 0.0 112.538 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.55 112.75 5.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -104.51 133.82 48.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.292 0.568 . . . . 0.0 112.205 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.79 105.29 11.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.981 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.492 ' HD2' HG21 ' A' ' 16' ' ' ILE . 18.3 mtm-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.347 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.089 0 CA-C-O 121.022 0.439 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 140.82 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.477 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.69 149.71 28.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.19 -122.1 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.824 -1.179 . . . . 0.0 113.115 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.1 163.77 39.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.726 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.7 p90 -138.44 155.12 48.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.521 0.677 . . . . 0.0 112.192 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -119.98 127.24 52.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.891 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.957 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.1 t -104.73 130.89 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 112.124 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -141.75 98.14 3.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.79 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 59.69 43.61 97.63 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.298 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.12 -7.58 1.34 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.426 0.291 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 125.25 38.24 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.754 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.02 148.33 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.225 0.536 . . . . 0.0 112.148 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.547 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.33 144.3 49.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.881 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.8 m-85 -100.2 115.14 29.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.065 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -109.06 90.51 3.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.428 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -67.09 158.69 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.652 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -85.07 -12.71 52.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.176 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.67 25.05 2.83 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.774 0.321 . . . . 0.0 111.726 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.7 25.24 60.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.546 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.2 164.12 15.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.013 0.906 . . . . 0.0 109.971 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.45 11.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.98 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.62 121.82 13.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.509 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 7.0 p-10 -90.3 155.63 18.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.975 0.417 . . . . 0.0 111.454 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.25 -170.71 28.53 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.076 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.424 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.3 p30 -168.32 133.74 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 111.227 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.754 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.9 m-30 -72.76 110.5 7.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.1 m -82.53 -18.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.168 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.59 -169.43 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.22 -28.14 32.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -122.22 -0.25 9.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' HG23 ' A' ' 63' ' ' VAL . 6.0 tt0 -106.92 146.79 30.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.931 0.396 . . . . 0.0 110.726 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.91 142.0 50.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.371 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.3 m170 -126.38 107.9 10.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.759 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.64 135.41 26.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.87 21.52 44.77 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.048 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 23.78 60.53 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.49 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -114.71 164.87 13.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 m -118.37 107.35 13.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.981 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.986 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.1 m-85 -109.64 127.31 54.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.627 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 11.1 m-85 -104.66 145.12 30.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.482 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -70.73 139.5 51.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.504 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 C-N-CA 124.73 1.212 . . . . 0.0 113.155 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 32.2 Cg_exo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.659 0.191 . . . . 0.0 112.13 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE1' HG21 ' A' ' 43' ' ' VAL . 7.1 m-85 -146.81 -44.2 0.18 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.167 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.3 t 61.86 129.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.99 0.424 . . . . 0.0 111.145 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.624 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.12 146.24 4.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.301 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -93.09 96.67 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.462 0.648 . . . . 0.0 109.932 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.661 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 25.7 m95 -86.57 107.79 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.418 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 17' ' ' ARG . 77.6 t -113.56 155.33 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.755 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.453 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.51 -175.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.634 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.02 -20.25 33.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.42 -26.54 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.732 0.301 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.29 26.1 16.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.018 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -77.46 -29.12 52.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 154.67 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.407 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.782 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -137.56 133.51 34.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.926 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 10.9 tt0 -119.69 113.08 20.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.528 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -92.51 126.47 37.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.107 0.479 . . . . 0.0 111.551 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.762 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.0 mt -92.56 112.3 24.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.09 157.3 85.37 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.9 Cg_exo -64.33 -13.96 41.26 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.338 2.692 . . . . 0.0 111.929 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -93.45 20.0 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.98 50.05 63.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.6 mmt180 -137.65 -179.92 6.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.889 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.86 149.93 47.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.19 111.09 4.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.507 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -102.88 133.39 48.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.331 0.586 . . . . 0.0 111.91 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.32 105.42 10.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.351 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.997 -179.563 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.823 0.344 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -149.59 152.77 36.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.178 0.513 . . . . 0.0 111.578 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.47 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.46 149.4 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.804 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -120.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 163.97 39.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.762 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.3 p90 -137.26 155.65 49.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.441 0.638 . . . . 0.0 112.085 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.0 tt0 -119.97 127.19 52.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.128 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.015 HG21 ' CE1' ' A' ' 5' ' ' TYR . 49.2 t -102.7 129.65 53.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.426 . . . . 0.0 112.025 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -136.82 82.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.22 44.76 74.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.272 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.55 -13.14 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.6 0.36 . . . . 0.0 111.497 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.88 126.05 38.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.03 152.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.234 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.85 151.14 51.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.783 178.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.6 m-85 -100.32 116.45 32.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.158 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.0 t90 -109.1 90.41 3.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.007 0.432 . . . . 0.0 109.907 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.62 158.36 32.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.743 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -85.16 -12.75 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.858 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -91.08 25.23 2.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.85 0.357 . . . . 0.0 111.755 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.7 26.3 61.08 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.505 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.16 163.86 17.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.928 0.864 . . . . 0.0 109.866 179.008 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.68 142.4 12.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.975 178.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.52 121.56 12.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.677 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 31.3 p-10 -90.37 152.08 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.397 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -153.52 -167.49 15.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.034 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.11 131.93 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.7 m-30 -77.05 110.24 11.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.577 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.7 m -84.84 -14.29 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.32 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.73 177.93 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.82 -27.95 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 2.3 m-20 -121.08 -2.62 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.593 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.0 tt0 -106.94 141.92 37.38 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.899 0.38 . . . . 0.0 110.733 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.027 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -128.18 142.97 51.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.536 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.712 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 108.02 10.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.786 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.83 137.01 29.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.668 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.35 22.75 38.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.122 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.55 25.23 61.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.373 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.3 165.12 13.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.1 m -117.9 107.57 14.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.147 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.027 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.9 m-85 -110.12 123.37 49.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 8.3 m-85 -102.95 140.34 37.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.475 ' O ' ' C ' ' A' ' 78' ' ' GLU . 3.8 tpp180 -54.06 148.21 11.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.931 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.3 mt-10 . . . . . 0 N--CA 1.47 0.525 0 O-C-N 124.388 1.055 . . . . 0.0 112.564 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.439 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 72.0 Cg_exo . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.805 0.252 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 43' ' ' VAL . 15.3 m-85 -144.88 -42.34 0.24 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.2 t 60.32 129.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.022 0.439 . . . . 0.0 111.3 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.592 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.24 146.63 4.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -93.84 96.93 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.084 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.667 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.1 m95 -89.54 107.48 19.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.695 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 17' ' ' ARG . 71.1 t -113.95 155.59 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.329 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.427 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.72 1.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.104 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.612 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -79.6 -19.36 49.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.515 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.45 -26.16 12.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.995 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.04 24.83 26.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.221 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.48 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -77.13 -28.35 54.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.516 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.17 155.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.435 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -136.89 133.09 35.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.863 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.1 tt0 -121.47 113.2 19.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -94.46 128.45 41.04 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.059 0.457 . . . . 0.0 111.513 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.772 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.3 mt -92.58 113.26 25.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 156.34 86.66 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -64.0 -17.01 58.12 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.556 2.838 . . . . 0.0 112.49 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.58 24.08 6.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 110.759 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.11 54.13 22.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.92 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.0 mmm-85 -143.37 -179.93 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.593 0.235 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.72 149.2 47.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.6 . . . . 0.0 112.407 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.53 112.45 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.487 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -104.17 131.54 51.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.288 0.566 . . . . 0.0 111.907 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.4 105.21 11.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.635 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 144.33 24.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.729 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.95 149.81 26.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.25 -120.95 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.099 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.772 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.3 p90 -138.56 155.75 48.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.414 0.626 . . . . 0.0 112.323 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.99 127.21 52.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.717 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.0 t -104.98 130.46 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.173 0.511 . . . . 0.0 112.083 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 11.3 mtm105 -142.05 99.87 3.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.784 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.85 43.34 96.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.287 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.59 -7.03 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.47 0.308 . . . . 0.0 111.67 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 125.73 38.6 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.752 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.97 148.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.273 0.559 . . . . 0.0 112.153 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.547 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.43 144.13 49.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.891 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -99.6 114.79 28.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.12 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -108.97 90.29 3.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.025 0.44 . . . . 0.0 109.865 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.63 159.1 28.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.653 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -85.1 -12.65 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.987 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -91.58 25.51 2.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.809 0.337 . . . . 0.0 111.612 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.19 26.52 61.67 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.097 -0.573 . . . . 0.0 114.478 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.96 164.26 15.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.858 0.829 . . . . 0.0 109.831 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.13 142.65 11.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 178.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.52 121.71 13.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.515 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.5 p30 -89.61 155.43 19.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -162.48 -171.42 28.62 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -168.12 133.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 111.285 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.752 ' CE1' HG21 ' A' ' 48' ' ' ILE . 9.0 m-30 -72.99 110.34 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.104 0.478 . . . . 0.0 110.716 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.64 -18.09 10.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.356 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -148.68 -169.13 3.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.351 . . . . 0.0 110.958 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.79 -30.2 32.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -121.67 1.34 10.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.485 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.7 tt0 -107.0 147.93 29.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.921 0.391 . . . . 0.0 110.581 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.001 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.17 144.22 49.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.414 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.742 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.48 108.92 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.443 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.33 135.86 32.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.582 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.95 23.78 17.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.177 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.23 67.25 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.31 164.18 12.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.026 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 m -117.23 107.63 14.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.001 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.2 m-85 -109.48 127.13 54.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.355 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.612 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 9.5 m-85 -105.16 143.58 33.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -68.18 140.68 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 124.569 1.148 . . . . 0.0 112.955 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 46.2 Cg_exo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.718 0.216 . . . . 0.0 112.279 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.027 ' CE1' HG21 ' A' ' 43' ' ' VAL . 5.3 m-85 -145.64 -44.81 0.21 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.941 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.0 t 62.24 129.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.188 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 153.87 146.14 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.388 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.542 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.71 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.411 0.624 . . . . 0.0 109.856 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.647 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.6 m95 -86.38 108.47 18.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.381 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 17' ' ' ARG . 75.7 t -114.32 155.7 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.778 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.421 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -65.68 -175.16 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.331 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.0 -20.45 32.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.05 -25.48 12.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.828 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.59 23.21 24.34 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.315 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -73.91 -26.87 60.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.742 0.306 . . . . 0.0 110.271 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.864 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -143.67 157.7 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.345 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.864 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -140.27 138.33 34.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.6 tt0 -125.44 112.91 16.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.66 126.67 36.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 111.669 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.747 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.4 mt -92.91 111.66 23.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.06 156.32 81.07 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.06 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.9 -17.22 58.97 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.467 2.778 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.7 22.9 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.27 52.54 26.51 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.843 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.7 mmt85 -140.94 -179.81 6.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.562 0.22 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -137.0 150.36 48.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.41 0.624 . . . . 0.0 112.459 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.16 110.74 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.0 tt0 -103.3 132.48 49.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.415 0.626 . . . . 0.0 111.895 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.58 105.16 10.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.352 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 4.4 mtm180 . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.051 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.798 0.332 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.409 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -151.0 153.48 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.038 0.447 . . . . 0.0 111.754 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.82 148.92 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.045 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.98 -121.82 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.982 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.14 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.747 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.2 p90 -138.09 157.64 45.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.355 0.597 . . . . 0.0 112.284 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.38 127.21 49.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.087 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.027 HG21 ' CE1' ' A' ' 5' ' ' TYR . 29.8 t -101.07 135.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.209 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -141.45 82.86 1.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.492 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.38 44.7 72.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.223 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 86.04 -14.4 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.551 0.34 . . . . 0.0 111.539 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.56 39.69 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.76 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.48 149.54 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.471 0.653 . . . . 0.0 112.516 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 2.6 t30 -117.69 166.81 11.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.94 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 57' ' ' THR . 72.2 m-85 -125.22 113.07 17.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.597 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -109.0 91.67 3.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 110.058 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.4 159.18 29.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.642 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.98 -12.81 52.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.216 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -91.53 25.64 2.57 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.841 0.353 . . . . 0.0 111.681 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.13 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.378 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.84 164.27 15.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.842 0.821 . . . . 0.0 109.903 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.47 142.32 11.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.7 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -149.07 125.89 11.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.847 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.2 p30 -92.92 152.79 19.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.417 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.22 15.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.074 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' NE2' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.07 132.7 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 0.0 111.274 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.5 m-30 -79.64 110.33 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.5 m -79.48 -19.69 12.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.304 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -150.2 -175.64 5.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.27 57.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.064 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 2.8 m-20 -116.69 -2.64 11.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.439 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.7 tt0 -106.92 144.4 33.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.963 0.411 . . . . 0.0 110.643 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.029 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.54 143.98 51.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.509 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.734 ' N ' HD13 ' A' ' 68' ' ' LEU . 3.3 m170 -126.36 108.91 11.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.841 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.46 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.95 136.93 32.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.56 23.5 14.26 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.138 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.21 67.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.729 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.46 164.06 12.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.011 0.405 . . . . 0.0 111.064 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -116.46 107.64 15.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.029 ' HB2' HD12 ' A' ' 68' ' ' LEU . 24.7 m-85 -110.0 123.58 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.403 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.626 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.8 m-85 -101.2 140.91 34.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -58.31 147.51 30.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.226 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.6 mt-10 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 124.674 1.19 . . . . 0.0 113.071 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 50.3 Cg_exo . . . . . 0 N--CA 1.47 0.138 0 CA-C-O 120.773 0.239 . . . . 0.0 112.631 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.934 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.6 m-85 -145.49 -42.46 0.22 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.798 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 21' ' ' LEU . 20.5 t 60.57 128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.206 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.573 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.14 147.51 4.89 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.27 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.75 96.77 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.396 0.617 . . . . 0.0 110.009 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.679 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.2 m95 -88.88 108.59 19.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.8 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 17' ' ' ARG . 73.9 t -116.42 155.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.425 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.44 -178.29 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.139 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.636 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -81.84 -19.54 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.475 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.74 -27.2 11.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.72 0.295 . . . . 0.0 110.933 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 26.21 16.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.192 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.33 -29.32 47.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.353 . . . . 0.0 110.106 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.85 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -139.45 157.3 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.27 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.85 ' N ' HD12 ' A' ' 16' ' ' ILE . 4.2 ttp-105 -137.81 141.73 40.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.884 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 16.0 tt0 -131.01 111.92 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.594 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -94.76 127.71 40.95 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.047 0.451 . . . . 0.0 111.655 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.792 HD22 ' CE2' ' A' ' 41' ' ' TYR . 9.3 mt -91.89 114.01 26.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.3 156.53 88.06 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.57 -17.41 59.87 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.47 2.78 . . . . 0.0 112.498 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.22 23.75 6.32 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.842 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.09 53.95 23.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.905 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 4.5 mmm-85 -142.99 -179.76 6.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 0.0 111.251 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.42 149.72 48.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.396 0.617 . . . . 0.0 112.543 -178.42 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 112.02 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.435 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -104.03 132.36 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.353 0.597 . . . . 0.0 111.958 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.44 105.18 10.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.782 0.325 . . . . 0.0 111.636 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.41 153.58 36.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.187 0.518 . . . . 0.0 111.672 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.92 149.48 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.818 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.78 -120.32 0.54 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 119.691 -1.243 . . . . 0.0 113.075 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.14 164.18 38.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.792 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.8 p90 -139.7 154.72 47.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 112.354 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.9 127.34 52.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.824 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.934 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.2 t -104.15 131.37 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 112.078 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -142.72 100.48 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.741 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.26 42.84 95.64 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.369 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.98 -7.98 1.33 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 122.514 0.326 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 127.19 39.43 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.674 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.97 148.65 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.194 0.521 . . . . 0.0 112.153 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.72 143.83 49.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.878 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 57' ' ' THR . 45.5 m-85 -98.95 114.66 27.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.037 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -109.03 90.25 3.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.929 0.395 . . . . 0.0 109.94 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.94 158.46 30.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.91 -12.81 52.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.981 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.1 t -91.38 25.14 2.68 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.848 0.356 . . . . 0.0 111.73 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.74 26.52 60.57 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.932 -0.651 . . . . 0.0 114.425 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.86 163.91 16.82 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.915 0.858 . . . . 0.0 109.935 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.37 142.37 12.77 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.882 178.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -141.34 121.74 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.477 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -88.49 156.08 19.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.085 0.469 . . . . 0.0 111.402 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.1 -174.76 35.13 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -168.14 132.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.38 . . . . 0.0 111.328 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.674 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.42 110.29 5.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.716 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -82.31 -19.2 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.253 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -147.25 -168.68 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.77 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.197 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -122.94 -0.08 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.579 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.7 tt0 -106.93 147.23 30.07 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.023 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.6 142.84 50.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 -179.453 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.699 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.4 m170 -126.19 107.8 10.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.213 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.485 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -145.96 137.72 25.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.691 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.69 22.26 39.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.915 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.63 23.39 64.84 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.368 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.02 164.45 14.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.217 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -117.03 107.5 14.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.54 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.023 ' HB2' HD12 ' A' ' 68' ' ' LEU . 22.0 m-85 -110.67 127.43 55.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 15.2 m-85 -102.69 146.04 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.481 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.471 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 1.5 tpp85 -73.07 136.87 45.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.955 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 124.688 1.195 . . . . 0.0 113.266 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 77.5 Cg_exo . . . . . 0 N--CA 1.471 0.196 0 CA-C-O 120.827 0.261 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.988 ' CE1' HG21 ' A' ' 43' ' ' VAL . 22.2 m-85 -146.26 -41.71 0.2 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.2 t 60.53 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.62 146.58 4.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.79 96.93 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.496 0.665 . . . . 0.0 110.133 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.655 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 18.8 m95 -89.52 107.32 19.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.601 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 17' ' ' ARG . 79.6 t -113.28 155.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.401 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.401 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -68.76 172.75 5.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.193 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.636 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -74.77 -19.47 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.7 -25.95 13.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.94 24.14 36.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.151 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.497 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.69 -26.07 44.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.279 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.577 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.64 156.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.281 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.746 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -139.16 130.97 27.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.962 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 11.5 tt0 -117.64 112.67 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -93.74 127.33 39.41 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.739 HD22 ' CE2' ' A' ' 41' ' ' TYR . 8.1 mt -92.48 113.97 26.4 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.46 156.75 87.82 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -175.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.9 -17.18 58.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.448 2.765 . . . . 0.0 112.499 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.7 24.23 6.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.428 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.08 53.52 25.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.94 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.4 mmt85 -142.22 -179.78 6.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.649 0.261 . . . . 0.0 111.438 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.23 148.65 48.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.26 0.552 . . . . 0.0 112.424 -178.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 109.65 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.9 tt0 -102.9 134.29 46.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.396 0.617 . . . . 0.0 112.134 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.11 105.29 12.11 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.063 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.385 -179.369 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.941 0.4 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 142.23 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -150.94 150.35 30.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.845 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.55 -122.73 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.037 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -154.14 164.05 39.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.739 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.0 p90 -138.73 157.34 46.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.612 0.72 . . . . 0.0 112.221 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -120.73 127.27 51.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.834 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.988 HG21 ' CE1' ' A' ' 5' ' ' TYR . 81.0 t -104.59 128.77 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 112.133 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.93 98.61 3.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 59.69 43.21 97.98 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.232 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.76 -6.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.458 0.303 . . . . 0.0 111.608 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.75 125.33 38.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.745 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.15 148.05 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.292 0.567 . . . . 0.0 111.995 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.538 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -134.9 145.24 48.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.675 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.7 m-85 -97.47 117.03 30.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.007 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.2 t90 -109.32 90.9 3.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.996 0.427 . . . . 0.0 109.953 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.61 155.64 40.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.742 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.35 -12.62 51.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.088 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -90.85 24.18 2.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 0.0 111.918 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.6 22.43 60.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.32 163.48 17.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.224 1.012 . . . . 0.0 109.893 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.89 141.29 14.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.897 178.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -127.21 178.37 6.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 22.5 p-10 -147.07 148.8 32.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.112 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -166.13 -174.09 35.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.329 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -168.12 129.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.745 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.9 m-30 -68.58 110.5 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.48 . . . . 0.0 110.81 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -85.81 -17.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.273 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -148.37 -168.05 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.82 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.63 -26.92 29.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 0.97 7.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HB3' HG23 ' A' ' 63' ' ' VAL . 1.4 tt0 -107.18 146.54 31.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.98 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.53 142.88 50.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.73 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.63 107.85 10.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.02 135.99 26.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.711 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.31 22.13 43.04 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.029 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.29 23.85 62.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.487 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.64 13.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.901 0.381 . . . . 0.0 111.017 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 m -118.17 107.43 13.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.874 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.98 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.3 m-85 -109.33 126.26 53.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.309 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.636 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 13.1 m-85 -103.36 145.45 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.491 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -71.87 137.65 47.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.69 -179.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.426 0 C-N-CA 124.671 1.188 . . . . 0.0 113.354 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 61.1 Cg_exo . . . . . 0 N--CA 1.471 0.152 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.005 ' CE1' HG21 ' A' ' 43' ' ' VAL . 17.1 m-85 -146.43 -43.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.4 t 60.74 129.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.285 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.69 146.95 4.65 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.418 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.79 96.96 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.518 0.675 . . . . 0.0 110.15 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.678 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.6 m95 -89.08 107.82 19.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.571 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 17' ' ' ARG . 76.2 t -113.99 155.29 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.466 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.431 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.28 176.76 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.245 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.647 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.91 -19.95 53.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.36 -25.19 13.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.012 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.41 23.79 33.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.204 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -76.56 -27.23 55.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.85 0.357 . . . . 0.0 110.128 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.712 HD13 ' OE1' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -141.95 154.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.388 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.725 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.32 132.73 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 21.6 tt0 -121.82 114.13 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.891 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -93.34 128.55 39.41 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.514 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.755 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.4 mt -93.26 113.69 25.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.534 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 158.13 80.47 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.511 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.8 Cg_exo -63.26 -18.79 66.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.586 2.858 . . . . 0.0 112.868 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.66 20.92 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.741 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.37 51.27 27.66 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.382 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 87.5 mmt-85 -137.17 -179.81 5.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.599 -0.3 . . . . 0.0 110.927 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.6 152.32 50.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.426 0.632 . . . . 0.0 112.512 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.01 110.6 4.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.425 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.712 ' OE1' HD13 ' A' ' 16' ' ' ILE . 2.5 tt0 -103.12 134.09 47.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 112.102 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.26 105.1 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.969 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.502 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.906 0.384 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.06 141.61 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.504 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.46 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.42 149.86 29.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.5 -122.46 0.64 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.912 -1.137 . . . . 0.0 113.088 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.03 164.18 38.87 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.755 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.6 p90 -138.45 156.73 47.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.537 0.684 . . . . 0.0 112.317 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -120.21 127.35 52.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.953 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.005 HG21 ' CE1' ' A' ' 5' ' ' TYR . 77.2 t -104.06 126.82 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 111.952 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -136.38 92.34 2.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 63.2 43.3 98.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.199 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.98 -10.25 0.93 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 122.558 0.343 . . . . 0.0 111.706 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.9 125.59 38.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.646 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -139.43 147.28 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.184 0.516 . . . . 0.0 112.263 -179.059 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -129.23 146.56 51.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.642 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' THR . 42.8 m-85 -97.08 118.26 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.38 0.133 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.416 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 30.4 t90 -109.47 91.29 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.145 0.498 . . . . 0.0 110.003 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.21 155.1 41.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.744 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.2 -12.65 52.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.055 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 t -90.17 23.52 2.83 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.885 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.45 22.32 58.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -121.05 162.73 19.48 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.251 1.026 . . . . 0.0 110.048 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.78 140.71 16.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.748 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -125.66 178.47 5.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.4 p-10 -145.73 145.87 31.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -176.96 33.84 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.355 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.0 p-10 -168.1 123.62 1.0 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.059 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 4.9 m-30 -64.96 110.15 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.8 m -83.48 -19.2 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.246 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.47 -166.33 2.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.4 -29.18 26.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.208 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -122.83 1.12 9.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.604 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 63' ' ' VAL . 7.6 tt0 -107.02 149.52 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.883 0.373 . . . . 0.0 110.705 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.024 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.61 144.53 49.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.741 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.4 108.24 11.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -139.45 134.96 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.61 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.22 23.55 18.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.16 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.72 66.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.698 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.35 163.87 12.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.956 0.407 . . . . 0.0 111.093 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 m -116.74 107.75 15.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.894 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.024 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.2 m-85 -109.78 127.57 54.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.647 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 14.6 m-85 -103.7 145.96 29.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.26 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.463 ' CZ ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -72.56 137.87 46.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.916 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 124.753 1.221 . . . . 0.0 113.249 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 52.2 Cg_exo . . . . . 0 N--CA 1.47 0.128 0 CA-C-O 120.77 0.238 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.999 ' CE1' HG21 ' A' ' 43' ' ' VAL . 12.3 m-85 -143.29 -43.78 0.29 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.715 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.1 t 60.6 129.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.9 147.37 4.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.273 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.23 96.88 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.582 0.706 . . . . 0.0 110.151 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.664 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.5 m95 -89.25 106.63 18.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.707 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 17' ' ' ARG . 74.8 t -113.67 155.76 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.267 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.443 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.129 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -79.09 -19.62 50.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -27.19 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.73 24.38 23.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.077 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.443 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.06 -31.62 58.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 109.956 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.565 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -138.34 155.89 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.455 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.704 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.44 132.27 33.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.678 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.6 tt0 -120.32 112.61 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -93.2 127.6 38.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.539 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.76 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.2 mt -92.51 112.79 24.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.89 156.29 84.13 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.03 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.3 Cg_exo -63.68 -17.27 59.22 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.569 2.846 . . . . 0.0 112.514 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.09 23.71 6.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 53.45 25.73 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.882 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.9 mmm-85 -143.11 -179.78 6.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.457 0.17 . . . . 0.0 111.42 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.29 149.85 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.438 0.637 . . . . 0.0 112.639 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.92 111.89 5.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.358 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.43 135.65 45.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.394 0.616 . . . . 0.0 112.16 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.16 105.35 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.972 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HD2' HG21 ' A' ' 16' ' ' ILE . 14.1 mtm180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.433 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.016 0 CA-C-O 120.898 0.38 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 149.89 31.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.464 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.96 149.72 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.96 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.7 -121.59 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 119.826 -1.178 . . . . 0.0 112.926 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.01 162.72 40.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.76 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.5 p90 -136.86 155.52 49.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.381 0.61 . . . . 0.0 112.094 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.65 127.17 52.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.167 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.999 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.7 t -103.46 129.21 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.108 0.48 . . . . 0.0 111.973 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.31 94.34 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.653 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 61.66 42.81 99.82 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.259 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 84.17 -11.57 0.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.392 0.277 . . . . 0.0 111.725 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.89 128.96 40.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.628 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.85 153.43 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.225 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.518 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.37 151.0 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.907 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 57' ' ' THR . 51.3 m-85 -101.79 115.89 31.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.414 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 87.9 t90 -109.11 90.55 3.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.019 0.438 . . . . 0.0 110.12 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.62 158.84 28.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.778 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.14 -12.71 52.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.01 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.7 t -91.38 25.2 2.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.871 0.367 . . . . 0.0 111.72 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.19 25.73 61.15 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.014 -0.613 . . . . 0.0 114.505 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.02 163.71 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.044 0.922 . . . . 0.0 109.935 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.19 142.37 11.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.121 178.156 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.46 121.56 12.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.462 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p30 -90.97 153.13 20.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 0.0 111.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -154.13 -164.92 13.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.223 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 9.1 p-10 -168.09 133.31 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.042 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.7 m-30 -76.63 110.31 11.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.664 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -87.25 -10.17 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.043 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.85 156.51 11.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.824 0.345 . . . . 0.0 110.611 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.27 32.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.552 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -119.06 -10.53 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.853 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.664 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.2 tt0 -106.66 147.84 29.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.027 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.16 143.23 49.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.289 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.713 ' N ' HD13 ' A' ' 68' ' ' LEU . 3.7 m170 -126.45 108.78 11.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.847 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 136.44 29.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.65 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.61 22.96 34.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.21 63.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.538 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.01 164.33 13.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 m -117.84 107.58 14.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.006 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.027 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.4 m-85 -109.33 126.28 53.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.381 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.626 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 10.9 m-85 -103.81 145.36 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.252 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.438 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -72.33 137.7 46.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.933 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 113.478 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 83.5 Cg_exo . . . . . 0 C--O 1.231 0.151 0 N-CA-C 112.86 0.292 . . . . 0.0 112.86 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.008 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.5 m-85 -136.62 -46.4 0.61 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.1 t 59.9 125.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.566 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.27 148.63 5.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.14 96.68 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.181 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.636 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.7 m95 -89.22 106.71 18.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.612 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 17' ' ' ARG . 78.7 t -111.08 155.78 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.349 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -69.32 172.14 7.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.228 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -73.6 -19.94 60.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.13 -16.86 14.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 17.13 68.58 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.293 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -23.41 62.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 0.0 110.284 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -147.71 156.4 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.563 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.762 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.77 131.32 31.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.771 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 27.9 tt0 -119.2 112.55 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.004 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -92.64 127.14 38.03 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 111.326 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.764 HD22 ' CE1' ' A' ' 41' ' ' TYR . 11.8 mt -93.08 112.66 24.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.58 156.69 81.77 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.497 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 27.9 Cg_exo -62.92 -17.97 62.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.583 2.855 . . . . 0.0 112.438 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -94.74 21.95 6.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.942 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.34 50.5 38.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 84.5 mmt-85 -139.36 -179.73 6.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.385 0.136 . . . . 0.0 111.02 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.36 150.99 50.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 0.0 112.758 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.69 109.93 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.275 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 3.1 tt0 -103.26 134.51 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.393 0.616 . . . . 0.0 112.183 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.61 105.29 11.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.061 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HD2' HG21 ' A' ' 16' ' ' ILE . 15.2 mtm180 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 121.069 0.461 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 152.42 35.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.282 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.479 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -158.89 149.9 20.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.075 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.71 -128.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.908 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.14 164.2 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.764 ' CE1' HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -133.47 157.38 45.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.502 0.668 . . . . 0.0 112.184 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.1 tt0 -119.87 127.47 52.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.983 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.008 HG21 ' CE1' ' A' ' 5' ' ' TYR . 54.6 t -102.88 126.08 57.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.141 0.496 . . . . 0.0 112.214 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -137.2 88.62 2.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.669 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 64.83 43.85 95.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.398 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 84.47 -12.15 0.78 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.43 0.292 . . . . 0.0 111.66 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.71 127.02 39.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.73 HG21 ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -140.18 151.07 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.043 -179.04 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -133.43 145.15 50.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.987 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' A' ' 57' ' ' THR . 34.5 m-85 -93.49 117.24 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.952 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -109.28 91.36 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.977 0.418 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -71.4 155.37 40.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.684 -179.176 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.22 -12.72 51.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.029 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -90.66 24.12 2.8 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.73 22.4 59.94 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 114.87 0.708 . . . . 0.0 114.87 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.52 163.4 17.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.318 1.059 . . . . 0.0 109.935 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.57 140.7 13.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.934 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -127.07 178.31 6.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.069 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 28.4 p-10 -146.78 146.76 30.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.163 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -157.66 -170.56 22.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 9.5 p-10 -168.04 123.12 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 48' ' ' ILE . 89.8 m-85 -65.82 110.34 2.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 67' ' ' GLU . 1.7 m -91.14 -6.02 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.29 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.14 173.49 10.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.44 -22.45 63.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.22 1.56 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.783 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 63' ' ' VAL . 8.7 tt0 -111.25 149.06 31.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.927 0.394 . . . . 0.0 111.006 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.048 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.95 144.08 48.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.299 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.725 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.5 m170 -126.5 107.91 10.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.48 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.48 141.55 29.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 179.197 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.19 19.13 22.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.084 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.04 68.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.999 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ttm -115.72 171.8 7.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.289 0.545 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.8 m -117.54 107.99 14.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.711 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.048 ' HB2' HD12 ' A' ' 68' ' ' LEU . 20.5 m-85 -106.03 121.88 45.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.627 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 16.5 m-85 -100.39 147.12 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.912 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HD2' ' HA3' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -73.01 137.43 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.8 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 C-N-CA 124.79 1.236 . . . . 0.0 113.416 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 76.6 Cg_exo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.878 0.282 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.023 ' CE1' HG21 ' A' ' 43' ' ' VAL . 7.5 m-85 -144.48 -44.09 0.25 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.6 t 61.58 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.612 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.48 145.0 4.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.393 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.67 96.56 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.516 0.674 . . . . 0.0 109.872 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.0 m95 -85.87 108.04 17.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.243 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.807 HG22 ' HB2' ' A' ' 17' ' ' ARG . 72.9 t -113.41 155.07 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.849 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.43 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -66.38 -177.04 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.311 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.649 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.09 -20.1 35.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.526 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.61 -25.26 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.77 25.77 24.23 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.022 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.03 -28.01 48.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.132 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.561 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.98 155.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.376 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.807 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.69 138.1 37.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 8.3 tt0 -124.3 111.95 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.937 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 38.5 tt0 -90.09 125.21 35.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.755 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.2 mt -92.61 113.54 25.85 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.534 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.16 158.26 82.11 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -176.001 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -63.65 -18.84 65.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.642 2.894 . . . . 0.0 112.868 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.78 22.27 7.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.331 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.411 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.68 53.03 22.1 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.575 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -138.64 179.06 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.849 -0.175 . . . . 0.0 110.954 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.01 152.75 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.474 0.654 . . . . 0.0 112.745 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.04 110.56 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.28 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.89 134.99 45.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.423 0.63 . . . . 0.0 112.079 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.37 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.161 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.361 -179.439 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 142.1 22.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.38 149.79 28.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.93 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.39 -122.57 0.64 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.038 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.04 163.6 39.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.755 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.7 p90 -138.92 154.92 48.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.516 0.674 . . . . 0.0 112.31 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -120.39 127.47 52.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.285 178.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.023 HG21 ' CE1' ' A' ' 5' ' ' TYR . 58.0 t -102.27 132.01 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 112.003 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -138.59 83.32 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.715 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.29 44.46 74.87 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.183 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.6 -13.02 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.593 0.357 . . . . 0.0 111.441 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 126.02 38.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.035 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.735 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.77 147.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 2.6 t30 -118.41 166.72 12.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.847 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 57' ' ' THR . 73.1 m-85 -125.17 113.59 17.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.642 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.402 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 84.6 t90 -108.82 91.39 3.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.041 0.448 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.12 160.06 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.439 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.08 -12.8 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.26 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.95 25.58 2.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.888 0.375 . . . . 0.0 111.72 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.88 25.73 61.8 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.384 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 164.5 14.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.839 0.819 . . . . 0.0 109.908 179.041 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.16 143.03 12.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.75 177.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -146.78 124.5 11.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.872 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 29.6 t70 -91.23 153.14 20.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.52 -168.93 17.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.104 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 11.2 p-10 -168.09 132.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 7.4 m-30 -77.28 110.35 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -83.94 -14.63 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.396 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 t -156.42 179.83 8.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.99 62.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.289 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -120.3 -3.15 10.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.494 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.614 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.2 tt0 -106.84 145.61 31.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.017 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.74 143.82 50.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.301 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.735 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.4 109.08 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.896 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.448 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.53 136.0 32.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.663 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.17 23.73 18.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.192 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.99 19.44 67.38 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.726 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 164.54 12.44 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.04 0.448 . . . . 0.0 111.016 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.6 m -117.22 107.58 14.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.017 ' HB2' HD12 ' A' ' 68' ' ' LEU . 34.4 m-85 -109.76 122.94 48.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.484 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 12.1 m-85 -100.21 141.86 32.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.63 148.45 33.65 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.1 mt-10 . . . . . 0 N--CA 1.465 0.3 0 C-N-CA 124.758 1.223 . . . . 0.0 113.125 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 49.5 Cg_exo . . . . . 0 N--CA 1.471 0.178 0 CA-C-O 120.757 0.232 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 43' ' ' VAL . 13.5 m-85 -145.38 -42.75 0.22 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 18.9 t 60.31 129.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.14 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.16 147.67 4.9 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.295 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.86 96.79 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 110.225 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.67 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.7 m95 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.748 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 17' ' ' ARG . 68.9 t -114.11 155.7 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -66.83 176.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.146 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.629 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -78.01 -19.47 54.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.93 -23.84 13.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.22 21.76 40.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.334 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.416 ' CD ' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.92 -24.65 59.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.716 0.293 . . . . 0.0 110.392 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.498 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.36 156.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.301 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.7 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -137.58 135.41 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.9 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 5.3 tt0 -122.34 113.6 19.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.6 126.92 41.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.079 0.466 . . . . 0.0 111.457 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.739 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.0 mt -91.64 113.64 25.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.05 157.63 86.44 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.056 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.42 -13.49 38.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.326 2.684 . . . . 0.0 111.852 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -93.89 20.09 8.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.145 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.6 49.89 65.89 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.5 mmt85 -137.37 -179.84 5.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.129 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.19 149.28 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.16 112.14 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.441 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -104.24 132.66 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.324 0.583 . . . . 0.0 112.15 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.74 105.37 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.983 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 16' ' ' ILE . 7.2 mtm180 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.137 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.697 0.284 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.7 27.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 111.794 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.97 149.78 26.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.541 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.23 -122.14 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.699 -1.239 . . . . 0.0 113.194 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.11 164.12 39.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.739 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.7 p90 -139.31 155.68 47.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.519 0.676 . . . . 0.0 112.275 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.89 127.15 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.89 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.5 t -104.32 129.89 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.463 . . . . 0.0 112.097 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 99.6 3.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.707 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.73 42.93 96.63 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.306 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.0 -7.76 1.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.393 0.277 . . . . 0.0 111.629 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.93 126.43 39.13 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.68 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -137.28 148.87 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.221 0.534 . . . . 0.0 112.237 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.29 144.68 49.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.789 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.684 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.4 m-85 -98.61 115.06 27.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.012 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.7 t90 -109.05 90.45 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.035 0.445 . . . . 0.0 109.899 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.68 158.91 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.08 -12.63 52.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.038 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.55 25.29 2.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.796 0.331 . . . . 0.0 111.711 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.45 26.76 60.68 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.14 164.17 15.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.768 0.784 . . . . 0.0 109.765 179.077 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.34 142.68 11.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.965 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.68 121.65 12.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.5 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 9.9 p-10 -88.95 157.61 18.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 111.651 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.16 -172.1 32.2 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.888 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -168.17 132.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.308 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.68 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.8 m-30 -71.63 110.24 6.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.538 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.0 m -81.74 -18.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.335 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 t -148.61 -168.47 3.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.853 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.95 -28.25 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.194 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -122.12 -0.13 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.582 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HB3' HG23 ' A' ' 63' ' ' VAL . 6.7 tt0 -106.89 147.75 29.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.74 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.64 142.24 49.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.715 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.2 m170 -126.39 107.88 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.72 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.67 135.61 26.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.7 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.67 21.7 43.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.1 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.92 24.53 59.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.418 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -115.43 164.71 13.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -118.26 107.37 13.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.063 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.986 ' HB2' HD12 ' A' ' 68' ' ' LEU . 29.1 m-85 -109.83 127.77 54.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.34 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.629 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 15.2 m-85 -104.17 146.31 28.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.461 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 1.3 tpp85 -73.37 135.42 44.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.916 0.389 . . . . 0.0 111.991 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 124.599 1.16 . . . . 0.0 113.37 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 67.0 Cg_exo . . . . . 0 N--CA 1.472 0.209 0 CA-C-O 120.726 0.219 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.953 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.6 m-85 -145.58 -42.29 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.866 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 20.0 t 60.19 128.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.029 0.443 . . . . 0.0 111.263 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.568 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.58 148.45 5.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.242 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -96.05 96.57 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.592 0.711 . . . . 0.0 110.035 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.68 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.1 m95 -88.42 107.63 18.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.597 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' HB2' ' A' ' 17' ' ' ARG . 69.7 t -114.44 155.74 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.411 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -65.76 176.9 1.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.385 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.611 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.5 -19.9 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.574 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.41 -24.82 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.707 0.289 . . . . 0.0 110.945 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.15 22.98 30.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.461 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.562 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -76.49 -28.32 56.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.81 0.338 . . . . 0.0 110.165 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -139.1 158.39 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.851 ' N ' HD12 ' A' ' 16' ' ' ILE . 3.7 ttp180 -138.67 142.76 39.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.804 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 2.8 tt0 -130.21 111.88 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -95.14 127.11 40.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.764 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.5 mt -92.14 113.91 26.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.27 156.58 87.84 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.44 -17.57 60.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.62 2.88 . . . . 0.0 112.474 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -95.86 23.26 6.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.44 53.55 24.38 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.846 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.8 mmt85 -141.94 -179.97 6.53 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 111.413 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.08 149.28 47.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 112.562 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.33 110.93 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.381 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.66 134.08 47.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.61 . . . . 0.0 112.277 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.32 105.03 11.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.775 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 -179.095 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.848 0.356 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.84 141.84 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.469 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.14 149.9 29.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.737 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.32 -120.74 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 119.833 -1.175 . . . . 0.0 113.03 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 164.02 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.764 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.4 p90 -138.42 155.78 48.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.484 0.659 . . . . 0.0 112.276 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -120.46 127.28 52.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.843 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.953 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.2 t -105.2 130.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.537 . . . . 0.0 112.085 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.19 96.91 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.777 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 60.5 43.85 98.36 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.351 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.13 -7.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.417 0.287 . . . . 0.0 111.563 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.79 124.91 38.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.753 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.5 148.15 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.0 112.153 -178.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.5 144.09 49.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.895 178.671 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.5 m-85 -99.35 115.04 28.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -109.14 90.18 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.012 0.434 . . . . 0.0 109.849 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.65 158.69 29.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.704 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -85.09 -12.7 52.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.975 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.5 t -91.41 25.26 2.65 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 120.907 0.384 . . . . 0.0 111.807 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 26.09 61.22 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.026 -0.606 . . . . 0.0 114.467 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.9 164.09 15.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.873 0.836 . . . . 0.0 109.918 179.082 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.95 142.69 12.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.94 178.07 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.72 121.7 12.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.601 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.0 p30 -89.44 156.24 18.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.585 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.53 -171.67 30.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.025 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.3 p-10 -168.19 133.74 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.236 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.753 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.3 m-30 -73.57 110.42 7.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.28 -18.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.215 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.46 -168.81 3.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.876 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.82 -27.62 28.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -123.01 2.05 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.588 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.9 tt0 -108.97 149.8 28.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 110.78 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.992 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -133.2 143.46 49.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.715 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.37 107.77 10.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.246 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.448 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -151.99 137.33 17.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.224 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.86 13.19 58.91 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.762 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.23 20.18 59.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.945 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.4 ttm -120.49 171.57 8.45 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.216 0.508 . . . . 0.0 111.714 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 m -116.41 107.64 15.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.348 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.992 ' HB2' HD12 ' A' ' 68' ' ' LEU . 13.6 m-85 -106.01 127.77 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.334 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.611 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 18.9 m-85 -102.46 147.13 27.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.728 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.482 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 2.1 tpp85 -75.71 130.42 38.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.103 0.478 . . . . 0.0 112.228 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 55.0 Cg_exo . . . . . 0 C--O 1.231 0.158 0 N-CA-C 112.871 0.296 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.001 ' CE1' HG21 ' A' ' 43' ' ' VAL . 9.7 m-85 -145.77 -43.43 0.21 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.792 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 19.9 t 60.86 129.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 111.286 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.602 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.29 145.49 4.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -91.94 96.82 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.36 0.6 . . . . 0.0 110.141 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.664 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.5 m95 -88.24 108.18 19.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.405 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.702 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.1 t -113.75 155.15 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.694 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.511 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.94 -176.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.312 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -83.53 -20.41 33.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.584 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.67 -24.47 12.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.987 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.87 23.79 26.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.024 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.511 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -74.96 -30.66 61.27 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.515 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.44 155.81 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.58 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.702 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -137.93 128.66 26.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.9 tt0 -116.31 112.2 21.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.92 126.83 38.2 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.504 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.795 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.0 mt -91.84 113.26 25.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -68.04 157.41 87.09 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.475 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.5 Cg_exo -64.72 -13.18 37.7 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.445 2.763 . . . . 0.0 111.854 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -93.89 20.3 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.173 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.46 50.4 62.52 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -139.93 -179.91 6.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.971 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.25 149.57 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.59 110.34 5.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.255 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.59 133.09 49.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.414 0.626 . . . . 0.0 112.288 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.85 105.45 11.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.905 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 16' ' ' ILE . 20.8 mtm-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.905 0.383 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 143.59 25.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.466 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.82 149.9 29.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.877 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.03 -123.65 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.899 -1.144 . . . . 0.0 113.025 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.04 164.05 39.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.795 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.5 p90 -139.78 154.74 47.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 112.142 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.78 127.34 52.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.249 178.474 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.001 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.9 t -102.84 129.49 54.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.857 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.68 92.26 2.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.629 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 62.5 43.61 98.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.357 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.7 0.85 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 122.461 0.304 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.9 128.9 40.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.005 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.698 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.36 151.5 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.073 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 1.3 m-20 -127.24 171.17 11.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.551 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.718 ' O ' ' HA ' ' A' ' 57' ' ' THR . 79.1 m-85 -124.1 114.84 20.24 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.08 90.99 3.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.64 160.39 22.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.694 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -12.76 52.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.157 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -92.19 25.32 2.94 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.821 0.343 . . . . 0.0 111.719 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 25.79 61.67 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.59 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.16 164.32 14.95 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 117.82 0.81 . . . . 0.0 109.783 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.62 142.48 10.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.008 177.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -143.93 121.55 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.545 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p-10 -90.37 150.75 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 0.0 111.523 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -156.24 -171.92 23.08 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.109 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 2.0 p30 -168.28 132.97 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.262 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -73.1 110.33 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.8 m -81.93 -18.91 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.335 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -147.3 -169.04 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.99 -29.28 32.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.217 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -121.77 -0.14 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.512 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.1 tt0 -106.82 148.8 28.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 110.702 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.051 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.42 144.4 49.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.35 108.76 11.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.85 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.426 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -139.95 135.32 32.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.621 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.04 23.72 17.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.276 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.62 18.95 67.07 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.717 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -108.76 164.05 12.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 111.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.5 m -116.73 107.66 14.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.051 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.0 m-85 -110.27 124.63 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.099 0.476 . . . . 0.0 111.667 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.652 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 28.3 m-85 -97.72 147.18 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.769 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.478 ' CD ' ' CE2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -73.03 140.68 47.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.33 0.586 . . . . 0.0 112.318 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.612 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.289 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 47.9 Cg_exo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.753 0.231 . . . . 0.0 112.476 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.0 ' CE1' HG21 ' A' ' 43' ' ' VAL . 10.8 m-85 -145.54 -43.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 20.5 t 60.8 128.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.352 . . . . 0.0 111.302 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.76 147.23 4.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.324 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.8 98.85 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.356 0.598 . . . . 0.0 110.206 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.646 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.7 m95 -91.38 105.34 17.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.707 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 17' ' ' ARG . 75.7 t -109.98 155.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.282 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.451 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.72 178.67 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.368 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.605 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -78.97 -20.27 49.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.62 -24.6 13.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.14 23.56 31.86 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.59 -0.815 . . . . 0.0 112.234 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.52 -27.73 58.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.068 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.5 155.89 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.589 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.71 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.25 126.13 22.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.519 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 35.4 tt0 -115.72 114.35 24.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.672 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -94.33 127.15 40.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.367 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.725 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.8 mt -90.65 112.75 24.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -67.39 157.62 84.94 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.31 -13.4 37.97 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.291 2.661 . . . . 0.0 111.872 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -93.56 19.93 7.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.192 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.41 50.22 64.06 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.0 mmt85 -139.8 -179.89 6.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.527 -0.337 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -135.95 149.63 48.98 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.73 114.64 6.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.181 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -105.66 132.23 52.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.0 112.185 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -113.64 105.18 13.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.058 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.406 -179.313 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.063 0.459 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.53 140.1 19.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.042 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.44 149.76 29.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.927 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.68 -123.92 0.7 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.982 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.03 164.0 39.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.725 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.9 p90 -138.34 155.08 48.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.443 0.64 . . . . 0.0 112.056 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.2 tt0 -119.75 127.25 52.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.069 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.0 HG21 ' CE1' ' A' ' 5' ' ' TYR . 67.6 t -104.42 127.27 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.969 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.26 91.99 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 63.21 43.25 98.85 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.14 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.05 0.89 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.506 0.322 . . . . 0.0 111.564 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.75 127.11 39.3 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.618 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.19 152.68 16.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 112.252 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.514 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -133.46 149.3 51.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.858 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.81 115.44 30.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 t90 -109.08 90.43 3.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.69 157.83 33.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.604 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -85.16 -12.68 52.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -91.73 24.31 3.19 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.878 0.371 . . . . 0.0 111.866 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.18 22.77 60.23 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 163.48 16.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.172 0.986 . . . . 0.0 109.963 179.057 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.46 11.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.879 178.208 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.98 121.68 11.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 6.9 p-10 -90.33 152.22 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 111.346 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.03 -167.58 16.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.024 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.7 p-10 -168.11 130.8 1.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.319 . . . . 0.0 111.218 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.6 m-30 -74.03 110.04 8.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.688 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.603 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.6 m -86.58 -11.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -158.59 -177.95 6.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.835 0.35 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -25.77 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.259 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.01 1.52 7.98 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.631 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.2 tt0 -109.43 147.87 32.11 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.819 0.342 . . . . 0.0 110.792 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.035 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.27 144.15 49.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.724 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.47 109.25 11.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.915 0.388 . . . . 0.0 110.712 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.421 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.37 134.49 30.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.11 22.96 22.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.144 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.69 67.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.752 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -107.49 163.55 12.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 111.041 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 m -116.77 107.64 14.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.775 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.035 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.4 m-85 -108.98 125.11 51.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.605 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 21.5 m-85 -102.08 147.12 26.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.462 ' CZ ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -74.26 137.17 42.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.812 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 124.607 1.163 . . . . 0.0 113.012 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 31.3 Cg_exo . . . . . 0 N--CA 1.471 0.147 0 CA-C-O 120.783 0.243 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.891 ' OH ' HG11 ' A' ' 43' ' ' VAL . 15.0 m-85 -143.78 -42.62 0.28 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 21' ' ' LEU . 18.6 t 60.73 131.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.619 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.45 144.98 4.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.36 96.55 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.523 0.678 . . . . 0.0 109.782 179.288 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.684 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 26.0 m95 -86.48 109.88 19.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.167 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.3 t -115.24 154.82 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.777 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.484 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.06 -176.88 0.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.15 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.659 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.33 -19.97 35.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.6 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.1 -27.04 12.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 24.98 18.02 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.055 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.484 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.09 -31.06 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.31 155.48 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.161 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.768 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.31 131.23 29.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.686 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.7 tt0 -118.38 113.75 21.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.828 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 38.8 tt0 -92.16 125.68 36.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.552 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.75 HD22 ' CE2' ' A' ' 41' ' ' TYR . 6.8 mt -90.9 112.13 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.57 156.64 81.9 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.089 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.18 -17.81 61.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.513 2.809 . . . . 0.0 112.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.61 23.11 6.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.46 52.03 33.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.005 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -140.05 -179.79 6.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.382 0.134 . . . . 0.0 110.963 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.69 149.95 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.17 111.23 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.523 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -102.93 134.33 46.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.968 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.79 105.27 11.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.321 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.316 -179.593 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.006 0.432 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.04 140.06 19.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.217 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.43 150.1 29.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.735 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.95 -122.52 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.054 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.99 39.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.75 ' CE2' HD22 ' A' ' 20' ' ' LEU . 3.3 p90 -138.02 157.89 45.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.539 0.685 . . . . 0.0 112.403 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -122.54 127.42 49.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.804 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.891 HG11 ' OH ' ' A' ' 5' ' ' TYR . 79.2 t -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 82.57 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.17 -96.35 2.05 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.99 15.26 7.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.425 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -111.12 141.42 44.65 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.173 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.765 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -147.66 148.26 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.244 -179.312 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.3 144.92 50.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.708 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -102.2 115.4 30.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.157 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -109.23 90.64 3.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.7 157.82 33.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.74 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.12 -12.7 52.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.199 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.7 24.77 2.96 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.9 0.381 . . . . 0.0 111.898 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.3 23.36 61.07 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.766 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.64 164.02 15.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.049 0.924 . . . . 0.0 109.931 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.25 141.34 12.21 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.735 177.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -140.34 121.76 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.619 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 3.4 p30 -92.67 151.16 20.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 111.465 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.12 -170.98 26.49 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.875 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.9 p-10 -168.15 132.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.765 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.3 m-30 -68.28 110.18 3.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.516 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.6 m -84.86 -16.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.284 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -152.03 -175.26 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 0.0 110.813 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.76 -26.69 50.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 2.2 m-20 -122.48 -2.38 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.646 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.0 tt0 -106.98 144.86 32.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 111.004 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.037 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -129.97 143.58 50.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.365 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 107.82 10.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.41 ' CD2' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -143.71 137.42 28.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.607 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.52 22.82 40.33 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.091 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.87 62.17 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 165.94 12.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 0.0 111.151 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 m -118.07 107.54 14.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.082 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.037 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.5 m-85 -110.72 126.64 54.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.328 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.8 m-85 -103.19 141.71 35.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.816 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.5 ' HG3' ' HG3' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -58.28 146.18 35.1 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.899 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.2 mt-10 . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 124.553 1.141 . . . . 0.0 113.104 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.4 Cg_exo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.669 0.195 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.939 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.5 m-85 -145.38 -42.88 0.22 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.888 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.5 t 60.72 129.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 111.265 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.593 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.85 147.29 4.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.342 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.486 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -94.8 96.89 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 110.119 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.646 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.2 m95 -88.91 106.95 18.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.729 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 17' ' ' ARG . 71.6 t -114.33 155.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.376 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.427 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.27 178.95 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.182 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -80.0 -18.79 49.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.48 -27.54 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 26.3 18.83 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.158 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.48 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -79.08 -28.4 43.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.133 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.534 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 155.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.35 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.734 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -137.19 137.8 39.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.834 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.5 tt0 -125.17 112.94 17.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.731 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.4 127.4 39.01 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.588 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.706 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.3 mt -93.09 113.0 25.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.36 158.01 79.66 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.53 -18.91 66.5 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.644 2.896 . . . . 0.0 112.953 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.23 21.54 7.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.62 52.33 21.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.473 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 10.3 mmt180 -138.39 179.89 6.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.21 . . . . 0.0 111.115 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.509 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -138.53 153.01 48.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.471 0.653 . . . . 0.0 112.561 -178.138 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.22 111.76 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.92 131.33 49.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.306 0.574 . . . . 0.0 111.962 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.27 105.28 11.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.143 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.41 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.807 0.337 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.77 148.18 28.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.242 0.544 . . . . 0.0 111.766 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.486 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.73 149.67 25.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.127 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.3 -122.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.651 -1.261 . . . . 0.0 113.108 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.09 163.77 39.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.706 ' CE1' HD22 ' A' ' 20' ' ' LEU . 7.5 p90 -137.9 156.4 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 0.0 112.414 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -120.98 127.27 51.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.729 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.939 HG21 ' CE1' ' A' ' 5' ' ' TYR . 75.5 t -105.2 131.93 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.183 0.515 . . . . 0.0 112.226 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -142.94 101.45 3.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.651 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 57.87 42.94 94.93 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.406 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.72 -6.9 1.46 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.458 0.303 . . . . 0.0 111.679 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.84 126.24 38.92 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.766 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.54 148.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.302 0.572 . . . . 0.0 112.069 -178.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.552 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.35 143.25 48.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.952 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.7 m-85 -99.5 113.97 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.946 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -109.1 89.9 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.99 0.424 . . . . 0.0 109.985 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.8 158.07 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.648 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.93 -12.68 52.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.164 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -92.0 24.84 3.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.852 0.358 . . . . 0.0 111.708 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 27.26 55.97 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.621 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.38 164.1 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.006 0.903 . . . . 0.0 109.823 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.36 143.05 11.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.125 178.063 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.59 121.79 12.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.553 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 8.8 t70 -88.81 155.16 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -171.77 27.6 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.051 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 3.8 p-10 -168.21 133.88 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.341 . . . . 0.0 111.15 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.766 ' CE1' HG21 ' A' ' 48' ' ' ILE . 9.4 m-30 -75.63 110.33 9.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -83.24 -18.43 10.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.881 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.21 174.72 13.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.38 -21.57 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.298 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -121.41 -8.55 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.802 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.7 tt0 -106.61 149.01 27.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 111.166 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.958 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.4 142.41 50.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.278 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.72 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 107.88 10.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.8 135.8 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.724 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.69 21.84 44.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.049 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.24 25.13 59.93 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.389 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.86 165.15 13.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.991 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -118.59 107.44 13.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.004 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.958 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.1 m-85 -110.14 128.78 55.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 13.0 m-85 -105.02 145.83 29.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 1.1 tpp85 -72.26 136.78 46.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 C-N-CA 124.569 1.148 . . . . 0.0 113.1 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.0 Cg_exo . . . . . 0 N--CA 1.471 0.193 0 CA-C-O 120.787 0.245 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.919 ' CE1' HG21 ' A' ' 43' ' ' VAL . 11.7 m-85 -144.79 -43.29 0.24 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.801 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 21' ' ' LEU . 20.9 t 61.22 130.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.933 0.397 . . . . 0.0 111.401 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.603 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 155.69 145.82 4.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.254 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.98 96.8 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 121.452 0.644 . . . . 0.0 109.84 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.8 m95 -87.41 109.8 19.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.419 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.709 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.1 t -117.22 155.0 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.766 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.413 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.37 -176.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.219 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.13 -20.19 35.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.69 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -23.39 12.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.317 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.48 21.66 33.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.376 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.413 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -72.02 -25.46 61.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.29 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.558 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.83 155.3 11.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.389 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.709 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -136.0 138.75 42.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.644 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.2 tt0 -125.33 111.88 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -92.51 125.63 37.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 111.535 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.812 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.4 mt -91.61 111.98 23.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -64.78 155.97 80.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -176.167 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.4 Cg_exo -64.11 -16.76 56.77 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.571 2.848 . . . . 0.0 112.47 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.38 23.6 6.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.769 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.52 53.6 23.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.926 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 5.6 mmm-85 -143.3 -179.85 6.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.512 0.196 . . . . 0.0 111.31 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.03 150.1 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.494 0.664 . . . . 0.0 112.716 -178.343 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.47 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.221 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.79 137.6 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.368 0.604 . . . . 0.0 112.448 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.15 105.57 9.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.851 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 16' ' ' ILE . 10.5 mtm180 . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.023 0.44 . . . . 0.0 111.867 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.86 0.362 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.72 150.44 32.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.326 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -159.39 149.88 19.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.98 179.403 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.67 -121.38 0.58 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.913 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.81 39.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.812 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.9 p90 -138.64 154.11 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 112.274 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -119.84 127.29 52.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.828 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.919 HG21 ' CE1' ' A' ' 5' ' ' TYR . 72.4 t -104.2 131.37 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.178 0.513 . . . . 0.0 112.01 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.05 100.85 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.24 42.81 95.59 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.335 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.61 -7.22 1.45 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.369 0.268 . . . . 0.0 111.53 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.02 39.4 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.739 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.1 148.43 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 112.167 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.45 144.81 49.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.881 178.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.97 114.48 28.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.136 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -109.08 90.34 3.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.031 0.443 . . . . 0.0 109.955 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.86 158.52 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.65 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.04 -12.6 52.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.99 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -91.58 24.81 2.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.787 0.327 . . . . 0.0 111.752 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.64 25.61 60.39 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.5 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.61 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.99 163.44 16.94 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 117.888 0.844 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.31 142.24 12.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -141.46 121.71 13.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 5.1 p-10 -90.63 154.79 19.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.69 -172.5 31.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.922 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.9 p-10 -168.18 132.93 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.861 0.362 . . . . 0.0 111.305 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.739 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.73 110.28 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.71 -18.58 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.407 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -170.02 3.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.46 -29.34 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.158 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -122.07 0.21 9.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.656 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HB3' HG23 ' A' ' 63' ' ' VAL . 14.1 tt0 -106.89 149.53 27.35 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.383 . . . . 0.0 110.664 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.037 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -134.04 144.46 48.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.721 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.875 0.369 . . . . 0.0 110.908 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.447 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.38 136.04 32.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.491 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.08 23.58 17.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.245 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.56 67.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.743 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.68 164.82 12.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.848 0.356 . . . . 0.0 111.072 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.6 m -117.26 107.77 14.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.02 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.037 ' HB2' HD12 ' A' ' 68' ' ' LEU . 33.2 m-85 -110.03 125.68 53.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.661 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 25.1 m-85 -98.68 147.03 25.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.834 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HD3' ' CZ2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -71.67 141.13 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.293 0.568 . . . . 0.0 112.252 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 8' ' ' ILE . 11.5 mt-10 . . . . . 0 CA--C 1.51 -0.584 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.268 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 35.0 Cg_exo . . . . . 0 N--CA 1.472 0.231 0 CA-C-O 120.642 0.184 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.96 ' CE1' HG21 ' A' ' 43' ' ' VAL . 19.0 m-85 -145.74 -42.48 0.21 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.995 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.0 t 60.26 129.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.581 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.45 148.2 5.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.382 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.59 96.88 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.589 0.709 . . . . 0.0 110.16 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.668 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.2 m95 -89.19 105.31 17.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.693 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 17' ' ' ARG . 74.9 t -111.24 155.92 12.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.494 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.408 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -69.74 171.77 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.137 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.642 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -73.6 -19.55 60.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.14 -26.86 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.17 25.61 30.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.111 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.551 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -81.39 -26.5 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.361 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.563 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -140.0 156.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.239 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.782 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -139.98 128.65 23.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.795 0.331 . . . . 0.0 110.973 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 15.3 tt0 -114.56 112.0 22.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.682 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.7 126.56 38.95 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.98 0.419 . . . . 0.0 111.336 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD22 ' CE2' ' A' ' 41' ' ' TYR . 9.4 mt -91.84 114.31 26.82 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -68.68 157.53 88.21 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.044 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.4 Cg_exo -64.77 -12.86 36.1 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.343 2.695 . . . . 0.0 111.792 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.4 20.42 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.096 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.39 50.66 60.7 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.1 mmm-85 -139.61 -179.88 6.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.965 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -135.36 149.28 49.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.294 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 109.63 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.205 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -103.49 134.18 47.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.421 0.629 . . . . 0.0 112.355 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.95 105.26 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.852 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.367 -179.145 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.892 0.377 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.68 143.49 26.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.546 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.98 150.05 29.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.844 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.3 -122.1 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.099 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.17 164.05 39.14 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.779 ' CE2' HD22 ' A' ' 20' ' ' LEU . 3.4 p90 -138.37 156.45 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.499 0.666 . . . . 0.0 112.229 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -119.94 127.17 52.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.902 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.96 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.6 t -104.74 127.66 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.044 0.449 . . . . 0.0 112.078 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -140.24 101.53 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.627 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.16 42.65 95.36 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.253 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.33 -6.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 126.12 38.94 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.749 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.38 147.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.286 0.565 . . . . 0.0 111.985 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.528 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -135.11 145.58 48.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.826 179.266 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 41.4 m-85 -97.81 116.99 31.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.013 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.415 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.6 t90 -109.28 90.85 3.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 109.835 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.72 155.65 40.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.855 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -85.22 -12.63 52.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.008 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 t -90.66 24.46 2.67 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.866 0.365 . . . . 0.0 111.917 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 23.38 60.7 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 114.811 0.685 . . . . 0.0 114.811 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.6 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.99 163.46 17.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.11 0.955 . . . . 0.0 109.9 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.54 141.3 14.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.998 178.336 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -126.42 178.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.007 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.2 t70 -148.79 147.86 29.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.257 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.58 -173.21 33.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.261 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -167.96 130.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.749 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.9 m-30 -69.68 110.44 4.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.788 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.1 m -84.83 -17.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.158 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.24 -166.41 2.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.894 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.68 -27.14 27.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.235 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.43 0.97 7.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.0 tt0 -107.1 147.06 30.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.976 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.09 142.68 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.388 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 6.0 m170 -126.47 107.9 10.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 135.55 26.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.752 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.45 21.84 42.9 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.042 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.27 21.71 64.37 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.503 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.08 164.45 13.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.3 m -118.26 107.31 13.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.801 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.976 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.8 m-85 -109.44 126.37 53.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.367 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.642 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 19.1 m-85 -102.77 146.88 27.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.463 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.422 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -74.33 130.98 40.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 112.066 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.677 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.214 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.884 0.374 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -146.42 156.9 43.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -133.4 98.8 14.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 73.0 Cg_exo -52.27 164.83 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.852 2.368 . . . . 0.0 112.584 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.967 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.1 m-85 -146.43 -42.06 0.2 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.2 t 60.51 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.211 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.5 147.46 4.85 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.274 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.32 96.92 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.029 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.672 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.06 107.42 19.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.799 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.721 HG22 ' HB2' ' A' ' 17' ' ' ARG . 69.4 t -115.04 155.77 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.433 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.46 179.38 0.79 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.146 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -79.86 -19.65 47.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.532 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.11 -28.52 11.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.669 0.271 . . . . 0.0 110.916 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.45 26.26 14.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.991 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -78.68 -31.04 46.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.01 155.51 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.481 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.721 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -136.32 138.82 42.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.831 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 20.1 tt0 -125.76 111.95 15.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.639 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.76 127.2 39.36 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 111.563 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 41' ' ' TYR . 8.3 mt -92.12 114.09 26.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.492 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.29 156.42 88.29 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.496 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.92 -17.15 58.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.506 2.804 . . . . 0.0 112.545 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.37 23.98 6.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.0 54.36 21.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.876 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.2 mmm-85 -143.32 -179.74 6.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.632 0.253 . . . . 0.0 111.334 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.472 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.14 149.97 48.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.432 0.634 . . . . 0.0 112.558 -178.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.32 111.72 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.34 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.25 134.62 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.376 0.608 . . . . 0.0 111.972 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.13 105.37 10.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.09 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.486 ' HD2' HG21 ' A' ' 16' ' ' ILE . 14.7 mtm-85 -97.72 148.0 23.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.75 128.48 15.52 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.848 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.46 31.14 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.2 tpt180 -172.67 38.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 168.84 0.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.658 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 47.4 29.83 1.42 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.442 . . . . 0.0 110.643 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 33' ' ' ARG . . . -56.82 -53.74 54.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.631 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 153.88 38.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 111.882 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.29 149.83 15.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.82 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.82 -120.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.17 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.16 164.18 38.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.737 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.4 p90 -139.39 156.89 46.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.529 0.68 . . . . 0.0 112.219 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 2.8 tt0 -120.39 127.34 52.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.857 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.967 HG21 ' CE1' ' A' ' 5' ' ' TYR . 72.0 t -104.39 127.98 58.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.149 0.5 . . . . 0.0 112.038 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -139.51 99.76 3.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.93 42.83 96.96 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.289 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.77 -7.32 1.42 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.487 0.315 . . . . 0.0 111.664 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.4 ' ND1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.8 125.65 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.665 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.54 145.99 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.273 0.558 . . . . 0.0 112.158 -178.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.55 145.3 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.746 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 41.9 m-85 -96.81 117.11 30.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.88 -0.146 . . . . 0.0 110.867 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.429 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.5 t90 -109.22 90.95 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 109.887 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.16 155.57 40.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.85 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.21 -12.67 52.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.0 t -90.01 24.76 2.33 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.806 0.336 . . . . 0.0 111.843 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.55 60.72 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -121.38 163.64 18.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.042 0.921 . . . . 0.0 109.904 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.63 141.3 14.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.848 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -126.68 178.42 5.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.132 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.8 p30 -146.77 147.25 30.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.383 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.34 -175.12 35.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.176 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' HB3' ' ND1' ' A' ' 47' ' ' HIS . 11.5 p30 -168.17 129.49 1.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.165 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.665 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -67.5 110.34 3.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 110.857 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.0 m -84.35 -18.59 9.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.189 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 -168.13 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 110.835 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.57 -27.19 29.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -124.24 0.1 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.626 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.2 tt0 -107.02 148.51 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.876 0.369 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.975 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.13 142.64 49.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.345 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.723 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.57 107.79 10.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.27 136.42 26.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.816 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.4 22.0 43.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 26.13 58.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.4 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.35 165.18 13.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.945 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.1 m -118.52 107.41 13.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.975 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.4 m-85 -109.63 128.06 54.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.487 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.625 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 13.9 m-85 -103.95 146.3 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.518 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.756 ' O ' ' N ' ' A' ' 79' ' ' LYS . 2.0 tpp85 -72.88 135.34 45.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.089 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 43.78 -55.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 113.403 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.756 ' N ' ' O ' ' A' ' 77' ' ' ARG . 7.2 mtpm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.912 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.819 0.342 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -79.28 169.17 18.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.804 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.72 95.92 24.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.236 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 38.6 Cg_exo -61.51 159.37 32.22 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.754 2.303 . . . . 0.0 112.071 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE1' HG21 ' A' ' 43' ' ' VAL . 10.0 m-85 -145.91 -43.88 0.21 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.169 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 21' ' ' LEU . 24.2 t 61.86 130.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.961 0.41 . . . . 0.0 110.993 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.98 146.93 4.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.307 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.473 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -93.18 98.66 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.423 0.63 . . . . 0.0 110.293 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.643 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.0 m95 -91.32 106.82 18.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.627 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.739 HG22 ' HB2' ' A' ' 17' ' ' ARG . 73.8 t -112.78 155.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.147 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.426 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -68.14 176.33 2.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.298 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -76.74 -19.56 57.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.681 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -26.13 13.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.708 0.29 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.02 23.71 29.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.154 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.76 -29.51 58.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.054 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.57 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -140.59 156.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.519 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.739 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.5 132.51 33.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.837 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 13.0 tt0 -120.17 112.5 19.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.03 127.46 38.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.401 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.748 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.5 mt -92.95 110.21 21.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -62.75 156.18 66.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.0 Cg_exo -64.11 -16.84 57.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.495 2.796 . . . . 0.0 112.538 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -96.27 23.41 6.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.93 52.84 26.23 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.882 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mmt85 -141.58 -179.81 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 111.327 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -136.9 149.23 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.354 0.597 . . . . 0.0 112.54 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.43 111.61 5.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.346 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.7 tt0 -104.25 134.04 48.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.373 0.606 . . . . 0.0 112.196 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.87 105.2 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.868 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.478 ' HD2' HG21 ' A' ' 16' ' ' ILE . 10.3 mtm180 -99.62 106.58 18.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.545 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.9 -146.08 10.05 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.932 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -55.68 -23.12 26.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.752 0.311 . . . . 0.0 111.142 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -93.6 79.63 4.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.549 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 169.05 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.507 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.87 29.14 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.788 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.93 -47.9 67.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.257 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.22 141.56 23.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.46 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.5 149.89 29.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.827 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.96 -121.0 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.158 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.19 38.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.748 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.5 p90 -137.32 155.29 49.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.382 0.61 . . . . 0.0 112.116 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -119.91 127.14 52.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.195 178.557 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.015 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.1 t -102.65 129.99 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 111.942 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 87.44 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.73 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 65.53 44.0 93.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.326 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.2 -13.14 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.516 0.326 . . . . 0.0 111.606 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.94 128.81 40.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.64 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.71 153.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.176 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.8 150.12 52.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' A' ' 57' ' ' THR . 46.5 m-85 -99.95 116.6 32.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.165 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -109.14 90.16 3.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 0.0 109.977 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.57 158.78 28.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.16 -12.7 52.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.009 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.3 t -91.13 25.06 2.61 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.908 0.385 . . . . 0.0 111.817 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 25.92 60.9 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.541 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.75 163.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.936 0.868 . . . . 0.0 109.989 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.35 142.5 12.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.867 178.198 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.57 121.52 12.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.598 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 16.2 p30 -90.27 152.29 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -150.68 -163.8 11.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.133 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 6.3 p-10 -168.08 132.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.506 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.9 m-30 -77.48 110.19 12.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.744 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.4 m -85.01 -10.71 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.477 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -160.46 -176.07 5.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.867 0.365 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.13 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.056 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -120.69 4.13 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.572 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.693 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.0 tt0 -106.72 145.28 32.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.398 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.036 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.91 143.88 50.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.645 -179.121 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.72 ' N ' HD13 ' A' ' 68' ' ' LEU . 2.6 m170 -126.32 110.01 12.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.44 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.95 135.13 30.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.641 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 23.12 21.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.286 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.61 65.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.696 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.14 163.63 13.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.921 0.391 . . . . 0.0 111.024 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -117.11 107.69 14.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.946 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.036 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.3 m-85 -109.17 120.97 44.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.42 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.573 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 5.0 m-85 -101.38 141.95 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.834 ' O ' ' N ' ' A' ' 79' ' ' LYS . 4.9 ttt180 -71.16 142.53 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.863 0.363 . . . . 0.0 111.735 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 37.11 -56.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.743 1.217 . . . . 0.0 113.284 179.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.834 ' N ' ' O ' ' A' ' 77' ' ' ARG . 33.7 mtpt . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.774 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.32 165.3 12.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -139.62 110.35 7.42 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.831 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 48.1 Cg_exo -57.74 162.69 10.29 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.889 2.393 . . . . 0.0 112.49 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.957 ' CE1' HG21 ' A' ' 43' ' ' VAL . 16.6 m-85 -145.21 -42.5 0.23 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.914 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 21' ' ' LEU . 19.9 t 60.7 129.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.999 0.428 . . . . 0.0 111.329 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.599 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.06 146.73 4.56 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.34 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.45 97.01 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.534 0.683 . . . . 0.0 110.074 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.588 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 17' ' ' ARG . 78.0 t -114.01 155.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.397 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.5 176.12 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.083 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.56 -19.43 55.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.445 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.65 -23.1 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.47 20.35 48.65 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.336 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' CD ' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -72.51 -24.3 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 110.395 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.56 156.71 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.451 179.35 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.48 131.34 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 8.7 tt0 -119.24 114.33 22.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -94.66 127.37 40.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.584 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.726 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.8 mt -92.12 113.02 25.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.46 156.61 85.28 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -175.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.37 -17.57 60.67 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.509 2.806 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -96.01 23.45 6.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 52.86 28.97 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.032 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 41.7 mmt-85 -141.27 -179.97 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.582 0.229 . . . . 0.0 111.276 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.06 149.35 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.413 0.625 . . . . 0.0 112.538 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.55 112.75 5.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -104.51 133.82 48.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.292 0.568 . . . . 0.0 112.205 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.79 105.29 11.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.981 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.492 ' HD2' HG21 ' A' ' 16' ' ' ILE . 18.3 mtm-85 -103.14 114.0 27.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.347 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.41 -154.72 11.26 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.719 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -56.79 -22.57 37.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.732 0.301 . . . . 0.0 111.093 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -91.43 83.88 5.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.718 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 169.36 17.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.511 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.21 29.99 7.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.79 0.329 . . . . 0.0 110.717 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.58 71.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 140.82 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.477 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.69 149.71 28.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.19 -122.1 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.824 -1.179 . . . . 0.0 113.115 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.1 163.77 39.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.726 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.7 p90 -138.44 155.12 48.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.521 0.677 . . . . 0.0 112.192 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -119.98 127.24 52.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.891 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.957 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.1 t -104.73 130.89 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 112.124 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -141.75 98.14 3.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.79 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 59.69 43.61 97.63 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.298 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.12 -7.58 1.34 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.426 0.291 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 125.25 38.24 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.754 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.02 148.33 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.225 0.536 . . . . 0.0 112.148 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.547 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.33 144.3 49.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.881 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.8 m-85 -100.2 115.14 29.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.065 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -109.06 90.51 3.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -67.09 158.69 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.652 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -85.07 -12.71 52.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.176 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.67 25.05 2.83 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.774 0.321 . . . . 0.0 111.726 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.7 25.24 60.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.546 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.2 164.12 15.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.013 0.906 . . . . 0.0 109.971 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.45 11.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.98 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.62 121.82 13.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.509 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 7.0 p-10 -90.3 155.63 18.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.975 0.417 . . . . 0.0 111.454 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.25 -170.71 28.53 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.076 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.424 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.3 p30 -168.32 133.74 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 111.227 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.754 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.9 m-30 -72.76 110.5 7.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.1 m -82.53 -18.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.168 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.59 -169.43 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.22 -28.14 32.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -122.22 -0.25 9.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' HG23 ' A' ' 63' ' ' VAL . 6.0 tt0 -106.92 146.79 30.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.931 0.396 . . . . 0.0 110.726 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.91 142.0 50.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.371 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.3 m170 -126.38 107.9 10.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.759 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.64 135.41 26.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.87 21.52 44.77 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.048 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 23.78 60.53 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.49 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -114.71 164.87 13.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 m -118.37 107.35 13.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.981 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.986 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.1 m-85 -109.64 127.31 54.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.627 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 11.1 m-85 -104.66 145.12 30.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.482 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.851 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -70.73 139.5 51.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.504 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 34.28 -57.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.73 1.212 . . . . 0.0 113.155 179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.851 ' N ' ' O ' ' A' ' 77' ' ' ARG . 1.9 mttt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.818 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.797 0.332 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 165.13 11.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.982 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.84 96.57 13.09 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 32.2 Cg_exo -59.29 159.27 23.37 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.686 2.257 . . . . 0.0 112.13 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE1' HG21 ' A' ' 43' ' ' VAL . 7.1 m-85 -146.81 -44.2 0.18 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.167 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.3 t 61.86 129.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.99 0.424 . . . . 0.0 111.145 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.624 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.12 146.24 4.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.301 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -93.09 96.67 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.462 0.648 . . . . 0.0 109.932 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.661 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 25.7 m95 -86.57 107.79 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.418 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 17' ' ' ARG . 77.6 t -113.56 155.33 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.755 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.453 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.51 -175.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.634 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.02 -20.25 33.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.42 -26.54 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.732 0.301 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.29 26.1 16.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.018 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -77.46 -29.12 52.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 154.67 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.407 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.782 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -137.56 133.51 34.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.926 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 10.9 tt0 -119.69 113.08 20.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.528 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -92.51 126.47 37.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.107 0.479 . . . . 0.0 111.551 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.762 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.0 mt -92.56 112.3 24.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.09 157.3 85.37 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.9 Cg_exo -64.33 -13.96 41.26 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.338 2.692 . . . . 0.0 111.929 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -93.45 20.0 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.98 50.05 63.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.6 mmt180 -137.65 -179.92 6.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.889 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.86 149.93 47.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.19 111.09 4.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.507 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -102.88 133.39 48.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.331 0.586 . . . . 0.0 111.91 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.32 105.42 10.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.351 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -97.77 149.24 22.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.997 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.27 133.88 28.9 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.702 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.9 t30 56.98 27.26 12.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.809 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -176.49 58.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 169.19 17.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.419 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 48.19 29.38 1.83 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.882 0.373 . . . . 0.0 110.661 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.69 -51.99 63.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.563 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -149.59 152.77 36.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.178 0.513 . . . . 0.0 111.578 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.47 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.46 149.4 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.804 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -120.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 163.97 39.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.762 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.3 p90 -137.26 155.65 49.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.441 0.638 . . . . 0.0 112.085 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.0 tt0 -119.97 127.19 52.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.128 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.015 HG21 ' CE1' ' A' ' 5' ' ' TYR . 49.2 t -102.7 129.65 53.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.426 . . . . 0.0 112.025 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -136.82 82.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.22 44.76 74.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.272 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.55 -13.14 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.6 0.36 . . . . 0.0 111.497 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.88 126.05 38.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.03 152.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.234 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.85 151.14 51.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.783 178.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.6 m-85 -100.32 116.45 32.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.158 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.0 t90 -109.1 90.41 3.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.007 0.432 . . . . 0.0 109.907 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.62 158.36 32.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.743 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -85.16 -12.75 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.858 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -91.08 25.23 2.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.85 0.357 . . . . 0.0 111.755 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.7 26.3 61.08 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.505 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.16 163.86 17.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.928 0.864 . . . . 0.0 109.866 179.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.68 142.4 12.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.975 178.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.52 121.56 12.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.677 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 31.3 p-10 -90.37 152.08 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.397 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -153.52 -167.49 15.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.034 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.11 131.93 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.7 m-30 -77.05 110.24 11.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.577 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.7 m -84.84 -14.29 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.32 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.73 177.93 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.82 -27.95 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 2.3 m-20 -121.08 -2.62 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.593 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.0 tt0 -106.94 141.92 37.38 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.899 0.38 . . . . 0.0 110.733 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.027 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -128.18 142.97 51.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.536 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.712 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 108.02 10.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.786 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.83 137.01 29.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.668 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.35 22.75 38.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.122 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.55 25.23 61.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.373 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.3 165.12 13.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.1 m -117.9 107.57 14.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.147 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.027 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.9 m-85 -110.12 123.37 49.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 8.3 m-85 -102.95 140.34 37.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.692 ' O ' ' N ' ' A' ' 79' ' ' LYS . 3.8 tpp180 -54.06 148.21 11.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.931 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.3 mt-10 9.78 -65.14 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.388 1.055 . . . . 0.0 112.564 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.871 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.745 0.307 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.72 157.95 17.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -121.02 91.13 47.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.439 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 72.0 Cg_exo -52.76 164.88 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.907 2.405 . . . . 0.0 112.67 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 43' ' ' VAL . 15.3 m-85 -144.88 -42.34 0.24 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.2 t 60.32 129.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.022 0.439 . . . . 0.0 111.3 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.592 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.24 146.63 4.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -93.84 96.93 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.084 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.667 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.1 m95 -89.54 107.48 19.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.695 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 17' ' ' ARG . 71.1 t -113.95 155.59 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.329 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.427 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.72 1.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.104 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.612 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -79.6 -19.36 49.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.515 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.45 -26.16 12.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.995 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.04 24.83 26.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.221 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -77.13 -28.35 54.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.516 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.17 155.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.435 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -136.89 133.09 35.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.863 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.1 tt0 -121.47 113.2 19.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -94.46 128.45 41.04 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.059 0.457 . . . . 0.0 111.513 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.772 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.3 mt -92.58 113.26 25.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 156.34 86.66 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -64.0 -17.01 58.12 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.556 2.838 . . . . 0.0 112.49 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.58 24.08 6.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 110.759 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.11 54.13 22.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.92 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.0 mmm-85 -143.37 -179.93 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.593 0.235 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.72 149.2 47.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.6 . . . . 0.0 112.407 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.53 112.45 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.487 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -104.17 131.54 51.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.288 0.566 . . . . 0.0 111.907 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.4 105.21 11.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -98.62 150.47 21.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.55 -41.19 56.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.643 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -58.99 -30.86 68.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 0.0 110.799 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -179.6 119.54 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.553 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.91 169.43 13.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.342 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.52 29.13 1.96 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.891 0.377 . . . . 0.0 110.52 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.56 -49.89 66.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.503 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 144.33 24.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.729 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.95 149.81 26.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.25 -120.95 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.099 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.772 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.3 p90 -138.56 155.75 48.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.414 0.626 . . . . 0.0 112.323 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.99 127.21 52.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.717 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.0 t -104.98 130.46 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.173 0.511 . . . . 0.0 112.083 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 11.3 mtm105 -142.05 99.87 3.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.784 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.85 43.34 96.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.287 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.59 -7.03 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.47 0.308 . . . . 0.0 111.67 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 125.73 38.6 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.752 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.97 148.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.273 0.559 . . . . 0.0 112.153 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.547 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.43 144.13 49.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.891 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -99.6 114.79 28.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.12 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -108.97 90.29 3.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.025 0.44 . . . . 0.0 109.865 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.63 159.1 28.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.653 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -85.1 -12.65 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.987 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -91.58 25.51 2.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.809 0.337 . . . . 0.0 111.612 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.19 26.52 61.67 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.097 -0.573 . . . . 0.0 114.478 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.96 164.26 15.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.858 0.829 . . . . 0.0 109.831 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.13 142.65 11.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 178.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.52 121.71 13.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.515 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.5 p30 -89.61 155.43 19.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -162.48 -171.42 28.62 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -168.12 133.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 111.285 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.752 ' CE1' HG21 ' A' ' 48' ' ' ILE . 9.0 m-30 -72.99 110.34 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.104 0.478 . . . . 0.0 110.716 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.64 -18.09 10.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.356 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -148.68 -169.13 3.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.351 . . . . 0.0 110.958 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.79 -30.2 32.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -121.67 1.34 10.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.485 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.7 tt0 -107.0 147.93 29.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.921 0.391 . . . . 0.0 110.581 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.001 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.17 144.22 49.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.414 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.742 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.48 108.92 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.443 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.33 135.86 32.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.582 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.95 23.78 17.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.177 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.23 67.25 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.31 164.18 12.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.026 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 m -117.23 107.63 14.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.001 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.2 m-85 -109.48 127.13 54.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.355 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.612 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 9.5 m-85 -105.16 143.58 33.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.861 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.18 140.68 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 31.36 -58.26 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.569 1.148 . . . . 0.0 112.955 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.861 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.746 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.831 0.348 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 153.77 42.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.96 95.44 47.57 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 46.2 Cg_exo -57.0 159.63 14.34 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.73 2.287 . . . . 0.0 112.279 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.027 ' CE1' HG21 ' A' ' 43' ' ' VAL . 5.3 m-85 -145.64 -44.81 0.21 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.941 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.0 t 62.24 129.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.188 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 153.87 146.14 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.388 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.542 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.71 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.411 0.624 . . . . 0.0 109.856 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.647 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.6 m95 -86.38 108.47 18.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.381 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 17' ' ' ARG . 75.7 t -114.32 155.7 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.778 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.421 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -65.68 -175.16 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.331 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.0 -20.45 32.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.05 -25.48 12.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.828 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.59 23.21 24.34 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.315 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -73.91 -26.87 60.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.742 0.306 . . . . 0.0 110.271 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.864 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -143.67 157.7 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.345 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.864 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -140.27 138.33 34.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.6 tt0 -125.44 112.91 16.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.66 126.67 36.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 111.669 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.747 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.4 mt -92.91 111.66 23.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.06 156.32 81.07 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.06 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.9 -17.22 58.97 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.467 2.778 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.7 22.9 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.27 52.54 26.51 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.843 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.7 mmt85 -140.94 -179.81 6.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.562 0.22 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -137.0 150.36 48.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.41 0.624 . . . . 0.0 112.459 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.16 110.74 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.0 tt0 -103.3 132.48 49.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.415 0.626 . . . . 0.0 111.895 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.58 105.16 10.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.352 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 4.4 mtm180 -97.81 146.64 25.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.051 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.99 136.59 24.55 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.853 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.95 25.16 10.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 0.0 111.036 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -176.98 58.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.389 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 169.93 14.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.459 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 49.34 29.93 2.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.934 0.397 . . . . 0.0 110.619 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -52.42 61.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.685 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.409 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -151.0 153.48 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.038 0.447 . . . . 0.0 111.754 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.82 148.92 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.045 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.98 -121.82 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.982 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.14 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.747 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.2 p90 -138.09 157.64 45.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.355 0.597 . . . . 0.0 112.284 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.38 127.21 49.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.087 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.027 HG21 ' CE1' ' A' ' 5' ' ' TYR . 29.8 t -101.07 135.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.209 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -141.45 82.86 1.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.492 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.38 44.7 72.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.223 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 86.04 -14.4 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.551 0.34 . . . . 0.0 111.539 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.56 39.69 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.76 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.48 149.54 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.471 0.653 . . . . 0.0 112.516 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 2.6 t30 -117.69 166.81 11.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.94 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 57' ' ' THR . 72.2 m-85 -125.22 113.07 17.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.597 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -109.0 91.67 3.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 110.058 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.4 159.18 29.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.642 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.98 -12.81 52.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.216 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -91.53 25.64 2.57 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.841 0.353 . . . . 0.0 111.681 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.13 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.378 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.84 164.27 15.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.842 0.821 . . . . 0.0 109.903 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.47 142.32 11.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.7 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -149.07 125.89 11.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.847 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.2 p30 -92.92 152.79 19.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.417 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.22 15.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.074 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' NE2' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.07 132.7 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 0.0 111.274 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.5 m-30 -79.64 110.33 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.5 m -79.48 -19.69 12.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.304 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -150.2 -175.64 5.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.27 57.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.064 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 2.8 m-20 -116.69 -2.64 11.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.439 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.7 tt0 -106.92 144.4 33.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.963 0.411 . . . . 0.0 110.643 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.029 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.54 143.98 51.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.509 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.734 ' N ' HD13 ' A' ' 68' ' ' LEU . 3.3 m170 -126.36 108.91 11.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.841 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.46 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.95 136.93 32.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.56 23.5 14.26 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.138 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.21 67.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.729 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.46 164.06 12.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.011 0.405 . . . . 0.0 111.064 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -116.46 107.64 15.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.029 ' HB2' HD12 ' A' ' 68' ' ' LEU . 24.7 m-85 -110.0 123.58 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.403 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.626 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.8 m-85 -101.2 140.91 34.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.799 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -58.31 147.51 30.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.226 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.6 mt-10 15.96 -62.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.674 1.19 . . . . 0.0 113.071 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.799 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.869 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtp . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.832 0.349 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.01 151.99 41.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -124.74 102.33 32.24 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 50.3 Cg_exo -55.22 163.6 4.48 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.827 2.351 . . . . 0.0 112.631 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.934 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.6 m-85 -145.49 -42.46 0.22 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.798 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 21' ' ' LEU . 20.5 t 60.57 128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.206 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.573 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.14 147.51 4.89 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.27 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.75 96.77 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.396 0.617 . . . . 0.0 110.009 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.679 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.2 m95 -88.88 108.59 19.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.8 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 17' ' ' ARG . 73.9 t -116.42 155.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.425 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.44 -178.29 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.139 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.636 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -81.84 -19.54 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.475 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.74 -27.2 11.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.72 0.295 . . . . 0.0 110.933 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 26.21 16.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.192 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.33 -29.32 47.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.353 . . . . 0.0 110.106 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.85 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -139.45 157.3 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.85 ' N ' HD12 ' A' ' 16' ' ' ILE . 4.2 ttp-105 -137.81 141.73 40.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.884 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 16.0 tt0 -131.01 111.92 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.594 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -94.76 127.71 40.95 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.047 0.451 . . . . 0.0 111.655 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.792 HD22 ' CE2' ' A' ' 41' ' ' TYR . 9.3 mt -91.89 114.01 26.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.3 156.53 88.06 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.57 -17.41 59.87 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.47 2.78 . . . . 0.0 112.498 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.22 23.75 6.32 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.842 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.09 53.95 23.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.905 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 4.5 mmm-85 -142.99 -179.76 6.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 0.0 111.251 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.42 149.72 48.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.396 0.617 . . . . 0.0 112.543 -178.42 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 112.02 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.435 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -104.03 132.36 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.353 0.597 . . . . 0.0 111.958 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.44 105.18 10.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -97.62 148.31 23.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.6 137.64 25.76 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.778 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 56.51 24.04 8.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -177.02 65.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 169.65 17.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.565 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.05 29.92 2.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 110.58 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.18 -52.45 61.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.636 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.41 153.58 36.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.187 0.518 . . . . 0.0 111.672 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.92 149.48 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.818 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.78 -120.32 0.54 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 119.691 -1.243 . . . . 0.0 113.075 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.14 164.18 38.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.792 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.8 p90 -139.7 154.72 47.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 112.354 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.9 127.34 52.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.824 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.934 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.2 t -104.15 131.37 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 112.078 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -142.72 100.48 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.741 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.26 42.84 95.64 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.369 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.98 -7.98 1.33 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 122.514 0.326 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 127.19 39.43 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.674 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.97 148.65 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.194 0.521 . . . . 0.0 112.153 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.72 143.83 49.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.878 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 57' ' ' THR . 45.5 m-85 -98.95 114.66 27.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.037 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -109.03 90.25 3.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.929 0.395 . . . . 0.0 109.94 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.94 158.46 30.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.91 -12.81 52.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.981 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.1 t -91.38 25.14 2.68 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.848 0.356 . . . . 0.0 111.73 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.74 26.52 60.57 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.932 -0.651 . . . . 0.0 114.425 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.86 163.91 16.82 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.915 0.858 . . . . 0.0 109.935 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.37 142.37 12.77 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.882 178.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -141.34 121.74 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.477 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -88.49 156.08 19.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.085 0.469 . . . . 0.0 111.402 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.1 -174.76 35.13 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -168.14 132.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.38 . . . . 0.0 111.328 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.674 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.42 110.29 5.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.716 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -82.31 -19.2 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.253 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -147.25 -168.68 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.77 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.197 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -122.94 -0.08 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.579 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.7 tt0 -106.93 147.23 30.07 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.023 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.6 142.84 50.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 -179.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.699 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.4 m170 -126.19 107.8 10.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.213 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.485 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -145.96 137.72 25.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.691 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.69 22.26 39.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.915 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.63 23.39 64.84 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.368 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.02 164.45 14.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.217 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -117.03 107.5 14.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.54 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.023 ' HB2' HD12 ' A' ' 68' ' ' LEU . 22.0 m-85 -110.67 127.43 55.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 15.2 m-85 -102.69 146.04 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.481 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.798 ' O ' ' N ' ' A' ' 79' ' ' LYS . 1.5 tpp85 -73.07 136.87 45.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.955 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 39.88 -56.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.688 1.195 . . . . 0.0 113.266 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.798 ' N ' ' O ' ' A' ' 77' ' ' ARG . 4.0 mtpm? . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.818 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.832 0.348 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -158.73 160.54 36.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -131.29 97.58 19.63 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 77.5 Cg_exo -51.83 165.12 0.85 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.795 2.33 . . . . 0.0 112.65 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.988 ' CE1' HG21 ' A' ' 43' ' ' VAL . 22.2 m-85 -146.26 -41.71 0.2 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.2 t 60.53 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.62 146.58 4.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.79 96.93 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.496 0.665 . . . . 0.0 110.133 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.655 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 18.8 m95 -89.52 107.32 19.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.601 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 17' ' ' ARG . 79.6 t -113.28 155.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.401 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.401 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -68.76 172.75 5.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.193 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.636 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -74.77 -19.47 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.7 -25.95 13.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.94 24.14 36.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.151 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.497 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.69 -26.07 44.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.279 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.577 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.64 156.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.281 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.746 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -139.16 130.97 27.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.962 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 11.5 tt0 -117.64 112.67 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -93.74 127.33 39.41 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.739 HD22 ' CE2' ' A' ' 41' ' ' TYR . 8.1 mt -92.48 113.97 26.4 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.46 156.75 87.82 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -175.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.9 -17.18 58.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.448 2.765 . . . . 0.0 112.499 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.7 24.23 6.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.428 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.08 53.52 25.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.94 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.4 mmt85 -142.22 -179.78 6.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.649 0.261 . . . . 0.0 111.438 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.23 148.65 48.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.26 0.552 . . . . 0.0 112.424 -178.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 109.65 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.9 tt0 -102.9 134.29 46.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.396 0.617 . . . . 0.0 112.134 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.11 105.29 12.11 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.063 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -103.66 117.44 34.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.385 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.3 -157.03 6.47 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.801 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -56.26 -23.22 34.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.694 0.283 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -89.24 83.61 6.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.506 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -75.73 172.0 13.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.44 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 4.3 m 43.87 34.56 0.92 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.295 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.59 -47.17 63.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.171 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 142.23 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -150.94 150.35 30.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.845 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.55 -122.73 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.037 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -154.14 164.05 39.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.739 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.0 p90 -138.73 157.34 46.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.612 0.72 . . . . 0.0 112.221 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -120.73 127.27 51.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.834 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.988 HG21 ' CE1' ' A' ' 5' ' ' TYR . 81.0 t -104.59 128.77 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 112.133 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.93 98.61 3.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 59.69 43.21 97.98 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.232 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.76 -6.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.458 0.303 . . . . 0.0 111.608 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.75 125.33 38.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.745 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.15 148.05 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.292 0.567 . . . . 0.0 111.995 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.538 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -134.9 145.24 48.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.675 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.7 m-85 -97.47 117.03 30.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.007 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.2 t90 -109.32 90.9 3.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.996 0.427 . . . . 0.0 109.953 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.61 155.64 40.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.742 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.35 -12.62 51.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.088 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -90.85 24.18 2.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 0.0 111.918 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.6 22.43 60.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.32 163.48 17.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.224 1.012 . . . . 0.0 109.893 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.89 141.29 14.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.897 178.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -127.21 178.37 6.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 22.5 p-10 -147.07 148.8 32.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.112 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -166.13 -174.09 35.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.329 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -168.12 129.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.745 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.9 m-30 -68.58 110.5 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.48 . . . . 0.0 110.81 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -85.81 -17.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.273 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -148.37 -168.05 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.82 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.63 -26.92 29.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 0.97 7.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HB3' HG23 ' A' ' 63' ' ' VAL . 1.4 tt0 -107.18 146.54 31.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.98 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.53 142.88 50.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.73 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.63 107.85 10.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.02 135.99 26.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.711 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.31 22.13 43.04 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.029 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.29 23.85 62.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.487 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.64 13.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.901 0.381 . . . . 0.0 111.017 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 m -118.17 107.43 13.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.874 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.98 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.3 m-85 -109.33 126.26 53.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.309 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.636 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 13.1 m-85 -103.36 145.45 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.491 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.787 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -71.87 137.65 47.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.69 -179.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 39.83 -55.89 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.671 1.188 . . . . 0.0 113.354 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.787 ' N ' ' O ' ' A' ' 77' ' ' ARG . 2.4 mttt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.853 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.764 0.316 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.78 157.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -129.46 104.76 17.57 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.79 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 61.1 Cg_exo -53.22 164.45 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.798 2.332 . . . . 0.0 112.841 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.005 ' CE1' HG21 ' A' ' 43' ' ' VAL . 17.1 m-85 -146.43 -43.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.4 t 60.74 129.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.285 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.69 146.95 4.65 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.418 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.79 96.96 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.518 0.675 . . . . 0.0 110.15 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.678 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.6 m95 -89.08 107.82 19.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.571 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 17' ' ' ARG . 76.2 t -113.99 155.29 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.466 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.431 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.28 176.76 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.245 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.647 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.91 -19.95 53.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.36 -25.19 13.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.012 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.41 23.79 33.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.204 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -76.56 -27.23 55.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.85 0.357 . . . . 0.0 110.128 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.712 HD13 ' OE1' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -141.95 154.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.388 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.725 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.32 132.73 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 21.6 tt0 -121.82 114.13 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.891 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -93.34 128.55 39.41 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.514 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.755 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.4 mt -93.26 113.69 25.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.534 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 158.13 80.47 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.8 Cg_exo -63.26 -18.79 66.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.586 2.858 . . . . 0.0 112.868 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.66 20.92 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.741 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.37 51.27 27.66 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.382 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 87.5 mmt-85 -137.17 -179.81 5.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.599 -0.3 . . . . 0.0 110.927 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.6 152.32 50.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.426 0.632 . . . . 0.0 112.512 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.01 110.6 4.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.425 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.712 ' OE1' HD13 ' A' ' 16' ' ' ILE . 2.5 tt0 -103.12 134.09 47.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 112.102 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.26 105.1 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.969 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.91 111.74 24.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.502 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.34 -150.72 11.04 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.884 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -58.54 -20.44 46.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.703 0.287 . . . . 0.0 111.167 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.68 76.91 4.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.838 0.352 . . . . 0.0 110.75 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.69 169.52 18.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.455 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 51.91 30.07 6.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.68 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -43.07 71.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.176 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.06 141.61 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.504 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.46 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.42 149.86 29.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.5 -122.46 0.64 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.912 -1.137 . . . . 0.0 113.088 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.03 164.18 38.87 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.755 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.6 p90 -138.45 156.73 47.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.537 0.684 . . . . 0.0 112.317 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -120.21 127.35 52.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.953 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.005 HG21 ' CE1' ' A' ' 5' ' ' TYR . 77.2 t -104.06 126.82 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 111.952 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -136.38 92.34 2.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 63.2 43.3 98.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.199 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.98 -10.25 0.93 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 122.558 0.343 . . . . 0.0 111.706 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.9 125.59 38.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.646 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -139.43 147.28 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.184 0.516 . . . . 0.0 112.263 -179.059 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -129.23 146.56 51.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.642 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' THR . 42.8 m-85 -97.08 118.26 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.38 0.133 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.416 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 30.4 t90 -109.47 91.29 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.145 0.498 . . . . 0.0 110.003 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.21 155.1 41.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.744 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.2 -12.65 52.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.055 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 t -90.17 23.52 2.83 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.885 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.45 22.32 58.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -121.05 162.73 19.48 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.251 1.026 . . . . 0.0 110.048 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.78 140.71 16.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.748 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -125.66 178.47 5.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.4 p-10 -145.73 145.87 31.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -176.96 33.84 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.355 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.0 p-10 -168.1 123.62 1.0 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.059 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 4.9 m-30 -64.96 110.15 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.8 m -83.48 -19.2 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.246 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.47 -166.33 2.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.4 -29.18 26.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.208 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -122.83 1.12 9.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.604 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 63' ' ' VAL . 7.6 tt0 -107.02 149.52 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.883 0.373 . . . . 0.0 110.705 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.024 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.61 144.53 49.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.741 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.4 108.24 11.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -139.45 134.96 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.61 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.22 23.55 18.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.16 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.72 66.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.698 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.35 163.87 12.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.956 0.407 . . . . 0.0 111.093 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 m -116.74 107.75 15.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.894 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.024 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.2 m-85 -109.78 127.57 54.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.647 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 14.6 m-85 -103.7 145.96 29.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.26 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.798 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -72.56 137.87 46.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.916 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 39.88 -56.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.753 1.221 . . . . 0.0 113.249 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.798 ' N ' ' O ' ' A' ' 77' ' ' ARG . 3.7 mtpm? . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.8 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' O ' ' CD2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -89.58 -24.61 21.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.246 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.409 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 15.0 m80 -155.39 91.3 2.84 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.954 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 52.2 Cg_exo -55.73 163.04 5.88 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.693 2.262 . . . . 0.0 112.315 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.999 ' CE1' HG21 ' A' ' 43' ' ' VAL . 12.3 m-85 -143.29 -43.78 0.29 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.715 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.1 t 60.6 129.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.9 147.37 4.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.273 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.23 96.88 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.582 0.706 . . . . 0.0 110.151 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.664 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.5 m95 -89.25 106.63 18.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.707 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 17' ' ' ARG . 74.8 t -113.67 155.76 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.267 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.443 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.129 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -79.09 -19.62 50.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -27.19 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.73 24.38 23.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.077 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.443 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.06 -31.62 58.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 109.956 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.565 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -138.34 155.89 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.455 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.704 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.44 132.27 33.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.678 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.6 tt0 -120.32 112.61 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -93.2 127.6 38.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.539 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.76 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.2 mt -92.51 112.79 24.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.89 156.29 84.13 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.03 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.3 Cg_exo -63.68 -17.27 59.22 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.569 2.846 . . . . 0.0 112.514 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.09 23.71 6.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 53.45 25.73 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.882 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.9 mmm-85 -143.11 -179.78 6.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.457 0.17 . . . . 0.0 111.42 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.29 149.85 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.438 0.637 . . . . 0.0 112.639 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.92 111.89 5.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.358 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.43 135.65 45.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.394 0.616 . . . . 0.0 112.16 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.16 105.35 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.972 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HD2' HG21 ' A' ' 16' ' ' ILE . 14.1 mtm180 -102.17 112.53 25.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.433 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.82 -150.54 9.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.946 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -58.13 -20.98 44.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 0.0 111.187 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 tpp85 -93.59 79.18 4.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.839 0.352 . . . . 0.0 110.73 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 169.33 17.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.439 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.18 29.58 6.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 110.762 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.89 -46.61 71.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.184 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 149.89 31.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.464 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.96 149.72 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.96 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.7 -121.59 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 119.826 -1.178 . . . . 0.0 112.926 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.01 162.72 40.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.76 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.5 p90 -136.86 155.52 49.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.381 0.61 . . . . 0.0 112.094 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.65 127.17 52.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.167 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.999 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.7 t -103.46 129.21 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.108 0.48 . . . . 0.0 111.973 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.31 94.34 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.653 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 61.66 42.81 99.82 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.259 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 84.17 -11.57 0.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.392 0.277 . . . . 0.0 111.725 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.89 128.96 40.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.628 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.85 153.43 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.225 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.518 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.37 151.0 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.907 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 57' ' ' THR . 51.3 m-85 -101.79 115.89 31.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.414 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 87.9 t90 -109.11 90.55 3.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.019 0.438 . . . . 0.0 110.12 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.62 158.84 28.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.778 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.14 -12.71 52.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.01 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.7 t -91.38 25.2 2.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.871 0.367 . . . . 0.0 111.72 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.19 25.73 61.15 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.014 -0.613 . . . . 0.0 114.505 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.02 163.71 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.044 0.922 . . . . 0.0 109.935 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.19 142.37 11.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.121 178.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.46 121.56 12.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.462 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p30 -90.97 153.13 20.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 0.0 111.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -154.13 -164.92 13.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.223 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 9.1 p-10 -168.09 133.31 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.042 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.7 m-30 -76.63 110.31 11.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.664 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -87.25 -10.17 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.043 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.85 156.51 11.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.824 0.345 . . . . 0.0 110.611 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.27 32.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.552 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -119.06 -10.53 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.853 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.664 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.2 tt0 -106.66 147.84 29.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.027 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.16 143.23 49.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.289 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.713 ' N ' HD13 ' A' ' 68' ' ' LEU . 3.7 m170 -126.45 108.78 11.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.847 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 136.44 29.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.65 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.61 22.96 34.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.21 63.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.538 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.01 164.33 13.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 m -117.84 107.58 14.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.006 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.027 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.4 m-85 -109.33 126.28 53.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.381 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.626 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 10.9 m-85 -103.81 145.36 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.252 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.766 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -72.33 137.7 46.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.933 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 42.64 -54.53 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 113.478 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' A' ' 77' ' ' ARG . 21.9 mtpp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.749 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.78 0.324 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -117.58 156.17 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -129.4 111.45 17.92 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 83.5 Cg_exo -46.78 160.92 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.721 2.281 . . . . 0.0 112.86 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.008 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.5 m-85 -136.62 -46.4 0.61 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.1 t 59.9 125.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.566 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.27 148.63 5.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.14 96.68 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.181 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.636 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.7 m95 -89.22 106.71 18.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.612 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 17' ' ' ARG . 78.7 t -111.08 155.78 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.349 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -69.32 172.14 7.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.228 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -73.6 -19.94 60.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.13 -16.86 14.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 17.13 68.58 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.293 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -23.41 62.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 0.0 110.284 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -147.71 156.4 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.563 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.762 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.77 131.32 31.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.771 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 27.9 tt0 -119.2 112.55 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.004 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -92.64 127.14 38.03 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 111.326 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.764 HD22 ' CE1' ' A' ' 41' ' ' TYR . 11.8 mt -93.08 112.66 24.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.58 156.69 81.77 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.497 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 27.9 Cg_exo -62.92 -17.97 62.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.583 2.855 . . . . 0.0 112.438 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -94.74 21.95 6.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.942 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.34 50.5 38.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 84.5 mmt-85 -139.36 -179.73 6.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.385 0.136 . . . . 0.0 111.02 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.36 150.99 50.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 0.0 112.758 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.69 109.93 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.275 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 3.1 tt0 -103.26 134.51 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.393 0.616 . . . . 0.0 112.183 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.61 105.29 11.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.061 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HD2' HG21 ' A' ' 16' ' ' ILE . 15.2 mtm180 -103.79 116.99 33.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.34 -153.46 6.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.906 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -58.04 -21.3 44.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.679 0.276 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -92.48 80.84 4.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.701 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 169.67 17.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.413 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.28 30.83 6.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 110.669 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.21 -45.61 68.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.069 0.461 . . . . 0.0 111.084 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 152.42 35.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.282 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.479 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -158.89 149.9 20.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.075 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.71 -128.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.908 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.14 164.2 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.764 ' CE1' HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -133.47 157.38 45.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.502 0.668 . . . . 0.0 112.184 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.1 tt0 -119.87 127.47 52.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.983 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.008 HG21 ' CE1' ' A' ' 5' ' ' TYR . 54.6 t -102.88 126.08 57.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.141 0.496 . . . . 0.0 112.214 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -137.2 88.62 2.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.669 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 64.83 43.85 95.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.398 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 84.47 -12.15 0.78 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.43 0.292 . . . . 0.0 111.66 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.71 127.02 39.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.73 HG21 ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -140.18 151.07 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.043 -179.04 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -133.43 145.15 50.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.987 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' A' ' 57' ' ' THR . 34.5 m-85 -93.49 117.24 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.952 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -109.28 91.36 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.977 0.418 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -71.4 155.37 40.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.684 -179.176 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.22 -12.72 51.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.029 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -90.66 24.12 2.8 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.73 22.4 59.94 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 114.87 0.708 . . . . 0.0 114.87 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.52 163.4 17.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.318 1.059 . . . . 0.0 109.935 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.57 140.7 13.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.934 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -127.07 178.31 6.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.069 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 28.4 p-10 -146.78 146.76 30.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.163 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -157.66 -170.56 22.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 9.5 p-10 -168.04 123.12 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 48' ' ' ILE . 89.8 m-85 -65.82 110.34 2.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 67' ' ' GLU . 1.7 m -91.14 -6.02 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.29 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.14 173.49 10.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.44 -22.45 63.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.22 1.56 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.783 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 63' ' ' VAL . 8.7 tt0 -111.25 149.06 31.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.927 0.394 . . . . 0.0 111.006 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.048 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.95 144.08 48.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.299 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.725 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.5 m170 -126.5 107.91 10.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.48 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.48 141.55 29.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 179.197 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.19 19.13 22.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.084 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.04 68.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.999 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ttm -115.72 171.8 7.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.289 0.545 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.8 m -117.54 107.99 14.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.711 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.048 ' HB2' HD12 ' A' ' 68' ' ' LEU . 20.5 m-85 -106.03 121.88 45.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.627 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 16.5 m-85 -100.39 147.12 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.912 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.788 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -73.01 137.43 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.8 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 40.02 -55.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.79 1.236 . . . . 0.0 113.416 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 77' ' ' ARG . 13.5 mtpp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.855 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpp . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.762 0.315 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -101.87 161.54 13.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -116.86 104.19 51.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 76.6 Cg_exo -51.67 164.11 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.588 2.192 . . . . 0.0 112.67 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.023 ' CE1' HG21 ' A' ' 43' ' ' VAL . 7.5 m-85 -144.48 -44.09 0.25 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.6 t 61.58 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.612 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.48 145.0 4.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.393 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.67 96.56 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.516 0.674 . . . . 0.0 109.872 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.0 m95 -85.87 108.04 17.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.243 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.807 HG22 ' HB2' ' A' ' 17' ' ' ARG . 72.9 t -113.41 155.07 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.849 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.43 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -66.38 -177.04 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.311 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.649 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.09 -20.1 35.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.526 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.61 -25.26 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.77 25.77 24.23 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.022 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.03 -28.01 48.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.132 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.561 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.98 155.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.376 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.807 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.69 138.1 37.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 8.3 tt0 -124.3 111.95 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.937 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 38.5 tt0 -90.09 125.21 35.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.755 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.2 mt -92.61 113.54 25.85 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.534 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.16 158.26 82.11 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -176.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -63.65 -18.84 65.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.642 2.894 . . . . 0.0 112.868 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.78 22.27 7.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.331 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.68 53.03 22.1 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.575 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -138.64 179.06 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.849 -0.175 . . . . 0.0 110.954 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.01 152.75 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.474 0.654 . . . . 0.0 112.745 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.04 110.56 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.28 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.89 134.99 45.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.423 0.63 . . . . 0.0 112.079 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.37 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.161 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -100.24 111.86 24.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.361 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.06 -148.48 10.67 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.932 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -58.38 -20.63 45.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.556 0.217 . . . . 0.0 111.226 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -94.7 80.5 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.775 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 169.25 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.589 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.1 30.2 7.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.799 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.17 -44.44 75.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.163 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 142.1 22.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.38 149.79 28.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.93 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.39 -122.57 0.64 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.038 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.04 163.6 39.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.755 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.7 p90 -138.92 154.92 48.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.516 0.674 . . . . 0.0 112.31 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -120.39 127.47 52.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.285 178.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.023 HG21 ' CE1' ' A' ' 5' ' ' TYR . 58.0 t -102.27 132.01 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 112.003 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -138.59 83.32 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.715 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.29 44.46 74.87 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.183 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.6 -13.02 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.593 0.357 . . . . 0.0 111.441 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 126.02 38.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.035 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.735 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.77 147.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 2.6 t30 -118.41 166.72 12.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.847 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 57' ' ' THR . 73.1 m-85 -125.17 113.59 17.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.642 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.402 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 84.6 t90 -108.82 91.39 3.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.041 0.448 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.12 160.06 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.439 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.08 -12.8 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.26 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.95 25.58 2.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.888 0.375 . . . . 0.0 111.72 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.88 25.73 61.8 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.384 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 164.5 14.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.839 0.819 . . . . 0.0 109.908 179.041 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.16 143.03 12.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.75 177.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -146.78 124.5 11.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.872 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 29.6 t70 -91.23 153.14 20.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.52 -168.93 17.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.104 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 11.2 p-10 -168.09 132.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 7.4 m-30 -77.28 110.35 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -83.94 -14.63 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.396 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 t -156.42 179.83 8.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.99 62.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.289 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -120.3 -3.15 10.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.494 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.614 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.2 tt0 -106.84 145.61 31.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.017 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.74 143.82 50.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.301 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.735 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.4 109.08 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.896 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.53 136.0 32.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.663 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.17 23.73 18.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.192 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.99 19.44 67.38 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.726 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 164.54 12.44 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.04 0.448 . . . . 0.0 111.016 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.6 m -117.22 107.58 14.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.017 ' HB2' HD12 ' A' ' 68' ' ' LEU . 34.4 m-85 -109.76 122.94 48.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.484 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 12.1 m-85 -100.21 141.86 32.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.812 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -59.63 148.45 33.65 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.026 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.1 mt-10 17.81 -62.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.758 1.223 . . . . 0.0 113.125 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.812 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.862 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.899 0.38 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -126.61 160.78 29.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -108.28 109.11 61.68 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 49.5 Cg_exo -57.49 162.65 9.84 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.718 2.279 . . . . 0.0 112.546 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 43' ' ' VAL . 13.5 m-85 -145.38 -42.75 0.22 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 18.9 t 60.31 129.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.14 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.16 147.67 4.9 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.295 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.86 96.79 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 110.225 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.67 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.7 m95 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.748 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 17' ' ' ARG . 68.9 t -114.11 155.7 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -66.83 176.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.146 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.629 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -78.01 -19.47 54.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.93 -23.84 13.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.22 21.76 40.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.334 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' CD ' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.92 -24.65 59.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.716 0.293 . . . . 0.0 110.392 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.498 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.36 156.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.301 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.7 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -137.58 135.41 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.9 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 5.3 tt0 -122.34 113.6 19.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.6 126.92 41.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.079 0.466 . . . . 0.0 111.457 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.739 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.0 mt -91.64 113.64 25.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.05 157.63 86.44 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.056 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.42 -13.49 38.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.326 2.684 . . . . 0.0 111.852 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -93.89 20.09 8.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.145 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.6 49.89 65.89 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.5 mmt85 -137.37 -179.84 5.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.129 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.19 149.28 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.16 112.14 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.441 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -104.24 132.66 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.324 0.583 . . . . 0.0 112.15 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.74 105.37 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.983 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 16' ' ' ILE . 7.2 mtm180 -97.58 149.53 22.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.137 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.51 138.7 13.16 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.992 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.92 22.16 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 0.0 111.268 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -177.8 79.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.025 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 169.21 14.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.398 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.87 29.56 2.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.984 0.421 . . . . 0.0 110.515 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.99 -51.18 67.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.71 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.7 27.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 111.794 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.97 149.78 26.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.541 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.23 -122.14 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.699 -1.239 . . . . 0.0 113.194 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.11 164.12 39.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.739 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.7 p90 -139.31 155.68 47.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.519 0.676 . . . . 0.0 112.275 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.89 127.15 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.89 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.5 t -104.32 129.89 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.463 . . . . 0.0 112.097 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 99.6 3.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.707 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.73 42.93 96.63 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.306 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.0 -7.76 1.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.393 0.277 . . . . 0.0 111.629 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.93 126.43 39.13 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.68 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -137.28 148.87 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.221 0.534 . . . . 0.0 112.237 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.29 144.68 49.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.789 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.684 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.4 m-85 -98.61 115.06 27.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.012 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.7 t90 -109.05 90.45 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.035 0.445 . . . . 0.0 109.899 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.68 158.91 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.08 -12.63 52.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.038 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.55 25.29 2.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.796 0.331 . . . . 0.0 111.711 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.45 26.76 60.68 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.14 164.17 15.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.768 0.784 . . . . 0.0 109.765 179.077 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.34 142.68 11.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.965 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.68 121.65 12.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.5 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 9.9 p-10 -88.95 157.61 18.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 111.651 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.16 -172.1 32.2 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.888 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -168.17 132.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.308 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.68 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.8 m-30 -71.63 110.24 6.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.538 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.0 m -81.74 -18.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.335 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 t -148.61 -168.47 3.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.853 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.95 -28.25 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.194 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -122.12 -0.13 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.582 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HB3' HG23 ' A' ' 63' ' ' VAL . 6.7 tt0 -106.89 147.75 29.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.74 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.64 142.24 49.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.715 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.2 m170 -126.39 107.88 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.72 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.67 135.61 26.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.7 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.67 21.7 43.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.1 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.92 24.53 59.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.418 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -115.43 164.71 13.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -118.26 107.37 13.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.063 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.986 ' HB2' HD12 ' A' ' 68' ' ' LEU . 29.1 m-85 -109.83 127.77 54.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.34 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.629 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 15.2 m-85 -104.17 146.31 28.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.754 ' O ' ' N ' ' A' ' 79' ' ' LYS . 1.3 tpp85 -73.37 135.42 44.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.916 0.389 . . . . 0.0 111.991 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 44.01 -55.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.599 1.16 . . . . 0.0 113.37 178.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' A' ' 77' ' ' ARG . 7.2 mttm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.878 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.833 0.349 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -114.68 160.79 18.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -118.11 100.21 51.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 67.0 Cg_exo -53.09 164.45 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.726 2.284 . . . . 0.0 112.656 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.953 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.6 m-85 -145.58 -42.29 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.866 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 20.0 t 60.19 128.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.029 0.443 . . . . 0.0 111.263 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.568 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.58 148.45 5.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.242 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -96.05 96.57 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.592 0.711 . . . . 0.0 110.035 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.68 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.1 m95 -88.42 107.63 18.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.597 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' HB2' ' A' ' 17' ' ' ARG . 69.7 t -114.44 155.74 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.411 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -65.76 176.9 1.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.385 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.611 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.5 -19.9 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.574 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.41 -24.82 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.707 0.289 . . . . 0.0 110.945 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.15 22.98 30.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.461 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.562 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -76.49 -28.32 56.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.81 0.338 . . . . 0.0 110.165 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -139.1 158.39 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.851 ' N ' HD12 ' A' ' 16' ' ' ILE . 3.7 ttp180 -138.67 142.76 39.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.804 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 2.8 tt0 -130.21 111.88 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -95.14 127.11 40.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.764 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.5 mt -92.14 113.91 26.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.27 156.58 87.84 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.44 -17.57 60.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.62 2.88 . . . . 0.0 112.474 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -95.86 23.26 6.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.44 53.55 24.38 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.846 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.8 mmt85 -141.94 -179.97 6.53 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 111.413 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.08 149.28 47.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 112.562 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.33 110.93 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.381 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.66 134.08 47.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.61 . . . . 0.0 112.277 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.32 105.03 11.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.775 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -100.28 108.05 20.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.36 -148.95 13.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.859 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -57.06 -22.03 36.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.74 0.305 . . . . 0.0 111.188 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -93.52 79.96 4.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.625 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 169.45 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.49 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.72 29.66 6.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.399 . . . . 0.0 110.626 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.08 -47.09 72.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.117 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.84 141.84 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.469 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.14 149.9 29.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.737 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.32 -120.74 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 119.833 -1.175 . . . . 0.0 113.03 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 164.02 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.764 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.4 p90 -138.42 155.78 48.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.484 0.659 . . . . 0.0 112.276 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -120.46 127.28 52.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.843 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.953 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.2 t -105.2 130.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.537 . . . . 0.0 112.085 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.19 96.91 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.777 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 60.5 43.85 98.36 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.351 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.13 -7.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.417 0.287 . . . . 0.0 111.563 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.79 124.91 38.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.753 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.5 148.15 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.0 112.153 -178.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.5 144.09 49.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.895 178.671 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.5 m-85 -99.35 115.04 28.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -109.14 90.18 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.012 0.434 . . . . 0.0 109.849 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.65 158.69 29.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.704 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -85.09 -12.7 52.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.975 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.5 t -91.41 25.26 2.65 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 120.907 0.384 . . . . 0.0 111.807 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 26.09 61.22 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.026 -0.606 . . . . 0.0 114.467 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.9 164.09 15.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.873 0.836 . . . . 0.0 109.918 179.082 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.95 142.69 12.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.94 178.07 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.72 121.7 12.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.601 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.0 p30 -89.44 156.24 18.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.585 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.53 -171.67 30.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.025 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.3 p-10 -168.19 133.74 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.236 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.753 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.3 m-30 -73.57 110.42 7.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.28 -18.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.215 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.46 -168.81 3.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.876 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.82 -27.62 28.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -123.01 2.05 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.588 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.9 tt0 -108.97 149.8 28.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 110.78 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.992 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -133.2 143.46 49.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.715 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.37 107.77 10.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.246 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -151.99 137.33 17.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.224 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.86 13.19 58.91 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.762 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.23 20.18 59.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.945 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.4 ttm -120.49 171.57 8.45 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.216 0.508 . . . . 0.0 111.714 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 m -116.41 107.64 15.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.348 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.992 ' HB2' HD12 ' A' ' 68' ' ' LEU . 13.6 m-85 -106.01 127.77 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.334 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.611 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 18.9 m-85 -102.46 147.13 27.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.728 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 79' ' ' LYS . 2.1 tpp85 -75.71 130.42 38.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.103 0.478 . . . . 0.0 112.228 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 53.73 -35.37 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 178.17 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.819 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.893 0.377 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.18 163.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -119.46 100.07 49.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 55.0 Cg_exo -53.89 163.6 2.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.732 2.288 . . . . 0.0 112.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.001 ' CE1' HG21 ' A' ' 43' ' ' VAL . 9.7 m-85 -145.77 -43.43 0.21 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.792 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 19.9 t 60.86 129.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 111.286 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.602 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.29 145.49 4.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -91.94 96.82 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.36 0.6 . . . . 0.0 110.141 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.664 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.5 m95 -88.24 108.18 19.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.405 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.702 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.1 t -113.75 155.15 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.694 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.511 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.94 -176.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.312 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -83.53 -20.41 33.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.584 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.67 -24.47 12.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.987 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.87 23.79 26.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.024 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.511 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -74.96 -30.66 61.27 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.515 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.44 155.81 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.58 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.702 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -137.93 128.66 26.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.9 tt0 -116.31 112.2 21.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.92 126.83 38.2 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.504 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.795 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.0 mt -91.84 113.26 25.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -68.04 157.41 87.09 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.475 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.5 Cg_exo -64.72 -13.18 37.7 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.445 2.763 . . . . 0.0 111.854 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -93.89 20.3 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.173 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.46 50.4 62.52 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -139.93 -179.91 6.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.971 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.25 149.57 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.59 110.34 5.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.255 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.59 133.09 49.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.414 0.626 . . . . 0.0 112.288 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.85 105.45 11.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.905 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 16' ' ' ILE . 20.8 mtm-85 -101.6 109.45 21.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.11 -150.73 18.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.799 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.83 -21.28 41.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.721 0.296 . . . . 0.0 111.096 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.18 80.4 4.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.922 0.391 . . . . 0.0 110.624 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 168.88 18.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.645 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.0 30.35 7.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.943 0.402 . . . . 0.0 110.714 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.57 -47.11 73.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.229 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 143.59 25.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.466 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.82 149.9 29.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.877 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.03 -123.65 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.899 -1.144 . . . . 0.0 113.025 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.04 164.05 39.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.795 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.5 p90 -139.78 154.74 47.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 112.142 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.78 127.34 52.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.249 178.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.001 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.9 t -102.84 129.49 54.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.857 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.68 92.26 2.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.629 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 62.5 43.61 98.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.357 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.7 0.85 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 122.461 0.304 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.9 128.9 40.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.005 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.698 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.36 151.5 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.073 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 1.3 m-20 -127.24 171.17 11.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.551 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.718 ' O ' ' HA ' ' A' ' 57' ' ' THR . 79.1 m-85 -124.1 114.84 20.24 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.08 90.99 3.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.64 160.39 22.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.694 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -12.76 52.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.157 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -92.19 25.32 2.94 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.821 0.343 . . . . 0.0 111.719 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 25.79 61.67 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.59 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.16 164.32 14.95 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 117.82 0.81 . . . . 0.0 109.783 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.62 142.48 10.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.008 177.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -143.93 121.55 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.545 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p-10 -90.37 150.75 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 0.0 111.523 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -156.24 -171.92 23.08 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.109 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 2.0 p30 -168.28 132.97 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.262 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -73.1 110.33 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.8 m -81.93 -18.91 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.335 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -147.3 -169.04 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.99 -29.28 32.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.217 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -121.77 -0.14 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.512 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.1 tt0 -106.82 148.8 28.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 110.702 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.051 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.42 144.4 49.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.35 108.76 11.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.85 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.426 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -139.95 135.32 32.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.621 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.04 23.72 17.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.276 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.62 18.95 67.07 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.717 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -108.76 164.05 12.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 111.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.5 m -116.73 107.66 14.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.051 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.0 m-85 -110.27 124.63 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.099 0.476 . . . . 0.0 111.667 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.652 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 28.3 m-85 -97.72 147.18 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.769 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.478 ' CD ' ' CE2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -73.03 140.68 47.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.33 0.586 . . . . 0.0 112.318 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER 27.84 104.37 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.289 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt . . . . . 0 C--N 1.308 -1.235 0 CA-C-N 113.237 -1.801 . . . . 0.0 110.931 179.656 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.891 0.377 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.02 164.62 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -130.34 113.99 17.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 47.9 Cg_exo -57.61 161.76 11.64 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.79 2.327 . . . . 0.0 112.476 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.0 ' CE1' HG21 ' A' ' 43' ' ' VAL . 10.8 m-85 -145.54 -43.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 20.5 t 60.8 128.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.352 . . . . 0.0 111.302 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.76 147.23 4.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.324 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.8 98.85 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.356 0.598 . . . . 0.0 110.206 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.646 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.7 m95 -91.38 105.34 17.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.707 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 17' ' ' ARG . 75.7 t -109.98 155.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.282 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.451 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.72 178.67 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.368 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.605 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -78.97 -20.27 49.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.62 -24.6 13.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.14 23.56 31.86 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.59 -0.815 . . . . 0.0 112.234 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.52 -27.73 58.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.068 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.5 155.89 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.589 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.71 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.25 126.13 22.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.519 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 35.4 tt0 -115.72 114.35 24.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.672 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -94.33 127.15 40.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.367 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.725 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.8 mt -90.65 112.75 24.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -67.39 157.62 84.94 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.31 -13.4 37.97 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.291 2.661 . . . . 0.0 111.872 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -93.56 19.93 7.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.192 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.41 50.22 64.06 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.0 mmt85 -139.8 -179.89 6.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.527 -0.337 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -135.95 149.63 48.98 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.73 114.64 6.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.181 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -105.66 132.23 52.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.0 112.185 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -113.64 105.18 13.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.058 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -108.36 128.37 54.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.406 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.73 -148.49 31.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.598 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -67.43 -25.41 65.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.629 0.252 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -89.86 109.23 20.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.628 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.37 169.55 10.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.103 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 47.39 29.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.692 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.52 -34.92 27.12 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.782 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.53 140.1 19.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.042 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.44 149.76 29.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.927 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.68 -123.92 0.7 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.982 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.03 164.0 39.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.725 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.9 p90 -138.34 155.08 48.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.443 0.64 . . . . 0.0 112.056 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.2 tt0 -119.75 127.25 52.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.069 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.0 HG21 ' CE1' ' A' ' 5' ' ' TYR . 67.6 t -104.42 127.27 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.969 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.26 91.99 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 63.21 43.25 98.85 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.14 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.05 0.89 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.506 0.322 . . . . 0.0 111.564 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.75 127.11 39.3 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.618 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.19 152.68 16.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 112.252 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.514 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -133.46 149.3 51.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.858 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.81 115.44 30.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 t90 -109.08 90.43 3.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.69 157.83 33.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.604 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -85.16 -12.68 52.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -91.73 24.31 3.19 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.878 0.371 . . . . 0.0 111.866 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.18 22.77 60.23 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 163.48 16.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.172 0.986 . . . . 0.0 109.963 179.057 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.46 11.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.879 178.208 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.98 121.68 11.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 6.9 p-10 -90.33 152.22 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 111.346 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.03 -167.58 16.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.024 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.7 p-10 -168.11 130.8 1.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.319 . . . . 0.0 111.218 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.6 m-30 -74.03 110.04 8.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.688 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.603 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.6 m -86.58 -11.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -158.59 -177.95 6.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.835 0.35 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -25.77 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.259 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.01 1.52 7.98 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.631 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.2 tt0 -109.43 147.87 32.11 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.819 0.342 . . . . 0.0 110.792 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.035 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.27 144.15 49.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.724 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.47 109.25 11.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.915 0.388 . . . . 0.0 110.712 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.421 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.37 134.49 30.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.11 22.96 22.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.144 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.69 67.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.752 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -107.49 163.55 12.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 111.041 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 m -116.77 107.64 14.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.775 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.035 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.4 m-85 -108.98 125.11 51.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.605 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 21.5 m-85 -102.08 147.12 26.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.782 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -74.26 137.17 42.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.812 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 41.16 -56.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.607 1.163 . . . . 0.0 113.012 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.782 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.909 0.385 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.32 160.57 32.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -117.59 113.05 38.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.805 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 31.3 Cg_exo -60.47 160.96 21.95 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.702 2.268 . . . . 0.0 112.562 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.891 ' OH ' HG11 ' A' ' 43' ' ' VAL . 15.0 m-85 -143.78 -42.62 0.28 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 21' ' ' LEU . 18.6 t 60.73 131.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.619 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.45 144.98 4.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.36 96.55 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.523 0.678 . . . . 0.0 109.782 179.288 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.684 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 26.0 m95 -86.48 109.88 19.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.167 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.3 t -115.24 154.82 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.777 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.484 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.06 -176.88 0.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.15 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.659 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.33 -19.97 35.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.6 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.1 -27.04 12.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 24.98 18.02 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.055 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.484 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.09 -31.06 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.31 155.48 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.161 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.768 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.31 131.23 29.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.686 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.7 tt0 -118.38 113.75 21.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.828 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 38.8 tt0 -92.16 125.68 36.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.552 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.75 HD22 ' CE2' ' A' ' 41' ' ' TYR . 6.8 mt -90.9 112.13 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.57 156.64 81.9 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.089 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.18 -17.81 61.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.513 2.809 . . . . 0.0 112.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.61 23.11 6.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.46 52.03 33.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.005 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -140.05 -179.79 6.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.382 0.134 . . . . 0.0 110.963 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.69 149.95 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.17 111.23 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.523 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -102.93 134.33 46.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.968 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.79 105.27 11.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.321 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -104.29 115.68 30.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.316 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.4 -153.78 7.55 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.894 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -58.04 -21.74 46.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.699 0.285 . . . . 0.0 111.154 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -91.94 82.33 5.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.86 0.362 . . . . 0.0 110.755 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.71 169.21 18.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.486 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 51.88 29.12 5.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.694 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.77 -43.46 58.46 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.998 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.04 140.06 19.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.217 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.43 150.1 29.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.735 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.95 -122.52 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.054 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.99 39.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.75 ' CE2' HD22 ' A' ' 20' ' ' LEU . 3.3 p90 -138.02 157.89 45.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.539 0.685 . . . . 0.0 112.403 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -122.54 127.42 49.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.804 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.891 HG11 ' OH ' ' A' ' 5' ' ' TYR . 79.2 t -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 82.57 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.17 -96.35 2.05 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.99 15.26 7.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.425 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -111.12 141.42 44.65 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.173 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.765 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -147.66 148.26 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.244 -179.312 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.3 144.92 50.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.708 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -102.2 115.4 30.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.157 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -109.23 90.64 3.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.7 157.82 33.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.74 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.12 -12.7 52.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.199 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.7 24.77 2.96 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.9 0.381 . . . . 0.0 111.898 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.3 23.36 61.07 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.766 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.64 164.02 15.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.049 0.924 . . . . 0.0 109.931 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.25 141.34 12.21 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.735 177.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -140.34 121.76 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.619 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 3.4 p30 -92.67 151.16 20.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 111.465 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.12 -170.98 26.49 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.875 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.9 p-10 -168.15 132.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.765 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.3 m-30 -68.28 110.18 3.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.516 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.6 m -84.86 -16.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.284 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -152.03 -175.26 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 0.0 110.813 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.76 -26.69 50.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 2.2 m-20 -122.48 -2.38 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.646 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.0 tt0 -106.98 144.86 32.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 111.004 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.037 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -129.97 143.58 50.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.365 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 107.82 10.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.41 ' CD2' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -143.71 137.42 28.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.607 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.52 22.82 40.33 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.091 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.87 62.17 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 165.94 12.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 0.0 111.151 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 m -118.07 107.54 14.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.082 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.037 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.5 m-85 -110.72 126.64 54.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.328 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.8 m-85 -103.19 141.71 35.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.816 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.812 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -58.28 146.18 35.1 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.899 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.2 mt-10 15.29 -61.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.553 1.141 . . . . 0.0 113.104 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.812 ' N ' ' O ' ' A' ' 77' ' ' ARG . 1.1 mtpm? . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.86 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.696 0.284 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.89 167.43 12.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.954 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -139.31 115.8 8.48 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.4 Cg_exo -59.04 162.04 14.57 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.748 2.299 . . . . 0.0 112.46 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.939 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.5 m-85 -145.38 -42.88 0.22 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.888 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.5 t 60.72 129.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 111.265 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.593 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.85 147.29 4.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.342 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.486 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -94.8 96.89 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 110.119 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.646 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.2 m95 -88.91 106.95 18.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.729 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 17' ' ' ARG . 71.6 t -114.33 155.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.376 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.427 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.27 178.95 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.182 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -80.0 -18.79 49.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.48 -27.54 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 26.3 18.83 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.158 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -79.08 -28.4 43.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.133 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.534 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 155.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.35 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.734 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -137.19 137.8 39.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.834 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.5 tt0 -125.17 112.94 17.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.731 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.4 127.4 39.01 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.588 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.706 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.3 mt -93.09 113.0 25.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.36 158.01 79.66 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.53 -18.91 66.5 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.644 2.896 . . . . 0.0 112.953 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.23 21.54 7.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.62 52.33 21.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.473 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 10.3 mmt180 -138.39 179.89 6.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.21 . . . . 0.0 111.115 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -138.53 153.01 48.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.471 0.653 . . . . 0.0 112.561 -178.138 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.22 111.76 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.92 131.33 49.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.306 0.574 . . . . 0.0 111.962 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.27 105.28 11.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.143 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -97.76 149.27 22.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.97 139.83 17.98 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.938 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 57.48 21.84 7.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.596 0.236 . . . . 0.0 111.072 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.2 tpp85 -179.24 78.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.959 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 169.66 13.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.432 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.05 29.52 2.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.967 0.413 . . . . 0.0 110.548 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.86 66.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.531 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.77 148.18 28.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.242 0.544 . . . . 0.0 111.766 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.486 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.73 149.67 25.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.3 -122.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.651 -1.261 . . . . 0.0 113.108 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.09 163.77 39.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.706 ' CE1' HD22 ' A' ' 20' ' ' LEU . 7.5 p90 -137.9 156.4 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 0.0 112.414 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -120.98 127.27 51.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.729 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.939 HG21 ' CE1' ' A' ' 5' ' ' TYR . 75.5 t -105.2 131.93 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.183 0.515 . . . . 0.0 112.226 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -142.94 101.45 3.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.651 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 57.87 42.94 94.93 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.406 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.72 -6.9 1.46 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.458 0.303 . . . . 0.0 111.679 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.84 126.24 38.92 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.766 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.54 148.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.302 0.572 . . . . 0.0 112.069 -178.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.552 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.35 143.25 48.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.952 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.7 m-85 -99.5 113.97 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.946 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -109.1 89.9 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.99 0.424 . . . . 0.0 109.985 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.8 158.07 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.648 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.93 -12.68 52.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.164 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -92.0 24.84 3.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.852 0.358 . . . . 0.0 111.708 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 27.26 55.97 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.621 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.38 164.1 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.006 0.903 . . . . 0.0 109.823 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.36 143.05 11.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.125 178.063 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.59 121.79 12.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.553 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 8.8 t70 -88.81 155.16 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -171.77 27.6 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.051 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 3.8 p-10 -168.21 133.88 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.341 . . . . 0.0 111.15 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.766 ' CE1' HG21 ' A' ' 48' ' ' ILE . 9.4 m-30 -75.63 110.33 9.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -83.24 -18.43 10.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.881 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.21 174.72 13.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.38 -21.57 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.298 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -121.41 -8.55 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.802 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.488 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.7 tt0 -106.61 149.01 27.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 111.166 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.958 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.4 142.41 50.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.278 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.72 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 107.88 10.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.8 135.8 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.724 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.69 21.84 44.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.049 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.24 25.13 59.93 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.389 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.86 165.15 13.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.991 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -118.59 107.44 13.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.004 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.958 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.1 m-85 -110.14 128.78 55.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 13.0 m-85 -105.02 145.83 29.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.817 ' O ' ' N ' ' A' ' 79' ' ' LYS . 1.1 tpp85 -72.26 136.78 46.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 38.47 -57.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.569 1.148 . . . . 0.0 113.1 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.817 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.291 -0.862 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.09 148.45 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -109.86 112.42 58.13 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.829 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.0 Cg_exo -58.97 161.28 16.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.72 2.28 . . . . 0.0 112.507 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.919 ' CE1' HG21 ' A' ' 43' ' ' VAL . 11.7 m-85 -144.79 -43.29 0.24 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.801 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 21' ' ' LEU . 20.9 t 61.22 130.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.933 0.397 . . . . 0.0 111.401 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.603 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 155.69 145.82 4.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.254 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.98 96.8 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 121.452 0.644 . . . . 0.0 109.84 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.8 m95 -87.41 109.8 19.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.419 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.709 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.1 t -117.22 155.0 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.766 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.413 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.37 -176.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.219 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.13 -20.19 35.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.69 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -23.39 12.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.317 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.48 21.66 33.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.376 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.413 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -72.02 -25.46 61.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.29 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.558 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.83 155.3 11.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.389 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.709 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -136.0 138.75 42.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.644 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.2 tt0 -125.33 111.88 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -92.51 125.63 37.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 111.535 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.812 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.4 mt -91.61 111.98 23.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -64.78 155.97 80.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -176.167 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.4 Cg_exo -64.11 -16.76 56.77 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.571 2.848 . . . . 0.0 112.47 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.38 23.6 6.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.769 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.52 53.6 23.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.926 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 5.6 mmm-85 -143.3 -179.85 6.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.512 0.196 . . . . 0.0 111.31 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.03 150.1 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.494 0.664 . . . . 0.0 112.716 -178.343 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.47 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.221 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.79 137.6 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.368 0.604 . . . . 0.0 112.448 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 34' ' ' LYS . . . -124.15 105.57 9.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.851 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 16' ' ' ILE . 10.5 mtm180 -98.01 107.14 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.023 0.44 . . . . 0.0 111.867 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 46.74 -143.17 5.18 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.25 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -50.55 -27.06 6.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.248 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -96.57 100.66 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.605 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -102.52 170.03 8.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.495 179.432 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.8 27.68 3.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.392 . . . . 0.0 110.491 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.45 67.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.287 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.72 150.44 32.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.326 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -159.39 149.88 19.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.98 179.403 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.67 -121.38 0.58 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.913 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.81 39.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.812 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.9 p90 -138.64 154.11 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 112.274 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -119.84 127.29 52.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.828 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.919 HG21 ' CE1' ' A' ' 5' ' ' TYR . 72.4 t -104.2 131.37 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.178 0.513 . . . . 0.0 112.01 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.05 100.85 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.24 42.81 95.59 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.335 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.61 -7.22 1.45 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.369 0.268 . . . . 0.0 111.53 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.02 39.4 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.739 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.1 148.43 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 112.167 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.45 144.81 49.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.881 178.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.97 114.48 28.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.136 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -109.08 90.34 3.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.031 0.443 . . . . 0.0 109.955 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.86 158.52 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.65 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.04 -12.6 52.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.99 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -91.58 24.81 2.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.787 0.327 . . . . 0.0 111.752 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.64 25.61 60.39 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.5 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.61 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.99 163.44 16.94 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 117.888 0.844 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.31 142.24 12.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -141.46 121.71 13.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 5.1 p-10 -90.63 154.79 19.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.69 -172.5 31.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.922 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.9 p-10 -168.18 132.93 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.861 0.362 . . . . 0.0 111.305 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.739 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.73 110.28 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.71 -18.58 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.407 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -170.02 3.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.46 -29.34 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.158 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -122.07 0.21 9.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.656 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HB3' HG23 ' A' ' 63' ' ' VAL . 14.1 tt0 -106.89 149.53 27.35 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.383 . . . . 0.0 110.664 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.037 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -134.04 144.46 48.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.721 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.875 0.369 . . . . 0.0 110.908 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.447 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.38 136.04 32.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.491 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.08 23.58 17.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.245 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.56 67.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.743 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.68 164.82 12.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.848 0.356 . . . . 0.0 111.072 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.6 m -117.26 107.77 14.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.02 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.037 ' HB2' HD12 ' A' ' 68' ' ' LEU . 33.2 m-85 -110.03 125.68 53.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.661 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 25.1 m-85 -98.68 147.03 25.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.834 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HD3' ' CZ2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -71.67 141.13 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.293 0.568 . . . . 0.0 112.252 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 8' ' ' ILE . 11.5 mt-10 26.66 104.28 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.268 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt . . . . . 0 C--N 1.308 -1.221 0 CA-C-N 113.314 -1.766 . . . . 0.0 110.903 179.696 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.744 0.307 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -127.32 164.81 20.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -126.02 114.4 24.17 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 35.0 Cg_exo -59.05 162.28 14.04 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.726 2.284 . . . . 0.0 112.432 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.96 ' CE1' HG21 ' A' ' 43' ' ' VAL . 19.0 m-85 -145.74 -42.48 0.21 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.995 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.0 t 60.26 129.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.581 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.45 148.2 5.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.382 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.59 96.88 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.589 0.709 . . . . 0.0 110.16 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.668 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.2 m95 -89.19 105.31 17.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.693 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 17' ' ' ARG . 74.9 t -111.24 155.92 12.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.494 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.408 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -69.74 171.77 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.137 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.642 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -73.6 -19.55 60.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.14 -26.86 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.17 25.61 30.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.111 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.551 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -81.39 -26.5 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.361 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.563 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -140.0 156.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.239 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.782 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -139.98 128.65 23.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.795 0.331 . . . . 0.0 110.973 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 15.3 tt0 -114.56 112.0 22.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.682 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.7 126.56 38.95 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.98 0.419 . . . . 0.0 111.336 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD22 ' CE2' ' A' ' 41' ' ' TYR . 9.4 mt -91.84 114.31 26.82 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -68.68 157.53 88.21 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.044 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.4 Cg_exo -64.77 -12.86 36.1 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.343 2.695 . . . . 0.0 111.792 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.4 20.42 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.096 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.39 50.66 60.7 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.1 mmm-85 -139.61 -179.88 6.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.965 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -135.36 149.28 49.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.294 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 109.63 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.205 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -103.49 134.18 47.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.421 0.629 . . . . 0.0 112.355 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.95 105.26 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.852 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -101.96 111.84 24.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.367 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.25 -152.98 13.17 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.687 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -56.56 -22.48 33.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.783 0.325 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -91.94 83.87 5.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.607 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.82 169.19 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.554 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.55 30.1 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 110.762 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.92 -47.57 71.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.199 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.68 143.49 26.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.546 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.98 150.05 29.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.844 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.3 -122.1 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.099 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.17 164.05 39.14 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.779 ' CE2' HD22 ' A' ' 20' ' ' LEU . 3.4 p90 -138.37 156.45 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.499 0.666 . . . . 0.0 112.229 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -119.94 127.17 52.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.902 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.96 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.6 t -104.74 127.66 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.044 0.449 . . . . 0.0 112.078 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -140.24 101.53 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.627 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.16 42.65 95.36 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.253 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.33 -6.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 126.12 38.94 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.749 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.38 147.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.286 0.565 . . . . 0.0 111.985 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.528 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -135.11 145.58 48.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.826 179.266 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 41.4 m-85 -97.81 116.99 31.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.013 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.415 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.6 t90 -109.28 90.85 3.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 109.835 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.72 155.65 40.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.855 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -85.22 -12.63 52.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.008 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 t -90.66 24.46 2.67 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.866 0.365 . . . . 0.0 111.917 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 23.38 60.7 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 114.811 0.685 . . . . 0.0 114.811 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.6 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.99 163.46 17.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.11 0.955 . . . . 0.0 109.9 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.54 141.3 14.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.998 178.336 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -126.42 178.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.007 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.2 t70 -148.79 147.86 29.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.257 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.58 -173.21 33.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.261 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -167.96 130.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.749 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.9 m-30 -69.68 110.44 4.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.788 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.1 m -84.83 -17.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.158 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.24 -166.41 2.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.894 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.68 -27.14 27.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.235 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.43 0.97 7.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.0 tt0 -107.1 147.06 30.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.976 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.09 142.68 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.388 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 6.0 m170 -126.47 107.9 10.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 135.55 26.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.752 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.45 21.84 42.9 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.042 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.27 21.71 64.37 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.503 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.08 164.45 13.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.3 m -118.26 107.31 13.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.801 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.976 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.8 m-85 -109.44 126.37 53.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.367 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.642 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 19.1 m-85 -102.77 146.88 27.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.463 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -74.33 130.98 40.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 112.066 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 53.21 -36.75 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.214 178.424 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 73.0 Cg_exo . . . . . 0 N--CA 1.471 0.188 0 CA-C-O 120.753 0.23 . . . . 0.0 112.584 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.967 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.1 m-85 -146.43 -42.06 0.2 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.2 t 60.51 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.211 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.5 147.46 4.85 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.274 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.32 96.92 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.029 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.672 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.06 107.42 19.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.799 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.721 HG22 ' HB2' ' A' ' 17' ' ' ARG . 69.4 t -115.04 155.77 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.433 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.46 179.38 0.79 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.146 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -79.86 -19.65 47.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.532 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.11 -28.52 11.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.669 0.271 . . . . 0.0 110.916 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.45 26.26 14.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.991 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -78.68 -31.04 46.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.01 155.51 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.481 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.721 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -136.32 138.82 42.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.831 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.9 tt0 -125.76 111.95 15.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.639 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.76 127.2 39.36 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 111.563 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 41' ' ' TYR . 8.3 mt -92.12 114.09 26.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.492 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.29 156.42 88.29 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.496 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.92 -17.15 58.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.506 2.804 . . . . 0.0 112.545 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.37 23.98 6.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.0 54.36 21.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.876 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.2 mmm-85 -143.32 -179.74 6.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.632 0.253 . . . . 0.0 111.334 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.472 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.14 149.97 48.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.432 0.634 . . . . 0.0 112.558 -178.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.32 111.72 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.34 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.25 134.62 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.376 0.608 . . . . 0.0 111.972 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.13 105.37 10.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.09 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.486 ' HD2' HG21 ' A' ' 16' ' ' ILE . 14.7 mtm-85 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.775 0.322 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 153.88 38.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 111.882 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.29 149.83 15.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.82 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.82 -120.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.17 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.16 164.18 38.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.737 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.4 p90 -139.39 156.89 46.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.529 0.68 . . . . 0.0 112.219 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 2.8 tt0 -120.39 127.34 52.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.857 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.967 HG21 ' CE1' ' A' ' 5' ' ' TYR . 72.0 t -104.39 127.98 58.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.149 0.5 . . . . 0.0 112.038 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -139.51 99.76 3.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.93 42.83 96.96 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.289 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.77 -7.32 1.42 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.487 0.315 . . . . 0.0 111.664 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.4 ' ND1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.8 125.65 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.665 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.54 145.99 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.273 0.558 . . . . 0.0 112.158 -178.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.55 145.3 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.746 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 41.9 m-85 -96.81 117.11 30.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.88 -0.146 . . . . 0.0 110.867 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.429 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.5 t90 -109.22 90.95 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 109.887 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.16 155.57 40.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.85 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.21 -12.67 52.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.0 t -90.01 24.76 2.33 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.806 0.336 . . . . 0.0 111.843 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.55 60.72 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -121.38 163.64 18.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.042 0.921 . . . . 0.0 109.904 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.63 141.3 14.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.848 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -126.68 178.42 5.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.132 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.8 p30 -146.77 147.25 30.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.383 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.34 -175.12 35.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.176 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' HB3' ' ND1' ' A' ' 47' ' ' HIS . 11.5 p30 -168.17 129.49 1.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.165 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.665 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -67.5 110.34 3.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 110.857 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.0 m -84.35 -18.59 9.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.189 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 -168.13 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 110.835 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.57 -27.19 29.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.24 0.1 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.2 tt0 -107.02 148.51 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.876 0.369 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.975 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.13 142.64 49.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.345 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.723 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.57 107.79 10.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.27 136.42 26.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.816 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.4 22.0 43.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 26.13 58.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.4 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.35 165.18 13.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.945 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.1 m -118.52 107.41 13.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.975 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.4 m-85 -109.63 128.06 54.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.487 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.625 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 13.9 m-85 -103.95 146.3 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.518 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.464 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 2.0 tpp85 -72.88 135.34 45.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.089 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 113.403 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 38.6 Cg_exo . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.552 0.147 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE1' HG21 ' A' ' 43' ' ' VAL . 10.0 m-85 -145.91 -43.88 0.21 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.169 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 21' ' ' LEU . 24.2 t 61.86 130.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.961 0.41 . . . . 0.0 110.993 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.98 146.93 4.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.307 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.473 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -93.18 98.66 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.423 0.63 . . . . 0.0 110.293 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.643 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.0 m95 -91.32 106.82 18.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.627 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.739 HG22 ' HB2' ' A' ' 17' ' ' ARG . 73.8 t -112.78 155.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.147 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.426 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -68.14 176.33 2.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.298 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -76.74 -19.56 57.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.681 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -26.13 13.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.708 0.29 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.02 23.71 29.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.154 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.76 -29.51 58.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.054 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.57 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -140.59 156.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.519 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.739 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.5 132.51 33.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.837 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.5 tt0 -120.17 112.5 19.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.03 127.46 38.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.401 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.748 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.5 mt -92.95 110.21 21.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -62.75 156.18 66.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.0 Cg_exo -64.11 -16.84 57.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.495 2.796 . . . . 0.0 112.538 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -96.27 23.41 6.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.93 52.84 26.23 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.882 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mmt85 -141.58 -179.81 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 111.327 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -136.9 149.23 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.354 0.597 . . . . 0.0 112.54 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.43 111.61 5.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.346 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.7 tt0 -104.25 134.04 48.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.373 0.606 . . . . 0.0 112.196 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.87 105.2 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.868 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.478 ' HD2' HG21 ' A' ' 16' ' ' ILE . 10.3 mtm180 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.545 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.928 0.394 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.22 141.56 23.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.46 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.5 149.89 29.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.827 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.96 -121.0 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.158 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.19 38.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.748 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.5 p90 -137.32 155.29 49.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.382 0.61 . . . . 0.0 112.116 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -119.91 127.14 52.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.195 178.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.015 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.1 t -102.65 129.99 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 111.942 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 87.44 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.73 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 65.53 44.0 93.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.326 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.2 -13.14 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.516 0.326 . . . . 0.0 111.606 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.94 128.81 40.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.64 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.71 153.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.176 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.8 150.12 52.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' A' ' 57' ' ' THR . 46.5 m-85 -99.95 116.6 32.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.165 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -109.14 90.16 3.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 0.0 109.977 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.57 158.78 28.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.16 -12.7 52.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.009 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.3 t -91.13 25.06 2.61 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.908 0.385 . . . . 0.0 111.817 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 25.92 60.9 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.541 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.75 163.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.936 0.868 . . . . 0.0 109.989 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.35 142.5 12.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.867 178.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.57 121.52 12.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.598 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 16.2 p30 -90.27 152.29 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -150.68 -163.8 11.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.133 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 6.3 p-10 -168.08 132.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.506 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.9 m-30 -77.48 110.19 12.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.744 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.4 m -85.01 -10.71 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.477 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -160.46 -176.07 5.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.867 0.365 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.13 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.056 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.69 4.13 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.572 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.693 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.0 tt0 -106.72 145.28 32.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.398 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.036 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.91 143.88 50.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.645 -179.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.72 ' N ' HD13 ' A' ' 68' ' ' LEU . 2.6 m170 -126.32 110.01 12.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.44 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.95 135.13 30.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.641 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 23.12 21.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.286 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.61 65.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.696 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.14 163.63 13.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.921 0.391 . . . . 0.0 111.024 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -117.11 107.69 14.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.946 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.036 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.3 m-85 -109.17 120.97 44.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.42 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.573 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 5.0 m-85 -101.38 141.95 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -71.16 142.53 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.863 0.363 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 124.743 1.217 . . . . 0.0 113.284 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 48.1 Cg_exo . . . . . 0 N--CA 1.471 0.169 0 CA-C-O 120.767 0.236 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.957 ' CE1' HG21 ' A' ' 43' ' ' VAL . 16.6 m-85 -145.21 -42.5 0.23 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.914 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 21' ' ' LEU . 19.9 t 60.7 129.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.999 0.428 . . . . 0.0 111.329 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.599 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.06 146.73 4.56 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.34 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.45 97.01 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.534 0.683 . . . . 0.0 110.074 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.588 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 17' ' ' ARG . 78.0 t -114.01 155.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.397 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.5 176.12 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.083 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.56 -19.43 55.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.445 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.65 -23.1 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.47 20.35 48.65 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.336 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' CD ' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -72.51 -24.3 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 110.395 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.56 156.71 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.451 179.35 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.48 131.34 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.6 tt0 -119.24 114.33 22.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -94.66 127.37 40.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.584 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.726 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.8 mt -92.12 113.02 25.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.46 156.61 85.28 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -175.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.37 -17.57 60.67 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.509 2.806 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -96.01 23.45 6.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 52.86 28.97 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.032 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 41.7 mmt-85 -141.27 -179.97 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.582 0.229 . . . . 0.0 111.276 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.06 149.35 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.413 0.625 . . . . 0.0 112.538 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.55 112.75 5.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -104.51 133.82 48.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.292 0.568 . . . . 0.0 112.205 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.79 105.29 11.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.981 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.492 ' HD2' HG21 ' A' ' 16' ' ' ILE . 18.3 mtm-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.347 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.089 0 CA-C-O 121.022 0.439 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 140.82 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.477 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.69 149.71 28.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.19 -122.1 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.824 -1.179 . . . . 0.0 113.115 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.1 163.77 39.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.726 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.7 p90 -138.44 155.12 48.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.521 0.677 . . . . 0.0 112.192 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -119.98 127.24 52.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.891 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.957 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.1 t -104.73 130.89 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 112.124 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -141.75 98.14 3.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.79 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 59.69 43.61 97.63 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.298 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.12 -7.58 1.34 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.426 0.291 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 125.25 38.24 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.754 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.02 148.33 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.225 0.536 . . . . 0.0 112.148 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.547 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.33 144.3 49.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.881 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.8 m-85 -100.2 115.14 29.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.065 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -109.06 90.51 3.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.428 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -67.09 158.69 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.652 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -85.07 -12.71 52.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.176 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.67 25.05 2.83 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.774 0.321 . . . . 0.0 111.726 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.7 25.24 60.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.546 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.2 164.12 15.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.013 0.906 . . . . 0.0 109.971 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.45 11.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.98 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.62 121.82 13.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.509 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 7.0 p-10 -90.3 155.63 18.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.975 0.417 . . . . 0.0 111.454 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.25 -170.71 28.53 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.076 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.424 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.3 p30 -168.32 133.74 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 111.227 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.754 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.9 m-30 -72.76 110.5 7.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.1 m -82.53 -18.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.168 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.59 -169.43 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.22 -28.14 32.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.22 -0.25 9.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' HG23 ' A' ' 63' ' ' VAL . 6.0 tt0 -106.92 146.79 30.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.931 0.396 . . . . 0.0 110.726 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.91 142.0 50.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.371 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.3 m170 -126.38 107.9 10.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.759 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.64 135.41 26.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.87 21.52 44.77 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.048 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 23.78 60.53 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.49 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -114.71 164.87 13.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 m -118.37 107.35 13.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.981 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.986 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.1 m-85 -109.64 127.31 54.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.627 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 11.1 m-85 -104.66 145.12 30.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.482 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -70.73 139.5 51.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.504 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 C-N-CA 124.73 1.212 . . . . 0.0 113.155 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 32.2 Cg_exo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.659 0.191 . . . . 0.0 112.13 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE1' HG21 ' A' ' 43' ' ' VAL . 7.1 m-85 -146.81 -44.2 0.18 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.167 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.3 t 61.86 129.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.99 0.424 . . . . 0.0 111.145 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.624 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.12 146.24 4.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.301 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -93.09 96.67 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.462 0.648 . . . . 0.0 109.932 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.661 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 25.7 m95 -86.57 107.79 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.418 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 17' ' ' ARG . 77.6 t -113.56 155.33 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.755 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.453 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.51 -175.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.634 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.02 -20.25 33.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.42 -26.54 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.732 0.301 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.29 26.1 16.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.018 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -77.46 -29.12 52.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 154.67 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.407 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.782 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -137.56 133.51 34.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.926 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.5 tt0 -119.69 113.08 20.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.528 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -92.51 126.47 37.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.107 0.479 . . . . 0.0 111.551 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.762 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.0 mt -92.56 112.3 24.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.09 157.3 85.37 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.9 Cg_exo -64.33 -13.96 41.26 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.338 2.692 . . . . 0.0 111.929 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -93.45 20.0 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.98 50.05 63.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.6 mmt180 -137.65 -179.92 6.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.889 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.86 149.93 47.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.19 111.09 4.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.507 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -102.88 133.39 48.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.331 0.586 . . . . 0.0 111.91 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.32 105.42 10.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.351 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.997 -179.563 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.823 0.344 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -149.59 152.77 36.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.178 0.513 . . . . 0.0 111.578 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.47 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.46 149.4 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.804 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -120.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 163.97 39.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.762 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.3 p90 -137.26 155.65 49.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.441 0.638 . . . . 0.0 112.085 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.0 tt0 -119.97 127.19 52.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.128 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.015 HG21 ' CE1' ' A' ' 5' ' ' TYR . 49.2 t -102.7 129.65 53.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.426 . . . . 0.0 112.025 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -136.82 82.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.22 44.76 74.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.272 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.55 -13.14 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.6 0.36 . . . . 0.0 111.497 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.88 126.05 38.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.03 152.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.234 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.85 151.14 51.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.783 178.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.6 m-85 -100.32 116.45 32.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.158 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.0 t90 -109.1 90.41 3.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.007 0.432 . . . . 0.0 109.907 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.62 158.36 32.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.743 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -85.16 -12.75 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.858 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -91.08 25.23 2.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.85 0.357 . . . . 0.0 111.755 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.7 26.3 61.08 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.505 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.16 163.86 17.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.928 0.864 . . . . 0.0 109.866 179.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.68 142.4 12.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.975 178.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.52 121.56 12.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.677 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 31.3 p-10 -90.37 152.08 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.397 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -153.52 -167.49 15.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.034 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.11 131.93 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.7 m-30 -77.05 110.24 11.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.577 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.7 m -84.84 -14.29 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.32 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.73 177.93 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.82 -27.95 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -121.08 -2.62 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.593 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.0 tt0 -106.94 141.92 37.38 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.899 0.38 . . . . 0.0 110.733 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.027 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -128.18 142.97 51.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.536 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.712 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 108.02 10.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.786 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.83 137.01 29.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.668 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.35 22.75 38.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.122 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.55 25.23 61.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.373 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.3 165.12 13.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.1 m -117.9 107.57 14.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.147 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.027 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.9 m-85 -110.12 123.37 49.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 8.3 m-85 -102.95 140.34 37.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.475 ' O ' ' C ' ' A' ' 78' ' ' GLU . 3.8 tpp180 -54.06 148.21 11.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.931 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.3 mt-10 . . . . . 0 N--CA 1.47 0.525 0 O-C-N 124.388 1.055 . . . . 0.0 112.564 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.439 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 72.0 Cg_exo . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.805 0.252 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 43' ' ' VAL . 15.3 m-85 -144.88 -42.34 0.24 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.2 t 60.32 129.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.022 0.439 . . . . 0.0 111.3 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.592 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.24 146.63 4.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -93.84 96.93 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.084 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.667 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.1 m95 -89.54 107.48 19.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.695 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 17' ' ' ARG . 71.1 t -113.95 155.59 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.329 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.427 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.72 1.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.104 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.612 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -79.6 -19.36 49.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.515 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.45 -26.16 12.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.995 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.04 24.83 26.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.221 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.48 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -77.13 -28.35 54.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.516 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.17 155.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.435 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -136.89 133.09 35.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.863 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.1 tt0 -121.47 113.2 19.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -94.46 128.45 41.04 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.059 0.457 . . . . 0.0 111.513 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.772 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.3 mt -92.58 113.26 25.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 156.34 86.66 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -64.0 -17.01 58.12 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.556 2.838 . . . . 0.0 112.49 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.58 24.08 6.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 110.759 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.11 54.13 22.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.92 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.0 mmm-85 -143.37 -179.93 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.593 0.235 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.72 149.2 47.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.6 . . . . 0.0 112.407 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.53 112.45 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.487 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -104.17 131.54 51.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.288 0.566 . . . . 0.0 111.907 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.4 105.21 11.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.635 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 144.33 24.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.729 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.95 149.81 26.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.25 -120.95 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.099 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.772 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.3 p90 -138.56 155.75 48.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.414 0.626 . . . . 0.0 112.323 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.99 127.21 52.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.717 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.0 t -104.98 130.46 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.173 0.511 . . . . 0.0 112.083 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 11.3 mtm105 -142.05 99.87 3.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.784 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.85 43.34 96.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.287 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.59 -7.03 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.47 0.308 . . . . 0.0 111.67 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.82 125.73 38.6 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.752 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.97 148.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.273 0.559 . . . . 0.0 112.153 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.547 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.43 144.13 49.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.891 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -99.6 114.79 28.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.12 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -108.97 90.29 3.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.025 0.44 . . . . 0.0 109.865 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.63 159.1 28.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.653 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -85.1 -12.65 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.987 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -91.58 25.51 2.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.809 0.337 . . . . 0.0 111.612 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.19 26.52 61.67 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.097 -0.573 . . . . 0.0 114.478 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.96 164.26 15.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.858 0.829 . . . . 0.0 109.831 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.13 142.65 11.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 178.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.52 121.71 13.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.515 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.5 p30 -89.61 155.43 19.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -162.48 -171.42 28.62 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 6.9 p-10 -168.12 133.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 111.285 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.752 ' CE1' HG21 ' A' ' 48' ' ' ILE . 9.0 m-30 -72.99 110.34 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.104 0.478 . . . . 0.0 110.716 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.64 -18.09 10.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.356 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -148.68 -169.13 3.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.351 . . . . 0.0 110.958 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.79 -30.2 32.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.67 1.34 10.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.485 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.7 tt0 -107.0 147.93 29.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.921 0.391 . . . . 0.0 110.581 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.001 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.17 144.22 49.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.414 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.742 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.48 108.92 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.443 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.33 135.86 32.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.582 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.95 23.78 17.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.177 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.23 67.25 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.31 164.18 12.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.026 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 m -117.23 107.63 14.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.001 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.2 m-85 -109.48 127.13 54.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.355 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.612 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 9.5 m-85 -105.16 143.58 33.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -68.18 140.68 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 124.569 1.148 . . . . 0.0 112.955 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 46.2 Cg_exo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.718 0.216 . . . . 0.0 112.279 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.027 ' CE1' HG21 ' A' ' 43' ' ' VAL . 5.3 m-85 -145.64 -44.81 0.21 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.941 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.0 t 62.24 129.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.188 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 153.87 146.14 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.388 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.542 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.71 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.411 0.624 . . . . 0.0 109.856 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.647 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.6 m95 -86.38 108.47 18.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.381 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 17' ' ' ARG . 75.7 t -114.32 155.7 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.778 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.421 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -65.68 -175.16 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.331 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.0 -20.45 32.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.05 -25.48 12.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.828 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.59 23.21 24.34 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.315 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -73.91 -26.87 60.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.742 0.306 . . . . 0.0 110.271 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.864 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -143.67 157.7 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.345 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.864 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -140.27 138.33 34.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.6 tt0 -125.44 112.91 16.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.66 126.67 36.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 111.669 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.747 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.4 mt -92.91 111.66 23.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.06 156.32 81.07 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.9 -17.22 58.97 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.467 2.778 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.7 22.9 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.27 52.54 26.51 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.843 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.7 mmt85 -140.94 -179.81 6.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.562 0.22 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -137.0 150.36 48.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.41 0.624 . . . . 0.0 112.459 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.16 110.74 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.0 tt0 -103.3 132.48 49.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.415 0.626 . . . . 0.0 111.895 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.58 105.16 10.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.352 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 4.4 mtm180 . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.051 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.798 0.332 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.409 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -151.0 153.48 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.038 0.447 . . . . 0.0 111.754 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.82 148.92 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.045 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.98 -121.82 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.982 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.14 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.747 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.2 p90 -138.09 157.64 45.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.355 0.597 . . . . 0.0 112.284 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.38 127.21 49.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.087 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.027 HG21 ' CE1' ' A' ' 5' ' ' TYR . 29.8 t -101.07 135.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.209 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -141.45 82.86 1.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.492 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.38 44.7 72.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.223 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 86.04 -14.4 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.551 0.34 . . . . 0.0 111.539 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.56 39.69 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.76 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.48 149.54 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.471 0.653 . . . . 0.0 112.516 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 4.5 t-20 -117.69 166.81 11.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.94 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 57' ' ' THR . 72.2 m-85 -125.22 113.07 17.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.597 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -109.0 91.67 3.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 110.058 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.4 159.18 29.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.642 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.98 -12.81 52.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.216 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -91.53 25.64 2.57 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.841 0.353 . . . . 0.0 111.681 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.13 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.378 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.84 164.27 15.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.842 0.821 . . . . 0.0 109.903 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.47 142.32 11.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.7 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -149.07 125.89 11.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.847 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.2 p30 -92.92 152.79 19.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.417 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.22 15.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.074 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' NE2' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.07 132.7 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 0.0 111.274 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.5 m-30 -79.64 110.33 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.5 m -79.48 -19.69 12.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.304 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -150.2 -175.64 5.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.27 57.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.064 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -116.69 -2.64 11.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.439 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.7 tt0 -106.92 144.4 33.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.963 0.411 . . . . 0.0 110.643 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.029 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.54 143.98 51.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.509 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.734 ' N ' HD13 ' A' ' 68' ' ' LEU . 3.3 m170 -126.36 108.91 11.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.841 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.46 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.95 136.93 32.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.56 23.5 14.26 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.138 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.21 67.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.729 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.46 164.06 12.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.011 0.405 . . . . 0.0 111.064 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -116.46 107.64 15.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.029 ' HB2' HD12 ' A' ' 68' ' ' LEU . 24.7 m-85 -110.0 123.58 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.403 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.626 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.8 m-85 -101.2 140.91 34.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -58.31 147.51 30.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.226 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.6 mt-10 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 124.674 1.19 . . . . 0.0 113.071 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 50.3 Cg_exo . . . . . 0 N--CA 1.47 0.138 0 CA-C-O 120.773 0.239 . . . . 0.0 112.631 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.934 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.6 m-85 -145.49 -42.46 0.22 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.798 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 21' ' ' LEU . 20.5 t 60.57 128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.206 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.573 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.14 147.51 4.89 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.27 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.75 96.77 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.396 0.617 . . . . 0.0 110.009 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.679 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.2 m95 -88.88 108.59 19.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.8 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 17' ' ' ARG . 73.9 t -116.42 155.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.425 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.44 -178.29 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.139 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.636 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -81.84 -19.54 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.475 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.74 -27.2 11.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.72 0.295 . . . . 0.0 110.933 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 26.21 16.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.192 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.33 -29.32 47.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.353 . . . . 0.0 110.106 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.85 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -139.45 157.3 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.85 ' N ' HD12 ' A' ' 16' ' ' ILE . 4.2 ttp-105 -137.81 141.73 40.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.884 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.4 tt0 -131.01 111.92 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.594 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -94.76 127.71 40.95 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.047 0.451 . . . . 0.0 111.655 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.792 HD22 ' CE2' ' A' ' 41' ' ' TYR . 9.3 mt -91.89 114.01 26.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.3 156.53 88.06 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.57 -17.41 59.87 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.47 2.78 . . . . 0.0 112.498 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.22 23.75 6.32 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.842 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.09 53.95 23.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.905 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 4.5 mmm-85 -142.99 -179.76 6.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 0.0 111.251 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.42 149.72 48.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.396 0.617 . . . . 0.0 112.543 -178.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 112.02 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.435 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -104.03 132.36 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.353 0.597 . . . . 0.0 111.958 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.44 105.18 10.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.782 0.325 . . . . 0.0 111.636 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.41 153.58 36.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.187 0.518 . . . . 0.0 111.672 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.92 149.48 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.818 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.78 -120.32 0.54 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 119.691 -1.243 . . . . 0.0 113.075 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.14 164.18 38.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.792 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.8 p90 -139.7 154.72 47.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 112.354 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.9 127.34 52.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.824 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.934 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.2 t -104.15 131.37 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 112.078 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -142.72 100.48 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.741 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.26 42.84 95.64 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.369 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.98 -7.98 1.33 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 122.514 0.326 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.82 127.19 39.43 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.674 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.97 148.65 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.194 0.521 . . . . 0.0 112.153 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.72 143.83 49.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.878 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 57' ' ' THR . 45.5 m-85 -98.95 114.66 27.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.037 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -109.03 90.25 3.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.929 0.395 . . . . 0.0 109.94 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.94 158.46 30.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.91 -12.81 52.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.981 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.1 t -91.38 25.14 2.68 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.848 0.356 . . . . 0.0 111.73 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.74 26.52 60.57 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.932 -0.651 . . . . 0.0 114.425 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.86 163.91 16.82 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.915 0.858 . . . . 0.0 109.935 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.37 142.37 12.77 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.882 178.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -141.34 121.74 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.477 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -88.49 156.08 19.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.085 0.469 . . . . 0.0 111.402 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.1 -174.76 35.13 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.4 p-10 -168.14 132.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.38 . . . . 0.0 111.328 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.674 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.42 110.29 5.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.716 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -82.31 -19.2 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.253 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -147.25 -168.68 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.77 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.197 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.94 -0.08 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.579 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.7 tt0 -106.93 147.23 30.07 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.023 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.6 142.84 50.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 -179.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.699 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.4 m170 -126.19 107.8 10.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.213 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.485 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -145.96 137.72 25.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.691 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.69 22.26 39.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.915 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.63 23.39 64.84 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.368 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.02 164.45 14.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.217 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -117.03 107.5 14.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.54 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.023 ' HB2' HD12 ' A' ' 68' ' ' LEU . 22.0 m-85 -110.67 127.43 55.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 15.2 m-85 -102.69 146.04 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.481 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.471 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 1.5 tpp85 -73.07 136.87 45.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.955 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 124.688 1.195 . . . . 0.0 113.266 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 77.5 Cg_exo . . . . . 0 N--CA 1.471 0.196 0 CA-C-O 120.827 0.261 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.988 ' CE1' HG21 ' A' ' 43' ' ' VAL . 22.2 m-85 -146.26 -41.71 0.2 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.2 t 60.53 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.62 146.58 4.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.79 96.93 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.496 0.665 . . . . 0.0 110.133 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.655 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 18.8 m95 -89.52 107.32 19.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.601 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 17' ' ' ARG . 79.6 t -113.28 155.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.401 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.401 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -68.76 172.75 5.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.193 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.636 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -74.77 -19.47 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.7 -25.95 13.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.94 24.14 36.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.151 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.497 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.69 -26.07 44.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.279 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.577 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.64 156.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.281 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.746 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -139.16 130.97 27.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.962 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 2.4 tt0 -117.64 112.67 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -93.74 127.33 39.41 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.739 HD22 ' CE2' ' A' ' 41' ' ' TYR . 8.1 mt -92.48 113.97 26.4 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.46 156.75 87.82 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -175.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.9 -17.18 58.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.448 2.765 . . . . 0.0 112.499 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.7 24.23 6.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.428 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.08 53.52 25.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.94 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.4 mmt85 -142.22 -179.78 6.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.649 0.261 . . . . 0.0 111.438 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.23 148.65 48.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.26 0.552 . . . . 0.0 112.424 -178.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 109.65 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.9 tt0 -102.9 134.29 46.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.396 0.617 . . . . 0.0 112.134 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.11 105.29 12.11 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.063 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.385 -179.369 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.941 0.4 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 142.23 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -150.94 150.35 30.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.845 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.55 -122.73 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.037 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -154.14 164.05 39.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.739 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.0 p90 -138.73 157.34 46.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.612 0.72 . . . . 0.0 112.221 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -120.73 127.27 51.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.834 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.988 HG21 ' CE1' ' A' ' 5' ' ' TYR . 81.0 t -104.59 128.77 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 112.133 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.93 98.61 3.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 59.69 43.21 97.98 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.232 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.76 -6.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.458 0.303 . . . . 0.0 111.608 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.75 125.33 38.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.745 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.15 148.05 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.292 0.567 . . . . 0.0 111.995 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.538 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -134.9 145.24 48.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.675 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.7 m-85 -97.47 117.03 30.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.007 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.2 t90 -109.32 90.9 3.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.996 0.427 . . . . 0.0 109.953 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.61 155.64 40.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.742 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.35 -12.62 51.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.088 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -90.85 24.18 2.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 0.0 111.918 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.6 22.43 60.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.32 163.48 17.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.224 1.012 . . . . 0.0 109.893 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.89 141.29 14.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.897 178.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -127.21 178.37 6.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 22.5 p-10 -147.07 148.8 32.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.112 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -166.13 -174.09 35.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.329 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -168.12 129.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.745 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.9 m-30 -68.58 110.5 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.48 . . . . 0.0 110.81 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -85.81 -17.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.273 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -148.37 -168.05 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.82 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.63 -26.92 29.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 0.97 7.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HB3' HG23 ' A' ' 63' ' ' VAL . 1.4 tt0 -107.18 146.54 31.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.98 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.53 142.88 50.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.73 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.63 107.85 10.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.02 135.99 26.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.711 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.31 22.13 43.04 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.029 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.29 23.85 62.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.487 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.64 13.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.901 0.381 . . . . 0.0 111.017 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 m -118.17 107.43 13.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.874 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.98 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.3 m-85 -109.33 126.26 53.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.309 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.636 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 13.1 m-85 -103.36 145.45 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.491 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -71.87 137.65 47.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.69 -179.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.426 0 C-N-CA 124.671 1.188 . . . . 0.0 113.354 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 61.1 Cg_exo . . . . . 0 N--CA 1.471 0.152 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.005 ' CE1' HG21 ' A' ' 43' ' ' VAL . 17.1 m-85 -146.43 -43.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.4 t 60.74 129.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.285 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.69 146.95 4.65 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.418 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.79 96.96 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.518 0.675 . . . . 0.0 110.15 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.678 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.6 m95 -89.08 107.82 19.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.571 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 17' ' ' ARG . 76.2 t -113.99 155.29 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.466 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.431 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.28 176.76 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.245 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.647 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.91 -19.95 53.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.36 -25.19 13.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.012 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.41 23.79 33.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.204 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -76.56 -27.23 55.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.85 0.357 . . . . 0.0 110.128 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.712 HD13 ' OE1' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -141.95 154.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.388 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.725 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.32 132.73 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 21.6 tt0 -121.82 114.13 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.891 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -93.34 128.55 39.41 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.514 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.755 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.4 mt -93.26 113.69 25.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.534 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 158.13 80.47 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.511 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.8 Cg_exo -63.26 -18.79 66.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.586 2.858 . . . . 0.0 112.868 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.66 20.92 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.741 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.37 51.27 27.66 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.382 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 87.5 mmt-85 -137.17 -179.81 5.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.599 -0.3 . . . . 0.0 110.927 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.6 152.32 50.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.426 0.632 . . . . 0.0 112.512 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.01 110.6 4.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.425 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.712 ' OE1' HD13 ' A' ' 16' ' ' ILE . 2.5 tt0 -103.12 134.09 47.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 112.102 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.26 105.1 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.969 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.502 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.906 0.384 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.06 141.61 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.504 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.46 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.42 149.86 29.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.5 -122.46 0.64 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.912 -1.137 . . . . 0.0 113.088 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.03 164.18 38.87 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.755 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.6 p90 -138.45 156.73 47.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.537 0.684 . . . . 0.0 112.317 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -120.21 127.35 52.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.953 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.005 HG21 ' CE1' ' A' ' 5' ' ' TYR . 77.2 t -104.06 126.82 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 111.952 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -136.38 92.34 2.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 63.2 43.3 98.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.199 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.98 -10.25 0.93 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 122.558 0.343 . . . . 0.0 111.706 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.9 125.59 38.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.646 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -139.43 147.28 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.184 0.516 . . . . 0.0 112.263 -179.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -129.23 146.56 51.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.642 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' THR . 42.8 m-85 -97.08 118.26 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.38 0.133 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.416 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 30.4 t90 -109.47 91.29 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.145 0.498 . . . . 0.0 110.003 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.21 155.1 41.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.744 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.2 -12.65 52.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.055 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 t -90.17 23.52 2.83 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.885 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.45 22.32 58.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -121.05 162.73 19.48 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.251 1.026 . . . . 0.0 110.048 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.78 140.71 16.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.748 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -125.66 178.47 5.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.4 p-10 -145.73 145.87 31.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -176.96 33.84 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.355 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.0 p-10 -168.1 123.62 1.0 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.059 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 4.9 m-30 -64.96 110.15 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.8 m -83.48 -19.2 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.246 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.47 -166.33 2.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.4 -29.18 26.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.208 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.83 1.12 9.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.604 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 63' ' ' VAL . 7.6 tt0 -107.02 149.52 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.883 0.373 . . . . 0.0 110.705 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.024 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.61 144.53 49.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.741 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.4 108.24 11.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -139.45 134.96 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.61 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.22 23.55 18.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.16 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.72 66.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.698 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.35 163.87 12.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.956 0.407 . . . . 0.0 111.093 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 m -116.74 107.75 15.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.894 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.024 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.2 m-85 -109.78 127.57 54.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.647 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 14.6 m-85 -103.7 145.96 29.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.26 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.463 ' CZ ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -72.56 137.87 46.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.916 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 124.753 1.221 . . . . 0.0 113.249 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 52.2 Cg_exo . . . . . 0 N--CA 1.47 0.128 0 CA-C-O 120.77 0.238 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.999 ' CE1' HG21 ' A' ' 43' ' ' VAL . 12.3 m-85 -143.29 -43.78 0.29 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.715 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.1 t 60.6 129.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.9 147.37 4.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.273 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.23 96.88 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.582 0.706 . . . . 0.0 110.151 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.664 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.5 m95 -89.25 106.63 18.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.707 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 17' ' ' ARG . 74.8 t -113.67 155.76 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.267 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.443 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.129 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -79.09 -19.62 50.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -27.19 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.73 24.38 23.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.077 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.443 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.06 -31.62 58.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 109.956 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.565 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -138.34 155.89 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.455 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.704 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.44 132.27 33.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.678 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.6 tt0 -120.32 112.61 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -93.2 127.6 38.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.539 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.76 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.2 mt -92.51 112.79 24.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.89 156.29 84.13 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.3 Cg_exo -63.68 -17.27 59.22 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.569 2.846 . . . . 0.0 112.514 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.09 23.71 6.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 53.45 25.73 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.882 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.9 mmm-85 -143.11 -179.78 6.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.457 0.17 . . . . 0.0 111.42 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.29 149.85 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.438 0.637 . . . . 0.0 112.639 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.92 111.89 5.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.358 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.43 135.65 45.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.394 0.616 . . . . 0.0 112.16 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.16 105.35 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.972 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HD2' HG21 ' A' ' 16' ' ' ILE . 14.1 mtm180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.433 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.016 0 CA-C-O 120.898 0.38 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 149.89 31.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.464 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.96 149.72 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.96 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.7 -121.59 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 119.826 -1.178 . . . . 0.0 112.926 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.01 162.72 40.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.76 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.5 p90 -136.86 155.52 49.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.381 0.61 . . . . 0.0 112.094 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.65 127.17 52.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.167 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.999 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.7 t -103.46 129.21 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.108 0.48 . . . . 0.0 111.973 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.31 94.34 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.653 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 61.66 42.81 99.82 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.259 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 84.17 -11.57 0.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.392 0.277 . . . . 0.0 111.725 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.89 128.96 40.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.628 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.85 153.43 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.225 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.518 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.37 151.0 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.907 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 57' ' ' THR . 51.3 m-85 -101.79 115.89 31.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.414 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 87.9 t90 -109.11 90.55 3.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.019 0.438 . . . . 0.0 110.12 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.62 158.84 28.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.778 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.14 -12.71 52.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.01 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.7 t -91.38 25.2 2.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.871 0.367 . . . . 0.0 111.72 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.19 25.73 61.15 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.014 -0.613 . . . . 0.0 114.505 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.02 163.71 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.044 0.922 . . . . 0.0 109.935 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.19 142.37 11.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.121 178.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.46 121.56 12.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.462 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p30 -90.97 153.13 20.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 0.0 111.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -154.13 -164.92 13.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.223 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 9.1 p-10 -168.09 133.31 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.042 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.7 m-30 -76.63 110.31 11.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.664 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -87.25 -10.17 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.043 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.85 156.51 11.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.824 0.345 . . . . 0.0 110.611 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.27 32.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.552 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -119.06 -10.53 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.853 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.664 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.2 tt0 -106.66 147.84 29.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.027 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.16 143.23 49.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.289 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.713 ' N ' HD13 ' A' ' 68' ' ' LEU . 3.7 m170 -126.45 108.78 11.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.847 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.529 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.38 136.44 29.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.61 22.96 34.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.21 63.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.538 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.01 164.33 13.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 m -117.84 107.58 14.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.006 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.027 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.4 m-85 -109.33 126.28 53.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.381 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.626 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 10.9 m-85 -103.81 145.36 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.252 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.438 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -72.33 137.7 46.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.933 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 113.478 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 83.5 Cg_exo . . . . . 0 C--O 1.231 0.151 0 N-CA-C 112.86 0.292 . . . . 0.0 112.86 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.008 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.5 m-85 -136.62 -46.4 0.61 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.1 t 59.9 125.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.566 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.27 148.63 5.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.14 96.68 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.181 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.636 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.7 m95 -89.22 106.71 18.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.612 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 17' ' ' ARG . 78.7 t -111.08 155.78 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.349 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -69.32 172.14 7.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.228 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -73.6 -19.94 60.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.13 -16.86 14.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 17.13 68.58 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.293 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -23.41 62.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 0.0 110.284 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -147.71 156.4 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.563 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.762 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.77 131.32 31.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.771 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 27.9 tt0 -119.2 112.55 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.004 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -92.64 127.14 38.03 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 111.326 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.764 HD22 ' CE1' ' A' ' 41' ' ' TYR . 11.8 mt -93.08 112.66 24.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.58 156.69 81.77 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.497 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 27.9 Cg_exo -62.92 -17.97 62.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.583 2.855 . . . . 0.0 112.438 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -94.74 21.95 6.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.942 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.34 50.5 38.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 84.5 mmt-85 -139.36 -179.73 6.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.385 0.136 . . . . 0.0 111.02 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.36 150.99 50.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 0.0 112.758 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.69 109.93 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.275 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 3.1 tt0 -103.26 134.51 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.393 0.616 . . . . 0.0 112.183 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.61 105.29 11.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.061 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HD2' HG21 ' A' ' 16' ' ' ILE . 15.2 mtm180 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 121.069 0.461 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 152.42 35.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.282 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.479 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -158.89 149.9 20.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.075 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.71 -128.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.908 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.14 164.2 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.764 ' CE1' HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -133.47 157.38 45.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.502 0.668 . . . . 0.0 112.184 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.1 tt0 -119.87 127.47 52.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.983 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.008 HG21 ' CE1' ' A' ' 5' ' ' TYR . 54.6 t -102.88 126.08 57.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.141 0.496 . . . . 0.0 112.214 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -137.2 88.62 2.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.669 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 64.83 43.85 95.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.398 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 84.47 -12.15 0.78 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.43 0.292 . . . . 0.0 111.66 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.71 127.02 39.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.73 HG21 ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -140.18 151.07 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.043 -179.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -133.43 145.15 50.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.987 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' A' ' 57' ' ' THR . 34.5 m-85 -93.49 117.24 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.952 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -109.28 91.36 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.977 0.418 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -71.4 155.37 40.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.684 -179.176 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.22 -12.72 51.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.029 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -90.66 24.12 2.8 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.73 22.4 59.94 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 114.87 0.708 . . . . 0.0 114.87 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.52 163.4 17.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.318 1.059 . . . . 0.0 109.935 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.57 140.7 13.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.934 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -127.07 178.31 6.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.069 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 28.4 p-10 -146.78 146.76 30.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.163 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -157.66 -170.56 22.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 9.5 p-10 -168.04 123.12 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 48' ' ' ILE . 89.8 m-85 -65.82 110.34 2.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 67' ' ' GLU . 1.7 m -91.14 -6.02 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.29 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.14 173.49 10.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.44 -22.45 63.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.22 1.56 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.783 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 63' ' ' VAL . 8.7 tt0 -111.25 149.06 31.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.927 0.394 . . . . 0.0 111.006 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.048 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.95 144.08 48.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.299 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.725 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.5 m170 -126.5 107.91 10.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.48 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.48 141.55 29.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 179.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.19 19.13 22.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.084 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.04 68.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.999 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ttm -115.72 171.8 7.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.289 0.545 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.8 m -117.54 107.99 14.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.711 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.048 ' HB2' HD12 ' A' ' 68' ' ' LEU . 20.5 m-85 -106.03 121.88 45.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.627 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 16.5 m-85 -100.39 147.12 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.912 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HD2' ' HA3' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -73.01 137.43 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.8 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 C-N-CA 124.79 1.236 . . . . 0.0 113.416 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 76.6 Cg_exo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.878 0.282 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.023 ' CE1' HG21 ' A' ' 43' ' ' VAL . 7.5 m-85 -144.48 -44.09 0.25 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.6 t 61.58 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.612 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.48 145.0 4.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.393 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.67 96.56 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.516 0.674 . . . . 0.0 109.872 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.0 m95 -85.87 108.04 17.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.243 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.807 HG22 ' HB2' ' A' ' 17' ' ' ARG . 72.9 t -113.41 155.07 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.849 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.43 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -66.38 -177.04 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.311 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.649 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.09 -20.1 35.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.526 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.61 -25.26 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.77 25.77 24.23 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.022 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.03 -28.01 48.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.132 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.561 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.98 155.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.376 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.807 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.69 138.1 37.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -124.3 111.95 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.937 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 38.5 tt0 -90.09 125.21 35.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.755 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.2 mt -92.61 113.54 25.85 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.534 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.16 158.26 82.11 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -176.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -63.65 -18.84 65.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.642 2.894 . . . . 0.0 112.868 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.78 22.27 7.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.331 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.411 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.68 53.03 22.1 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.575 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -138.64 179.06 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.849 -0.175 . . . . 0.0 110.954 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.01 152.75 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.474 0.654 . . . . 0.0 112.745 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.04 110.56 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.28 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.89 134.99 45.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.423 0.63 . . . . 0.0 112.079 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.37 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.161 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.361 -179.439 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 142.1 22.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.38 149.79 28.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.93 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.39 -122.57 0.64 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.038 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.04 163.6 39.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.755 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.7 p90 -138.92 154.92 48.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.516 0.674 . . . . 0.0 112.31 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -120.39 127.47 52.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.285 178.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.023 HG21 ' CE1' ' A' ' 5' ' ' TYR . 58.0 t -102.27 132.01 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 112.003 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -138.59 83.32 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.715 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.29 44.46 74.87 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.183 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.6 -13.02 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.593 0.357 . . . . 0.0 111.441 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 126.02 38.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.035 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.735 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.77 147.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 4.8 t-20 -118.41 166.72 12.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.847 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 57' ' ' THR . 73.1 m-85 -125.17 113.59 17.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.642 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.402 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 84.6 t90 -108.82 91.39 3.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.041 0.448 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.12 160.06 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.439 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.08 -12.8 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.26 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.95 25.58 2.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.888 0.375 . . . . 0.0 111.72 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.88 25.73 61.8 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.384 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 164.5 14.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.839 0.819 . . . . 0.0 109.908 179.041 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.16 143.03 12.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.75 177.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -146.78 124.5 11.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.872 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 29.6 t70 -91.23 153.14 20.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.52 -168.93 17.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.104 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 11.2 p-10 -168.09 132.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 7.4 m-30 -77.28 110.35 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -83.94 -14.63 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.396 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 t -156.42 179.83 8.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.99 62.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.289 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.3 -3.15 10.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.494 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.614 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.2 tt0 -106.84 145.61 31.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.017 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.74 143.82 50.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.301 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.735 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.4 109.08 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.896 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.448 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.53 136.0 32.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.663 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.17 23.73 18.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.192 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.99 19.44 67.38 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.726 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 164.54 12.44 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.04 0.448 . . . . 0.0 111.016 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.6 m -117.22 107.58 14.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.017 ' HB2' HD12 ' A' ' 68' ' ' LEU . 34.4 m-85 -109.76 122.94 48.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.484 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 12.1 m-85 -100.21 141.86 32.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.63 148.45 33.65 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.1 mt-10 . . . . . 0 N--CA 1.465 0.3 0 C-N-CA 124.758 1.223 . . . . 0.0 113.125 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 49.5 Cg_exo . . . . . 0 N--CA 1.471 0.178 0 CA-C-O 120.757 0.232 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 43' ' ' VAL . 13.5 m-85 -145.38 -42.75 0.22 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 18.9 t 60.31 129.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.14 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.16 147.67 4.9 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.295 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.86 96.79 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 110.225 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.67 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.7 m95 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.748 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 17' ' ' ARG . 68.9 t -114.11 155.7 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -66.83 176.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.146 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.629 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -78.01 -19.47 54.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.93 -23.84 13.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.22 21.76 40.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.334 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.416 ' CD ' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.92 -24.65 59.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.716 0.293 . . . . 0.0 110.392 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.498 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.36 156.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.301 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.7 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -137.58 135.41 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.9 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 5.3 tt0 -122.34 113.6 19.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.6 126.92 41.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.079 0.466 . . . . 0.0 111.457 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.739 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.0 mt -91.64 113.64 25.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.05 157.63 86.44 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.056 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.42 -13.49 38.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.326 2.684 . . . . 0.0 111.852 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -93.89 20.09 8.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.145 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.6 49.89 65.89 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.5 mmt85 -137.37 -179.84 5.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.129 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.19 149.28 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.16 112.14 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.441 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -104.24 132.66 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.324 0.583 . . . . 0.0 112.15 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.74 105.37 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.983 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 16' ' ' ILE . 7.2 mtm180 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.137 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.697 0.284 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.7 27.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 111.794 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.97 149.78 26.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.541 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.23 -122.14 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.699 -1.239 . . . . 0.0 113.194 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.11 164.12 39.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.739 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.7 p90 -139.31 155.68 47.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.519 0.676 . . . . 0.0 112.275 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.89 127.15 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.89 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.5 t -104.32 129.89 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.463 . . . . 0.0 112.097 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 99.6 3.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.707 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.73 42.93 96.63 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.306 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.0 -7.76 1.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.393 0.277 . . . . 0.0 111.629 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.93 126.43 39.13 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.68 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -137.28 148.87 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.221 0.534 . . . . 0.0 112.237 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.29 144.68 49.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.789 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.684 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.4 m-85 -98.61 115.06 27.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.012 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.7 t90 -109.05 90.45 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.035 0.445 . . . . 0.0 109.899 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.68 158.91 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.08 -12.63 52.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.038 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.55 25.29 2.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.796 0.331 . . . . 0.0 111.711 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.45 26.76 60.68 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.14 164.17 15.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.768 0.784 . . . . 0.0 109.765 179.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.34 142.68 11.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.965 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.68 121.65 12.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.5 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 9.9 p-10 -88.95 157.61 18.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 111.651 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.16 -172.1 32.2 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.888 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -168.17 132.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.308 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.68 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.8 m-30 -71.63 110.24 6.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.538 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.0 m -81.74 -18.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.335 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 t -148.61 -168.47 3.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.853 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.95 -28.25 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.194 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 -0.13 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.582 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HB3' HG23 ' A' ' 63' ' ' VAL . 6.7 tt0 -106.89 147.75 29.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.74 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.64 142.24 49.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.715 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.2 m170 -126.39 107.88 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.72 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.67 135.61 26.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.7 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.67 21.7 43.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.1 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.92 24.53 59.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.418 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -115.43 164.71 13.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -118.26 107.37 13.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.063 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.986 ' HB2' HD12 ' A' ' 68' ' ' LEU . 29.1 m-85 -109.83 127.77 54.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.34 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.629 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 15.2 m-85 -104.17 146.31 28.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.461 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 1.3 tpp85 -73.37 135.42 44.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.916 0.389 . . . . 0.0 111.991 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 124.599 1.16 . . . . 0.0 113.37 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 67.0 Cg_exo . . . . . 0 N--CA 1.472 0.209 0 CA-C-O 120.726 0.219 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.953 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.6 m-85 -145.58 -42.29 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.866 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 20.0 t 60.19 128.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.029 0.443 . . . . 0.0 111.263 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.568 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.58 148.45 5.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.242 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -96.05 96.57 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.592 0.711 . . . . 0.0 110.035 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.68 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.1 m95 -88.42 107.63 18.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.597 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' HB2' ' A' ' 17' ' ' ARG . 69.7 t -114.44 155.74 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.411 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -65.76 176.9 1.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.385 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.611 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.5 -19.9 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.574 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.41 -24.82 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.707 0.289 . . . . 0.0 110.945 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.15 22.98 30.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.461 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.562 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -76.49 -28.32 56.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.81 0.338 . . . . 0.0 110.165 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -139.1 158.39 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.851 ' N ' HD12 ' A' ' 16' ' ' ILE . 3.7 ttp180 -138.67 142.76 39.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.804 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 14.9 tt0 -130.21 111.88 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -95.14 127.11 40.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.764 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.5 mt -92.14 113.91 26.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.27 156.58 87.84 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.44 -17.57 60.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.62 2.88 . . . . 0.0 112.474 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -95.86 23.26 6.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.44 53.55 24.38 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.846 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.8 mmt85 -141.94 -179.97 6.53 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 111.413 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.08 149.28 47.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 112.562 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.33 110.93 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.381 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.66 134.08 47.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.61 . . . . 0.0 112.277 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.32 105.03 11.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.775 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 -179.095 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.848 0.356 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.84 141.84 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.469 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.14 149.9 29.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.737 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.32 -120.74 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 119.833 -1.175 . . . . 0.0 113.03 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 164.02 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.764 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.4 p90 -138.42 155.78 48.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.484 0.659 . . . . 0.0 112.276 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -120.46 127.28 52.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.843 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.953 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.2 t -105.2 130.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.537 . . . . 0.0 112.085 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.19 96.91 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.777 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 60.5 43.85 98.36 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.351 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.13 -7.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.417 0.287 . . . . 0.0 111.563 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.79 124.91 38.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.753 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.5 148.15 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.0 112.153 -178.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.5 144.09 49.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.895 178.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.5 m-85 -99.35 115.04 28.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -109.14 90.18 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.012 0.434 . . . . 0.0 109.849 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.65 158.69 29.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.704 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -85.09 -12.7 52.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.975 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.5 t -91.41 25.26 2.65 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 120.907 0.384 . . . . 0.0 111.807 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 26.09 61.22 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.026 -0.606 . . . . 0.0 114.467 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.9 164.09 15.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.873 0.836 . . . . 0.0 109.918 179.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.95 142.69 12.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.94 178.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.72 121.7 12.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.601 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.0 p30 -89.44 156.24 18.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.585 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.53 -171.67 30.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.025 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.3 p-10 -168.19 133.74 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.236 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.753 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.3 m-30 -73.57 110.42 7.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.28 -18.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.215 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.46 -168.81 3.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.876 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.82 -27.62 28.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.01 2.05 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.588 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.9 tt0 -108.97 149.8 28.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 110.78 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.992 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -133.2 143.46 49.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.715 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.37 107.77 10.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.246 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.448 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -151.99 137.33 17.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.224 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.86 13.19 58.91 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.762 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.23 20.18 59.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.945 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.4 ttm -120.49 171.57 8.45 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.216 0.508 . . . . 0.0 111.714 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 m -116.41 107.64 15.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.348 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.992 ' HB2' HD12 ' A' ' 68' ' ' LEU . 13.6 m-85 -106.01 127.77 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.334 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.611 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 18.9 m-85 -102.46 147.13 27.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.728 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.482 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 2.1 tpp85 -75.71 130.42 38.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.103 0.478 . . . . 0.0 112.228 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 55.0 Cg_exo . . . . . 0 C--O 1.231 0.158 0 N-CA-C 112.871 0.296 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.001 ' CE1' HG21 ' A' ' 43' ' ' VAL . 9.7 m-85 -145.77 -43.43 0.21 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.792 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 19.9 t 60.86 129.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 111.286 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.602 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.29 145.49 4.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -91.94 96.82 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.36 0.6 . . . . 0.0 110.141 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.664 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.5 m95 -88.24 108.18 19.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.405 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.702 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.1 t -113.75 155.15 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.694 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.511 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.94 -176.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.312 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -83.53 -20.41 33.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.584 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.67 -24.47 12.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.987 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.87 23.79 26.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.024 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.511 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -74.96 -30.66 61.27 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.515 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.44 155.81 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.58 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.702 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -137.93 128.66 26.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.9 tt0 -116.31 112.2 21.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.92 126.83 38.2 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.504 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.795 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.0 mt -91.84 113.26 25.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -68.04 157.41 87.09 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.475 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.5 Cg_exo -64.72 -13.18 37.7 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.445 2.763 . . . . 0.0 111.854 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -93.89 20.3 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.173 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.46 50.4 62.52 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -139.93 -179.91 6.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.971 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.25 149.57 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.59 110.34 5.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.255 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.59 133.09 49.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.414 0.626 . . . . 0.0 112.288 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.85 105.45 11.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.905 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 16' ' ' ILE . 20.8 mtm-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.905 0.383 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 143.59 25.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.466 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.82 149.9 29.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.877 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.03 -123.65 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.899 -1.144 . . . . 0.0 113.025 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.04 164.05 39.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.795 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.5 p90 -139.78 154.74 47.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 112.142 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.78 127.34 52.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.249 178.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.001 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.9 t -102.84 129.49 54.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.857 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.68 92.26 2.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.629 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 62.5 43.61 98.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.357 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.7 0.85 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 122.461 0.304 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.9 128.9 40.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.698 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.36 151.5 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.073 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 1.3 m-20 -127.24 171.17 11.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.551 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.718 ' O ' ' HA ' ' A' ' 57' ' ' THR . 79.1 m-85 -124.1 114.84 20.24 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.08 90.99 3.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.64 160.39 22.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.694 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -12.76 52.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.157 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -92.19 25.32 2.94 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.821 0.343 . . . . 0.0 111.719 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 25.79 61.67 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.59 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.16 164.32 14.95 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 117.82 0.81 . . . . 0.0 109.783 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.62 142.48 10.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.008 177.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -143.93 121.55 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.545 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p-10 -90.37 150.75 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 0.0 111.523 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -156.24 -171.92 23.08 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.109 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 2.0 p30 -168.28 132.97 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.262 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -73.1 110.33 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.8 m -81.93 -18.91 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.335 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -147.3 -169.04 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.99 -29.28 32.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.217 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.77 -0.14 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.512 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.1 tt0 -106.82 148.8 28.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 110.702 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.051 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.42 144.4 49.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.35 108.76 11.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.85 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.426 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -139.95 135.32 32.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.621 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.04 23.72 17.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.276 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.62 18.95 67.07 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.717 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -108.76 164.05 12.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 111.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.5 m -116.73 107.66 14.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.051 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.0 m-85 -110.27 124.63 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.099 0.476 . . . . 0.0 111.667 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.652 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 28.3 m-85 -97.72 147.18 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.769 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.478 ' CD ' ' CE2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -73.03 140.68 47.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.33 0.586 . . . . 0.0 112.318 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.612 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.289 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 47.9 Cg_exo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.753 0.231 . . . . 0.0 112.476 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.0 ' CE1' HG21 ' A' ' 43' ' ' VAL . 10.8 m-85 -145.54 -43.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 20.5 t 60.8 128.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.352 . . . . 0.0 111.302 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.76 147.23 4.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.324 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.8 98.85 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.356 0.598 . . . . 0.0 110.206 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.646 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.7 m95 -91.38 105.34 17.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.707 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 17' ' ' ARG . 75.7 t -109.98 155.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.282 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.451 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.72 178.67 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.368 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.605 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -78.97 -20.27 49.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.62 -24.6 13.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.14 23.56 31.86 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.59 -0.815 . . . . 0.0 112.234 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.52 -27.73 58.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.068 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.5 155.89 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.589 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.71 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.25 126.13 22.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.519 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 35.4 tt0 -115.72 114.35 24.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.672 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -94.33 127.15 40.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.367 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.725 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.8 mt -90.65 112.75 24.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -67.39 157.62 84.94 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.31 -13.4 37.97 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.291 2.661 . . . . 0.0 111.872 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -93.56 19.93 7.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.192 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.41 50.22 64.06 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.0 mmt85 -139.8 -179.89 6.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.527 -0.337 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -135.95 149.63 48.98 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.73 114.64 6.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.181 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -105.66 132.23 52.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.0 112.185 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -113.64 105.18 13.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.058 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.406 -179.313 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.063 0.459 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.53 140.1 19.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.042 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.44 149.76 29.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.927 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.68 -123.92 0.7 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.982 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.03 164.0 39.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.725 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.9 p90 -138.34 155.08 48.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.443 0.64 . . . . 0.0 112.056 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.2 tt0 -119.75 127.25 52.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.069 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.0 HG21 ' CE1' ' A' ' 5' ' ' TYR . 67.6 t -104.42 127.27 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.969 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.26 91.99 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 63.21 43.25 98.85 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.14 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.05 0.89 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.506 0.322 . . . . 0.0 111.564 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.75 127.11 39.3 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.618 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.19 152.68 16.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 112.252 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.514 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.46 149.3 51.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.858 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.81 115.44 30.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 t90 -109.08 90.43 3.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.69 157.83 33.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.604 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -85.16 -12.68 52.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -91.73 24.31 3.19 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.878 0.371 . . . . 0.0 111.866 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.18 22.77 60.23 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 163.48 16.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.172 0.986 . . . . 0.0 109.963 179.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.46 11.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.879 178.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.98 121.68 11.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 6.9 p-10 -90.33 152.22 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 111.346 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.03 -167.58 16.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.024 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.7 p-10 -168.11 130.8 1.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.319 . . . . 0.0 111.218 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.6 m-30 -74.03 110.04 8.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.688 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.603 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.6 m -86.58 -11.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -158.59 -177.95 6.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.835 0.35 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -25.77 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.259 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.01 1.52 7.98 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.631 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.2 tt0 -109.43 147.87 32.11 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.819 0.342 . . . . 0.0 110.792 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.035 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.27 144.15 49.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.724 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.47 109.25 11.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.915 0.388 . . . . 0.0 110.712 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.421 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.37 134.49 30.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.11 22.96 22.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.144 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.69 67.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.752 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -107.49 163.55 12.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 111.041 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 m -116.77 107.64 14.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.775 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.035 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.4 m-85 -108.98 125.11 51.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.605 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 21.5 m-85 -102.08 147.12 26.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.462 ' CZ ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -74.26 137.17 42.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.812 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 124.607 1.163 . . . . 0.0 113.012 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 31.3 Cg_exo . . . . . 0 N--CA 1.471 0.147 0 CA-C-O 120.783 0.243 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.891 ' OH ' HG11 ' A' ' 43' ' ' VAL . 15.0 m-85 -143.78 -42.62 0.28 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 21' ' ' LEU . 18.6 t 60.73 131.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.619 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.45 144.98 4.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.36 96.55 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.523 0.678 . . . . 0.0 109.782 179.288 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.684 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 26.0 m95 -86.48 109.88 19.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.167 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.3 t -115.24 154.82 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.777 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.484 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.06 -176.88 0.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.15 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.659 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.33 -19.97 35.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.6 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.1 -27.04 12.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 24.98 18.02 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.055 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.484 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.09 -31.06 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.31 155.48 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.768 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.31 131.23 29.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.686 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.7 tt0 -118.38 113.75 21.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.828 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 38.8 tt0 -92.16 125.68 36.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.552 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.75 HD22 ' CE2' ' A' ' 41' ' ' TYR . 6.8 mt -90.9 112.13 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.57 156.64 81.9 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.18 -17.81 61.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.513 2.809 . . . . 0.0 112.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.61 23.11 6.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.46 52.03 33.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.005 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -140.05 -179.79 6.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.382 0.134 . . . . 0.0 110.963 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.69 149.95 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.17 111.23 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.523 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -102.93 134.33 46.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.968 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.79 105.27 11.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.321 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.316 -179.593 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.006 0.432 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.04 140.06 19.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.217 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.43 150.1 29.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.735 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.95 -122.52 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.054 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.99 39.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.75 ' CE2' HD22 ' A' ' 20' ' ' LEU . 3.3 p90 -138.02 157.89 45.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.539 0.685 . . . . 0.0 112.403 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -122.54 127.42 49.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.804 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.891 HG11 ' OH ' ' A' ' 5' ' ' TYR . 79.2 t -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 82.57 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.17 -96.35 2.05 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.99 15.26 7.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.425 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -111.12 141.42 44.65 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.173 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.765 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -147.66 148.26 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.244 -179.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.3 144.92 50.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.708 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -102.2 115.4 30.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.157 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -109.23 90.64 3.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.7 157.82 33.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.74 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.12 -12.7 52.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.199 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.7 24.77 2.96 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.9 0.381 . . . . 0.0 111.898 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.3 23.36 61.07 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.766 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.64 164.02 15.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.049 0.924 . . . . 0.0 109.931 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.25 141.34 12.21 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.735 177.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -140.34 121.76 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.619 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 3.4 p30 -92.67 151.16 20.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 111.465 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.12 -170.98 26.49 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.875 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.9 p-10 -168.15 132.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.765 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.3 m-30 -68.28 110.18 3.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.516 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.6 m -84.86 -16.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.284 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -152.03 -175.26 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 0.0 110.813 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.76 -26.69 50.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -122.48 -2.38 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.646 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.0 tt0 -106.98 144.86 32.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 111.004 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.037 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -129.97 143.58 50.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.365 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 107.82 10.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.522 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -143.71 137.42 28.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.607 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.52 22.82 40.33 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.091 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.87 62.17 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 165.94 12.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 0.0 111.151 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 m -118.07 107.54 14.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.082 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.037 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.5 m-85 -110.72 126.64 54.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.328 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.8 m-85 -103.19 141.71 35.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.816 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.5 ' HG3' ' HG3' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -58.28 146.18 35.1 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.899 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.2 mt-10 . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 124.553 1.141 . . . . 0.0 113.104 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.4 Cg_exo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.669 0.195 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.939 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.5 m-85 -145.38 -42.88 0.22 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.888 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.5 t 60.72 129.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 111.265 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.593 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.85 147.29 4.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.342 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.486 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -94.8 96.89 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 110.119 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.646 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.2 m95 -88.91 106.95 18.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.729 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 17' ' ' ARG . 71.6 t -114.33 155.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.376 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.427 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.27 178.95 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.182 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -80.0 -18.79 49.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.48 -27.54 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 26.3 18.83 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.158 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.48 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -79.08 -28.4 43.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.133 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.534 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 155.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.35 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.734 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -137.19 137.8 39.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.834 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.5 tt0 -125.17 112.94 17.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.731 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.4 127.4 39.01 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.588 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.706 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.3 mt -93.09 113.0 25.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.36 158.01 79.66 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.53 -18.91 66.5 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.644 2.896 . . . . 0.0 112.953 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.23 21.54 7.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.62 52.33 21.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.473 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 10.3 mmt180 -138.39 179.89 6.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.21 . . . . 0.0 111.115 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.509 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -138.53 153.01 48.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.471 0.653 . . . . 0.0 112.561 -178.138 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.22 111.76 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.92 131.33 49.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.306 0.574 . . . . 0.0 111.962 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.27 105.28 11.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.143 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.41 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.807 0.337 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.77 148.18 28.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.242 0.544 . . . . 0.0 111.766 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.486 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.73 149.67 25.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.3 -122.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.651 -1.261 . . . . 0.0 113.108 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.09 163.77 39.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.706 ' CE1' HD22 ' A' ' 20' ' ' LEU . 7.5 p90 -137.9 156.4 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 0.0 112.414 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -120.98 127.27 51.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.729 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.939 HG21 ' CE1' ' A' ' 5' ' ' TYR . 75.5 t -105.2 131.93 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.183 0.515 . . . . 0.0 112.226 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -142.94 101.45 3.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.651 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 57.87 42.94 94.93 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.406 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.72 -6.9 1.46 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.458 0.303 . . . . 0.0 111.679 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.84 126.24 38.92 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.766 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.54 148.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.302 0.572 . . . . 0.0 112.069 -178.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.552 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.35 143.25 48.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.952 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.7 m-85 -99.5 113.97 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.946 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -109.1 89.9 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.99 0.424 . . . . 0.0 109.985 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.8 158.07 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.648 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.93 -12.68 52.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.164 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -92.0 24.84 3.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.852 0.358 . . . . 0.0 111.708 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 27.26 55.97 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.621 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.38 164.1 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.006 0.903 . . . . 0.0 109.823 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.36 143.05 11.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.125 178.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.59 121.79 12.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.553 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 8.8 t70 -88.81 155.16 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -171.77 27.6 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.051 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 3.8 p-10 -168.21 133.88 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.341 . . . . 0.0 111.15 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.766 ' CE1' HG21 ' A' ' 48' ' ' ILE . 9.4 m-30 -75.63 110.33 9.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -83.24 -18.43 10.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.881 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.21 174.72 13.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.38 -21.57 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.298 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -121.41 -8.55 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.802 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.7 tt0 -106.61 149.01 27.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 111.166 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.958 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.4 142.41 50.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.278 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.72 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 107.88 10.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.8 135.8 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.724 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.69 21.84 44.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.049 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.24 25.13 59.93 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.389 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.86 165.15 13.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.991 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -118.59 107.44 13.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.004 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.958 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.1 m-85 -110.14 128.78 55.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 13.0 m-85 -105.02 145.83 29.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 9' ' ' TRP . 1.1 tpp85 -72.26 136.78 46.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 C-N-CA 124.569 1.148 . . . . 0.0 113.1 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.0 Cg_exo . . . . . 0 N--CA 1.471 0.193 0 CA-C-O 120.787 0.245 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.919 ' CE1' HG21 ' A' ' 43' ' ' VAL . 11.7 m-85 -144.79 -43.29 0.24 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.801 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 21' ' ' LEU . 20.9 t 61.22 130.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.933 0.397 . . . . 0.0 111.401 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.603 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 155.69 145.82 4.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.254 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.98 96.8 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 121.452 0.644 . . . . 0.0 109.84 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.8 m95 -87.41 109.8 19.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.419 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.709 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.1 t -117.22 155.0 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.766 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.413 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.37 -176.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.219 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.13 -20.19 35.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.69 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -23.39 12.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.317 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.48 21.66 33.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.376 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.413 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -72.02 -25.46 61.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.29 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.558 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.83 155.3 11.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.389 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.709 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -136.0 138.75 42.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.644 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.2 tt0 -125.33 111.88 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -92.51 125.63 37.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 111.535 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.812 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.4 mt -91.61 111.98 23.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -64.78 155.97 80.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -176.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.4 Cg_exo -64.11 -16.76 56.77 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.571 2.848 . . . . 0.0 112.47 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.38 23.6 6.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.769 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.52 53.6 23.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.926 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 5.6 mmm-85 -143.3 -179.85 6.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.512 0.196 . . . . 0.0 111.31 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.03 150.1 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.494 0.664 . . . . 0.0 112.716 -178.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.47 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.221 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.79 137.6 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.368 0.604 . . . . 0.0 112.448 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.15 105.57 9.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.851 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 16' ' ' ILE . 10.5 mtm180 . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.023 0.44 . . . . 0.0 111.867 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.86 0.362 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.72 150.44 32.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.326 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -159.39 149.88 19.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.98 179.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.67 -121.38 0.58 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.913 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.81 39.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.812 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.9 p90 -138.64 154.11 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 112.274 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -119.84 127.29 52.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.828 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.919 HG21 ' CE1' ' A' ' 5' ' ' TYR . 72.4 t -104.2 131.37 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.178 0.513 . . . . 0.0 112.01 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.05 100.85 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.24 42.81 95.59 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.335 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.61 -7.22 1.45 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.369 0.268 . . . . 0.0 111.53 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.02 39.4 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.739 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.1 148.43 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 112.167 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.45 144.81 49.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.881 178.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.97 114.48 28.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.136 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -109.08 90.34 3.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.031 0.443 . . . . 0.0 109.955 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.86 158.52 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.65 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.04 -12.6 52.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.99 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -91.58 24.81 2.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.787 0.327 . . . . 0.0 111.752 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.64 25.61 60.39 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.5 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.61 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.99 163.44 16.94 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 117.888 0.844 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.31 142.24 12.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -141.46 121.71 13.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 5.1 p-10 -90.63 154.79 19.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.69 -172.5 31.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.922 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.9 p-10 -168.18 132.93 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.861 0.362 . . . . 0.0 111.305 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.739 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.73 110.28 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.71 -18.58 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.407 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -170.02 3.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.46 -29.34 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.158 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 0.21 9.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.656 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HB3' HG23 ' A' ' 63' ' ' VAL . 14.1 tt0 -106.89 149.53 27.35 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.383 . . . . 0.0 110.664 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.037 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -134.04 144.46 48.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.721 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.875 0.369 . . . . 0.0 110.908 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.447 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.38 136.04 32.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.491 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.08 23.58 17.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.245 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.56 67.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.743 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.68 164.82 12.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.848 0.356 . . . . 0.0 111.072 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.6 m -117.26 107.77 14.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.02 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.037 ' HB2' HD12 ' A' ' 68' ' ' LEU . 33.2 m-85 -110.03 125.68 53.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.661 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 25.1 m-85 -98.68 147.03 25.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.834 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HD3' ' CZ2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -71.67 141.13 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.293 0.568 . . . . 0.0 112.252 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 8' ' ' ILE . 11.5 mt-10 . . . . . 0 CA--C 1.51 -0.584 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.268 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 35.0 Cg_exo . . . . . 0 N--CA 1.472 0.231 0 CA-C-O 120.642 0.184 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.96 ' CE1' HG21 ' A' ' 43' ' ' VAL . 19.0 m-85 -145.74 -42.48 0.21 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.995 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.0 t 60.26 129.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.581 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.45 148.2 5.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.382 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.59 96.88 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.589 0.709 . . . . 0.0 110.16 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.668 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.2 m95 -89.19 105.31 17.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.693 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 17' ' ' ARG . 74.9 t -111.24 155.92 12.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.494 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.408 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -69.74 171.77 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.137 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.642 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -73.6 -19.55 60.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.14 -26.86 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.17 25.61 30.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.111 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.551 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -81.39 -26.5 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.361 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.563 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -140.0 156.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.239 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.782 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -139.98 128.65 23.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.795 0.331 . . . . 0.0 110.973 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 tt0 -114.56 112.0 22.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.682 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.7 126.56 38.95 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.98 0.419 . . . . 0.0 111.336 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD22 ' CE2' ' A' ' 41' ' ' TYR . 9.4 mt -91.84 114.31 26.82 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -68.68 157.53 88.21 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.4 Cg_exo -64.77 -12.86 36.1 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.343 2.695 . . . . 0.0 111.792 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.4 20.42 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.096 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.39 50.66 60.7 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.1 mmm-85 -139.61 -179.88 6.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.965 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -135.36 149.28 49.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 109.63 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.205 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -103.49 134.18 47.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.421 0.629 . . . . 0.0 112.355 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.95 105.26 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.852 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.367 -179.145 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.892 0.377 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.68 143.49 26.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.546 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.98 150.05 29.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.844 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.3 -122.1 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.099 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.17 164.05 39.14 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.779 ' CE2' HD22 ' A' ' 20' ' ' LEU . 3.4 p90 -138.37 156.45 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.499 0.666 . . . . 0.0 112.229 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -119.94 127.17 52.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.902 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.96 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.6 t -104.74 127.66 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.044 0.449 . . . . 0.0 112.078 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -140.24 101.53 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.627 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.16 42.65 95.36 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.253 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.33 -6.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 126.12 38.94 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.749 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.38 147.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.286 0.565 . . . . 0.0 111.985 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.528 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -135.11 145.58 48.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.826 179.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 41.4 m-85 -97.81 116.99 31.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.013 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.415 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.6 t90 -109.28 90.85 3.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 109.835 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.72 155.65 40.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.855 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -85.22 -12.63 52.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.008 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 t -90.66 24.46 2.67 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.866 0.365 . . . . 0.0 111.917 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 23.38 60.7 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 114.811 0.685 . . . . 0.0 114.811 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.6 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.99 163.46 17.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.11 0.955 . . . . 0.0 109.9 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.54 141.3 14.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.998 178.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -126.42 178.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.007 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.2 t70 -148.79 147.86 29.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.257 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.58 -173.21 33.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.261 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -167.96 130.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.749 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.9 m-30 -69.68 110.44 4.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.788 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.1 m -84.83 -17.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.158 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.24 -166.41 2.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.894 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.68 -27.14 27.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.235 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.43 0.97 7.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.0 tt0 -107.1 147.06 30.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.976 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.09 142.68 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.388 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 6.0 m170 -126.47 107.9 10.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 135.55 26.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.752 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.45 21.84 42.9 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.042 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.27 21.71 64.37 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.503 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.08 164.45 13.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.3 m -118.26 107.31 13.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.801 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.976 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.8 m-85 -109.44 126.37 53.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.367 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.642 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 19.1 m-85 -102.77 146.88 27.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.463 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.422 ' NE ' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -74.33 130.98 40.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 112.066 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.677 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.214 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.884 0.374 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -146.42 156.9 43.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -133.4 98.8 14.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 73.0 Cg_exo -52.27 164.83 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.852 2.368 . . . . 0.0 112.584 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.967 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.1 m-85 -146.43 -42.06 0.2 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.2 t 60.51 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.211 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.5 147.46 4.85 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.274 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.32 96.92 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.029 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.672 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.06 107.42 19.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.799 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.721 HG22 ' HB2' ' A' ' 17' ' ' ARG . 69.4 t -115.04 155.77 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.433 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.46 179.38 0.79 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.146 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -79.86 -19.65 47.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.532 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.11 -28.52 11.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.669 0.271 . . . . 0.0 110.916 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.45 26.26 14.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.991 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -78.68 -31.04 46.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.01 155.51 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.481 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.721 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -136.32 138.82 42.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.831 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.9 tt0 -125.76 111.95 15.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.639 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.76 127.2 39.36 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 111.563 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 41' ' ' TYR . 8.3 mt -92.12 114.09 26.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.492 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.29 156.42 88.29 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.496 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.92 -17.15 58.69 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.506 2.804 . . . . 0.0 112.545 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.37 23.98 6.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.0 54.36 21.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.876 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.2 mmm-85 -143.32 -179.74 6.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.632 0.253 . . . . 0.0 111.334 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.472 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.14 149.97 48.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.432 0.634 . . . . 0.0 112.558 -178.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.32 111.72 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.34 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.25 134.62 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.376 0.608 . . . . 0.0 111.972 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.13 105.37 10.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.09 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.486 ' HD2' HG21 ' A' ' 16' ' ' ILE . 14.7 mtm-85 -97.72 148.0 23.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.75 128.48 15.52 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.848 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.46 31.14 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.2 tpt180 -172.67 38.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 168.84 0.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.658 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 47.4 29.83 1.42 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.442 . . . . 0.0 110.643 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 33' ' ' ARG . . . -56.82 -53.74 54.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.631 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 153.88 38.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.215 0.531 . . . . 0.0 111.882 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.29 149.83 15.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.82 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.82 -120.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.17 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.16 164.18 38.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.737 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.4 p90 -139.39 156.89 46.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.529 0.68 . . . . 0.0 112.219 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 2.8 tt0 -120.39 127.34 52.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.857 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.967 HG21 ' CE1' ' A' ' 5' ' ' TYR . 72.0 t -104.39 127.98 58.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.149 0.5 . . . . 0.0 112.038 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -139.51 99.76 3.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.93 42.83 96.96 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.289 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.77 -7.32 1.42 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.487 0.315 . . . . 0.0 111.664 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.4 ' ND1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.8 125.65 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.665 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.54 145.99 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.273 0.558 . . . . 0.0 112.158 -178.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.55 145.3 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.746 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 41.9 m-85 -96.81 117.11 30.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.88 -0.146 . . . . 0.0 110.867 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.429 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.5 t90 -109.22 90.95 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 109.887 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.16 155.57 40.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.85 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.21 -12.67 52.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.0 t -90.01 24.76 2.33 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.806 0.336 . . . . 0.0 111.843 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.41 24.55 60.72 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -121.38 163.64 18.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.042 0.921 . . . . 0.0 109.904 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.63 141.3 14.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.848 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -126.68 178.42 5.93 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.132 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.8 p30 -146.77 147.25 30.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.383 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.34 -175.12 35.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.176 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' HB3' ' ND1' ' A' ' 47' ' ' HIS . 11.5 p30 -168.17 129.49 1.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.165 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.665 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -67.5 110.34 3.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 110.857 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.0 m -84.35 -18.59 9.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.189 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 -168.13 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 110.835 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.57 -27.19 29.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.24 0.1 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.2 tt0 -107.02 148.51 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.876 0.369 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.975 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.13 142.64 49.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.345 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.723 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.57 107.79 10.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.27 136.42 26.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.816 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.4 22.0 43.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 26.13 58.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.4 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.35 165.18 13.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.945 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.1 m -118.52 107.41 13.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.975 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.4 m-85 -109.63 128.06 54.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.487 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.625 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 13.9 m-85 -103.95 146.3 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.518 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.756 ' O ' ' N ' ' A' ' 79' ' ' LYS . 2.0 tpp85 -72.88 135.34 45.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.089 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 43.78 -55.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 113.403 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.756 ' N ' ' O ' ' A' ' 77' ' ' ARG . 7.2 mtpm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.912 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.819 0.342 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -79.28 169.17 18.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.804 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.72 95.92 24.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.236 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 38.6 Cg_exo -61.51 159.37 32.22 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.754 2.303 . . . . 0.0 112.071 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE1' HG21 ' A' ' 43' ' ' VAL . 10.0 m-85 -145.91 -43.88 0.21 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.169 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 21' ' ' LEU . 24.2 t 61.86 130.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.961 0.41 . . . . 0.0 110.993 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.98 146.93 4.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.307 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.473 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -93.18 98.66 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.423 0.63 . . . . 0.0 110.293 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.643 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.0 m95 -91.32 106.82 18.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.627 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.739 HG22 ' HB2' ' A' ' 17' ' ' ARG . 73.8 t -112.78 155.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.147 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.426 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -68.14 176.33 2.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.298 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -76.74 -19.56 57.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.681 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -26.13 13.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.708 0.29 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.02 23.71 29.2 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.154 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.76 -29.51 58.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.054 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.57 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -140.59 156.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.519 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.739 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.5 132.51 33.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.837 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.5 tt0 -120.17 112.5 19.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.03 127.46 38.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.401 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.748 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.5 mt -92.95 110.21 21.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -62.75 156.18 66.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.0 Cg_exo -64.11 -16.84 57.23 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.495 2.796 . . . . 0.0 112.538 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -96.27 23.41 6.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.93 52.84 26.23 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.882 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mmt85 -141.58 -179.81 6.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 111.327 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -136.9 149.23 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.354 0.597 . . . . 0.0 112.54 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.43 111.61 5.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.346 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.7 tt0 -104.25 134.04 48.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.373 0.606 . . . . 0.0 112.196 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.87 105.2 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.868 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.478 ' HD2' HG21 ' A' ' 16' ' ' ILE . 10.3 mtm180 -99.62 106.58 18.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.545 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.9 -146.08 10.05 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.932 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -55.68 -23.12 26.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.752 0.311 . . . . 0.0 111.142 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -93.6 79.63 4.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.549 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 169.05 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.507 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.87 29.14 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.788 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.93 -47.9 67.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.257 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.22 141.56 23.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.46 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.5 149.89 29.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.827 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.96 -121.0 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.785 -1.198 . . . . 0.0 113.158 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.19 38.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.748 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.5 p90 -137.32 155.29 49.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.382 0.61 . . . . 0.0 112.116 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -119.91 127.14 52.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.195 178.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.015 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.1 t -102.65 129.99 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 111.942 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 87.44 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.73 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 65.53 44.0 93.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.326 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.2 -13.14 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.516 0.326 . . . . 0.0 111.606 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.94 128.81 40.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.64 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.71 153.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.176 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.8 150.12 52.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' A' ' 57' ' ' THR . 46.5 m-85 -99.95 116.6 32.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.165 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -109.14 90.16 3.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 0.0 109.977 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.57 158.78 28.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.16 -12.7 52.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.009 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.3 t -91.13 25.06 2.61 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.908 0.385 . . . . 0.0 111.817 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 25.92 60.9 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.541 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.75 163.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.936 0.868 . . . . 0.0 109.989 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.35 142.5 12.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.867 178.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.57 121.52 12.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.598 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 16.2 p30 -90.27 152.29 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -150.68 -163.8 11.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.133 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 6.3 p-10 -168.08 132.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.506 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.9 m-30 -77.48 110.19 12.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.744 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.4 m -85.01 -10.71 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.477 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -160.46 -176.07 5.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.867 0.365 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.13 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.056 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.69 4.13 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.572 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.693 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.0 tt0 -106.72 145.28 32.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.398 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.036 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.91 143.88 50.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.645 -179.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.72 ' N ' HD13 ' A' ' 68' ' ' LEU . 2.6 m170 -126.32 110.01 12.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.44 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.95 135.13 30.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.641 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 23.12 21.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.286 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.61 65.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.696 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.14 163.63 13.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.921 0.391 . . . . 0.0 111.024 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -117.11 107.69 14.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.946 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.036 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.3 m-85 -109.17 120.97 44.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.42 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.573 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 5.0 m-85 -101.38 141.95 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.834 ' O ' ' N ' ' A' ' 79' ' ' LYS . 4.9 ttt180 -71.16 142.53 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.863 0.363 . . . . 0.0 111.735 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 37.11 -56.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.743 1.217 . . . . 0.0 113.284 179.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.834 ' N ' ' O ' ' A' ' 77' ' ' ARG . 33.7 mtpt . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.774 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.32 165.3 12.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -139.62 110.35 7.42 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.831 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 48.1 Cg_exo -57.74 162.69 10.29 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.889 2.393 . . . . 0.0 112.49 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.957 ' CE1' HG21 ' A' ' 43' ' ' VAL . 16.6 m-85 -145.21 -42.5 0.23 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.914 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 21' ' ' LEU . 19.9 t 60.7 129.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.999 0.428 . . . . 0.0 111.329 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.599 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.06 146.73 4.56 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.34 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.45 97.01 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.534 0.683 . . . . 0.0 110.074 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.8 m95 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.588 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 17' ' ' ARG . 78.0 t -114.01 155.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.397 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.5 176.12 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.083 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.56 -19.43 55.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.445 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.65 -23.1 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.47 20.35 48.65 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.336 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' CD ' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -72.51 -24.3 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 110.395 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.56 156.71 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.451 179.35 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.48 131.34 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.6 tt0 -119.24 114.33 22.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -94.66 127.37 40.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.584 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.726 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.8 mt -92.12 113.02 25.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.46 156.61 85.28 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -175.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.37 -17.57 60.67 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.509 2.806 . . . . 0.0 112.477 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -96.01 23.45 6.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 52.86 28.97 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.032 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 41.7 mmt-85 -141.27 -179.97 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.582 0.229 . . . . 0.0 111.276 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.06 149.35 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.413 0.625 . . . . 0.0 112.538 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.55 112.75 5.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -104.51 133.82 48.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.292 0.568 . . . . 0.0 112.205 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.79 105.29 11.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.981 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.492 ' HD2' HG21 ' A' ' 16' ' ' ILE . 18.3 mtm-85 -103.14 114.0 27.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.347 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.41 -154.72 11.26 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.719 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -56.79 -22.57 37.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.732 0.301 . . . . 0.0 111.093 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -91.43 83.88 5.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.718 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 169.36 17.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.511 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.21 29.99 7.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.79 0.329 . . . . 0.0 110.717 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.58 71.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 140.82 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.477 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.69 149.71 28.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.19 -122.1 0.61 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.824 -1.179 . . . . 0.0 113.115 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.1 163.77 39.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.726 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.7 p90 -138.44 155.12 48.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.521 0.677 . . . . 0.0 112.192 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -119.98 127.24 52.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.891 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.957 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.1 t -104.73 130.89 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 112.124 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -141.75 98.14 3.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.79 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 59.69 43.61 97.63 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.298 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.12 -7.58 1.34 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.426 0.291 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 125.25 38.24 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.754 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.02 148.33 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.225 0.536 . . . . 0.0 112.148 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.547 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.33 144.3 49.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.881 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.8 m-85 -100.2 115.14 29.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.065 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -109.06 90.51 3.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -67.09 158.69 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.652 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -85.07 -12.71 52.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.176 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.67 25.05 2.83 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.774 0.321 . . . . 0.0 111.726 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.7 25.24 60.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.546 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.2 164.12 15.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.013 0.906 . . . . 0.0 109.971 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.45 11.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.98 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.62 121.82 13.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.509 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 7.0 p-10 -90.3 155.63 18.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.975 0.417 . . . . 0.0 111.454 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.25 -170.71 28.53 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.076 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.424 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.3 p30 -168.32 133.74 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 111.227 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.754 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.9 m-30 -72.76 110.5 7.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.1 m -82.53 -18.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.168 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.59 -169.43 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.22 -28.14 32.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.22 -0.25 9.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' HG23 ' A' ' 63' ' ' VAL . 6.0 tt0 -106.92 146.79 30.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.931 0.396 . . . . 0.0 110.726 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.91 142.0 50.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.371 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.3 m170 -126.38 107.9 10.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.759 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.64 135.41 26.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.87 21.52 44.77 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.048 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 23.78 60.53 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.49 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -114.71 164.87 13.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 m -118.37 107.35 13.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.981 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.986 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.1 m-85 -109.64 127.31 54.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.627 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 11.1 m-85 -104.66 145.12 30.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.482 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.851 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -70.73 139.5 51.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.504 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 34.28 -57.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.73 1.212 . . . . 0.0 113.155 179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.851 ' N ' ' O ' ' A' ' 77' ' ' ARG . 1.9 mttt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.818 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.797 0.332 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 165.13 11.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.982 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.84 96.57 13.09 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 32.2 Cg_exo -59.29 159.27 23.37 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.686 2.257 . . . . 0.0 112.13 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE1' HG21 ' A' ' 43' ' ' VAL . 7.1 m-85 -146.81 -44.2 0.18 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.167 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.3 t 61.86 129.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.99 0.424 . . . . 0.0 111.145 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.624 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.12 146.24 4.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.301 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -93.09 96.67 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.462 0.648 . . . . 0.0 109.932 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.661 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 25.7 m95 -86.57 107.79 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.418 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 17' ' ' ARG . 77.6 t -113.56 155.33 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.755 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.453 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.51 -175.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.634 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.02 -20.25 33.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.42 -26.54 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.732 0.301 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.29 26.1 16.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.018 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -77.46 -29.12 52.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 154.67 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.407 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.782 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -137.56 133.51 34.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.926 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.5 tt0 -119.69 113.08 20.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.528 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -92.51 126.47 37.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.107 0.479 . . . . 0.0 111.551 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.762 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.0 mt -92.56 112.3 24.2 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.09 157.3 85.37 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.9 Cg_exo -64.33 -13.96 41.26 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.338 2.692 . . . . 0.0 111.929 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -93.45 20.0 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.98 50.05 63.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.6 mmt180 -137.65 -179.92 6.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.889 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.86 149.93 47.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.19 111.09 4.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.507 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.5 tt0 -102.88 133.39 48.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.331 0.586 . . . . 0.0 111.91 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.32 105.42 10.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.351 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -97.77 149.24 22.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.997 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.27 133.88 28.9 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.702 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.9 t30 56.98 27.26 12.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.809 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -176.49 58.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 169.19 17.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.419 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 48.19 29.38 1.83 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.882 0.373 . . . . 0.0 110.661 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.69 -51.99 63.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.563 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -149.59 152.77 36.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.178 0.513 . . . . 0.0 111.578 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.47 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -161.46 149.4 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.804 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -120.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 163.97 39.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.762 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.3 p90 -137.26 155.65 49.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.441 0.638 . . . . 0.0 112.085 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.0 tt0 -119.97 127.19 52.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.128 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.015 HG21 ' CE1' ' A' ' 5' ' ' TYR . 49.2 t -102.7 129.65 53.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.426 . . . . 0.0 112.025 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -136.82 82.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.22 44.76 74.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.272 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.55 -13.14 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.6 0.36 . . . . 0.0 111.497 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.88 126.05 38.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.03 152.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.234 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -131.85 151.14 51.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.783 178.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.6 m-85 -100.32 116.45 32.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.158 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.0 t90 -109.1 90.41 3.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.007 0.432 . . . . 0.0 109.907 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.62 158.36 32.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.743 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -85.16 -12.75 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.858 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -91.08 25.23 2.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.85 0.357 . . . . 0.0 111.755 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.7 26.3 61.08 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.505 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.16 163.86 17.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.928 0.864 . . . . 0.0 109.866 179.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.68 142.4 12.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.975 178.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.52 121.56 12.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.677 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 31.3 p-10 -90.37 152.08 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.397 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -153.52 -167.49 15.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.034 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.11 131.93 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.7 m-30 -77.05 110.24 11.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.577 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.7 m -84.84 -14.29 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.32 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.73 177.93 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.82 -27.95 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -121.08 -2.62 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.593 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.0 tt0 -106.94 141.92 37.38 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.899 0.38 . . . . 0.0 110.733 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.027 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -128.18 142.97 51.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.536 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.712 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 108.02 10.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.786 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.83 137.01 29.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.668 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.35 22.75 38.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.122 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.55 25.23 61.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.373 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.3 165.12 13.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.023 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.1 m -117.9 107.57 14.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.147 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.027 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.9 m-85 -110.12 123.37 49.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 8.3 m-85 -102.95 140.34 37.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.692 ' O ' ' N ' ' A' ' 79' ' ' LYS . 3.8 tpp180 -54.06 148.21 11.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.931 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.3 mt-10 9.78 -65.14 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.388 1.055 . . . . 0.0 112.564 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.871 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.745 0.307 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.72 157.95 17.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -121.02 91.13 47.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.439 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 72.0 Cg_exo -52.76 164.88 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.907 2.405 . . . . 0.0 112.67 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 43' ' ' VAL . 15.3 m-85 -144.88 -42.34 0.24 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.2 t 60.32 129.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.022 0.439 . . . . 0.0 111.3 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.592 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.24 146.63 4.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -93.84 96.93 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.084 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.667 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.1 m95 -89.54 107.48 19.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.695 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 17' ' ' ARG . 71.1 t -113.95 155.59 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.329 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.427 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.72 1.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.104 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.612 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -79.6 -19.36 49.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.515 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.45 -26.16 12.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.995 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.04 24.83 26.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.221 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -77.13 -28.35 54.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.516 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.17 155.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.435 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -136.89 133.09 35.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.863 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.1 tt0 -121.47 113.2 19.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -94.46 128.45 41.04 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.059 0.457 . . . . 0.0 111.513 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.772 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.3 mt -92.58 113.26 25.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 156.34 86.66 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -64.0 -17.01 58.12 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.556 2.838 . . . . 0.0 112.49 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.58 24.08 6.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 110.759 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.11 54.13 22.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.92 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.0 mmm-85 -143.37 -179.93 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.593 0.235 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.72 149.2 47.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.6 . . . . 0.0 112.407 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.53 112.45 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.487 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -104.17 131.54 51.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.288 0.566 . . . . 0.0 111.907 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.4 105.21 11.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -98.62 150.47 21.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.55 -41.19 56.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.643 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -58.99 -30.86 68.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 0.0 110.799 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -179.6 119.54 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.553 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.91 169.43 13.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.342 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.52 29.13 1.96 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.891 0.377 . . . . 0.0 110.52 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.56 -49.89 66.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.503 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 144.33 24.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.729 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.95 149.81 26.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.25 -120.95 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.099 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.772 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.3 p90 -138.56 155.75 48.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.414 0.626 . . . . 0.0 112.323 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.99 127.21 52.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.717 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.0 t -104.98 130.46 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.173 0.511 . . . . 0.0 112.083 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 11.3 mtm105 -142.05 99.87 3.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.784 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.85 43.34 96.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.287 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.59 -7.03 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.47 0.308 . . . . 0.0 111.67 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.82 125.73 38.6 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.752 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.97 148.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.273 0.559 . . . . 0.0 112.153 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.547 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.43 144.13 49.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.891 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -99.6 114.79 28.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.12 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -108.97 90.29 3.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.025 0.44 . . . . 0.0 109.865 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.63 159.1 28.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.653 -179.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -85.1 -12.65 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.987 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -91.58 25.51 2.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.809 0.337 . . . . 0.0 111.612 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.19 26.52 61.67 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.097 -0.573 . . . . 0.0 114.478 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.96 164.26 15.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.858 0.829 . . . . 0.0 109.831 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.13 142.65 11.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.986 178.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.52 121.71 13.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.515 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.5 p30 -89.61 155.43 19.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -162.48 -171.42 28.62 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 6.9 p-10 -168.12 133.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 111.285 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.752 ' CE1' HG21 ' A' ' 48' ' ' ILE . 9.0 m-30 -72.99 110.34 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.104 0.478 . . . . 0.0 110.716 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.64 -18.09 10.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.356 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -148.68 -169.13 3.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.351 . . . . 0.0 110.958 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.79 -30.2 32.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.67 1.34 10.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.485 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.7 tt0 -107.0 147.93 29.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.921 0.391 . . . . 0.0 110.581 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.001 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.17 144.22 49.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.414 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.742 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.48 108.92 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.443 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.33 135.86 32.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.582 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.95 23.78 17.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.177 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.23 67.25 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.31 164.18 12.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.026 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 m -117.23 107.63 14.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.001 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.2 m-85 -109.48 127.13 54.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.355 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.612 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 9.5 m-85 -105.16 143.58 33.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.861 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.18 140.68 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 31.36 -58.26 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.569 1.148 . . . . 0.0 112.955 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.861 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.746 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.831 0.348 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 153.77 42.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.96 95.44 47.57 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 46.2 Cg_exo -57.0 159.63 14.34 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.73 2.287 . . . . 0.0 112.279 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.027 ' CE1' HG21 ' A' ' 43' ' ' VAL . 5.3 m-85 -145.64 -44.81 0.21 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.941 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.0 t 62.24 129.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.188 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 153.87 146.14 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.388 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.542 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.71 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.411 0.624 . . . . 0.0 109.856 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.647 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.6 m95 -86.38 108.47 18.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.381 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 17' ' ' ARG . 75.7 t -114.32 155.7 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.778 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.421 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -65.68 -175.16 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.331 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -84.0 -20.45 32.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.05 -25.48 12.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.828 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.59 23.21 24.34 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.315 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -73.91 -26.87 60.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.742 0.306 . . . . 0.0 110.271 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.864 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -143.67 157.7 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.345 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.864 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -140.27 138.33 34.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 3.6 tt0 -125.44 112.91 16.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.66 126.67 36.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 111.669 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.747 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.4 mt -92.91 111.66 23.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.06 156.32 81.07 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.9 -17.22 58.97 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.467 2.778 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.7 22.9 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.27 52.54 26.51 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.843 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.7 mmt85 -140.94 -179.81 6.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.562 0.22 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -137.0 150.36 48.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.41 0.624 . . . . 0.0 112.459 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.16 110.74 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.0 tt0 -103.3 132.48 49.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.415 0.626 . . . . 0.0 111.895 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.58 105.16 10.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.352 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 4.4 mtm180 -97.81 146.64 25.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.051 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.99 136.59 24.55 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.853 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.95 25.16 10.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 0.0 111.036 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -176.98 58.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.389 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 169.93 14.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.459 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 49.34 29.93 2.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.934 0.397 . . . . 0.0 110.619 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -52.42 61.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.685 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.409 ' CD2' ' OD2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -151.0 153.48 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.038 0.447 . . . . 0.0 111.754 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.82 148.92 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.045 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.98 -121.82 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.982 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.1 164.03 39.14 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.747 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.2 p90 -138.09 157.64 45.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.355 0.597 . . . . 0.0 112.284 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.38 127.21 49.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.087 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.027 HG21 ' CE1' ' A' ' 5' ' ' TYR . 29.8 t -101.07 135.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.209 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -141.45 82.86 1.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.492 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.38 44.7 72.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.223 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 86.04 -14.4 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.551 0.34 . . . . 0.0 111.539 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.56 39.69 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.76 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.48 149.54 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.471 0.653 . . . . 0.0 112.516 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 4.5 t-20 -117.69 166.81 11.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.94 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 57' ' ' THR . 72.2 m-85 -125.22 113.07 17.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.597 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -109.0 91.67 3.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 110.058 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.4 159.18 29.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.642 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.98 -12.81 52.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.216 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -91.53 25.64 2.57 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.841 0.353 . . . . 0.0 111.681 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.13 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.378 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.84 164.27 15.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.842 0.821 . . . . 0.0 109.903 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.47 142.32 11.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.7 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -149.07 125.89 11.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.847 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 2.2 p30 -92.92 152.79 19.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.417 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.22 15.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.074 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' NE2' ' A' ' 47' ' ' HIS . 4.7 p-10 -168.07 132.7 1.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.36 . . . . 0.0 111.274 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 6.5 m-30 -79.64 110.33 14.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.5 m -79.48 -19.69 12.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.304 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -150.2 -175.64 5.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.27 57.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.064 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -116.69 -2.64 11.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.439 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.7 tt0 -106.92 144.4 33.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.963 0.411 . . . . 0.0 110.643 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.029 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.54 143.98 51.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.509 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.734 ' N ' HD13 ' A' ' 68' ' ' LEU . 3.3 m170 -126.36 108.91 11.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.841 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.46 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.95 136.93 32.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.56 23.5 14.26 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.138 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.21 67.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.729 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.46 164.06 12.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.011 0.405 . . . . 0.0 111.064 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -116.46 107.64 15.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.029 ' HB2' HD12 ' A' ' 68' ' ' LEU . 24.7 m-85 -110.0 123.58 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.403 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.626 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.8 m-85 -101.2 140.91 34.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.799 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -58.31 147.51 30.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.226 -179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' ILE . 1.6 mt-10 15.96 -62.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.674 1.19 . . . . 0.0 113.071 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.799 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.869 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtp . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.832 0.349 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.01 151.99 41.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -124.74 102.33 32.24 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 50.3 Cg_exo -55.22 163.6 4.48 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.827 2.351 . . . . 0.0 112.631 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.934 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.6 m-85 -145.49 -42.46 0.22 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.798 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 21' ' ' LEU . 20.5 t 60.57 128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.206 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.573 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.14 147.51 4.89 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.27 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.75 96.77 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.396 0.617 . . . . 0.0 110.009 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.679 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.2 m95 -88.88 108.59 19.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.8 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 17' ' ' ARG . 73.9 t -116.42 155.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.425 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.44 -178.29 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.139 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.636 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -81.84 -19.54 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.475 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.74 -27.2 11.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.72 0.295 . . . . 0.0 110.933 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 26.21 16.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.192 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.33 -29.32 47.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.84 0.353 . . . . 0.0 110.106 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.85 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -139.45 157.3 27.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.85 ' N ' HD12 ' A' ' 16' ' ' ILE . 4.2 ttp-105 -137.81 141.73 40.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.884 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 1.4 tt0 -131.01 111.92 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.594 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -94.76 127.71 40.95 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.047 0.451 . . . . 0.0 111.655 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.792 HD22 ' CE2' ' A' ' 41' ' ' TYR . 9.3 mt -91.89 114.01 26.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.3 156.53 88.06 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.57 -17.41 59.87 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.47 2.78 . . . . 0.0 112.498 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -96.22 23.75 6.32 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.842 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.09 53.95 23.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.905 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 4.5 mmm-85 -142.99 -179.76 6.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 0.0 111.251 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.42 149.72 48.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.396 0.617 . . . . 0.0 112.543 -178.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 112.02 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.435 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -104.03 132.36 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.353 0.597 . . . . 0.0 111.958 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.44 105.18 10.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -97.62 148.31 23.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.6 137.64 25.76 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.778 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 56.51 24.04 8.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -177.02 65.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 169.65 17.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.565 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.05 29.92 2.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 110.58 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.18 -52.45 61.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.636 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.41 153.58 36.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.187 0.518 . . . . 0.0 111.672 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -161.92 149.48 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.818 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.78 -120.32 0.54 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 119.691 -1.243 . . . . 0.0 113.075 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.14 164.18 38.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.792 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.8 p90 -139.7 154.72 47.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.599 0.714 . . . . 0.0 112.354 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.9 127.34 52.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.824 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.934 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.2 t -104.15 131.37 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 112.078 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -142.72 100.48 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.741 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.26 42.84 95.64 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.369 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.98 -7.98 1.33 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 122.514 0.326 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.82 127.19 39.43 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.674 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.97 148.65 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.194 0.521 . . . . 0.0 112.153 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.72 143.83 49.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.878 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 57' ' ' THR . 45.5 m-85 -98.95 114.66 27.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.037 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -109.03 90.25 3.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.929 0.395 . . . . 0.0 109.94 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.94 158.46 30.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.91 -12.81 52.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.981 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.1 t -91.38 25.14 2.68 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.848 0.356 . . . . 0.0 111.73 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.74 26.52 60.57 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.932 -0.651 . . . . 0.0 114.425 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.86 163.91 16.82 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.915 0.858 . . . . 0.0 109.935 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.37 142.37 12.77 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.882 178.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -141.34 121.74 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.477 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -88.49 156.08 19.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.085 0.469 . . . . 0.0 111.402 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.1 -174.76 35.13 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.4 p-10 -168.14 132.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.38 . . . . 0.0 111.328 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.674 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.42 110.29 5.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.716 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -82.31 -19.2 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.253 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -147.25 -168.68 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.77 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.197 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.94 -0.08 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.579 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.7 tt0 -106.93 147.23 30.07 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.023 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.6 142.84 50.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 -179.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.699 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.4 m170 -126.19 107.8 10.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.213 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.485 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -145.96 137.72 25.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.691 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.69 22.26 39.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.915 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.63 23.39 64.84 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.368 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.02 164.45 14.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.217 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 m -117.03 107.5 14.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.54 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.023 ' HB2' HD12 ' A' ' 68' ' ' LEU . 22.0 m-85 -110.67 127.43 55.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 15.2 m-85 -102.69 146.04 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.481 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.798 ' O ' ' N ' ' A' ' 79' ' ' LYS . 1.5 tpp85 -73.07 136.87 45.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.955 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 39.88 -56.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.688 1.195 . . . . 0.0 113.266 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.798 ' N ' ' O ' ' A' ' 77' ' ' ARG . 4.0 mtpm? . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.818 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.832 0.348 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -158.73 160.54 36.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -131.29 97.58 19.63 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 77.5 Cg_exo -51.83 165.12 0.85 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.795 2.33 . . . . 0.0 112.65 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.988 ' CE1' HG21 ' A' ' 43' ' ' VAL . 22.2 m-85 -146.26 -41.71 0.2 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.2 t 60.53 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.62 146.58 4.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.79 96.93 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.496 0.665 . . . . 0.0 110.133 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.655 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 18.8 m95 -89.52 107.32 19.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.601 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 17' ' ' ARG . 79.6 t -113.28 155.85 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.401 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.401 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -68.76 172.75 5.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.193 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.636 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -74.77 -19.47 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.7 -25.95 13.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.94 24.14 36.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.151 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.497 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.69 -26.07 44.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.279 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.577 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.64 156.66 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.281 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.746 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -139.16 130.97 27.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.962 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 2.4 tt0 -117.64 112.67 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -93.74 127.33 39.41 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.52 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.739 HD22 ' CE2' ' A' ' 41' ' ' TYR . 8.1 mt -92.48 113.97 26.4 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.46 156.75 87.82 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -175.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.8 Cg_exo -63.9 -17.18 58.83 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.448 2.765 . . . . 0.0 112.499 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.7 24.23 6.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.428 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.08 53.52 25.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.94 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.4 mmt85 -142.22 -179.78 6.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.649 0.261 . . . . 0.0 111.438 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -136.23 148.65 48.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.26 0.552 . . . . 0.0 112.424 -178.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 109.65 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.9 tt0 -102.9 134.29 46.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.396 0.617 . . . . 0.0 112.134 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.11 105.29 12.11 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.063 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -103.66 117.44 34.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.385 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.3 -157.03 6.47 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.801 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -56.26 -23.22 34.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.694 0.283 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -89.24 83.61 6.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.506 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -75.73 172.0 13.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.44 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 4.3 m 43.87 34.56 0.92 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.295 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.59 -47.17 63.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.171 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 142.23 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.319 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -150.94 150.35 30.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.845 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.55 -122.73 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.037 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -154.14 164.05 39.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.739 ' CE2' HD22 ' A' ' 20' ' ' LEU . 4.0 p90 -138.73 157.34 46.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.612 0.72 . . . . 0.0 112.221 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -120.73 127.27 51.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.834 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.988 HG21 ' CE1' ' A' ' 5' ' ' TYR . 81.0 t -104.59 128.77 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 112.133 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.93 98.61 3.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.764 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 59.69 43.21 97.98 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.232 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.76 -6.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.458 0.303 . . . . 0.0 111.608 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.75 125.33 38.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.745 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.15 148.05 28.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.292 0.567 . . . . 0.0 111.995 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.538 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -134.9 145.24 48.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.675 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' THR . 41.7 m-85 -97.47 117.03 30.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.007 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.2 t90 -109.32 90.9 3.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.996 0.427 . . . . 0.0 109.953 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.61 155.64 40.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.742 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.35 -12.62 51.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.088 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -90.85 24.18 2.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 0.0 111.918 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.6 22.43 60.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.32 163.48 17.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.224 1.012 . . . . 0.0 109.893 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.89 141.29 14.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.897 178.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -127.21 178.37 6.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 22.5 p-10 -147.07 148.8 32.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.112 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -166.13 -174.09 35.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.329 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -168.12 129.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.745 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.9 m-30 -68.58 110.5 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.48 . . . . 0.0 110.81 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -85.81 -17.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.273 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -148.37 -168.05 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.813 0.339 . . . . 0.0 110.82 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.63 -26.92 29.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 0.97 7.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HB3' HG23 ' A' ' 63' ' ' VAL . 1.4 tt0 -107.18 146.54 31.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.98 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -130.53 142.88 50.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.73 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.63 107.85 10.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.02 135.99 26.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.711 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.31 22.13 43.04 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.029 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.29 23.85 62.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.487 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.64 13.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.901 0.381 . . . . 0.0 111.017 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 m -118.17 107.43 13.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.874 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.98 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.3 m-85 -109.33 126.26 53.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.309 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.636 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 13.1 m-85 -103.36 145.45 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.491 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.787 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -71.87 137.65 47.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.69 -179.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 39.83 -55.89 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.671 1.188 . . . . 0.0 113.354 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.787 ' N ' ' O ' ' A' ' 77' ' ' ARG . 2.4 mttt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.853 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.764 0.316 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.78 157.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -129.46 104.76 17.57 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.79 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 61.1 Cg_exo -53.22 164.45 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.798 2.332 . . . . 0.0 112.841 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.005 ' CE1' HG21 ' A' ' 43' ' ' VAL . 17.1 m-85 -146.43 -43.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.4 t 60.74 129.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.285 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.69 146.95 4.65 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.418 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -93.79 96.96 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.518 0.675 . . . . 0.0 110.15 179.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.678 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.6 m95 -89.08 107.82 19.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.571 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 17' ' ' ARG . 76.2 t -113.99 155.29 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.466 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.431 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.28 176.76 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.245 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.647 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.91 -19.95 53.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.36 -25.19 13.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.012 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.41 23.79 33.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.204 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -76.56 -27.23 55.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.85 0.357 . . . . 0.0 110.128 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.712 HD13 ' OE1' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -141.95 154.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.388 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.725 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.32 132.73 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 21.6 tt0 -121.82 114.13 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.891 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -93.34 128.55 39.41 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.514 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.755 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.4 mt -93.26 113.69 25.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.534 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.64 158.13 80.47 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.8 Cg_exo -63.26 -18.79 66.51 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.586 2.858 . . . . 0.0 112.868 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.66 20.92 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.741 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.37 51.27 27.66 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.382 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 87.5 mmt-85 -137.17 -179.81 5.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.599 -0.3 . . . . 0.0 110.927 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.6 152.32 50.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.426 0.632 . . . . 0.0 112.512 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.01 110.6 4.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.425 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.712 ' OE1' HD13 ' A' ' 16' ' ' ILE . 2.5 tt0 -103.12 134.09 47.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 112.102 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.26 105.1 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.969 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.91 111.74 24.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.502 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.34 -150.72 11.04 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.884 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -58.54 -20.44 46.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.703 0.287 . . . . 0.0 111.167 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.68 76.91 4.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.838 0.352 . . . . 0.0 110.75 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.69 169.52 18.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.455 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 51.91 30.07 6.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.68 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -43.07 71.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.176 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.06 141.61 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.504 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.46 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.42 149.86 29.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.5 -122.46 0.64 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.912 -1.137 . . . . 0.0 113.088 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.03 164.18 38.87 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.755 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.6 p90 -138.45 156.73 47.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.537 0.684 . . . . 0.0 112.317 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -120.21 127.35 52.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.953 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.005 HG21 ' CE1' ' A' ' 5' ' ' TYR . 77.2 t -104.06 126.82 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 111.952 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -136.38 92.34 2.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 63.2 43.3 98.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.199 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.98 -10.25 0.93 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 122.558 0.343 . . . . 0.0 111.706 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.9 125.59 38.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.646 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -139.43 147.28 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.184 0.516 . . . . 0.0 112.263 -179.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -129.23 146.56 51.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.642 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' THR . 42.8 m-85 -97.08 118.26 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.38 0.133 . . . . 0.0 110.725 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.416 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 30.4 t90 -109.47 91.29 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.145 0.498 . . . . 0.0 110.003 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -71.21 155.1 41.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.744 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.2 -12.65 52.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.055 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 t -90.17 23.52 2.83 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.885 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.45 22.32 58.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -121.05 162.73 19.48 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.251 1.026 . . . . 0.0 110.048 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.78 140.71 16.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.748 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -125.66 178.47 5.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.4 p-10 -145.73 145.87 31.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -176.96 33.84 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.355 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.0 p-10 -168.1 123.62 1.0 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.059 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 4.9 m-30 -64.96 110.15 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.8 m -83.48 -19.2 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.246 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.47 -166.33 2.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.813 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.4 -29.18 26.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.208 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.83 1.12 9.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.604 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 63' ' ' VAL . 7.6 tt0 -107.02 149.52 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.883 0.373 . . . . 0.0 110.705 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.024 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.61 144.53 49.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.741 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.4 108.24 11.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -139.45 134.96 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.61 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.22 23.55 18.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.16 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.72 66.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.698 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.35 163.87 12.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.956 0.407 . . . . 0.0 111.093 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 m -116.74 107.75 15.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.894 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.024 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.2 m-85 -109.78 127.57 54.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.318 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.647 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 14.6 m-85 -103.7 145.96 29.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.26 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.798 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -72.56 137.87 46.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.916 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 39.88 -56.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.753 1.221 . . . . 0.0 113.249 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.798 ' N ' ' O ' ' A' ' 77' ' ' ARG . 3.7 mtpm? . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.8 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' O ' ' CD2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -89.58 -24.61 21.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.246 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.409 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 15.0 m80 -155.39 91.3 2.84 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.954 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 52.2 Cg_exo -55.73 163.04 5.88 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.693 2.262 . . . . 0.0 112.315 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.999 ' CE1' HG21 ' A' ' 43' ' ' VAL . 12.3 m-85 -143.29 -43.78 0.29 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.715 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 21' ' ' LEU . 21.1 t 60.6 129.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 111.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.9 147.37 4.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.273 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.23 96.88 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.582 0.706 . . . . 0.0 110.151 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.664 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.5 m95 -89.25 106.63 18.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.707 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 17' ' ' ARG . 74.8 t -113.67 155.76 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.267 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.443 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.67 178.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.129 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -79.09 -19.62 50.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -27.19 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.73 24.38 23.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.077 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.443 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.06 -31.62 58.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 109.956 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.565 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -138.34 155.89 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.455 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.704 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.44 132.27 33.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.678 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.6 tt0 -120.32 112.61 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -93.2 127.6 38.83 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.539 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.76 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.2 mt -92.51 112.79 24.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.89 156.29 84.13 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.3 Cg_exo -63.68 -17.27 59.22 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.569 2.846 . . . . 0.0 112.514 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -96.09 23.71 6.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.24 53.45 25.73 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.882 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 6.9 mmm-85 -143.11 -179.78 6.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.457 0.17 . . . . 0.0 111.42 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -136.29 149.85 48.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.438 0.637 . . . . 0.0 112.639 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.92 111.89 5.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.358 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.43 135.65 45.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.394 0.616 . . . . 0.0 112.16 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.16 105.35 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.972 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HD2' HG21 ' A' ' 16' ' ' ILE . 14.1 mtm180 -102.17 112.53 25.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.433 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.82 -150.54 9.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.946 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -58.13 -20.98 44.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 0.0 111.187 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 tpp85 -93.59 79.18 4.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.839 0.352 . . . . 0.0 110.73 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 169.33 17.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.439 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.18 29.58 6.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 110.762 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.89 -46.61 71.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.184 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 149.89 31.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.464 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.96 149.72 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.96 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.7 -121.59 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 119.826 -1.178 . . . . 0.0 112.926 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.01 162.72 40.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.76 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.5 p90 -136.86 155.52 49.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.381 0.61 . . . . 0.0 112.094 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.65 127.17 52.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.167 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.999 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.7 t -103.46 129.21 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.108 0.48 . . . . 0.0 111.973 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.31 94.34 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.653 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 61.66 42.81 99.82 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.259 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 84.17 -11.57 0.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.392 0.277 . . . . 0.0 111.725 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.89 128.96 40.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.628 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.85 153.43 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.225 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.518 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.37 151.0 51.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.907 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 57' ' ' THR . 51.3 m-85 -101.79 115.89 31.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.414 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 87.9 t90 -109.11 90.55 3.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.019 0.438 . . . . 0.0 110.12 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.62 158.84 28.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.778 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.14 -12.71 52.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.01 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.7 t -91.38 25.2 2.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.871 0.367 . . . . 0.0 111.72 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.19 25.73 61.15 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.014 -0.613 . . . . 0.0 114.505 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.02 163.71 16.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.044 0.922 . . . . 0.0 109.935 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.19 142.37 11.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.121 178.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.46 121.56 12.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.462 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p30 -90.97 153.13 20.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 0.0 111.441 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -154.13 -164.92 13.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.223 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 9.1 p-10 -168.09 133.31 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.042 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.7 m-30 -76.63 110.31 11.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.664 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -87.25 -10.17 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.043 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.85 156.51 11.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.824 0.345 . . . . 0.0 110.611 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.27 32.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.552 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -119.06 -10.53 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.853 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.664 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.2 tt0 -106.66 147.84 29.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.956 0.407 . . . . 0.0 110.901 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.027 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -132.16 143.23 49.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.289 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.713 ' N ' HD13 ' A' ' 68' ' ' LEU . 3.7 m170 -126.45 108.78 11.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.847 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.529 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.38 136.44 29.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.61 22.96 34.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.21 63.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.538 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.01 164.33 13.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 m -117.84 107.58 14.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.006 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.027 ' HB2' HD12 ' A' ' 68' ' ' LEU . 32.4 m-85 -109.33 126.28 53.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.381 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.626 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 10.9 m-85 -103.81 145.36 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.252 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.766 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -72.33 137.7 46.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.933 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 42.64 -54.53 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 113.478 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' A' ' 77' ' ' ARG . 21.9 mtpp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.749 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.78 0.324 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -117.58 156.17 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -129.4 111.45 17.92 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 83.5 Cg_exo -46.78 160.92 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.721 2.281 . . . . 0.0 112.86 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.008 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.5 m-85 -136.62 -46.4 0.61 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 21' ' ' LEU . 22.1 t 59.9 125.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.566 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.27 148.63 5.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.14 96.68 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.181 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.636 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.7 m95 -89.22 106.71 18.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.612 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 17' ' ' ARG . 78.7 t -111.08 155.78 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.349 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -69.32 172.14 7.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.228 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -73.6 -19.94 60.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.13 -16.86 14.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 17.13 68.58 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.293 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -23.41 62.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 0.0 110.284 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -147.71 156.4 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.563 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.762 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.77 131.32 31.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.771 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 27.9 tt0 -119.2 112.55 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.004 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -92.64 127.14 38.03 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 111.326 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.764 HD22 ' CE1' ' A' ' 41' ' ' TYR . 11.8 mt -93.08 112.66 24.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.58 156.69 81.77 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.497 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 27.9 Cg_exo -62.92 -17.97 62.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.583 2.855 . . . . 0.0 112.438 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -94.74 21.95 6.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.942 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.34 50.5 38.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 84.5 mmt-85 -139.36 -179.73 6.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.385 0.136 . . . . 0.0 111.02 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.36 150.99 50.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 0.0 112.758 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.69 109.93 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.275 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 3.1 tt0 -103.26 134.51 46.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.393 0.616 . . . . 0.0 112.183 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.61 105.29 11.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.061 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HD2' HG21 ' A' ' 16' ' ' ILE . 15.2 mtm180 -103.79 116.99 33.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.413 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.34 -153.46 6.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.906 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -58.04 -21.3 44.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.679 0.276 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -92.48 80.84 4.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.701 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 169.67 17.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.413 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.28 30.83 6.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 110.669 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.21 -45.61 68.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.069 0.461 . . . . 0.0 111.084 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 152.42 35.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.282 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.479 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -158.89 149.9 20.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.075 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.71 -128.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.032 -1.08 . . . . 0.0 112.908 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.14 164.2 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.764 ' CE1' HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -133.47 157.38 45.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.502 0.668 . . . . 0.0 112.184 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.1 tt0 -119.87 127.47 52.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.983 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.008 HG21 ' CE1' ' A' ' 5' ' ' TYR . 54.6 t -102.88 126.08 57.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.141 0.496 . . . . 0.0 112.214 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -137.2 88.62 2.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.669 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 64.83 43.85 95.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.398 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 84.47 -12.15 0.78 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.43 0.292 . . . . 0.0 111.66 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.71 127.02 39.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.73 HG21 ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -140.18 151.07 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.043 -179.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -133.43 145.15 50.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.987 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' A' ' 57' ' ' THR . 34.5 m-85 -93.49 117.24 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.952 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -109.28 91.36 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.977 0.418 . . . . 0.0 110.042 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -71.4 155.37 40.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.684 -179.176 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.22 -12.72 51.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.029 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -90.66 24.12 2.8 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.73 22.4 59.94 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 114.87 0.708 . . . . 0.0 114.87 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.52 163.4 17.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.318 1.059 . . . . 0.0 109.935 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.57 140.7 13.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.934 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -127.07 178.31 6.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.069 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 28.4 p-10 -146.78 146.76 30.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.163 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -157.66 -170.56 22.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 9.5 p-10 -168.04 123.12 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 48' ' ' ILE . 89.8 m-85 -65.82 110.34 2.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 67' ' ' GLU . 1.7 m -91.14 -6.02 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.29 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.14 173.49 10.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.44 -22.45 63.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.22 1.56 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.783 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 63' ' ' VAL . 8.7 tt0 -111.25 149.06 31.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.927 0.394 . . . . 0.0 111.006 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.048 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.95 144.08 48.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.299 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.725 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.5 m170 -126.5 107.91 10.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.48 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.48 141.55 29.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 179.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.19 19.13 22.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.084 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.04 68.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.999 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ttm -115.72 171.8 7.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.289 0.545 . . . . 0.0 111.619 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.8 m -117.54 107.99 14.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.711 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.048 ' HB2' HD12 ' A' ' 68' ' ' LEU . 20.5 m-85 -106.03 121.88 45.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.627 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 16.5 m-85 -100.39 147.12 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.912 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.788 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -73.01 137.43 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.8 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 40.02 -55.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.79 1.236 . . . . 0.0 113.416 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 77' ' ' ARG . 13.5 mtpp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.855 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpp . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.762 0.315 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.87 161.54 13.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -116.86 104.19 51.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 76.6 Cg_exo -51.67 164.11 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.588 2.192 . . . . 0.0 112.67 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.023 ' CE1' HG21 ' A' ' 43' ' ' VAL . 7.5 m-85 -144.48 -44.09 0.25 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.6 t 61.58 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.612 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.48 145.0 4.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.393 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.67 96.56 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.516 0.674 . . . . 0.0 109.872 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.654 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 27.0 m95 -85.87 108.04 17.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.243 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.807 HG22 ' HB2' ' A' ' 17' ' ' ARG . 72.9 t -113.41 155.07 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.849 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.43 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -66.38 -177.04 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.311 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.649 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.09 -20.1 35.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.526 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.61 -25.26 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.77 25.77 24.23 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.022 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.03 -28.01 48.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.132 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.561 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.98 155.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.376 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.807 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.69 138.1 37.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -124.3 111.95 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.937 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 38.5 tt0 -90.09 125.21 35.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.755 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.2 mt -92.61 113.54 25.85 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.534 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.16 158.26 82.11 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -176.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -63.65 -18.84 65.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.642 2.894 . . . . 0.0 112.868 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.78 22.27 7.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.331 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 68.68 53.03 22.1 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.575 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -138.64 179.06 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.849 -0.175 . . . . 0.0 110.954 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.01 152.75 49.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.474 0.654 . . . . 0.0 112.745 -178.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.04 110.56 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.28 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.89 134.99 45.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.423 0.63 . . . . 0.0 112.079 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.37 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.161 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -100.24 111.86 24.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.361 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.06 -148.48 10.67 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.932 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -58.38 -20.63 45.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.556 0.217 . . . . 0.0 111.226 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -94.7 80.5 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.775 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 169.25 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.589 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.1 30.2 7.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.799 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.17 -44.44 75.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.163 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 142.1 22.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.38 149.79 28.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.93 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.39 -122.57 0.64 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.038 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.04 163.6 39.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.755 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.7 p90 -138.92 154.92 48.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.516 0.674 . . . . 0.0 112.31 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -120.39 127.47 52.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.285 178.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.023 HG21 ' CE1' ' A' ' 5' ' ' TYR . 58.0 t -102.27 132.01 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 112.003 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -138.59 83.32 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.715 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 68.29 44.46 74.87 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.183 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 85.6 -13.02 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.593 0.357 . . . . 0.0 111.441 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.73 126.02 38.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.035 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.735 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.77 147.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 4.8 t-20 -118.41 166.72 12.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.847 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 57' ' ' THR . 73.1 m-85 -125.17 113.59 17.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.642 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.402 ' O ' ' CE3' ' A' ' 51' ' ' TRP . 84.6 t90 -108.82 91.39 3.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.041 0.448 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -66.12 160.06 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.439 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.08 -12.8 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.26 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.95 25.58 2.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.888 0.375 . . . . 0.0 111.72 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.88 25.73 61.8 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.384 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.614 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 164.5 14.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.839 0.819 . . . . 0.0 109.908 179.041 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.16 143.03 12.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.75 177.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -146.78 124.5 11.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.872 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 29.6 t70 -91.23 153.14 20.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.52 -168.93 17.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.104 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 11.2 p-10 -168.09 132.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 7.4 m-30 -77.28 110.35 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -83.94 -14.63 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.396 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 t -156.42 179.83 8.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.821 0.343 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.99 62.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.289 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.3 -3.15 10.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.494 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.614 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.2 tt0 -106.84 145.61 31.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.017 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.74 143.82 50.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.301 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.735 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.4 109.08 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.896 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.53 136.0 32.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.663 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.17 23.73 18.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.192 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.99 19.44 67.38 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.726 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 164.54 12.44 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.04 0.448 . . . . 0.0 111.016 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.6 m -117.22 107.58 14.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.017 ' HB2' HD12 ' A' ' 68' ' ' LEU . 34.4 m-85 -109.76 122.94 48.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.484 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 12.1 m-85 -100.21 141.86 32.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.812 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -59.63 148.45 33.65 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.026 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.1 mt-10 17.81 -62.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.758 1.223 . . . . 0.0 113.125 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.812 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.862 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.899 0.38 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.61 160.78 29.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -108.28 109.11 61.68 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 49.5 Cg_exo -57.49 162.65 9.84 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.718 2.279 . . . . 0.0 112.546 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 43' ' ' VAL . 13.5 m-85 -145.38 -42.75 0.22 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 18.9 t 60.31 129.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.14 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.16 147.67 4.9 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.295 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -94.86 96.79 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 110.225 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.67 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.7 m95 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.748 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 17' ' ' ARG . 68.9 t -114.11 155.7 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -66.83 176.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.146 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.629 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -78.01 -19.47 54.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.93 -23.84 13.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.22 21.76 40.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.334 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' CD ' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.92 -24.65 59.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.716 0.293 . . . . 0.0 110.392 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.498 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.36 156.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.301 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.7 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -137.58 135.41 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.9 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 5.3 tt0 -122.34 113.6 19.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.6 126.92 41.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.079 0.466 . . . . 0.0 111.457 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.739 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.0 mt -91.64 113.64 25.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.05 157.63 86.44 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.056 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.42 -13.49 38.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.326 2.684 . . . . 0.0 111.852 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -93.89 20.09 8.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.145 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.6 49.89 65.89 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 28.5 mmt85 -137.37 -179.84 5.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.129 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.19 149.28 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.16 112.14 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.441 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -104.24 132.66 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.324 0.583 . . . . 0.0 112.15 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.74 105.37 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.983 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 16' ' ' ILE . 7.2 mtm180 -97.58 149.53 22.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.137 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.51 138.7 13.16 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.992 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 56.92 22.16 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 0.0 111.268 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -177.8 79.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.025 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 169.21 14.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.398 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.87 29.56 2.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.984 0.421 . . . . 0.0 110.515 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.99 -51.18 67.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.71 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.7 27.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 111.794 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -154.97 149.78 26.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.541 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.23 -122.14 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.699 -1.239 . . . . 0.0 113.194 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.11 164.12 39.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.739 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.7 p90 -139.31 155.68 47.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.519 0.676 . . . . 0.0 112.275 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.89 127.15 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.89 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 5' ' ' TYR . 78.5 t -104.32 129.89 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.463 . . . . 0.0 112.097 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 99.6 3.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.707 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.73 42.93 96.63 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.306 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.0 -7.76 1.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.393 0.277 . . . . 0.0 111.629 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.93 126.43 39.13 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.68 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -137.28 148.87 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.221 0.534 . . . . 0.0 112.237 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.29 144.68 49.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.789 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.684 ' O ' ' HA ' ' A' ' 57' ' ' THR . 47.4 m-85 -98.61 115.06 27.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.012 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.7 t90 -109.05 90.45 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.035 0.445 . . . . 0.0 109.899 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.68 158.91 28.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.08 -12.63 52.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.038 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -91.55 25.29 2.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.796 0.331 . . . . 0.0 111.711 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.45 26.76 60.68 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.14 164.17 15.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.768 0.784 . . . . 0.0 109.765 179.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.34 142.68 11.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.965 178.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.68 121.65 12.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.5 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 9.9 p-10 -88.95 157.61 18.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 111.651 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.16 -172.1 32.2 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.888 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -168.17 132.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 111.308 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.68 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.8 m-30 -71.63 110.24 6.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.538 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.0 m -81.74 -18.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.335 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 t -148.61 -168.47 3.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.853 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.95 -28.25 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.194 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 -0.13 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.582 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HB3' HG23 ' A' ' 63' ' ' VAL . 6.7 tt0 -106.89 147.75 29.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.74 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.64 142.24 49.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.715 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.2 m170 -126.39 107.88 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.72 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.67 135.61 26.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.7 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.67 21.7 43.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.1 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.92 24.53 59.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.418 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -115.43 164.71 13.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -118.26 107.37 13.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.063 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.986 ' HB2' HD12 ' A' ' 68' ' ' LEU . 29.1 m-85 -109.83 127.77 54.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.34 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.629 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 15.2 m-85 -104.17 146.31 28.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.754 ' O ' ' N ' ' A' ' 79' ' ' LYS . 1.3 tpp85 -73.37 135.42 44.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.916 0.389 . . . . 0.0 111.991 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 44.01 -55.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.599 1.16 . . . . 0.0 113.37 178.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' A' ' 77' ' ' ARG . 7.2 mttm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.878 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.833 0.349 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -114.68 160.79 18.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -118.11 100.21 51.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 67.0 Cg_exo -53.09 164.45 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.726 2.284 . . . . 0.0 112.656 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.953 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.6 m-85 -145.58 -42.29 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.866 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 20.0 t 60.19 128.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.029 0.443 . . . . 0.0 111.263 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.568 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 159.58 148.45 5.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.242 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -96.05 96.57 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.592 0.711 . . . . 0.0 110.035 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.68 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.1 m95 -88.42 107.63 18.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.597 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' HB2' ' A' ' 17' ' ' ARG . 69.7 t -114.44 155.74 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.411 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -65.76 176.9 1.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.385 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.611 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -77.5 -19.9 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.574 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.41 -24.82 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.707 0.289 . . . . 0.0 110.945 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.15 22.98 30.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.461 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.562 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -76.49 -28.32 56.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.81 0.338 . . . . 0.0 110.165 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -139.1 158.39 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.851 ' N ' HD12 ' A' ' 16' ' ' ILE . 3.7 ttp180 -138.67 142.76 39.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.804 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 14.9 tt0 -130.21 111.88 12.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -95.14 127.11 40.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.764 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.5 mt -92.14 113.91 26.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.27 156.58 87.84 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.6 Cg_exo -63.44 -17.57 60.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.62 2.88 . . . . 0.0 112.474 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -95.86 23.26 6.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.44 53.55 24.38 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.846 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 25.8 mmt85 -141.94 -179.97 6.53 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 111.413 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -137.08 149.28 47.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 112.562 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.33 110.93 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.381 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.66 134.08 47.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.61 . . . . 0.0 112.277 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.32 105.03 11.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.775 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -100.28 108.05 20.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.36 -148.95 13.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.859 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -57.06 -22.03 36.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.74 0.305 . . . . 0.0 111.188 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -93.52 79.96 4.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.625 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 169.45 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.49 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.72 29.66 6.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.399 . . . . 0.0 110.626 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.08 -47.09 72.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.117 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.84 141.84 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.469 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.14 149.9 29.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.737 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.32 -120.74 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 119.833 -1.175 . . . . 0.0 113.03 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 164.02 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.764 ' CE1' HD22 ' A' ' 20' ' ' LEU . 5.4 p90 -138.42 155.78 48.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.484 0.659 . . . . 0.0 112.276 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -120.46 127.28 52.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.843 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.953 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.2 t -105.2 130.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.537 . . . . 0.0 112.085 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.19 96.91 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.777 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 60.5 43.85 98.36 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.351 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 82.13 -7.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.417 0.287 . . . . 0.0 111.563 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.79 124.91 38.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.753 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.5 148.15 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.0 112.153 -178.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.5 144.09 49.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.895 178.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.5 m-85 -99.35 115.04 28.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -109.14 90.18 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.012 0.434 . . . . 0.0 109.849 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.65 158.69 29.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.704 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -85.09 -12.7 52.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.975 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.5 t -91.41 25.26 2.65 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 120.907 0.384 . . . . 0.0 111.807 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 26.09 61.22 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.026 -0.606 . . . . 0.0 114.467 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.9 164.09 15.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.873 0.836 . . . . 0.0 109.918 179.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.95 142.69 12.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.94 178.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -142.72 121.7 12.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.601 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 20.0 p30 -89.44 156.24 18.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.585 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.53 -171.67 30.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.025 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.3 p-10 -168.19 133.74 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 111.236 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.753 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.3 m-30 -73.57 110.42 7.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.28 -18.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.215 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.46 -168.81 3.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.876 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.82 -27.62 28.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.01 2.05 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.588 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.9 tt0 -108.97 149.8 28.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 110.78 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.992 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -133.2 143.46 49.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.715 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.37 107.77 10.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.246 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -151.99 137.33 17.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.224 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.86 13.19 58.91 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.762 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.23 20.18 59.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.945 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.4 ttm -120.49 171.57 8.45 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.216 0.508 . . . . 0.0 111.714 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 m -116.41 107.64 15.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.348 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.992 ' HB2' HD12 ' A' ' 68' ' ' LEU . 13.6 m-85 -106.01 127.77 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.334 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.611 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 18.9 m-85 -102.46 147.13 27.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.728 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 79' ' ' LYS . 2.1 tpp85 -75.71 130.42 38.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.103 0.478 . . . . 0.0 112.228 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 53.73 -35.37 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 178.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.819 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.893 0.377 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.18 163.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -119.46 100.07 49.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 55.0 Cg_exo -53.89 163.6 2.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.732 2.288 . . . . 0.0 112.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.001 ' CE1' HG21 ' A' ' 43' ' ' VAL . 9.7 m-85 -145.77 -43.43 0.21 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.792 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 19.9 t 60.86 129.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 111.286 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.602 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.29 145.49 4.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -91.94 96.82 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.36 0.6 . . . . 0.0 110.141 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.664 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.5 m95 -88.24 108.18 19.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.405 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.702 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.1 t -113.75 155.15 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.694 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.511 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.94 -176.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.312 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -83.53 -20.41 33.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.584 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.67 -24.47 12.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.987 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.87 23.79 26.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.024 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.511 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -74.96 -30.66 61.27 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.515 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.44 155.81 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.58 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.702 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -137.93 128.66 26.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 31.9 tt0 -116.31 112.2 21.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -92.92 126.83 38.2 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.504 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.795 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.0 mt -91.84 113.26 25.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -68.04 157.41 87.09 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.475 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.5 Cg_exo -64.72 -13.18 37.7 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.445 2.763 . . . . 0.0 111.854 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -93.89 20.3 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.173 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.46 50.4 62.52 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.0 mmm-85 -139.93 -179.91 6.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.971 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -135.25 149.57 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.59 110.34 5.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.255 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.6 tt0 -103.59 133.09 49.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.414 0.626 . . . . 0.0 112.288 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.85 105.45 11.95 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.905 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 16' ' ' ILE . 20.8 mtm-85 -101.6 109.45 21.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.11 -150.73 18.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.799 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.83 -21.28 41.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.721 0.296 . . . . 0.0 111.096 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.18 80.4 4.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.922 0.391 . . . . 0.0 110.624 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 168.88 18.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.645 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.0 30.35 7.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.943 0.402 . . . . 0.0 110.714 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.57 -47.11 73.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.229 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 143.59 25.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.466 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.82 149.9 29.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.877 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.03 -123.65 0.69 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.899 -1.144 . . . . 0.0 113.025 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.04 164.05 39.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.795 ' CE1' HD22 ' A' ' 20' ' ' LEU . 4.5 p90 -139.78 154.74 47.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 112.142 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.78 127.34 52.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.249 178.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.001 HG21 ' CE1' ' A' ' 5' ' ' TYR . 55.9 t -102.84 129.49 54.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.857 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.68 92.26 2.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.629 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 62.5 43.61 98.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.357 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.7 0.85 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 122.461 0.304 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.9 128.9 40.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.698 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.36 151.5 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.073 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 1.3 m-20 -127.24 171.17 11.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.551 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.718 ' O ' ' HA ' ' A' ' 57' ' ' THR . 79.1 m-85 -124.1 114.84 20.24 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.08 90.99 3.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.64 160.39 22.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.694 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -12.76 52.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.157 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -92.19 25.32 2.94 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.821 0.343 . . . . 0.0 111.719 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 25.79 61.67 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.59 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.16 164.32 14.95 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 117.82 0.81 . . . . 0.0 109.783 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.62 142.48 10.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.008 177.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 50' ' ' TYR . . . -143.93 121.55 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.545 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.7 p-10 -90.37 150.75 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 0.0 111.523 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -156.24 -171.92 23.08 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.109 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 2.0 p30 -168.28 132.97 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.262 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 48' ' ' ILE . 5.6 m-30 -73.1 110.33 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.8 m -81.93 -18.91 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.335 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -147.3 -169.04 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.99 -29.28 32.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.217 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.77 -0.14 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.512 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.1 tt0 -106.82 148.8 28.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 110.702 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.051 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.42 144.4 49.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.35 108.76 11.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.85 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.426 ' HB3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -139.95 135.32 32.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.621 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.04 23.72 17.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.276 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.62 18.95 67.07 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.717 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -108.76 164.05 12.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 111.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.5 m -116.73 107.66 14.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.051 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.0 m-85 -110.27 124.63 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.099 0.476 . . . . 0.0 111.667 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.652 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 28.3 m-85 -97.72 147.18 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.769 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.478 ' CD ' ' CE2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -73.03 140.68 47.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.33 0.586 . . . . 0.0 112.318 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER 27.84 104.37 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.289 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt . . . . . 0 C--N 1.308 -1.235 0 CA-C-N 113.237 -1.801 . . . . 0.0 110.931 179.656 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.891 0.377 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.02 164.62 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -130.34 113.99 17.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 47.9 Cg_exo -57.61 161.76 11.64 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.79 2.327 . . . . 0.0 112.476 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.0 ' CE1' HG21 ' A' ' 43' ' ' VAL . 10.8 m-85 -145.54 -43.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 20.5 t 60.8 128.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.352 . . . . 0.0 111.302 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 156.76 147.23 4.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.324 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.8 98.85 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.356 0.598 . . . . 0.0 110.206 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.646 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 20.7 m95 -91.38 105.34 17.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.707 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 17' ' ' ARG . 75.7 t -109.98 155.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.282 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.451 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -67.72 178.67 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.368 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.605 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -78.97 -20.27 49.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.62 -24.6 13.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.14 23.56 31.86 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.59 -0.815 . . . . 0.0 112.234 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -75.52 -27.73 58.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.068 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.5 155.89 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.589 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.71 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.25 126.13 22.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.519 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 35.4 tt0 -115.72 114.35 24.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.672 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -94.33 127.15 40.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.367 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.725 HD22 ' CE1' ' A' ' 41' ' ' TYR . 10.8 mt -90.65 112.75 24.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -67.39 157.62 84.94 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.31 -13.4 37.97 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.291 2.661 . . . . 0.0 111.872 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -93.56 19.93 7.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.192 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.41 50.22 64.06 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 12.0 mmt85 -139.8 -179.89 6.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.527 -0.337 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -135.95 149.63 48.98 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.73 114.64 6.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.181 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -105.66 132.23 52.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.0 112.185 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -113.64 105.18 13.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.058 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -108.36 128.37 54.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.406 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.73 -148.49 31.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.598 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -67.43 -25.41 65.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.629 0.252 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -89.86 109.23 20.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.628 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.37 169.55 10.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.103 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 47.39 29.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.692 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.52 -34.92 27.12 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.782 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.53 140.1 19.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.042 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.44 149.76 29.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.927 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.68 -123.92 0.7 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.982 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.03 164.0 39.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.725 ' CE1' HD22 ' A' ' 20' ' ' LEU . 6.9 p90 -138.34 155.08 48.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.443 0.64 . . . . 0.0 112.056 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 1.2 tt0 -119.75 127.25 52.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.069 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.0 HG21 ' CE1' ' A' ' 5' ' ' TYR . 67.6 t -104.42 127.27 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.969 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.26 91.99 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 63.21 43.25 98.85 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.14 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 83.97 -11.05 0.89 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.506 0.322 . . . . 0.0 111.564 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.75 127.11 39.3 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.618 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -143.19 152.68 16.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 112.252 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.514 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -133.46 149.3 51.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.858 178.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.81 115.44 30.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 t90 -109.08 90.43 3.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.69 157.83 33.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.604 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -85.16 -12.68 52.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.0 t -91.73 24.31 3.19 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.878 0.371 . . . . 0.0 111.866 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.18 22.77 60.23 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.02 163.48 16.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.172 0.986 . . . . 0.0 109.963 179.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.14 142.46 11.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.879 178.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.98 121.68 11.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 6.9 p-10 -90.33 152.22 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.952 0.406 . . . . 0.0 111.346 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.03 -167.58 16.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.024 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 10.7 p-10 -168.11 130.8 1.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.319 . . . . 0.0 111.218 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.6 m-30 -74.03 110.04 8.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.688 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.603 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.6 m -86.58 -11.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -158.59 -177.95 6.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.835 0.35 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -25.77 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.259 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.01 1.52 7.98 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.631 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.2 tt0 -109.43 147.87 32.11 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.819 0.342 . . . . 0.0 110.792 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.035 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -133.27 144.15 49.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.724 ' N ' HD13 ' A' ' 68' ' ' LEU . 4.0 m170 -126.47 109.25 11.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.915 0.388 . . . . 0.0 110.712 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.421 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.37 134.49 30.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.11 22.96 22.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.144 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.69 67.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.752 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -107.49 163.55 12.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 111.041 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 m -116.77 107.64 14.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.775 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.035 ' HB2' HD12 ' A' ' 68' ' ' LEU . 28.4 m-85 -108.98 125.11 51.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.605 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 21.5 m-85 -102.08 147.12 26.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.782 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -74.26 137.17 42.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.812 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 41.16 -56.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.607 1.163 . . . . 0.0 113.012 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.782 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.909 0.385 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.32 160.57 32.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -117.59 113.05 38.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.805 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 31.3 Cg_exo -60.47 160.96 21.95 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.702 2.268 . . . . 0.0 112.562 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.891 ' OH ' HG11 ' A' ' 43' ' ' VAL . 15.0 m-85 -143.78 -42.62 0.28 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 21' ' ' LEU . 18.6 t 60.73 131.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.619 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 154.45 144.98 4.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.36 96.55 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.523 0.678 . . . . 0.0 109.782 179.288 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.684 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 26.0 m95 -86.48 109.88 19.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.167 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.3 t -115.24 154.82 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.777 -178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.484 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.06 -176.88 0.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.15 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.659 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.33 -19.97 35.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.6 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.1 -27.04 12.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 24.98 18.02 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.055 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.484 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -76.09 -31.06 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -139.31 155.48 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.768 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.31 131.23 29.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.686 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.7 tt0 -118.38 113.75 21.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.828 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 38.8 tt0 -92.16 125.68 36.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.552 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.75 HD22 ' CE2' ' A' ' 41' ' ' TYR . 6.8 mt -90.9 112.13 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -65.57 156.64 81.9 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.9 Cg_exo -63.18 -17.81 61.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.513 2.809 . . . . 0.0 112.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -95.61 23.11 6.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.46 52.03 33.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.005 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -140.05 -179.79 6.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.382 0.134 . . . . 0.0 110.963 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.69 149.95 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.17 111.23 4.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.523 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.4 tt0 -102.93 134.33 46.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.968 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.79 105.27 11.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.321 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -104.29 115.68 30.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.316 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.4 -153.78 7.55 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.894 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -58.04 -21.74 46.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.699 0.285 . . . . 0.0 111.154 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -91.94 82.33 5.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.86 0.362 . . . . 0.0 110.755 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.71 169.21 18.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.486 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 51.88 29.12 5.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.694 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.77 -43.46 58.46 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.998 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.04 140.06 19.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.217 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -152.43 150.1 29.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.735 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.95 -122.52 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.844 -1.169 . . . . 0.0 113.054 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.99 39.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.75 ' CE2' HD22 ' A' ' 20' ' ' LEU . 3.3 p90 -138.02 157.89 45.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.539 0.685 . . . . 0.0 112.403 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -122.54 127.42 49.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.804 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.891 HG11 ' OH ' ' A' ' 5' ' ' TYR . 79.2 t -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 82.57 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.17 -96.35 2.05 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.99 15.26 7.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.425 ' CE1' ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -111.12 141.42 44.65 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.173 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.765 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -147.66 148.26 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.244 -179.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -132.3 144.92 50.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.708 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.0 m-85 -102.2 115.4 30.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.157 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -109.23 90.64 3.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -67.7 157.82 33.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.74 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.12 -12.7 52.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.199 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 t -91.7 24.77 2.96 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.9 0.381 . . . . 0.0 111.898 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.3 23.36 61.07 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.766 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -117.64 164.02 15.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.049 0.924 . . . . 0.0 109.931 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.25 141.34 12.21 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.735 177.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -140.34 121.76 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.619 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 3.4 p30 -92.67 151.16 20.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 111.465 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.12 -170.98 26.49 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.875 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 5.9 p-10 -168.15 132.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.385 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.765 ' CE1' HG21 ' A' ' 48' ' ' ILE . 8.3 m-30 -68.28 110.18 3.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.516 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.6 m -84.86 -16.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.284 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -152.03 -175.26 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 0.0 110.813 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.76 -26.69 50.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -122.48 -2.38 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.646 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.0 tt0 -106.98 144.86 32.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 111.004 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.037 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -129.97 143.58 50.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.365 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 107.82 10.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.522 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -143.71 137.42 28.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.607 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.52 22.82 40.33 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.091 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.87 62.17 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 165.94 12.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 0.0 111.151 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 m -118.07 107.54 14.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.082 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.037 ' HB2' HD12 ' A' ' 68' ' ' LEU . 30.5 m-85 -110.72 126.64 54.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.328 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 10.8 m-85 -103.19 141.71 35.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.816 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.812 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -58.28 146.18 35.1 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.899 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' ILE . 5.2 mt-10 15.29 -61.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.553 1.141 . . . . 0.0 113.104 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.812 ' N ' ' O ' ' A' ' 77' ' ' ARG . 1.1 mtpm? . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.86 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.696 0.284 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.89 167.43 12.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.954 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -139.31 115.8 8.48 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.4 Cg_exo -59.04 162.04 14.57 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.748 2.299 . . . . 0.0 112.46 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.939 ' CE1' HG21 ' A' ' 43' ' ' VAL . 14.5 m-85 -145.38 -42.88 0.22 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.888 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 21' ' ' LEU . 17.5 t 60.72 129.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 111.265 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.593 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 157.85 147.29 4.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.342 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.486 HG22 HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -94.8 96.89 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 110.119 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.646 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 21.2 m95 -88.91 106.95 18.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.729 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 17' ' ' ARG . 71.6 t -114.33 155.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.376 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.427 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -66.27 178.95 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.182 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -80.0 -18.79 49.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.48 -27.54 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 26.3 18.83 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.158 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -79.08 -28.4 43.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.133 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.534 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -141.25 155.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.35 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.734 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -137.19 137.8 39.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.834 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.5 tt0 -125.17 112.94 17.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.731 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.4 127.4 39.01 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.588 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.706 HD22 ' CE1' ' A' ' 41' ' ' TYR . 9.3 mt -93.09 113.0 25.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -66.36 158.01 79.66 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 25.7 Cg_exo -63.53 -18.91 66.5 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.644 2.896 . . . . 0.0 112.953 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.23 21.54 7.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 69.62 52.33 21.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.473 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 10.3 mmt180 -138.39 179.89 6.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.21 . . . . 0.0 111.115 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' CD2' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -138.53 153.01 48.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.471 0.653 . . . . 0.0 112.561 -178.138 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.22 111.76 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -102.92 131.33 49.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.306 0.574 . . . . 0.0 111.962 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.27 105.28 11.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.143 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -97.76 149.27 22.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.97 139.83 17.98 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.938 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 57.48 21.84 7.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.596 0.236 . . . . 0.0 111.072 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.2 tpp85 -179.24 78.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.959 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 169.66 13.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.432 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.05 29.52 2.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.967 0.413 . . . . 0.0 110.548 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.86 66.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.531 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.77 148.18 28.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.242 0.544 . . . . 0.0 111.766 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.486 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.73 149.67 25.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.3 -122.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.651 -1.261 . . . . 0.0 113.108 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -154.09 163.77 39.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.706 ' CE1' HD22 ' A' ' 20' ' ' LEU . 7.5 p90 -137.9 156.4 47.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 0.0 112.414 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -120.98 127.27 51.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.729 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.939 HG21 ' CE1' ' A' ' 5' ' ' TYR . 75.5 t -105.2 131.93 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.183 0.515 . . . . 0.0 112.226 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -142.94 101.45 3.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.651 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 57.87 42.94 94.93 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.406 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.72 -6.9 1.46 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.458 0.303 . . . . 0.0 111.679 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -93.84 126.24 38.92 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.766 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -134.54 148.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.302 0.572 . . . . 0.0 112.069 -178.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.552 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.35 143.25 48.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.952 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 57' ' ' THR . 48.7 m-85 -99.5 113.97 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.946 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -109.1 89.9 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.99 0.424 . . . . 0.0 109.985 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -65.8 158.07 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.648 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.93 -12.68 52.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.164 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -92.0 24.84 3.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.852 0.358 . . . . 0.0 111.708 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 27.26 55.97 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.621 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -120.38 164.1 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.006 0.903 . . . . 0.0 109.823 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -161.36 143.05 11.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.125 178.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -143.59 121.79 12.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.553 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 8.8 t70 -88.81 155.16 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -161.16 -171.77 27.6 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.051 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 3.8 p-10 -168.21 133.88 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.341 . . . . 0.0 111.15 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.766 ' CE1' HG21 ' A' ' 48' ' ' ILE . 9.4 m-30 -75.63 110.33 9.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.5 m -83.24 -18.43 10.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.881 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.21 174.72 13.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.38 -21.57 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.298 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -121.41 -8.55 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.802 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.488 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.7 tt0 -106.61 149.01 27.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 111.166 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.958 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.4 142.41 50.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.278 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.72 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.64 107.88 10.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.8 135.8 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.724 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.69 21.84 44.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.049 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.24 25.13 59.93 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.389 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.86 165.15 13.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.991 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -118.59 107.44 13.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.004 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.958 ' HB2' HD12 ' A' ' 68' ' ' LEU . 31.1 m-85 -110.14 128.78 55.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 13.0 m-85 -105.02 145.83 29.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.817 ' O ' ' N ' ' A' ' 79' ' ' LYS . 1.1 tpp85 -72.26 136.78 46.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 38.47 -57.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.569 1.148 . . . . 0.0 113.1 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.817 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.291 -0.862 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.09 148.45 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -109.86 112.42 58.13 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.829 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 36.0 Cg_exo -58.97 161.28 16.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.72 2.28 . . . . 0.0 112.507 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.919 ' CE1' HG21 ' A' ' 43' ' ' VAL . 11.7 m-85 -144.79 -43.29 0.24 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.801 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 21' ' ' LEU . 20.9 t 61.22 130.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.933 0.397 . . . . 0.0 111.401 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.603 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 155.69 145.82 4.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.254 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -92.98 96.8 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 121.452 0.644 . . . . 0.0 109.84 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 22.8 m95 -87.41 109.8 19.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.419 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.709 HG22 ' HB2' ' A' ' 17' ' ' ARG . 70.1 t -117.22 155.0 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.766 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.413 HG21 ' NE ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -65.37 -176.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.219 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . . . -83.13 -20.19 35.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.69 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -23.39 12.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.317 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.48 21.66 33.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.376 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.413 ' NE ' HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -72.02 -25.46 61.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.29 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.558 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -146.83 155.3 11.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.389 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.709 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -136.0 138.75 42.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.644 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 25.2 tt0 -125.33 111.88 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -92.51 125.63 37.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 111.535 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.812 HD22 ' CE1' ' A' ' 41' ' ' TYR . 8.4 mt -91.61 111.98 23.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -64.78 155.97 80.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -176.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 24.4 Cg_exo -64.11 -16.76 56.77 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.571 2.848 . . . . 0.0 112.47 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -96.38 23.6 6.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.769 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 67.52 53.6 23.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.926 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 5.6 mmm-85 -143.3 -179.85 6.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.512 0.196 . . . . 0.0 111.31 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -136.03 150.1 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.494 0.664 . . . . 0.0 112.716 -178.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.47 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.221 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -104.79 137.6 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.368 0.604 . . . . 0.0 112.448 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 34' ' ' LYS . . . -124.15 105.57 9.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.851 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 16' ' ' ILE . 10.5 mtm180 -98.01 107.14 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.023 0.44 . . . . 0.0 111.867 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 46.74 -143.17 5.18 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.25 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -50.55 -27.06 6.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.248 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -96.57 100.66 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.605 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -102.52 170.03 8.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.495 179.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.8 27.68 3.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.392 . . . . 0.0 110.491 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.45 67.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.287 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.72 150.44 32.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.326 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -159.39 149.88 19.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.98 179.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.67 -121.38 0.58 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.913 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 163.81 39.52 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.812 ' CE1' HD22 ' A' ' 20' ' ' LEU . 3.9 p90 -138.64 154.11 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 112.274 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.8 tt0 -119.84 127.29 52.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.828 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.919 HG21 ' CE1' ' A' ' 5' ' ' TYR . 72.4 t -104.2 131.37 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.178 0.513 . . . . 0.0 112.01 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.05 100.85 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.24 42.81 95.59 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.335 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.61 -7.22 1.45 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.369 0.268 . . . . 0.0 111.53 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -93.87 127.02 39.4 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.739 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -136.1 148.43 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 112.167 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.45 144.81 49.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.881 178.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 57' ' ' THR . 49.3 m-85 -100.97 114.48 28.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.136 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -109.08 90.34 3.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.031 0.443 . . . . 0.0 109.955 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' HB2' ' HD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -66.86 158.52 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.65 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.04 -12.6 52.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.99 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -91.58 24.81 2.9 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.787 0.327 . . . . 0.0 111.752 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.64 25.61 60.39 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.021 -0.609 . . . . 0.0 114.5 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.61 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -118.99 163.44 16.94 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 117.888 0.844 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -160.31 142.24 12.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . . . -141.46 121.71 13.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 5.1 p-10 -90.63 154.79 19.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.575 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -163.69 -172.5 31.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.922 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 47' ' ' HIS . 4.9 p-10 -168.18 132.93 1.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.861 0.362 . . . . 0.0 111.305 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.739 ' CE1' HG21 ' A' ' 48' ' ' ILE . 7.3 m-30 -70.73 110.28 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 67' ' ' GLU . 3.1 m -82.71 -18.58 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.407 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -170.02 3.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.46 -29.34 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.158 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 0.21 9.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.656 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HB3' HG23 ' A' ' 63' ' ' VAL . 14.1 tt0 -106.89 149.53 27.35 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.383 . . . . 0.0 110.664 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.037 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -134.04 144.46 48.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.721 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.875 0.369 . . . . 0.0 110.908 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.447 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -140.38 136.04 32.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.491 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.08 23.58 17.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.245 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.56 67.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.743 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.68 164.82 12.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.848 0.356 . . . . 0.0 111.072 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.6 m -117.26 107.77 14.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.02 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.037 ' HB2' HD12 ' A' ' 68' ' ' LEU . 33.2 m-85 -110.03 125.68 53.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.661 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 12' ' ' ALA . 25.1 m-85 -98.68 147.03 25.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.834 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HD3' ' CZ2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -71.67 141.13 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.293 0.568 . . . . 0.0 112.252 -178.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 8' ' ' ILE . 11.5 mt-10 26.66 104.28 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.268 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt . . . . . 0 C--N 1.308 -1.221 0 CA-C-N 113.314 -1.766 . . . . 0.0 110.903 179.696 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.744 0.307 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -127.32 164.81 20.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -126.02 114.4 24.17 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HB3' ' CA ' ' A' ' 24' ' ' GLY . 35.0 Cg_exo -59.05 162.28 14.04 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.726 2.284 . . . . 0.0 112.432 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.96 ' CE1' HG21 ' A' ' 43' ' ' VAL . 19.0 m-85 -145.74 -42.48 0.21 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.995 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 19.0 t 60.26 129.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.581 ' N ' ' HB2' ' A' ' 20' ' ' LEU . . . 158.45 148.2 5.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.382 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 78' ' ' GLU . 0.7 OUTLIER -95.59 96.88 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.589 0.709 . . . . 0.0 110.16 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.668 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 19.2 m95 -89.19 105.31 17.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.693 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 17' ' ' ARG . 74.9 t -111.24 155.92 12.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.494 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.408 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -69.74 171.77 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.137 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.642 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -73.6 -19.55 60.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.14 -26.86 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.17 25.61 30.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.111 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.551 ' HD3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -81.39 -26.5 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.361 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.563 HD11 ' CE1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -140.0 156.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.239 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.782 ' HB2' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -139.98 128.65 23.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.795 0.331 . . . . 0.0 110.973 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 4.1 tt0 -114.56 112.0 22.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.682 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.7 126.56 38.95 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.98 0.419 . . . . 0.0 111.336 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD22 ' CE2' ' A' ' 41' ' ' TYR . 9.4 mt -91.84 114.31 26.82 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -68.68 157.53 88.21 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 22.4 Cg_exo -64.77 -12.86 36.1 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.343 2.695 . . . . 0.0 111.792 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.4 20.42 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.096 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 4' ' ' PRO . . . 63.39 50.66 60.7 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.1 mmm-85 -139.61 -179.88 6.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.965 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -135.36 149.28 49.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 109.63 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.205 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 18' ' ' GLN . 2.8 tt0 -103.49 134.18 47.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.421 0.629 . . . . 0.0 112.355 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.95 105.26 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.852 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -101.96 111.84 24.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.367 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.25 -152.98 13.17 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.687 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -56.56 -22.48 33.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.783 0.325 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -91.94 83.87 5.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.607 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.82 169.19 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.554 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.55 30.1 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 110.762 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.92 -47.57 71.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.199 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.68 143.49 26.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.546 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -151.98 150.05 29.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.844 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.3 -122.1 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.099 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HD3' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -154.17 164.05 39.14 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.779 ' CE2' HD22 ' A' ' 20' ' ' LEU . 3.4 p90 -138.37 156.45 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.499 0.666 . . . . 0.0 112.229 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tt0 -119.94 127.17 52.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.902 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.96 HG21 ' CE1' ' A' ' 5' ' ' TYR . 73.6 t -104.74 127.66 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.044 0.449 . . . . 0.0 112.078 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -140.24 101.53 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.627 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . 58.16 42.65 95.36 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.253 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 45' ' ' GLY . . . 81.33 -6.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 126.12 38.94 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.749 HG21 ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -135.38 147.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.286 0.565 . . . . 0.0 111.985 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.528 ' N ' HG12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -135.11 145.58 48.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.826 179.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 41.4 m-85 -97.81 116.99 31.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.013 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.415 ' CE3' ' HD3' ' A' ' 40' ' ' ARG . 28.6 t90 -109.28 90.85 3.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 109.835 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' CD1' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -70.72 155.65 40.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.855 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -85.22 -12.63 52.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.008 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 t -90.66 24.46 2.67 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.866 0.365 . . . . 0.0 111.917 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 23.38 60.7 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 114.811 0.685 . . . . 0.0 114.811 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.6 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -119.99 163.46 17.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.11 0.955 . . . . 0.0 109.9 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -158.54 141.3 14.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.998 178.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 50' ' ' TYR . . . -126.42 178.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.007 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 4.2 t70 -148.79 147.86 29.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.257 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -165.58 -173.21 33.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.261 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -167.96 130.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.749 ' CE1' HG21 ' A' ' 48' ' ' ILE . 5.9 m-30 -69.68 110.44 4.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.788 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 67' ' ' GLU . 2.1 m -84.83 -17.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.158 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.24 -166.41 2.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.894 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.68 -27.14 27.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.235 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.43 0.97 7.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' A' ' 63' ' ' VAL . 4.0 tt0 -107.1 147.06 30.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.976 HD12 ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -131.09 142.68 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.388 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.719 ' N ' HD13 ' A' ' 68' ' ' LEU . 6.0 m170 -126.47 107.9 10.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 135.55 26.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.752 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.45 21.84 42.9 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.042 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.27 21.71 64.37 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.503 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.08 164.45 13.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.3 m -118.26 107.31 13.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.801 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.976 ' HB2' HD12 ' A' ' 68' ' ' LEU . 27.8 m-85 -109.44 126.37 53.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.367 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.642 ' HE1' ' HB2' ' A' ' 12' ' ' ALA . 19.1 m-85 -102.77 146.88 27.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.463 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -74.33 130.98 40.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 112.066 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER 53.21 -36.75 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.214 178.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 stop_ save_